{"docstore/data": {"098ccb5c-214c-46bf-b7dd-9dae7fed19d5": {"__data__": {"id_": "098ccb5c-214c-46bf-b7dd-9dae7fed19d5", "embedding": null, "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n ", "original_text": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc. ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45a8395b-0609-45de-ad6f-e8e3cce6c859", "node_type": "1", "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr. ", "original_text": "Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc. "}, "hash": "57d0cb503ad91fbaa6e431499fded5457827e55f0fcf49dc9eb28cd1f512e618", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc. ", "start_char_idx": 0, "end_char_idx": 48, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "45a8395b-0609-45de-ad6f-e8e3cce6c859": {"__data__": {"id_": "45a8395b-0609-45de-ad6f-e8e3cce6c859", "embedding": null, "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr. ", "original_text": "Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc. ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "098ccb5c-214c-46bf-b7dd-9dae7fed19d5", "node_type": "1", "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n ", "original_text": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc. ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b467db74ec06bce240b09a77673a9ad747753621c8392b04b3cc22d131b2a826", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "87ad53bb-b659-42f8-8706-40cf40a96774", "node_type": "1", "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.  ", "original_text": "First Quarter Fiscal Year 2020 Earnings conference call.  \n \n "}, "hash": "1386f82c1f38457022f1360b5a63bdd7c99d8256e846fb533fd4e818add00ad5", "class_name": "RelatedNodeInfo"}}, "text": "Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc. ", "start_char_idx": 48, "end_char_idx": 178, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "87ad53bb-b659-42f8-8706-40cf40a96774": {"__data__": {"id_": "87ad53bb-b659-42f8-8706-40cf40a96774", "embedding": null, "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.  ", "original_text": "First Quarter Fiscal Year 2020 Earnings conference call.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45a8395b-0609-45de-ad6f-e8e3cce6c859", "node_type": "1", "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr. ", "original_text": "Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc. ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6c9da37446233d2e8475f2ed7fe1b698b54721f3be41ca88f09e8465c950d9ae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "774fd6e0-1db6-4751-9d4b-fbc061993e21", "node_type": "1", "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n", "original_text": "Today\u2019s conference is being recorded.  \n \n "}, "hash": "1d3d379e7c253f2c8ed71813bdafd2c196deb071e82d98ceae005427c6214269", "class_name": "RelatedNodeInfo"}}, "text": "First Quarter Fiscal Year 2020 Earnings conference call.  \n \n ", "start_char_idx": 178, "end_char_idx": 240, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "774fd6e0-1db6-4751-9d4b-fbc061993e21": {"__data__": {"id_": "774fd6e0-1db6-4751-9d4b-fbc061993e21", "embedding": null, "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n", "original_text": "Today\u2019s conference is being recorded.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "87ad53bb-b659-42f8-8706-40cf40a96774", "node_type": "1", "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.  ", "original_text": "First Quarter Fiscal Year 2020 Earnings conference call.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "534a59b78a97a28ffd34a88e591dd2818256aede3b60568aaaa3812da874bfe6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad0ac148-29ae-40e9-a9ca-7ca7675d2ebb", "node_type": "1", "metadata": {"window": "Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n ", "original_text": "At this time, I would like to turn the conference over to Mr. "}, "hash": "1f9e0adeddd7f9bd8d2bb83a06f94d2306eddf46d8584aabb0f1cd8ab6170047", "class_name": "RelatedNodeInfo"}}, "text": "Today\u2019s conference is being recorded.  \n \n ", "start_char_idx": 240, "end_char_idx": 283, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ad0ac148-29ae-40e9-a9ca-7ca7675d2ebb": {"__data__": {"id_": "ad0ac148-29ae-40e9-a9ca-7ca7675d2ebb", "embedding": null, "metadata": {"window": "Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n ", "original_text": "At this time, I would like to turn the conference over to Mr. ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "774fd6e0-1db6-4751-9d4b-fbc061993e21", "node_type": "1", "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n", "original_text": "Today\u2019s conference is being recorded.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5a46ca9ef74e6cd881627b2cb60a393092a0291201d46b5e16916a30c1cd764c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "163e46d2-211c-45d1-9f8c-781e34b80a83", "node_type": "1", "metadata": {"window": "First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n ", "original_text": "Kevin Moran.  "}, "hash": "8a98b64d81e48c4c6ff7eaa362c818132395398a6dfd3f4579c1dfdb122e7a68", "class_name": "RelatedNodeInfo"}}, "text": "At this time, I would like to turn the conference over to Mr. ", "start_char_idx": 283, "end_char_idx": 345, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "163e46d2-211c-45d1-9f8c-781e34b80a83": {"__data__": {"id_": "163e46d2-211c-45d1-9f8c-781e34b80a83", "embedding": null, "metadata": {"window": "First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n ", "original_text": "Kevin Moran.  ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad0ac148-29ae-40e9-a9ca-7ca7675d2ebb", "node_type": "1", "metadata": {"window": "Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n ", "original_text": "At this time, I would like to turn the conference over to Mr. ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "16723a3a8390e300c0bf6cc628aa35a354e8ba8a96e2ab88650a471a679fd792", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08019cc7-7082-4aa3-9531-bd7053620f1e", "node_type": "1", "metadata": {"window": "Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n ", "original_text": "Please go ahead sir.  \n \n"}, "hash": "99e8e45e3911ce8b8a195e41142aca0e6a19ad11a11107e3a921d4210b8c174f", "class_name": "RelatedNodeInfo"}}, "text": "Kevin Moran.  ", "start_char_idx": 345, "end_char_idx": 359, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "08019cc7-7082-4aa3-9531-bd7053620f1e": {"__data__": {"id_": "08019cc7-7082-4aa3-9531-bd7053620f1e", "embedding": null, "metadata": {"window": "Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n ", "original_text": "Please go ahead sir.  \n \n", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "163e46d2-211c-45d1-9f8c-781e34b80a83", "node_type": "1", "metadata": {"window": "First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n ", "original_text": "Kevin Moran.  ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ebf626c5c72bd8604d1db693cc27f9107a5c91aef22ce5c635ee44dbf9f9a31a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c2e14cd-aab5-4dcf-86f0-786e1400edcb", "node_type": "1", "metadata": {"window": "At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.  ", "original_text": "Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n "}, "hash": "552b051716c15e815f1f32c990f1fdb0ff6ccfb80bab31432e62d6bc6ff8a977", "class_name": "RelatedNodeInfo"}}, "text": "Please go ahead sir.  \n \n", "start_char_idx": 359, "end_char_idx": 384, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7c2e14cd-aab5-4dcf-86f0-786e1400edcb": {"__data__": {"id_": "7c2e14cd-aab5-4dcf-86f0-786e1400edcb", "embedding": null, "metadata": {"window": "At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.  ", "original_text": "Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08019cc7-7082-4aa3-9531-bd7053620f1e", "node_type": "1", "metadata": {"window": "Today\u2019s conference is being recorded.  \n \n  At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n ", "original_text": "Please go ahead sir.  \n \n", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c89d96c1288c6a6df1aa4157348390816ff1fac5977789e9730db93f2599db12", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d54bf293-03eb-4329-b9f8-d6e311ba7da4", "node_type": "1", "metadata": {"window": "Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n ", "original_text": "Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n "}, "hash": "aee2266beff5f1f992196fef34e74e86f29728a901a1f0f6ecef23367ce83b62", "class_name": "RelatedNodeInfo"}}, "text": "Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n ", "start_char_idx": 384, "end_char_idx": 492, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d54bf293-03eb-4329-b9f8-d6e311ba7da4": {"__data__": {"id_": "d54bf293-03eb-4329-b9f8-d6e311ba7da4", "embedding": null, "metadata": {"window": "Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n ", "original_text": "Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c2e14cd-aab5-4dcf-86f0-786e1400edcb", "node_type": "1", "metadata": {"window": "At this time, I would like to turn the conference over to Mr.  Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.  ", "original_text": "Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a950b92777ce388654d266b78ba187f5b8cf52fa4ed0432119da85df0eea4730", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "973bc324-8b97-484b-aa3d-7b6a9dda50cf", "node_type": "1", "metadata": {"window": "Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n ", "original_text": "You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n "}, "hash": "c5c1fee5f0f70ef6224d9a883701f1ff9b3ea41991f5ea39bfd322bd16f528f5", "class_name": "RelatedNodeInfo"}}, "text": "Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n ", "start_char_idx": 492, "end_char_idx": 616, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "973bc324-8b97-484b-aa3d-7b6a9dda50cf": {"__data__": {"id_": "973bc324-8b97-484b-aa3d-7b6a9dda50cf", "embedding": null, "metadata": {"window": "Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n ", "original_text": "You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d54bf293-03eb-4329-b9f8-d6e311ba7da4", "node_type": "1", "metadata": {"window": "Kevin Moran.   Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n ", "original_text": "Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f6e4c6edcd5c81ce1a876e398f71fa598d68c5a43df9d38748f808c498721891", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1407d43-4f5f-41d5-a440-8a809addffdc", "node_type": "1", "metadata": {"window": "Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.  ", "original_text": "During the call we will be making forward -looking statements.  "}, "hash": "88a4dad31be6edbe356a0d4e81163b03390562fe26193083d151082aeab83113", "class_name": "RelatedNodeInfo"}}, "text": "You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n ", "start_char_idx": 616, "end_char_idx": 733, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d1407d43-4f5f-41d5-a440-8a809addffdc": {"__data__": {"id_": "d1407d43-4f5f-41d5-a440-8a809addffdc", "embedding": null, "metadata": {"window": "Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.  ", "original_text": "During the call we will be making forward -looking statements.  ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "973bc324-8b97-484b-aa3d-7b6a9dda50cf", "node_type": "1", "metadata": {"window": "Please go ahead sir.  \n \n Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n ", "original_text": "You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2ecd276e3636db952d4ed0dc99f5fe0f4010405746c40bc3d0706a53098861e1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "599204a7-28da-4d4a-8cf4-882aa2e8225f", "node_type": "1", "metadata": {"window": "Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n ", "original_text": "The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n "}, "hash": "0bdb13167139eafc2ed4833b63f1149bff73336f0f87b9232aa6cff6e8079d16", "class_name": "RelatedNodeInfo"}}, "text": "During the call we will be making forward -looking statements.  ", "start_char_idx": 733, "end_char_idx": 797, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "599204a7-28da-4d4a-8cf4-882aa2e8225f": {"__data__": {"id_": "599204a7-28da-4d4a-8cf4-882aa2e8225f", "embedding": null, "metadata": {"window": "Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n ", "original_text": "The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1407d43-4f5f-41d5-a440-8a809addffdc", "node_type": "1", "metadata": {"window": "Kevin Moran :  Good morning and welcome to Cardinal Health\u2019s First Quarter Fiscal 20 20 Earnings call.  \n \n  Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.  ", "original_text": "During the call we will be making forward -looking statements.  ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "17ce32a88bc75ea44f58a05717e6f360766ca5502a361db16fb2a57ed139da28", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b60da593-af2a-4841-9b5a-b11b706fac75", "node_type": "1", "metadata": {"window": "You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.  ", "original_text": "Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n "}, "hash": "8ca86cec90e22c43b87e4b4571c90d31fed59e1b317944604b00bec725987e37", "class_name": "RelatedNodeInfo"}}, "text": "The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n ", "start_char_idx": 797, "end_char_idx": 974, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b60da593-af2a-4841-9b5a-b11b706fac75": {"__data__": {"id_": "b60da593-af2a-4841-9b5a-b11b706fac75", "embedding": null, "metadata": {"window": "You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.  ", "original_text": "Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "599204a7-28da-4d4a-8cf4-882aa2e8225f", "node_type": "1", "metadata": {"window": "Today I\u2019m joined by Mike Kaufmann, our Chie f Executive Officer, and Dave Evans, our interim Chief Financial \nOfficer.  \n \n  You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n ", "original_text": "The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c6799c154f821c250189bdbdda9720b7da32475050ace60b6746c81bf2ff4cda", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9871689e-61d4-4b16-b46b-fcc718c869ec", "node_type": "1", "metadata": {"window": "During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n ", "original_text": "Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.  "}, "hash": "e7f28d0736ec0999fd39461fa026e0d2a1bd5a87412069d3c0a2494a1f8ce50a", "class_name": "RelatedNodeInfo"}}, "text": "Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n ", "start_char_idx": 974, "end_char_idx": 1145, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9871689e-61d4-4b16-b46b-fcc718c869ec": {"__data__": {"id_": "9871689e-61d4-4b16-b46b-fcc718c869ec", "embedding": null, "metadata": {"window": "During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n ", "original_text": "Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.  ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b60da593-af2a-4841-9b5a-b11b706fac75", "node_type": "1", "metadata": {"window": "You can find today\u2019s press release and presentation on the IR Section of our web site at ir.cardinalhealth.com.  \n \n  During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.  ", "original_text": "Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "aa7ee8dd2d99495b4e20efa3fb2fdddc9008b252bbdfaf75fc13e730216b5de9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d6d608f-3db6-40a1-a4a5-31b25151e9e9", "node_type": "1", "metadata": {"window": "The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n ", "original_text": "Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n "}, "hash": "82537f58d2e1a16f1acc6488c623834fdd65ec5df0424ab084e322bc543a82fe", "class_name": "RelatedNodeInfo"}}, "text": "Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.  ", "start_char_idx": 1145, "end_char_idx": 1276, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1d6d608f-3db6-40a1-a4a5-31b25151e9e9": {"__data__": {"id_": "1d6d608f-3db6-40a1-a4a5-31b25151e9e9", "embedding": null, "metadata": {"window": "The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n ", "original_text": "Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9871689e-61d4-4b16-b46b-fcc718c869ec", "node_type": "1", "metadata": {"window": "During the call we will be making forward -looking statements.   The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n ", "original_text": "Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.  ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a1c572ed79d9f51613ec9c9972c29b2d9a424c39d7def9c263695702a9ffd264", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ded9b265-37ec-42cc-a66e-05cd907e5946", "node_type": "1", "metadata": {"window": "Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.  "}, "hash": "e8c72d04034ddd3880a3d60da4256248a6b325e189d6a473843d68897c5539ea", "class_name": "RelatedNodeInfo"}}, "text": "Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n ", "start_char_idx": 1276, "end_char_idx": 1407, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ded9b265-37ec-42cc-a66e-05cd907e5946": {"__data__": {"id_": "ded9b265-37ec-42cc-a66e-05cd907e5946", "embedding": null, "metadata": {"window": "Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.  ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d6d608f-3db6-40a1-a4a5-31b25151e9e9", "node_type": "1", "metadata": {"window": "The  matters addressed in the statements are \nsubject to the risks and uncertainties that could cause actual results to differ materially from those projected or \nimplied.  \n \n  Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n ", "original_text": "Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "015e4982eee469ee9d33f06af0564538187496c451306fcdbc8d87726e42206e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e12ff96a-1753-463e-bf88-e39735af99ee", "node_type": "1", "metadata": {"window": "Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n "}, "hash": "8b887bc702c48327df5b794324ebb645da1b39195498e8035b780dadd907ba95", "class_name": "RelatedNodeInfo"}}, "text": "We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.  ", "start_char_idx": 1407, "end_char_idx": 1478, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e12ff96a-1753-463e-bf88-e39735af99ee": {"__data__": {"id_": "e12ff96a-1753-463e-bf88-e39735af99ee", "embedding": null, "metadata": {"window": "Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ded9b265-37ec-42cc-a66e-05cd907e5946", "node_type": "1", "metadata": {"window": "Please refer to our SEC filings and the forward -looking statement slide at the beginning of our presentation for a \nfull description of the risks and uncertainties.  \n \n  Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.  ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "705b79b4ddd8ef565470ad9ae590b52415d9935bfda179f1eb3c996a537997a3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e34b4ef3-8e0c-4de4-8474-ca6a8b4548c7", "node_type": "1", "metadata": {"window": "Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n "}, "hash": "7f725013f932351b4bb3b8092e8b3404de424fc0b71b6f2dfbbbfd70a80fed6a", "class_name": "RelatedNodeInfo"}}, "text": "We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n ", "start_char_idx": 1478, "end_char_idx": 1613, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e34b4ef3-8e0c-4de4-8474-ca6a8b4548c7": {"__data__": {"id_": "e34b4ef3-8e0c-4de4-8474-ca6a8b4548c7", "embedding": null, "metadata": {"window": "Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e12ff96a-1753-463e-bf88-e39735af99ee", "node_type": "1", "metadata": {"window": "Note that during the discussion today our comments will be on a non -GAAP basis unless they are specifically \ncalled out as GAAP.   Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cdc4cb71bd62bf301f46be0ec95496dd95042ffdafdc7abf5a2aea389812fcd6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1fe2718-1456-4fe2-9216-3165571aa96a", "node_type": "1", "metadata": {"window": "We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "With that, I\u2019ll now turn the call over to M ike. \n "}, "hash": "c043927109711b36f7f85ab3851a9cc813ce6419e9099bb7fc35261b383ad95d", "class_name": "RelatedNodeInfo"}}, "text": "During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n ", "start_char_idx": 1613, "end_char_idx": 1802, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d1fe2718-1456-4fe2-9216-3165571aa96a": {"__data__": {"id_": "d1fe2718-1456-4fe2-9216-3165571aa96a", "embedding": null, "metadata": {"window": "We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "With that, I\u2019ll now turn the call over to M ike. \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6", "node_type": "4", "metadata": {"page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf1a60f1f7118f563ae1724edd3380c42100a80c4d578f71834b7f1d6503fb61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e34b4ef3-8e0c-4de4-8474-ca6a8b4548c7", "node_type": "1", "metadata": {"window": "Our GAAP to non -GAAP reconciliations for  all relevant periods can be found in the \nschedules attached to our press release.  \n \n  We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bb0f06150e0470469f8a3f9a5ca40d51395b393762c30e35a28e56920b0e31b0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "72e31228-e1a0-41db-99a1-ef11cca01e75", "node_type": "1", "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.  ", "original_text": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.  "}, "hash": "ddee093a10f011bf2f6a81be110d5f121f3971ec27288396553e97826daf51a7", "class_name": "RelatedNodeInfo"}}, "text": "With that, I\u2019ll now turn the call over to M ike. \n ", "start_char_idx": 1802, "end_char_idx": 1853, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "72e31228-e1a0-41db-99a1-ef11cca01e75": {"__data__": {"id_": "72e31228-e1a0-41db-99a1-ef11cca01e75", "embedding": null, "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.  ", "original_text": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1fe2718-1456-4fe2-9216-3165571aa96a", "node_type": "1", "metadata": {"window": "We will provide an update to our FY \u201920 Outlook on a non -GAAP basis.   We do not provide guidance on a GAAP \nbasis due to the difficulty in predicting items that we exclude from our non -GAAP results.  \n \n  During the Q&A portion of today\u2019s call we kindly ask that you limit yourself to one question with one follow -up so \nthat we may give everyone in the queue a chance to ask a question.  \n \n  With that, I\u2019ll now turn the call over to M ike. \n ", "original_text": "With that, I\u2019ll now turn the call over to M ike. \n ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1f2e1f06a1952b815d736b2782d2e6c5259441bd6f88fbf59bb45e4afe3d9e0e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1af367e4-522c-4f06-bb55-820ce8ada41f", "node_type": "1", "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.  ", "original_text": "Good morning everyone.  "}, "hash": "66d1511f21028422cbb86b8ed4f47fea11e063b45fe8227088e472604fb9017d", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.  ", "start_char_idx": 0, "end_char_idx": 87, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1af367e4-522c-4f06-bb55-820ce8ada41f": {"__data__": {"id_": "1af367e4-522c-4f06-bb55-820ce8ada41f", "embedding": null, "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.  ", "original_text": "Good morning everyone.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "72e31228-e1a0-41db-99a1-ef11cca01e75", "node_type": "1", "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.  ", "original_text": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a13d3620d50fef27b701ab1420716c747ef473595efd27491f0c421a50cfcd45", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d23a4216-90a0-41b5-9ede-82229d4a762b", "node_type": "1", "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n ", "original_text": "Thanks for joining us \ntoday.  \n \n "}, "hash": "f5cb18d9debdec141acc2487cf3976c61b9439a92171a3b679320cfc5768a459", "class_name": "RelatedNodeInfo"}}, "text": "Good morning everyone.  ", "start_char_idx": 87, "end_char_idx": 111, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d23a4216-90a0-41b5-9ede-82229d4a762b": {"__data__": {"id_": "d23a4216-90a0-41b5-9ede-82229d4a762b", "embedding": null, "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n ", "original_text": "Thanks for joining us \ntoday.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1af367e4-522c-4f06-bb55-820ce8ada41f", "node_type": "1", "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.  ", "original_text": "Good morning everyone.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7b8b629e0af4a6008f39c3e4127e58d68868ab1481b2f62877dcadf195384a88", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9e64e4e9-1721-434e-a2af-2cbb9b06a3d4", "node_type": "1", "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.  ", "original_text": "I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.  "}, "hash": "e5bf87eff68d5928a2d7a9cfea45db7d7f2d6f97abdc312af68691f7497744af", "class_name": "RelatedNodeInfo"}}, "text": "Thanks for joining us \ntoday.  \n \n ", "start_char_idx": 111, "end_char_idx": 146, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9e64e4e9-1721-434e-a2af-2cbb9b06a3d4": {"__data__": {"id_": "9e64e4e9-1721-434e-a2af-2cbb9b06a3d4", "embedding": null, "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.  ", "original_text": "I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d23a4216-90a0-41b5-9ede-82229d4a762b", "node_type": "1", "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n ", "original_text": "Thanks for joining us \ntoday.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21f0326e3477f0750975db883ce2fc2131e5ab7301eb325dcbbb763e6c589513", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6723f5db-e9ea-43fe-ac32-bac9f2abf2e9", "node_type": "1", "metadata": {"window": "Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.  ", "original_text": "Dave has done a great \njob getting up to speed over the past few months.  "}, "hash": "83d11bab52ebf9dc5a000f9092cc47ed41761af2b2cbab74bd120c2d5fedbe69", "class_name": "RelatedNodeInfo"}}, "text": "I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.  ", "start_char_idx": 146, "end_char_idx": 239, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6723f5db-e9ea-43fe-ac32-bac9f2abf2e9": {"__data__": {"id_": "6723f5db-e9ea-43fe-ac32-bac9f2abf2e9", "embedding": null, "metadata": {"window": "Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.  ", "original_text": "Dave has done a great \njob getting up to speed over the past few months.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9e64e4e9-1721-434e-a2af-2cbb9b06a3d4", "node_type": "1", "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.  ", "original_text": "I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f726d7d7c54259fb95bfa05aa2412969835e62d97c3177147c770db70d80e6c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9a31ab3f-a91b-40e0-a7dd-7fef77c7d7d9", "node_type": "1", "metadata": {"window": "Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n ", "original_text": "I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n "}, "hash": "3ba4cf3f3801c5806008ba125740a32d23386d28e3c8d12eb197ca3e7ff4e2ab", "class_name": "RelatedNodeInfo"}}, "text": "Dave has done a great \njob getting up to speed over the past few months.  ", "start_char_idx": 239, "end_char_idx": 313, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9a31ab3f-a91b-40e0-a7dd-7fef77c7d7d9": {"__data__": {"id_": "9a31ab3f-a91b-40e0-a7dd-7fef77c7d7d9", "embedding": null, "metadata": {"window": "Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n ", "original_text": "I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6723f5db-e9ea-43fe-ac32-bac9f2abf2e9", "node_type": "1", "metadata": {"window": "Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.  ", "original_text": "Dave has done a great \njob getting up to speed over the past few months.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "dc54aebd55758927c9ed10882ef63c960398393727f7b63f02a92ab84654102b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "02fbbe68-6bf4-484b-abf9-ad607a64344e", "node_type": "1", "metadata": {"window": "I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.  ", "original_text": "This morning we\u2019ll cover our progress and our path forward.  "}, "hash": "e9cbcbdba748736e5030f9eab4310a0ffe2a7accbb00b1165a54fd6e9ca27b60", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n ", "start_char_idx": 313, "end_char_idx": 412, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "02fbbe68-6bf4-484b-abf9-ad607a64344e": {"__data__": {"id_": "02fbbe68-6bf4-484b-abf9-ad607a64344e", "embedding": null, "metadata": {"window": "I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.  ", "original_text": "This morning we\u2019ll cover our progress and our path forward.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9a31ab3f-a91b-40e0-a7dd-7fef77c7d7d9", "node_type": "1", "metadata": {"window": "Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n ", "original_text": "I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e1e0ee1c49aade2a7948331e5492bea8773b6455746da50e7496819d3405adb2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b59fcdcc-997f-42ca-aff5-887915b2c1a6", "node_type": "1", "metadata": {"window": "Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n ", "original_text": "I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.  "}, "hash": "f9878798e0220638309b6eaf67bd0984d5c6682b7be256d16fa3274482e43ff7", "class_name": "RelatedNodeInfo"}}, "text": "This morning we\u2019ll cover our progress and our path forward.  ", "start_char_idx": 412, "end_char_idx": 473, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b59fcdcc-997f-42ca-aff5-887915b2c1a6": {"__data__": {"id_": "b59fcdcc-997f-42ca-aff5-887915b2c1a6", "embedding": null, "metadata": {"window": "Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n ", "original_text": "I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "02fbbe68-6bf4-484b-abf9-ad607a64344e", "node_type": "1", "metadata": {"window": "I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.   Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.  ", "original_text": "This morning we\u2019ll cover our progress and our path forward.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4ec27a7eccd2c84f1bed909a4d487ad6254a6a67cb0b90bce90c2d12f50a5772", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb2bf6ef-47fe-490e-b2bd-9ed2b9fd9f19", "node_type": "1", "metadata": {"window": "I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n ", "original_text": "I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n "}, "hash": "0afe36b33c25706dcb1249a251fd1093799e0225c4137e86749f1026a361f476", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.  ", "start_char_idx": 473, "end_char_idx": 574, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "eb2bf6ef-47fe-490e-b2bd-9ed2b9fd9f19": {"__data__": {"id_": "eb2bf6ef-47fe-490e-b2bd-9ed2b9fd9f19", "embedding": null, "metadata": {"window": "I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n ", "original_text": "I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b59fcdcc-997f-42ca-aff5-887915b2c1a6", "node_type": "1", "metadata": {"window": "Dave has done a great \njob getting up to speed over the past few months.   I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n ", "original_text": "I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1df49fdc8858dd8475c92e8bc1e152a6bc905f75d6f80ee9f801e0160d419283", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c10d1631-6dcd-4a65-b04e-3c234e31219d", "node_type": "1", "metadata": {"window": "This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.  ", "original_text": "We remain confident in our strategic direction as we focus on driving both efficiency and growth.  "}, "hash": "5620d55877875306d8d2eeb6ad9def74ca52011e5d6e4d058f77192b84ed9b23", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n ", "start_char_idx": 574, "end_char_idx": 663, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c10d1631-6dcd-4a65-b04e-3c234e31219d": {"__data__": {"id_": "c10d1631-6dcd-4a65-b04e-3c234e31219d", "embedding": null, "metadata": {"window": "This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.  ", "original_text": "We remain confident in our strategic direction as we focus on driving both efficiency and growth.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb2bf6ef-47fe-490e-b2bd-9ed2b9fd9f19", "node_type": "1", "metadata": {"window": "I\u2019m grateful for his leadership and experience as we conduct \nour search for a permanent CFO.  \n \n  This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n ", "original_text": "I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ab24ac95622f27e2bc85621b8f754643be9258605550b7f248bfab5c83d6315f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0e3ba029-bdc3-4968-82e4-b2b0d18753d8", "node_type": "1", "metadata": {"window": "I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n ", "original_text": "Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n "}, "hash": "43c49cb0bdbcdb51c92b5197b1d4724f50d70c2e6d65296a6e218687b9f40dfc", "class_name": "RelatedNodeInfo"}}, "text": "We remain confident in our strategic direction as we focus on driving both efficiency and growth.  ", "start_char_idx": 663, "end_char_idx": 762, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0e3ba029-bdc3-4968-82e4-b2b0d18753d8": {"__data__": {"id_": "0e3ba029-bdc3-4968-82e4-b2b0d18753d8", "embedding": null, "metadata": {"window": "I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n ", "original_text": "Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c10d1631-6dcd-4a65-b04e-3c234e31219d", "node_type": "1", "metadata": {"window": "This morning we\u2019ll cover our progress and our path forward.   I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.  ", "original_text": "We remain confident in our strategic direction as we focus on driving both efficiency and growth.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7f4c8181b94789344798cc315aadcb5736cc4d58a6405d2cb808a8e252753f7e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac561d82-c488-4c3d-bea5-5be77cff3e27", "node_type": "1", "metadata": {"window": "I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n ", "original_text": "At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n "}, "hash": "c4bc40a0622b2f40a2ed579366069d5ff50890d01ad04e4190e3fdb15e72e28e", "class_name": "RelatedNodeInfo"}}, "text": "Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n ", "start_char_idx": 762, "end_char_idx": 845, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ac561d82-c488-4c3d-bea5-5be77cff3e27": {"__data__": {"id_": "ac561d82-c488-4c3d-bea5-5be77cff3e27", "embedding": null, "metadata": {"window": "I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n ", "original_text": "At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0e3ba029-bdc3-4968-82e4-b2b0d18753d8", "node_type": "1", "metadata": {"window": "I\u2019ll start with a few high level thoughts on the quar ter \nand then Dave will cover the financials.   I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n ", "original_text": "Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "332cd4168f28320e1819e96a718b2408ce31980bc5cb38244656a5e499a14283", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4c9b7ad1-4c46-472d-a812-ccdc318771c5", "node_type": "1", "metadata": {"window": "We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.  ", "original_text": "In the Pharma Segment we are seeing early signs of  positive trends.  "}, "hash": "5023b719d2b2aefb2ad9e416f4fec4534640f2c8f9d09faf79b08dfc62e24590", "class_name": "RelatedNodeInfo"}}, "text": "At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n ", "start_char_idx": 845, "end_char_idx": 1004, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4c9b7ad1-4c46-472d-a812-ccdc318771c5": {"__data__": {"id_": "4c9b7ad1-4c46-472d-a812-ccdc318771c5", "embedding": null, "metadata": {"window": "We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.  ", "original_text": "In the Pharma Segment we are seeing early signs of  positive trends.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac561d82-c488-4c3d-bea5-5be77cff3e27", "node_type": "1", "metadata": {"window": "I\u2019ll close with some thoughts on how we will build on the solid start to the \nyear.  \n \n  We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n ", "original_text": "At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9fc41c8367c9b6b9952cb35cf738344092c8b2a268846629832f50d94003cae6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "56127fc9-016e-4a57-bb04-67aac79e3b55", "node_type": "1", "metadata": {"window": "Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n", "original_text": "And although we still have work to do we \nare making progress in key areas.  \n \n "}, "hash": "8c2560eb80358ca61e7e7eee3ffcbf605fe3cd1990ccc2d34c9b2d5cf2376e73", "class_name": "RelatedNodeInfo"}}, "text": "In the Pharma Segment we are seeing early signs of  positive trends.  ", "start_char_idx": 1004, "end_char_idx": 1074, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "56127fc9-016e-4a57-bb04-67aac79e3b55": {"__data__": {"id_": "56127fc9-016e-4a57-bb04-67aac79e3b55", "embedding": null, "metadata": {"window": "Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n", "original_text": "And although we still have work to do we \nare making progress in key areas.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4c9b7ad1-4c46-472d-a812-ccdc318771c5", "node_type": "1", "metadata": {"window": "We remain confident in our strategic direction as we focus on driving both efficiency and growth.   Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.  ", "original_text": "In the Pharma Segment we are seeing early signs of  positive trends.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e9bc6c23e56779d6c2977b2ae9cb5dee9d427deca1e802fced18889ffd0d2c95", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "574ecb2d-b1eb-47f3-b593-59cc98906c6b", "node_type": "1", "metadata": {"window": "At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.  ", "original_text": "In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n "}, "hash": "a5d36f081e4bdd0743d9d3dd44c862ac78f561a7c69b6ec7cadc8070f90e38c6", "class_name": "RelatedNodeInfo"}}, "text": "And although we still have work to do we \nare making progress in key areas.  \n \n ", "start_char_idx": 1074, "end_char_idx": 1155, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "574ecb2d-b1eb-47f3-b593-59cc98906c6b": {"__data__": {"id_": "574ecb2d-b1eb-47f3-b593-59cc98906c6b", "embedding": null, "metadata": {"window": "At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.  ", "original_text": "In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "56127fc9-016e-4a57-bb04-67aac79e3b55", "node_type": "1", "metadata": {"window": "Our Q1 \nperformance validat es our short -term progress and longer term path.  \n \n  At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n", "original_text": "And although we still have work to do we \nare making progress in key areas.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "776235ddc8b81924ae487d02eda47517ccf76edf87f944f5d057fe2e571b3927", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a18fea6-517b-4ebf-af73-43936542f928", "node_type": "1", "metadata": {"window": "In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.  ", "original_text": "I\u2019ll share more about this work in both segments later in my remarks.  "}, "hash": "c98098aab559903a568fbbc9534fa1f215db7116f1e00dc20cf5bf6ed8c77dca", "class_name": "RelatedNodeInfo"}}, "text": "In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n ", "start_char_idx": 1155, "end_char_idx": 1318, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1a18fea6-517b-4ebf-af73-43936542f928": {"__data__": {"id_": "1a18fea6-517b-4ebf-af73-43936542f928", "embedding": null, "metadata": {"window": "In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.  ", "original_text": "I\u2019ll share more about this work in both segments later in my remarks.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "574ecb2d-b1eb-47f3-b593-59cc98906c6b", "node_type": "1", "metadata": {"window": "At the enterprise level our disciplined cost management is enabling strategic reinvestment across both segments \nas well as in critical functional areas.  \n \n  In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.  ", "original_text": "In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e6ae227f960b8bf020e7706a94ad73a7880da92874f2e87841ff5483441c5c42", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "54cd4fb9-a2c1-4820-9c3b-12136dc23702", "node_type": "1", "metadata": {"window": "And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.  ", "original_text": "But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n"}, "hash": "fdb0ed4d9f235bd840bf4f6c9618d0313671c2d812ed7070cd4f808e9b7e6ed2", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019ll share more about this work in both segments later in my remarks.  ", "start_char_idx": 1318, "end_char_idx": 1389, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "54cd4fb9-a2c1-4820-9c3b-12136dc23702": {"__data__": {"id_": "54cd4fb9-a2c1-4820-9c3b-12136dc23702", "embedding": null, "metadata": {"window": "And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.  ", "original_text": "But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a18fea6-517b-4ebf-af73-43936542f928", "node_type": "1", "metadata": {"window": "In the Pharma Segment we are seeing early signs of  positive trends.   And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.  ", "original_text": "I\u2019ll share more about this work in both segments later in my remarks.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "eb0c0965618d6be4c6ab930bbabcca06cf81cdb0802cb64882afefeaf3971ac5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b9cdf2ef-0275-4cb7-a4ac-fe0fa025f270", "node_type": "1", "metadata": {"window": "In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n ", "original_text": "Dave Evans :  Thanks Mike.  "}, "hash": "e797620da88f921fd36c0bec5590d7bd96ab3a13ec77456d0b4adcfd7e4d9c0e", "class_name": "RelatedNodeInfo"}}, "text": "But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n", "start_char_idx": 1389, "end_char_idx": 1501, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b9cdf2ef-0275-4cb7-a4ac-fe0fa025f270": {"__data__": {"id_": "b9cdf2ef-0275-4cb7-a4ac-fe0fa025f270", "embedding": null, "metadata": {"window": "In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n ", "original_text": "Dave Evans :  Thanks Mike.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "54cd4fb9-a2c1-4820-9c3b-12136dc23702", "node_type": "1", "metadata": {"window": "And although we still have work to do we \nare making progress in key areas.  \n \n  In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.  ", "original_text": "But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3f85f49e616c107b7e46ad490558bcd1a92c17297e9b8c3ae2d414c03e645c43", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4ce5a288-a297-4d6c-bcd6-d65642c32049", "node_type": "1", "metadata": {"window": "I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n ", "original_text": "And thanks everyone for being with us today.  "}, "hash": "a7f8880462c89616a9c7b38b633a7d24d77c08ae71f5d3fad18b8e1bfddf5b0b", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Thanks Mike.  ", "start_char_idx": 1501, "end_char_idx": 1529, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4ce5a288-a297-4d6c-bcd6-d65642c32049": {"__data__": {"id_": "4ce5a288-a297-4d6c-bcd6-d65642c32049", "embedding": null, "metadata": {"window": "I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n ", "original_text": "And thanks everyone for being with us today.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b9cdf2ef-0275-4cb7-a4ac-fe0fa025f270", "node_type": "1", "metadata": {"window": "In medical we are encouraged by early traction from our improvement efforts as well as the initial returns from \nongoing investments in our growth platforms.  \n \n  I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n ", "original_text": "Dave Evans :  Thanks Mike.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "801346735ad2e9b2bb1d7fdfaf9bc4a2aabae2d02a7476827a09b26a3d23c70b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40913cec-ad92-4ff9-b591-672f60e63825", "node_type": "1", "metadata": {"window": "But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.  ", "original_text": "I\u2019m pleased to join you on my first call.  "}, "hash": "ee4435e423d7f8b32d38deb6d5c8f44a2fa545e64324b5e014fe993fc0694a2f", "class_name": "RelatedNodeInfo"}}, "text": "And thanks everyone for being with us today.  ", "start_char_idx": 1529, "end_char_idx": 1575, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "40913cec-ad92-4ff9-b591-672f60e63825": {"__data__": {"id_": "40913cec-ad92-4ff9-b591-672f60e63825", "embedding": null, "metadata": {"window": "But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.  ", "original_text": "I\u2019m pleased to join you on my first call.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4ce5a288-a297-4d6c-bcd6-d65642c32049", "node_type": "1", "metadata": {"window": "I\u2019ll share more about this work in both segments later in my remarks.   But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n ", "original_text": "And thanks everyone for being with us today.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4fa541a17c20d0e6d74ddeac44a9cdf71a956d60d9c474aca023573ccac30fab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d04fe166-c60d-4e36-a75b-66b313bdd260", "node_type": "1", "metadata": {"window": "Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.  ", "original_text": "I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n "}, "hash": "7e74efbf8775a2950c9b200b2b06ff3afa6f543c4e33f096758fb7abaf55ce87", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019m pleased to join you on my first call.  ", "start_char_idx": 1575, "end_char_idx": 1618, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d04fe166-c60d-4e36-a75b-66b313bdd260": {"__data__": {"id_": "d04fe166-c60d-4e36-a75b-66b313bdd260", "embedding": null, "metadata": {"window": "Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.  ", "original_text": "I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40913cec-ad92-4ff9-b591-672f60e63825", "node_type": "1", "metadata": {"window": "But first I\u2019ll turn to Dave to walk you through \nour results and the specific milestones we achieved in Q1.  \n \n Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.  ", "original_text": "I\u2019m pleased to join you on my first call.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d7aa23733cad2147becd23e7a4c352e4c40584db468eacfeb1e5aeed27688f1f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c425d66-f153-4762-9bb7-ff70aca0bf27", "node_type": "1", "metadata": {"window": "And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n ", "original_text": "Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n "}, "hash": "94505605b0a19ba5d2f4c0f0d82f8e80f9f7f1a4634b32d370959eda555f4a4c", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n ", "start_char_idx": 1618, "end_char_idx": 1749, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1c425d66-f153-4762-9bb7-ff70aca0bf27": {"__data__": {"id_": "1c425d66-f153-4762-9bb7-ff70aca0bf27", "embedding": null, "metadata": {"window": "And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n ", "original_text": "Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d04fe166-c60d-4e36-a75b-66b313bdd260", "node_type": "1", "metadata": {"window": "Dave Evans :  Thanks Mike.   And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.  ", "original_text": "I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b4ba51906a3e274adb06f58936d87e4ae292808ea0009759da934fdae5ee332b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "045c6fb4-b661-4284-a794-dc28a9c7c807", "node_type": "1", "metadata": {"window": "I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.  ", "original_text": "Total company revenue increased 6% versus last year to $37.3 billion.  "}, "hash": "831df121f96cf63bddb22930f3d96347d484a8fb855e2fef3f01230b6a283e13", "class_name": "RelatedNodeInfo"}}, "text": "Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n ", "start_char_idx": 1749, "end_char_idx": 1889, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "045c6fb4-b661-4284-a794-dc28a9c7c807": {"__data__": {"id_": "045c6fb4-b661-4284-a794-dc28a9c7c807", "embedding": null, "metadata": {"window": "I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.  ", "original_text": "Total company revenue increased 6% versus last year to $37.3 billion.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c425d66-f153-4762-9bb7-ff70aca0bf27", "node_type": "1", "metadata": {"window": "And thanks everyone for being with us today.   I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n ", "original_text": "Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f417d29ca35b57e291934fab3bc1e6d8ed2f8a118f752370f684023ff10338d6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fd4c9c1c-10d5-4cba-a8df-78b98b53cb76", "node_type": "1", "metadata": {"window": "I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.  "}, "hash": "fa703a51342e536950564c404e410afc11a3793cf08a9343fef20983e765c94f", "class_name": "RelatedNodeInfo"}}, "text": "Total company revenue increased 6% versus last year to $37.3 billion.  ", "start_char_idx": 1889, "end_char_idx": 1960, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fd4c9c1c-10d5-4cba-a8df-78b98b53cb76": {"__data__": {"id_": "fd4c9c1c-10d5-4cba-a8df-78b98b53cb76", "embedding": null, "metadata": {"window": "I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "045c6fb4-b661-4284-a794-dc28a9c7c807", "node_type": "1", "metadata": {"window": "I\u2019m pleased to join you on my first call.   I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.  ", "original_text": "Total company revenue increased 6% versus last year to $37.3 billion.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "33cbda7425b71acce1fa9a59691f45c91d58dc83f3e7aa17570bf731e775249b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f1f40616-0dfb-4366-9b29-aa9a66bee849", "node_type": "1", "metadata": {"window": "Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n "}, "hash": "26993b8d1aca4b5c06737d4a2952e04e0d913064e42b91858549bab66879f736", "class_name": "RelatedNodeInfo"}}, "text": "Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.  ", "start_char_idx": 1960, "end_char_idx": 2039, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f1f40616-0dfb-4366-9b29-aa9a66bee849": {"__data__": {"id_": "f1f40616-0dfb-4366-9b29-aa9a66bee849", "embedding": null, "metadata": {"window": "Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fd4c9c1c-10d5-4cba-a8df-78b98b53cb76", "node_type": "1", "metadata": {"window": "I\u2019ll walk \nthrough the numbers and highlight a few actions taken in Q1 that demonstrate our commitment to long -term \ngrowth.  \n \n  Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "db4145cfc77c4d6a73dbb508b7847dd466d84eaea450216e9448095f316e9954", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "60b471ee-2ee2-40a7-acd0-803c619e819f", "node_type": "1", "metadata": {"window": "Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.  "}, "hash": "be971a163919e06383dc4a014bb4120e966efa0fc5683e3b385c408d81bcfe10", "class_name": "RelatedNodeInfo"}}, "text": "The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n ", "start_char_idx": 2039, "end_char_idx": 2188, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "60b471ee-2ee2-40a7-acd0-803c619e819f": {"__data__": {"id_": "60b471ee-2ee2-40a7-acd0-803c619e819f", "embedding": null, "metadata": {"window": "Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f1f40616-0dfb-4366-9b29-aa9a66bee849", "node_type": "1", "metadata": {"window": "Overall I\u2019m happy to report that we delivered earnings of $1.27 per share in the first q uarter which were ahead of \nour expectations.  \n \n  Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d888fdf4d18a1313f78c92e54925ba1bcbe4318943425360771542a66191308d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "14ba4a33-1002-4c41-be1f-1daef294e166", "node_type": "1", "metadata": {"window": "Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n "}, "hash": "2a03b8240d5cf9268b9d9ab4d99676290b9fc66adabaed69bc3061275042a8b9", "class_name": "RelatedNodeInfo"}}, "text": "SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.  ", "start_char_idx": 2188, "end_char_idx": 2285, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "14ba4a33-1002-4c41-be1f-1daef294e166": {"__data__": {"id_": "14ba4a33-1002-4c41-be1f-1daef294e166", "embedding": null, "metadata": {"window": "Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc", "node_type": "4", "metadata": {"page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "429c9f1b12e497e487a3c5315ce45c34c288d4445f6e88dd95d6ca75e0ab27eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "60b471ee-2ee2-40a7-acd0-803c619e819f", "node_type": "1", "metadata": {"window": "Total company revenue increased 6% versus last year to $37.3 billion.   Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "49ec98a73dc5560bc3118e8346092fb778ddc16842a6e29fc4f044154f3dc4fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1439f13-b668-40e3-b91f-1e389f727b98", "node_type": "1", "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.  ", "original_text": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.  "}, "hash": "f0a7b7a11b4cf87534744a124a5ff54d9fe00369f5c2179a9b78a9477146b512", "class_name": "RelatedNodeInfo"}}, "text": "This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "start_char_idx": 2285, "end_char_idx": 2388, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c1439f13-b668-40e3-b91f-1e389f727b98": {"__data__": {"id_": "c1439f13-b668-40e3-b91f-1e389f727b98", "embedding": null, "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.  ", "original_text": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "14ba4a33-1002-4c41-be1f-1daef294e166", "node_type": "1", "metadata": {"window": "Consolidated gross margin increased 1% \nfrom last year to about $1.7 billion.   The decline in gross margin rate principally reflects year -over-year pharma \ndistribution contract renewals and products and distribution mix.  \n \n  SG&A, which includes variable distribution related expenses improved 2% despite higher revenue.   This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "original_text": "This \nimprovement reflects sustained organizational wide efforts to streamli ne our cost structure.  \n ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6166a24db05b4243e12f2b967b9da7ee1835f9faa2f9961de08f102d502f101d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5c815d06-1bd7-407c-ba17-f235c90a0397", "node_type": "1", "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n ", "original_text": "But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n "}, "hash": "1353aa3e0e9a79dfc4d92069088a75fa9f941a2b42652701a00e2890a2a7f805", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.  ", "start_char_idx": 0, "end_char_idx": 88, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5c815d06-1bd7-407c-ba17-f235c90a0397": {"__data__": {"id_": "5c815d06-1bd7-407c-ba17-f235c90a0397", "embedding": null, "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n ", "original_text": "But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1439f13-b668-40e3-b91f-1e389f727b98", "node_type": "1", "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.  ", "original_text": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "71029a6dd258fbabdbdbf6fe3d342e2b530b7cd63808c0775b4e97e0c7d875a2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "157cc4e5-9d74-406e-a0b0-2e690b522c7d", "node_type": "1", "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.  ", "original_text": "Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.  "}, "hash": "f36524ce5ff4c5255e8723ea9835d707c8fba354e31e7f74853e9e7692e4ada5", "class_name": "RelatedNodeInfo"}}, "text": "But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n ", "start_char_idx": 88, "end_char_idx": 301, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "157cc4e5-9d74-406e-a0b0-2e690b522c7d": {"__data__": {"id_": "157cc4e5-9d74-406e-a0b0-2e690b522c7d", "embedding": null, "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.  ", "original_text": "Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5c815d06-1bd7-407c-ba17-f235c90a0397", "node_type": "1", "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n ", "original_text": "But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2ddd015ce0cf79d31b422aac9bf1f19fe122ae368d5a377e0340d96d3f6c70eb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1fabb335-b057-4672-b8c7-c9d1a999b210", "node_type": "1", "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n ", "original_text": "Interest and other expenses were roughly flat versus prior year at $80 million.  "}, "hash": "507be3f78d41a7c7678c73bd89cf4e8d9fff17198d93f56f167e38d153deb05d", "class_name": "RelatedNodeInfo"}}, "text": "Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.  ", "start_char_idx": 301, "end_char_idx": 427, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1fabb335-b057-4672-b8c7-c9d1a999b210": {"__data__": {"id_": "1fabb335-b057-4672-b8c7-c9d1a999b210", "embedding": null, "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n ", "original_text": "Interest and other expenses were roughly flat versus prior year at $80 million.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "157cc4e5-9d74-406e-a0b0-2e690b522c7d", "node_type": "1", "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.  ", "original_text": "Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f8745efed9350559d771539cd9eb74343d655149d79d591fa8fc36e51002cdee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7cc5cf5f-ef20-41af-99c4-1f88498a036f", "node_type": "1", "metadata": {"window": "But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.  ", "original_text": "This reflects a \ndecline in interest expense.  \n \n "}, "hash": "c6aac3dd2efb2ad68942b4ab4b55c38d2083cb96ddb2c70cf6a70c6362a79c39", "class_name": "RelatedNodeInfo"}}, "text": "Interest and other expenses were roughly flat versus prior year at $80 million.  ", "start_char_idx": 427, "end_char_idx": 508, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7cc5cf5f-ef20-41af-99c4-1f88498a036f": {"__data__": {"id_": "7cc5cf5f-ef20-41af-99c4-1f88498a036f", "embedding": null, "metadata": {"window": "But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.  ", "original_text": "This reflects a \ndecline in interest expense.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1fabb335-b057-4672-b8c7-c9d1a999b210", "node_type": "1", "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n ", "original_text": "Interest and other expenses were roughly flat versus prior year at $80 million.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5290391b5c5157c6b7aa6d28654599108ddfbe312ba93604eaf3f34e9e385aab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6c67a8b7-9437-4a0c-a7ba-e7d019b6b95d", "node_type": "1", "metadata": {"window": "Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.  ", "original_text": "Our effective tax rate for the quarter was 24%.  "}, "hash": "26417075f1e2f6497ccc95a4a10ba28349903c57a7a2c7637c535c90bd92ae08", "class_name": "RelatedNodeInfo"}}, "text": "This reflects a \ndecline in interest expense.  \n \n ", "start_char_idx": 508, "end_char_idx": 559, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6c67a8b7-9437-4a0c-a7ba-e7d019b6b95d": {"__data__": {"id_": "6c67a8b7-9437-4a0c-a7ba-e7d019b6b95d", "embedding": null, "metadata": {"window": "Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.  ", "original_text": "Our effective tax rate for the quarter was 24%.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7cc5cf5f-ef20-41af-99c4-1f88498a036f", "node_type": "1", "metadata": {"window": "But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.  ", "original_text": "This reflects a \ndecline in interest expense.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8c542b0044c4bc27b30a3c8781d1a95e5a276b60d44dc4f27af6ed0750204acc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9eaf2964-0686-4a90-a0d1-f46ddee4146a", "node_type": "1", "metadata": {"window": "Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n ", "original_text": "This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n "}, "hash": "8b438b51758a76c7c20409baf05c8bb3fabd93c2b9e78580fa98b26e45b4f2ae", "class_name": "RelatedNodeInfo"}}, "text": "Our effective tax rate for the quarter was 24%.  ", "start_char_idx": 559, "end_char_idx": 608, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9eaf2964-0686-4a90-a0d1-f46ddee4146a": {"__data__": {"id_": "9eaf2964-0686-4a90-a0d1-f46ddee4146a", "embedding": null, "metadata": {"window": "Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n ", "original_text": "This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c67a8b7-9437-4a0c-a7ba-e7d019b6b95d", "node_type": "1", "metadata": {"window": "Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.  ", "original_text": "Our effective tax rate for the quarter was 24%.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a4325b679d68fd48fdfdf54265db9a4079d2068cccaccd070492ac611481e87c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fc949598-c86f-42be-bc38-8687d6f9eadf", "node_type": "1", "metadata": {"window": "This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n ", "original_text": "Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.  "}, "hash": "69d0e83e532cd7a333f4c1969beb8dcea3bc9cb6a9bd868239d51a2d6ccfa32c", "class_name": "RelatedNodeInfo"}}, "text": "This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n ", "start_char_idx": 608, "end_char_idx": 731, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fc949598-c86f-42be-bc38-8687d6f9eadf": {"__data__": {"id_": "fc949598-c86f-42be-bc38-8687d6f9eadf", "embedding": null, "metadata": {"window": "This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n ", "original_text": "Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9eaf2964-0686-4a90-a0d1-f46ddee4146a", "node_type": "1", "metadata": {"window": "Interest and other expenses were roughly flat versus prior year at $80 million.   This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n ", "original_text": "This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b24a420d6af976f71bc4b3d663b8c340a51bf7e4701bacadc363b9a6a79fb499", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e39807c-f330-43f4-8143-6e615b59dde8", "node_type": "1", "metadata": {"window": "Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.  ", "original_text": "During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.  "}, "hash": "84abec4ebef32a6ac72fc7939525148be89e19885565e14c0931f2181002ed75", "class_name": "RelatedNodeInfo"}}, "text": "Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.  ", "start_char_idx": 731, "end_char_idx": 823, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1e39807c-f330-43f4-8143-6e615b59dde8": {"__data__": {"id_": "1e39807c-f330-43f4-8143-6e615b59dde8", "embedding": null, "metadata": {"window": "Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.  ", "original_text": "During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fc949598-c86f-42be-bc38-8687d6f9eadf", "node_type": "1", "metadata": {"window": "This reflects a \ndecline in interest expense.  \n \n  Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n ", "original_text": "Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f87341e20e8dd49fc62d95f8771fced79f7666c321cbc6f473303f049bec680f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e74ecf86-4f9e-4d37-bc25-dc7b0825d40e", "node_type": "1", "metadata": {"window": "This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.  ", "original_text": "We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n "}, "hash": "66468b322e36c102055a0a272b21b27cf4682f98d9f802a0e4addb16095a96fa", "class_name": "RelatedNodeInfo"}}, "text": "During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.  ", "start_char_idx": 823, "end_char_idx": 953, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e74ecf86-4f9e-4d37-bc25-dc7b0825d40e": {"__data__": {"id_": "e74ecf86-4f9e-4d37-bc25-dc7b0825d40e", "embedding": null, "metadata": {"window": "This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.  ", "original_text": "We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1e39807c-f330-43f4-8143-6e615b59dde8", "node_type": "1", "metadata": {"window": "Our effective tax rate for the quarter was 24%.   This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.  ", "original_text": "During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "34be90c8d4e8a296ef350c70f7688ae67a6954e4da1a47490e880660e585bf6c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fdedb4c4-b374-48ce-8580-43e72d300b53", "node_type": "1", "metadata": {"window": "Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n ", "original_text": "Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n "}, "hash": "c3ab00bb1118531e16e57cba0515403c361421f30a9810871beb43f266972470", "class_name": "RelatedNodeInfo"}}, "text": "We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n ", "start_char_idx": 953, "end_char_idx": 1055, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fdedb4c4-b374-48ce-8580-43e72d300b53": {"__data__": {"id_": "fdedb4c4-b374-48ce-8580-43e72d300b53", "embedding": null, "metadata": {"window": "Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n ", "original_text": "Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e74ecf86-4f9e-4d37-bc25-dc7b0825d40e", "node_type": "1", "metadata": {"window": "This compares to last year\u2019s rate of 14%, which was impacted by \nchanges to our international legal entity structure.  \n \n  Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.  ", "original_text": "We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "73d2d4ec925f9f801c00b999ed43f841f777aac75e9f9bb4acd7238b54f69ff0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "02917818-a776-4d2e-9628-2125ef6df6f8", "node_type": "1", "metadata": {"window": "During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n ", "original_text": "Moving o nto cash flow, operating cash for the quarter was a use of $653 million.  "}, "hash": "60418fe027f7d5224b18a112cf23ebc108354516ee6cef262beabea93ceeea2b", "class_name": "RelatedNodeInfo"}}, "text": "Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n ", "start_char_idx": 1055, "end_char_idx": 1293, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "02917818-a776-4d2e-9628-2125ef6df6f8": {"__data__": {"id_": "02917818-a776-4d2e-9628-2125ef6df6f8", "embedding": null, "metadata": {"window": "During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n ", "original_text": "Moving o nto cash flow, operating cash for the quarter was a use of $653 million.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fdedb4c4-b374-48ce-8580-43e72d300b53", "node_type": "1", "metadata": {"window": "Average diluted shares outstanding were 297 mi llion about 9 million fewer than last year.   During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n ", "original_text": "Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d568d8f91dbf47f5f7d04bce4e2028b0785d33a513aa014667bc439ad4faea4d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "71750c8b-fd72-4f80-b8fc-aa1df9590979", "node_type": "1", "metadata": {"window": "We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n ", "original_text": "As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.  "}, "hash": "dc155a3d1a03b3cc808c9388f4c28ab2fc9cc116454dc0270fa061a48c371a69", "class_name": "RelatedNodeInfo"}}, "text": "Moving o nto cash flow, operating cash for the quarter was a use of $653 million.  ", "start_char_idx": 1293, "end_char_idx": 1376, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "71750c8b-fd72-4f80-b8fc-aa1df9590979": {"__data__": {"id_": "71750c8b-fd72-4f80-b8fc-aa1df9590979", "embedding": null, "metadata": {"window": "We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n ", "original_text": "As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "02917818-a776-4d2e-9628-2125ef6df6f8", "node_type": "1", "metadata": {"window": "During the quarter we \nentered into an Accelerated Share Repurchase Program to opportunistically buy back $350 million of stock.   We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n ", "original_text": "Moving o nto cash flow, operating cash for the quarter was a use of $653 million.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ff215f99596bec8ed77d4c98534e4d6a9816e1e8d50c4d384515102e9c10fbad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ce658d9-0955-4af0-aeb5-0b99ffcf268e", "node_type": "1", "metadata": {"window": "Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.  ", "original_text": "This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n "}, "hash": "853e302a3df1c4155fa34fe4ccf46c5fd1f2ce0a3f0d31718771dcf37b5509d1", "class_name": "RelatedNodeInfo"}}, "text": "As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.  ", "start_char_idx": 1376, "end_char_idx": 1497, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7ce658d9-0955-4af0-aeb5-0b99ffcf268e": {"__data__": {"id_": "7ce658d9-0955-4af0-aeb5-0b99ffcf268e", "embedding": null, "metadata": {"window": "Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.  ", "original_text": "This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "71750c8b-fd72-4f80-b8fc-aa1df9590979", "node_type": "1", "metadata": {"window": "We \nretired 80% of these shares in Q1 and expect to complete the program in our sec ond quarter.  \n \n  Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n ", "original_text": "As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "61b8cc1f106a69ada1d66b8f0bfad5fce50ac7bbbc47775d97cd520c4e48c675", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20581369-bae2-472c-855f-898348593641", "node_type": "1", "metadata": {"window": "Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.  ", "original_text": "We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n "}, "hash": "3ccd17fcfd9125267295abd39120ebc01db8578352a45462e296cb7c6f54556c", "class_name": "RelatedNodeInfo"}}, "text": "This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n ", "start_char_idx": 1497, "end_char_idx": 1598, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "20581369-bae2-472c-855f-898348593641": {"__data__": {"id_": "20581369-bae2-472c-855f-898348593641", "embedding": null, "metadata": {"window": "Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.  ", "original_text": "We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7ce658d9-0955-4af0-aeb5-0b99ffcf268e", "node_type": "1", "metadata": {"window": "Combining share repurchases and dividends we returned well over $400 million to shareholders in the first \nquarter demonstrating our continued commitment to deploying capital on a balanced, disciplined and shareholder \nfriendly way.  \n \n  Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.  ", "original_text": "This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e2d3b669daa06bf66524c0fbbc84d74b306256019f8b9c296b067970fa4ba8ad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0df25b83-4c04-406b-8aac-3e45506a0c95", "node_type": "1", "metadata": {"window": "As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n ", "original_text": "So I\u2019ll now transition to segment results starting with pharma.  \n \n "}, "hash": "f47efefd727c8934e0651425f03e0fc325d70448ee56ec1b29f56ff5785fb772", "class_name": "RelatedNodeInfo"}}, "text": "We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n ", "start_char_idx": 1598, "end_char_idx": 1717, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0df25b83-4c04-406b-8aac-3e45506a0c95": {"__data__": {"id_": "0df25b83-4c04-406b-8aac-3e45506a0c95", "embedding": null, "metadata": {"window": "As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n ", "original_text": "So I\u2019ll now transition to segment results starting with pharma.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20581369-bae2-472c-855f-898348593641", "node_type": "1", "metadata": {"window": "Moving o nto cash flow, operating cash for the quarter was a use of $653 million.   As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.  ", "original_text": "We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4d84caa5a224da4ae1368ac27356093070bd65b8a09773b937166f911decaf61", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a96f5fb-3c42-4340-a20e-c5593d07a3a3", "node_type": "1", "metadata": {"window": "This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n ", "original_text": "Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.  "}, "hash": "caf1af668bd4028b10d6fb983c42d49a8204dd894d1a500c0034f54772e59a31", "class_name": "RelatedNodeInfo"}}, "text": "So I\u2019ll now transition to segment results starting with pharma.  \n \n ", "start_char_idx": 1717, "end_char_idx": 1786, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1a96f5fb-3c42-4340-a20e-c5593d07a3a3": {"__data__": {"id_": "1a96f5fb-3c42-4340-a20e-c5593d07a3a3", "embedding": null, "metadata": {"window": "This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n ", "original_text": "Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0df25b83-4c04-406b-8aac-3e45506a0c95", "node_type": "1", "metadata": {"window": "As a reminder, timing, in \nparticular they day of the week in which the quarter ends affects point -in-time cash flows.   This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n ", "original_text": "So I\u2019ll now transition to segment results starting with pharma.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "01c55c085364335339c56c2285b0d8e43b0ef1d9447cbbdb5b7a3fb69a16a447", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "63aec45e-1839-485c-bd00-1ac906b58995", "node_type": "1", "metadata": {"window": "We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.  ", "original_text": "Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.  "}, "hash": "915a677cdc559c47878b3873be893d32b679672ebe709e536c6256f2c9f387c8", "class_name": "RelatedNodeInfo"}}, "text": "Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.  ", "start_char_idx": 1786, "end_char_idx": 1918, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "63aec45e-1839-485c-bd00-1ac906b58995": {"__data__": {"id_": "63aec45e-1839-485c-bd00-1ac906b58995", "embedding": null, "metadata": {"window": "We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.  ", "original_text": "Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a96f5fb-3c42-4340-a20e-c5593d07a3a3", "node_type": "1", "metadata": {"window": "This dynamic \nnegatively impacted our year -over-year cash flow f or Q1 but will reverse in Q2.  \n \n  We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n ", "original_text": "Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "14f775b2959d499baf3d5176578688421ba530b66b6ca9145a1c6d10f27629d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a85db0f-bae1-4e0a-94c5-57f59cad43c9", "node_type": "1", "metadata": {"window": "So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n ", "original_text": "This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n "}, "hash": "07070cfe4695162e8b80b1efe04acea0d6820574012beea7ad6449b156317c72", "class_name": "RelatedNodeInfo"}}, "text": "Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.  ", "start_char_idx": 1918, "end_char_idx": 2044, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7a85db0f-bae1-4e0a-94c5-57f59cad43c9": {"__data__": {"id_": "7a85db0f-bae1-4e0a-94c5-57f59cad43c9", "embedding": null, "metadata": {"window": "So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n ", "original_text": "This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "63aec45e-1839-485c-bd00-1ac906b58995", "node_type": "1", "metadata": {"window": "We ended the quarter with a cash balance of $1.2 billion, which includes about $700 million held outside the U.S.  \n \n  So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.  ", "original_text": "Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "eee00e2c2e25ba8101be847c8c25fca171d0328a74a0e3c208e766266b5434ed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "581f93c5-4791-43f3-9361-ca2a4b0cd4f9", "node_type": "1", "metadata": {"window": "Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.  ", "original_text": "As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n "}, "hash": "f97fc52e2858c3949e443e94d929f5750426e4f82bc24ebd6c1578a7e5e99b82", "class_name": "RelatedNodeInfo"}}, "text": "This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n ", "start_char_idx": 2044, "end_char_idx": 2186, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "581f93c5-4791-43f3-9361-ca2a4b0cd4f9": {"__data__": {"id_": "581f93c5-4791-43f3-9361-ca2a4b0cd4f9", "embedding": null, "metadata": {"window": "Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.  ", "original_text": "As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a85db0f-bae1-4e0a-94c5-57f59cad43c9", "node_type": "1", "metadata": {"window": "So I\u2019ll now transition to segment results starting with pharma.  \n \n  Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n ", "original_text": "This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3cedb92f662fef5dadaeb271762d12fcac5ee7bb4e97630bcec43ef0f144f348", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f8b9e4b9-6ae8-4818-b6ab-e083931c4e0d", "node_type": "1", "metadata": {"window": "Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Before I leave pharma I want to note that our Generics Program performed roughly as expected.  "}, "hash": "51054816d7180f64a0d85d37ffaef1dc0dd91516d6be13eec4d533e3e3830677", "class_name": "RelatedNodeInfo"}}, "text": "As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n ", "start_char_idx": 2186, "end_char_idx": 2274, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f8b9e4b9-6ae8-4818-b6ab-e083931c4e0d": {"__data__": {"id_": "f8b9e4b9-6ae8-4818-b6ab-e083931c4e0d", "embedding": null, "metadata": {"window": "Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Before I leave pharma I want to note that our Generics Program performed roughly as expected.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "581f93c5-4791-43f3-9361-ca2a4b0cd4f9", "node_type": "1", "metadata": {"window": "Revenue increased 6% to $33 billion driven  by sales growth in our Pharmaceutical Distribution and Specialty \nSolutions Divisions.   Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.  ", "original_text": "As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4c821abb280adae706c009a79ba5976d743d11e1bafbe9c1e62731f4d65bb2f0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2bbad25f-9404-4488-821c-e4f15b68959f", "node_type": "1", "metadata": {"window": "This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n "}, "hash": "d62951b0080d8fccc4aa6a9b598567fd6455ed67d4f150f792908d46ec97d22c", "class_name": "RelatedNodeInfo"}}, "text": "Before I leave pharma I want to note that our Generics Program performed roughly as expected.  ", "start_char_idx": 2274, "end_char_idx": 2369, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2bbad25f-9404-4488-821c-e4f15b68959f": {"__data__": {"id_": "2bbad25f-9404-4488-821c-e4f15b68959f", "embedding": null, "metadata": {"window": "This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f8b9e4b9-6ae8-4818-b6ab-e083931c4e0d", "node_type": "1", "metadata": {"window": "Segment profit decreased 3% to $398 million, which reflects the impact from pharma \ndistribution customer contract renewals.   This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Before I leave pharma I want to note that our Generics Program performed roughly as expected.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d94c55687bbee7633017efbfa450517e85327292ada11bcc338ef90b1405627a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5bd8b147-1ad4-41c3-9a4b-96b47b41b7a0", "node_type": "1", "metadata": {"window": "As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.  "}, "hash": "a96a0e9c63ecb912792d0f286ef560fe76a372649af5c3366d473b45e1d2ab6f", "class_name": "RelatedNodeInfo"}}, "text": "While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n ", "start_char_idx": 2369, "end_char_idx": 2614, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5bd8b147-1ad4-41c3-9a4b-96b47b41b7a0": {"__data__": {"id_": "5bd8b147-1ad4-41c3-9a4b-96b47b41b7a0", "embedding": null, "metadata": {"window": "As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2bbad25f-9404-4488-821c-e4f15b68959f", "node_type": "1", "metadata": {"window": "This was partially offset by the benefits o f our ongoing cost savings \ninitiatives and performance in our specialty solutions business.  \n \n  As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "897c59802f02930b8a68d71768de8f4a557459441c819f71e568a0b36adfddc0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "026322db-61cc-4c97-8258-d2f1ae7e4a62", "node_type": "1", "metadata": {"window": "Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Mike will discuss our ongoing \nefforts to maintain this momentum.  \n "}, "hash": "5490c6f408a465ae06d819b1cb461a11cf2b312fc80f72be48fb498aec2c7827", "class_name": "RelatedNodeInfo"}}, "text": "Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.  ", "start_char_idx": 2614, "end_char_idx": 2693, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "026322db-61cc-4c97-8258-d2f1ae7e4a62": {"__data__": {"id_": "026322db-61cc-4c97-8258-d2f1ae7e4a62", "embedding": null, "metadata": {"window": "Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b", "node_type": "4", "metadata": {"page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "905bbbacae727e74f0a9a04fc3c77071372ee1175d1a2961bbff35a2ea1a68f3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5bd8b147-1ad4-41c3-9a4b-96b47b41b7a0", "node_type": "1", "metadata": {"window": "As a reminder, we record opioid related litigation expenses in the Pharma Segment.  \n \n  Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c0c6e88ccc2f67fab518ff7391b24ee0338727bfe3205e96491c3fb06a1ec371", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d482a44d-73d8-4f90-b93e-9b727adc2103", "node_type": "1", "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.  ", "original_text": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.  "}, "hash": "f7d2788e2f928a775f198efb4fe83736fd8acc1090ef5c45057a29ada54a06e5", "class_name": "RelatedNodeInfo"}}, "text": "Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "start_char_idx": 2693, "end_char_idx": 2762, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d482a44d-73d8-4f90-b93e-9b727adc2103": {"__data__": {"id_": "d482a44d-73d8-4f90-b93e-9b727adc2103", "embedding": null, "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.  ", "original_text": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "026322db-61cc-4c97-8258-d2f1ae7e4a62", "node_type": "1", "metadata": {"window": "Before I leave pharma I want to note that our Generics Program performed roughly as expected.   While we \ncontinue to see improvements in the market dynamics for generics I would remind you that several variables \nimpact the net performance of our Generics Program including sourcing, volume, new item launches and sell -side \npricing.  \n \n  Overall we\u2019re seeing positive trends and good progress in the Pharma Segment.   Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "original_text": "Mike will discuss our ongoing \nefforts to maintain this momentum.  \n ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a15d272b23b2283bf5894dfb652fa385aaa4cdd8fa135be33ca60a9f4a1465fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08041078-0d74-445a-93f7-7bdb6051c282", "node_type": "1", "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.  ", "original_text": "This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.  "}, "hash": "0da8f6dca86b6af71a17c69277c521106226c730e95a280314359e3a3e5c79d4", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.  ", "start_char_idx": 0, "end_char_idx": 103, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "08041078-0d74-445a-93f7-7bdb6051c282": {"__data__": {"id_": "08041078-0d74-445a-93f7-7bdb6051c282", "embedding": null, "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.  ", "original_text": "This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d482a44d-73d8-4f90-b93e-9b727adc2103", "node_type": "1", "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.  ", "original_text": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "45435860473321415a2a88a6f0387c42fbc2c7ade74bd43c49af206921aeece9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0596d63e-b820-4436-a572-869f0c8b80f8", "node_type": "1", "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n ", "original_text": "This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n "}, "hash": "3a1ea1d1c55f0aa64adc117d5cde3ef90d1f41bd7c575cdcbacf27eb641f9651", "class_name": "RelatedNodeInfo"}}, "text": "This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.  ", "start_char_idx": 103, "end_char_idx": 265, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0596d63e-b820-4436-a572-869f0c8b80f8": {"__data__": {"id_": "0596d63e-b820-4436-a572-869f0c8b80f8", "embedding": null, "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n ", "original_text": "This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08041078-0d74-445a-93f7-7bdb6051c282", "node_type": "1", "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.  ", "original_text": "This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f9d54f28f73b57a3d519d7a468db14740d379b31b69aec4c4b95021ebc696779", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "054736a5-9870-406c-a47b-cbe0bd883514", "node_type": "1", "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n ", "original_text": "Segment profit increased 2 6% to $170 million.  "}, "hash": "00704be9667722d0c888fc6ef40c5a6b9929d185b42bf99c9ad3d459d8f3b383", "class_name": "RelatedNodeInfo"}}, "text": "This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n ", "start_char_idx": 265, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "054736a5-9870-406c-a47b-cbe0bd883514": {"__data__": {"id_": "054736a5-9870-406c-a47b-cbe0bd883514", "embedding": null, "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n ", "original_text": "Segment profit increased 2 6% to $170 million.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0596d63e-b820-4436-a572-869f0c8b80f8", "node_type": "1", "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n ", "original_text": "This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "79b173b3757ad71e155bd3a413fe2d17d0929e270efa098eff4ead36a297479a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1ead1b5e-e3e2-4751-aeb7-6c7e9c4dfe7e", "node_type": "1", "metadata": {"window": "This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.  ", "original_text": "This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.  "}, "hash": "a53e57986c77274924d8e062a80b1cc0cc78b48f28d946fa891415c6b01128d5", "class_name": "RelatedNodeInfo"}}, "text": "Segment profit increased 2 6% to $170 million.  ", "start_char_idx": 352, "end_char_idx": 400, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1ead1b5e-e3e2-4751-aeb7-6c7e9c4dfe7e": {"__data__": {"id_": "1ead1b5e-e3e2-4751-aeb7-6c7e9c4dfe7e", "embedding": null, "metadata": {"window": "This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.  ", "original_text": "This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "054736a5-9870-406c-a47b-cbe0bd883514", "node_type": "1", "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n ", "original_text": "Segment profit increased 2 6% to $170 million.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b8c2213836fcd6b2f7a2a47312c83d302b807e36d3ef6785adc3e486cb78bcac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8763be95-2186-4752-bc63-3ee98b1f7bd9", "node_type": "1", "metadata": {"window": "This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n ", "original_text": "As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n "}, "hash": "37a4aecb36cb3c0e6a1e2917858c1ed87fbd0ff046462c24d907c159a31dec10", "class_name": "RelatedNodeInfo"}}, "text": "This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.  ", "start_char_idx": 400, "end_char_idx": 546, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8763be95-2186-4752-bc63-3ee98b1f7bd9": {"__data__": {"id_": "8763be95-2186-4752-bc63-3ee98b1f7bd9", "embedding": null, "metadata": {"window": "This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n ", "original_text": "As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ead1b5e-e3e2-4751-aeb7-6c7e9c4dfe7e", "node_type": "1", "metadata": {"window": "This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.  ", "original_text": "This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "90b5f2016f842c1c363d94cbfaa53c0c92f195577d310f4b23f720a966fa4a71", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3453cb2-4262-4775-8d77-ff14b47dfa31", "node_type": "1", "metadata": {"window": "Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.  ", "original_text": "To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n "}, "hash": "a07f8da9b1fa2d5eb25ea7ed8b24704abfd17d21eccc78d7881c2e716f7e3f58", "class_name": "RelatedNodeInfo"}}, "text": "As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n ", "start_char_idx": 546, "end_char_idx": 653, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f3453cb2-4262-4775-8d77-ff14b47dfa31": {"__data__": {"id_": "f3453cb2-4262-4775-8d77-ff14b47dfa31", "embedding": null, "metadata": {"window": "Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.  ", "original_text": "To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8763be95-2186-4752-bc63-3ee98b1f7bd9", "node_type": "1", "metadata": {"window": "This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n ", "original_text": "As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0cf3c6c60f0918f79ecc6d84b3dbc63ef1dc84fa5b8588c89b3d069b5481a2db", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5355d0f2-ba65-40e9-bbd9-4b732b9be5b2", "node_type": "1", "metadata": {"window": "This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.  ", "original_text": "Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.  "}, "hash": "ddf00a071f04f35dd1aa9c43e56299331ab4db028e68648d73210d7fc63fb04f", "class_name": "RelatedNodeInfo"}}, "text": "To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n ", "start_char_idx": 653, "end_char_idx": 828, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5355d0f2-ba65-40e9-bbd9-4b732b9be5b2": {"__data__": {"id_": "5355d0f2-ba65-40e9-bbd9-4b732b9be5b2", "embedding": null, "metadata": {"window": "This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.  ", "original_text": "Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3453cb2-4262-4775-8d77-ff14b47dfa31", "node_type": "1", "metadata": {"window": "Segment profit increased 2 6% to $170 million.   This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.  ", "original_text": "To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "fc52f85e7207bff26ad5d65f917bdffc77ca9db2b80b52b5106e187590b490f2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ee8a2ea1-4a13-4299-a4cf-a485d080ab11", "node_type": "1", "metadata": {"window": "As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n ", "original_text": "Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n "}, "hash": "10350f2b0d0dd3458e65b4c450858a1c36617c54f6e8869ac6363c457a932d68", "class_name": "RelatedNodeInfo"}}, "text": "Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.  ", "start_char_idx": 828, "end_char_idx": 988, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ee8a2ea1-4a13-4299-a4cf-a485d080ab11": {"__data__": {"id_": "ee8a2ea1-4a13-4299-a4cf-a485d080ab11", "embedding": null, "metadata": {"window": "As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n ", "original_text": "Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5355d0f2-ba65-40e9-bbd9-4b732b9be5b2", "node_type": "1", "metadata": {"window": "This reflects benefits from our cost savings initiatives as well as \ngrowth in products and distribution, services and Cardinal Health at -Home.   As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.  ", "original_text": "Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8744ec3f9e7a5bfe6b9c58e8312c18b466e2a94db1fd3240586133a68d36414d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fb8676d4-1d63-422a-8b9a-60df54a73436", "node_type": "1", "metadata": {"window": "To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.  ", "original_text": "Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.  "}, "hash": "fd9876bf94123e739ee5dff828ed0acd0570f5f5709c8ee524c0820cd440b897", "class_name": "RelatedNodeInfo"}}, "text": "Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n ", "start_char_idx": 988, "end_char_idx": 1076, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fb8676d4-1d63-422a-8b9a-60df54a73436": {"__data__": {"id_": "fb8676d4-1d63-422a-8b9a-60df54a73436", "embedding": null, "metadata": {"window": "To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.  ", "original_text": "Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ee8a2ea1-4a13-4299-a4cf-a485d080ab11", "node_type": "1", "metadata": {"window": "As with revenue these benefits were \npartially offset by the divestiture of the naviHealth b usiness.  \n \n  To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n ", "original_text": "Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ac236d94b9bcc8d841f67573d17fc645591d308ae025a69290bb897b2391b016", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f3c357d-c62c-43c1-a7a3-5379c93a0127", "node_type": "1", "metadata": {"window": "Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n ", "original_text": "At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.  "}, "hash": "a447c373ad52ff230d068f0f478d13052d16ec995ea884735abc2206fabbdad9", "class_name": "RelatedNodeInfo"}}, "text": "Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.  ", "start_char_idx": 1076, "end_char_idx": 1244, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9f3c357d-c62c-43c1-a7a3-5379c93a0127": {"__data__": {"id_": "9f3c357d-c62c-43c1-a7a3-5379c93a0127", "embedding": null, "metadata": {"window": "Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n ", "original_text": "At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fb8676d4-1d63-422a-8b9a-60df54a73436", "node_type": "1", "metadata": {"window": "To provide some additional clarity products and distribution includes both Cardinal Health Brand and national \nbrand products as well costs from our global supply chain.  \n \n  Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.  ", "original_text": "Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c9c1f1ac851d9e243a91ed03f82971617988c1cccf8e6d466311b7c25327e59f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25bf0932-e6bb-4555-a0bb-99133cabead6", "node_type": "1", "metadata": {"window": "Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.  ", "original_text": "We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n "}, "hash": "845da60abcbf537d564e4cb3204c063e3d2c0ff3c53d96e009438600cd79e4c3", "class_name": "RelatedNodeInfo"}}, "text": "At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.  ", "start_char_idx": 1244, "end_char_idx": 1356, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "25bf0932-e6bb-4555-a0bb-99133cabead6": {"__data__": {"id_": "25bf0932-e6bb-4555-a0bb-99133cabead6", "embedding": null, "metadata": {"window": "Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.  ", "original_text": "We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f3c357d-c62c-43c1-a7a3-5379c93a0127", "node_type": "1", "metadata": {"window": "Our work across the Medical Segment to integrate our infrastructure, strea mline our footprint and improve the \ncustomer experience is progressing as planned.   Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n ", "original_text": "At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f3434753c14e34d406a07de2163f8f701351ec5899882f8caff40f5b6f547497", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "10be7e52-e453-4c0f-971a-ebaeecef9b48", "node_type": "1", "metadata": {"window": "Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n ", "original_text": "Examples of external factors could be headwinds, which include tariffs and medical device tax.  "}, "hash": "56b212eb0f3331cd1de196cb9c382d33a6c3a5b98c5996e6016e622ca4902918", "class_name": "RelatedNodeInfo"}}, "text": "We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n ", "start_char_idx": 1356, "end_char_idx": 1449, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "10be7e52-e453-4c0f-971a-ebaeecef9b48": {"__data__": {"id_": "10be7e52-e453-4c0f-971a-ebaeecef9b48", "embedding": null, "metadata": {"window": "Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n ", "original_text": "Examples of external factors could be headwinds, which include tariffs and medical device tax.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "25bf0932-e6bb-4555-a0bb-99133cabead6", "node_type": "1", "metadata": {"window": "Mike will discuss how this work will transition into growth over \nthe longer term.  \n \n  Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.  ", "original_text": "We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f5503212a1d21f740557c1e071acf09708ebc1d29a95e1acb638059707792278", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8bc8590d-4ffa-4377-a340-51bf4d21b121", "node_type": "1", "metadata": {"window": "At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.  ", "original_text": "Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n "}, "hash": "830a1f678e865d128d684d9c7894657d30b21f19743a854c88e7b519dcc96705", "class_name": "RelatedNodeInfo"}}, "text": "Examples of external factors could be headwinds, which include tariffs and medical device tax.  ", "start_char_idx": 1449, "end_char_idx": 1545, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8bc8590d-4ffa-4377-a340-51bf4d21b121": {"__data__": {"id_": "8bc8590d-4ffa-4377-a340-51bf4d21b121", "embedding": null, "metadata": {"window": "At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.  ", "original_text": "Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "10be7e52-e453-4c0f-971a-ebaeecef9b48", "node_type": "1", "metadata": {"window": "Moving now to our full year outlook, with one quarter\u2019s results of \u2013 one quarter\u2019s worth  of results behind us, we\u2019ve \nincreased confidence in our full year guidance.   At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n ", "original_text": "Examples of external factors could be headwinds, which include tariffs and medical device tax.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1388600b418666ee5a592efa0d9ff9e1fb9927c83a950d8bb953c3a6f4b82452", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5a4e65d6-21ff-46c7-bc99-7d5abf4dfce7", "node_type": "1", "metadata": {"window": "We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n ", "original_text": "Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.  "}, "hash": "9da0625ffbb98136a28192f88962195868d4c04f4296d1657d2bfb9b0f0e7226", "class_name": "RelatedNodeInfo"}}, "text": "Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n ", "start_char_idx": 1545, "end_char_idx": 1648, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5a4e65d6-21ff-46c7-bc99-7d5abf4dfce7": {"__data__": {"id_": "5a4e65d6-21ff-46c7-bc99-7d5abf4dfce7", "embedding": null, "metadata": {"window": "We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n ", "original_text": "Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8bc8590d-4ffa-4377-a340-51bf4d21b121", "node_type": "1", "metadata": {"window": "At the same time, we continue to monitor external factors and key \nassumptions that could impact our forecast.   We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.  ", "original_text": "Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "70cebeb8746e7e234b1912172c0d01ee1d7d5353dcf02955e6f74ff0f71a3978", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a1715a76-f8cf-41d2-bbf0-b44667e2b609", "node_type": "1", "metadata": {"window": "Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.  ", "original_text": "While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n "}, "hash": "04ba87fda99d4fb38df7984438e40a2910b29914eedbf5ffe65039f90b643d46", "class_name": "RelatedNodeInfo"}}, "text": "Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.  ", "start_char_idx": 1648, "end_char_idx": 1796, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a1715a76-f8cf-41d2-bbf0-b44667e2b609": {"__data__": {"id_": "a1715a76-f8cf-41d2-bbf0-b44667e2b609", "embedding": null, "metadata": {"window": "Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.  ", "original_text": "While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5a4e65d6-21ff-46c7-bc99-7d5abf4dfce7", "node_type": "1", "metadata": {"window": "We also continue to track the timing and evolution of internal \ninvestment initiatives.  \n \n  Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n ", "original_text": "Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9c1135d45e9a3260f9e97d02e28ed076fc25e7673850f3716fd3ee1fc2bd7def", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d88703d7-9552-4736-9986-f3b34c2afb4b", "node_type": "1", "metadata": {"window": "Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n ", "original_text": "So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.  "}, "hash": "6ef3453125520667f86fbc0a3c9a899a30b5f26beebf491bb8a7c56582b0346e", "class_name": "RelatedNodeInfo"}}, "text": "While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n ", "start_char_idx": 1796, "end_char_idx": 1949, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d88703d7-9552-4736-9986-f3b34c2afb4b": {"__data__": {"id_": "d88703d7-9552-4736-9986-f3b34c2afb4b", "embedding": null, "metadata": {"window": "Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n ", "original_text": "So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a1715a76-f8cf-41d2-bbf0-b44667e2b609", "node_type": "1", "metadata": {"window": "Examples of external factors could be headwinds, which include tariffs and medical device tax.   Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.  ", "original_text": "While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d615bc08bc6714343341c43c29f61f427d4008829618ff7e912d61e4b8814153", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4bb83256-706a-4d1f-864b-c25df6679898", "node_type": "1", "metadata": {"window": "Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.  ", "original_text": "In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n "}, "hash": "b76400df32774d8f9ba0f7249bf35474776a5567797ddfee8bbf7337a73f9bd3", "class_name": "RelatedNodeInfo"}}, "text": "So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.  ", "start_char_idx": 1949, "end_char_idx": 2057, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4bb83256-706a-4d1f-864b-c25df6679898": {"__data__": {"id_": "4bb83256-706a-4d1f-864b-c25df6679898", "embedding": null, "metadata": {"window": "Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.  ", "original_text": "In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d88703d7-9552-4736-9986-f3b34c2afb4b", "node_type": "1", "metadata": {"window": "Examples of key \nassumptions we closely monitor include brand inflation and our Generics Program.  \n \n  Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n ", "original_text": "So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84f000c14f310e3d5b364af88e8ae38b274bce0d2b5165a376a2b19f15efd9bb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7b10dfe9-0175-4636-b872-8615dfa595fe", "node_type": "1", "metadata": {"window": "While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n ", "original_text": "We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.  "}, "hash": "1bf1263344936c04afa324b3535135a6200b9081aea90a31894bebf8f87287f8", "class_name": "RelatedNodeInfo"}}, "text": "In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n ", "start_char_idx": 2057, "end_char_idx": 2305, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7b10dfe9-0175-4636-b872-8615dfa595fe": {"__data__": {"id_": "7b10dfe9-0175-4636-b872-8615dfa595fe", "embedding": null, "metadata": {"window": "While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n ", "original_text": "We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4bb83256-706a-4d1f-864b-c25df6679898", "node_type": "1", "metadata": {"window": "Considering the potential fluctuation o f these and other items we are reaffirming our guidance along with our \ncorporate and segment assumptions.   While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.  ", "original_text": "In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "76b48ca293017e5ef48e5383c3b2b6774072ef8beb00c73ce3d616fad118ca9a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8fba5ad8-5d01-44f4-b5e9-922f183f8e46", "node_type": "1", "metadata": {"window": "So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n", "original_text": "And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n "}, "hash": "a06f1ee1282d0ede2585c37459199de62911e4798409ec94bf9171f63e9afaaa", "class_name": "RelatedNodeInfo"}}, "text": "We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.  ", "start_char_idx": 2305, "end_char_idx": 2426, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8fba5ad8-5d01-44f4-b5e9-922f183f8e46": {"__data__": {"id_": "8fba5ad8-5d01-44f4-b5e9-922f183f8e46", "embedding": null, "metadata": {"window": "So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n", "original_text": "And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7b10dfe9-0175-4636-b872-8615dfa595fe", "node_type": "1", "metadata": {"window": "While we generally don\u2019t provide quarterly guidance I will say that \ndirectionally we expect operating earnings in Q2 to be modestly lower than Q1.  \n \n  So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n ", "original_text": "We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4282fd69fa89ee861768d578331ffa6c98afd905ac53837d68a9231d296bf605", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7081d97a-73a9-4bb4-ad13-2c1cba02158e", "node_type": "1", "metadata": {"window": "In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.  ", "original_text": "For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.  "}, "hash": "94a14639cb975404e34cda27572a7dd38cd0df4b8be21fd5325d0dc2a4d263eb", "class_name": "RelatedNodeInfo"}}, "text": "And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n ", "start_char_idx": 2426, "end_char_idx": 2517, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7081d97a-73a9-4bb4-ad13-2c1cba02158e": {"__data__": {"id_": "7081d97a-73a9-4bb4-ad13-2c1cba02158e", "embedding": null, "metadata": {"window": "In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.  ", "original_text": "For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8fba5ad8-5d01-44f4-b5e9-922f183f8e46", "node_type": "1", "metadata": {"window": "So before I turn it back over to Mike I\u2019d like to mention a significant item included in our GAAP results.   In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n", "original_text": "And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c196ba09c5126aabf1d53c6de971441a94487783214cde6be2aa3f3e0a8ac216", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "99e62e57-f369-459e-a9d6-4083067758bc", "node_type": "1", "metadata": {"window": "We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.  ", "original_text": "If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n "}, "hash": "e05bf3438f068ccc0c759838c142b53f7f38e308c9a66ee0c6741e00c9a2446f", "class_name": "RelatedNodeInfo"}}, "text": "For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.  ", "start_char_idx": 2517, "end_char_idx": 2623, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "99e62e57-f369-459e-a9d6-4083067758bc": {"__data__": {"id_": "99e62e57-f369-459e-a9d6-4083067758bc", "embedding": null, "metadata": {"window": "We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.  ", "original_text": "If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7081d97a-73a9-4bb4-ad13-2c1cba02158e", "node_type": "1", "metadata": {"window": "In \nconnection with the recent opioid related settlement with Cuyahoga and Summit Counties and the agreement in \nprincipal amongst the parties involve d to a global settlement framework we accrued $5.1 billion after tax in the \nfirst quarter.  \n \n  We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.  ", "original_text": "For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f143e5aac13a076a2d0f5e6c60fbd0a470016ddfccd44ad169ac614fdda02448", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3cf5c00a-2e57-48fc-bf07-a5fe479bd8f1", "node_type": "1", "metadata": {"window": "And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "Let me now turn it back over to Mike to provid e further remarks.  \n \n"}, "hash": "606555297072e2b34eb0378353270e6d67a6277ab8ed1afdb41f8dbef720473e", "class_name": "RelatedNodeInfo"}}, "text": "If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n ", "start_char_idx": 2623, "end_char_idx": 2687, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3cf5c00a-2e57-48fc-bf07-a5fe479bd8f1": {"__data__": {"id_": "3cf5c00a-2e57-48fc-bf07-a5fe479bd8f1", "embedding": null, "metadata": {"window": "And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "Let me now turn it back over to Mike to provid e further remarks.  \n \n", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99e62e57-f369-459e-a9d6-4083067758bc", "node_type": "1", "metadata": {"window": "We believe this global settlement framework will serve as the basis for definitive settlement terms and \ndocumentation.   And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.  ", "original_text": "If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2dcc8b590107801ae808161149046c6c6ded2127574cd5fb70d2541fcdf6eff8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "73337b61-0bf1-4a5b-8b0e-2b07b4afa2c8", "node_type": "1", "metadata": {"window": "For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "Mike Kaufmann :  Thanks Dave.  "}, "hash": "f0bb2556da478cce79066f301e00cf24da343d10e404d9c9e5abec9a410ebc23", "class_name": "RelatedNodeInfo"}}, "text": "Let me now turn it back over to Mike to provid e further remarks.  \n \n", "start_char_idx": 2687, "end_char_idx": 2757, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "73337b61-0bf1-4a5b-8b0e-2b07b4afa2c8": {"__data__": {"id_": "73337b61-0bf1-4a5b-8b0e-2b07b4afa2c8", "embedding": null, "metadata": {"window": "For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "Mike Kaufmann :  Thanks Dave.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3cf5c00a-2e57-48fc-bf07-a5fe479bd8f1", "node_type": "1", "metadata": {"window": "And for this reason from a legal and accoun ting perspective this accrual is prudent.  \n \n  For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "Let me now turn it back over to Mike to provid e further remarks.  \n \n", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "918148a4aafa147d1b62bde05835b281c3a2c27c67148e17ab408653db334a64", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e58b8aff-6e68-45bf-8210-fc5b084f0980", "node_type": "1", "metadata": {"window": "If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.  "}, "hash": "414af995051ffcdc2b9b042c638817d608c68d48c31a6e2ca3fa10fef4ae7a16", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Thanks Dave.  ", "start_char_idx": 2757, "end_char_idx": 2788, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e58b8aff-6e68-45bf-8210-fc5b084f0980": {"__data__": {"id_": "e58b8aff-6e68-45bf-8210-fc5b084f0980", "embedding": null, "metadata": {"window": "If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "73337b61-0bf1-4a5b-8b0e-2b07b4afa2c8", "node_type": "1", "metadata": {"window": "For Cardinal Health the cash component of this settlement framework is up to $5.6 billion over 18 years.   If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "Mike Kaufmann :  Thanks Dave.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "daac31ecb2ffc48d59b7031a4549fa5feeca847ed11260c066687c3067f550b9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2744cbf2-c69b-4574-a35d-a7cc4e3a4c25", "node_type": "1", "metadata": {"window": "Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "The global framework, which is supported by a bipartisan group of state "}, "hash": "090d0417bee9887250f4442fefa2361ec52a7cc5023fef513fbcee4e275c4134", "class_name": "RelatedNodeInfo"}}, "text": "This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.  ", "start_char_idx": 2788, "end_char_idx": 2908, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2744cbf2-c69b-4574-a35d-a7cc4e3a4c25": {"__data__": {"id_": "2744cbf2-c69b-4574-a35d-a7cc4e3a4c25", "embedding": null, "metadata": {"window": "Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "The global framework, which is supported by a bipartisan group of state ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "9762b381-a11a-4358-99cd-84f89384b121", "node_type": "4", "metadata": {"page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19f88c18d4b3e9e634d6bfdd75b08f5fb407fb51c92ad4a15db554d7465d4412", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e58b8aff-6e68-45bf-8210-fc5b084f0980", "node_type": "1", "metadata": {"window": "If factors \nchange we\u2019ll adjust the accrual appropriately.  \n \n  Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1915f7e46ffd8b073d84452c90b2b25b1d6fcd0301cc358c93cda49005321847", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c26cdc12-c693-47ba-a229-84590021a68f", "node_type": "1", "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n ", "original_text": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n "}, "hash": "a4d707e871464e03651fb5989d95ceec2dd0a3aa8449f6600b93de2faaa123c1", "class_name": "RelatedNodeInfo"}}, "text": "The global framework, which is supported by a bipartisan group of state ", "start_char_idx": 2908, "end_char_idx": 2980, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c26cdc12-c693-47ba-a229-84590021a68f": {"__data__": {"id_": "c26cdc12-c693-47ba-a229-84590021a68f", "embedding": null, "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n ", "original_text": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2744cbf2-c69b-4574-a35d-a7cc4e3a4c25", "node_type": "1", "metadata": {"window": "Let me now turn it back over to Mike to provid e further remarks.  \n \n Mike Kaufmann :  Thanks Dave.   This settlement with the two Ohio counties enables the discussions around the global \nsettlement framework to proceed.   The global framework, which is supported by a bipartisan group of state ", "original_text": "The global framework, which is supported by a bipartisan group of state ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8a1f68dc0b02e8748a1cb37e7bb5be941348acbfe390e65c93828b959409ef53", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d2bb1da2-a477-4711-9b1b-c7c54e06e960", "node_type": "1", "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n ", "original_text": "Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.  "}, "hash": "3a5e8fa5fac0195c19f8e61e8707400e7b81f4a25fcfede8d679bfb77fdf49de", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n ", "start_char_idx": 0, "end_char_idx": 147, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d2bb1da2-a477-4711-9b1b-c7c54e06e960": {"__data__": {"id_": "d2bb1da2-a477-4711-9b1b-c7c54e06e960", "embedding": null, "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n ", "original_text": "Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c26cdc12-c693-47ba-a229-84590021a68f", "node_type": "1", "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n ", "original_text": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "fc767e2f2f95a19fdf2190695f251a6c0142c8145d8686d05306fd5cb383d2c6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cbe0d365-5afb-49fd-a6e5-be9ca6ee0f5c", "node_type": "1", "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.  ", "original_text": "We take that role and the \nresponsibility that comes with it seriously.  "}, "hash": "9fd74b8e9da9e58a91a4ab84b7b011325ba727010d3ba5e17d04824b6c33901c", "class_name": "RelatedNodeInfo"}}, "text": "Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.  ", "start_char_idx": 147, "end_char_idx": 427, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cbe0d365-5afb-49fd-a6e5-be9ca6ee0f5c": {"__data__": {"id_": "cbe0d365-5afb-49fd-a6e5-be9ca6ee0f5c", "embedding": null, "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.  ", "original_text": "We take that role and the \nresponsibility that comes with it seriously.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d2bb1da2-a477-4711-9b1b-c7c54e06e960", "node_type": "1", "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n ", "original_text": "Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ab69f24e23614cd3a27de840c77f818829d06cb9e9703e36e5f629092fbd205d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "58ddb258-630b-49dd-84c3-670b7ced8176", "node_type": "1", "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n ", "original_text": "We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n "}, "hash": "224b92ada3c3d432c0bc74af0a190ac245fb77cd0612a9beb57da1ea62ffcb62", "class_name": "RelatedNodeInfo"}}, "text": "We take that role and the \nresponsibility that comes with it seriously.  ", "start_char_idx": 427, "end_char_idx": 500, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "58ddb258-630b-49dd-84c3-670b7ced8176": {"__data__": {"id_": "58ddb258-630b-49dd-84c3-670b7ced8176", "embedding": null, "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n ", "original_text": "We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cbe0d365-5afb-49fd-a6e5-be9ca6ee0f5c", "node_type": "1", "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.  ", "original_text": "We take that role and the \nresponsibility that comes with it seriously.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2d21d68c7c264aaa24c0e4eafc1c9f37c1d781f65b72f10f35cdc82be29ef920", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b8766ae7-2803-46b6-b678-7812d986689e", "node_type": "1", "metadata": {"window": "Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.  ", "original_text": "With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n "}, "hash": "4da79bd44e9e661dfc705b272e9b23f2183ef85d5415ea1aaf5e3b39ef92a946", "class_name": "RelatedNodeInfo"}}, "text": "We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n ", "start_char_idx": 500, "end_char_idx": 688, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b8766ae7-2803-46b6-b678-7812d986689e": {"__data__": {"id_": "b8766ae7-2803-46b6-b678-7812d986689e", "embedding": null, "metadata": {"window": "Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.  ", "original_text": "With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "58ddb258-630b-49dd-84c3-670b7ced8176", "node_type": "1", "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n ", "original_text": "We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "38719af687260388c0e7976bf16832118b1ce714a16c27cccdb00754afa0df56", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b0de04c-a378-441b-afaa-44c6d13c2abb", "node_type": "1", "metadata": {"window": "We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n ", "original_text": "Shifting now to our strategic direction and the focus areas I m entioned last quarter.  "}, "hash": "e32b3a595a5649d801daeca266986f3117b81429702c6688ad751cd6f5fe4b72", "class_name": "RelatedNodeInfo"}}, "text": "With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n ", "start_char_idx": 688, "end_char_idx": 792, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5b0de04c-a378-441b-afaa-44c6d13c2abb": {"__data__": {"id_": "5b0de04c-a378-441b-afaa-44c6d13c2abb", "embedding": null, "metadata": {"window": "We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n ", "original_text": "Shifting now to our strategic direction and the focus areas I m entioned last quarter.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8766ae7-2803-46b6-b678-7812d986689e", "node_type": "1", "metadata": {"window": "Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.  ", "original_text": "With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "46fc3ecfa230017dff300c37dff0885be80cf0498754ca35a5089a14808226ba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "292e1438-4464-428b-aa55-c6df8ba31841", "node_type": "1", "metadata": {"window": "We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n ", "original_text": "I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n "}, "hash": "6b85c588bf95d6aafdd1dff2fa62236d2969d06db9b3455782eed79baf12684f", "class_name": "RelatedNodeInfo"}}, "text": "Shifting now to our strategic direction and the focus areas I m entioned last quarter.  ", "start_char_idx": 792, "end_char_idx": 880, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "292e1438-4464-428b-aa55-c6df8ba31841": {"__data__": {"id_": "292e1438-4464-428b-aa55-c6df8ba31841", "embedding": null, "metadata": {"window": "We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n ", "original_text": "I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b0de04c-a378-441b-afaa-44c6d13c2abb", "node_type": "1", "metadata": {"window": "We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n ", "original_text": "Shifting now to our strategic direction and the focus areas I m entioned last quarter.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ebe7d1acba4fd1ec1fe0cb6332d117f6f2230c2a014fcf2b0b29077cc979cf6b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bfd5c152-3018-4cda-bbef-31258545089a", "node_type": "1", "metadata": {"window": "With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.  ", "original_text": "Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.  "}, "hash": "c9ad52c9ed5c30b3e64603d568acd13d7b782a0f0ab66ad3e372591fdc11860a", "class_name": "RelatedNodeInfo"}}, "text": "I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n ", "start_char_idx": 880, "end_char_idx": 1048, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bfd5c152-3018-4cda-bbef-31258545089a": {"__data__": {"id_": "bfd5c152-3018-4cda-bbef-31258545089a", "embedding": null, "metadata": {"window": "With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.  ", "original_text": "Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "292e1438-4464-428b-aa55-c6df8ba31841", "node_type": "1", "metadata": {"window": "We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n  With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n ", "original_text": "I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "efad7dce0779523860470fa0d0a58cf8bd1ecfcf08977bb74b2b60f62a29614d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0a0dac8a-074e-4f0b-a011-0374e5218f61", "node_type": "1", "metadata": {"window": "Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n ", "original_text": "We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n "}, "hash": "cd1739cefaa0eaf75150ddc04250efa28c76d333923e6b42361d51cf8e358a0e", "class_name": "RelatedNodeInfo"}}, "text": "Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.  ", "start_char_idx": 1048, "end_char_idx": 1220, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0a0dac8a-074e-4f0b-a011-0374e5218f61": {"__data__": {"id_": "0a0dac8a-074e-4f0b-a011-0374e5218f61", "embedding": null, "metadata": {"window": "Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n ", "original_text": "We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bfd5c152-3018-4cda-bbef-31258545089a", "node_type": "1", "metadata": {"window": "With that said if this framework is not successful we are prepared to vigorously defend ourselves.  \n \n  Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.  ", "original_text": "Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8f628385f6cfcc17f1e67b6bcf3718a49f2df2b82035dd9c492694d97bf59abd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "27affbb6-098c-4605-a8b3-e9ea7f0cf721", "node_type": "1", "metadata": {"window": "I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.  ", "original_text": "For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n "}, "hash": "13ddf5b21d3929bcc65f9d2edfec21539cb3e60578dd90b60a19a477a5a19445", "class_name": "RelatedNodeInfo"}}, "text": "We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n ", "start_char_idx": 1220, "end_char_idx": 1328, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "27affbb6-098c-4605-a8b3-e9ea7f0cf721": {"__data__": {"id_": "27affbb6-098c-4605-a8b3-e9ea7f0cf721", "embedding": null, "metadata": {"window": "I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.  ", "original_text": "For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0a0dac8a-074e-4f0b-a011-0374e5218f61", "node_type": "1", "metadata": {"window": "Shifting now to our strategic direction and the focus areas I m entioned last quarter.   I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n ", "original_text": "We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "441e1991bd340e0dd8fcd76b630ed4fedd672ad5e967a2ad4aecc9034db09421", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "10df67a1-91fd-4f50-b32d-7de93aa219b1", "node_type": "1", "metadata": {"window": "Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n ", "original_text": "In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.  "}, "hash": "f4c5af839270c0317b04503921a8cbf4174d4aacaea0fd140f3907d09094a0e0", "class_name": "RelatedNodeInfo"}}, "text": "For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n ", "start_char_idx": 1328, "end_char_idx": 1456, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "10df67a1-91fd-4f50-b32d-7de93aa219b1": {"__data__": {"id_": "10df67a1-91fd-4f50-b32d-7de93aa219b1", "embedding": null, "metadata": {"window": "Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n ", "original_text": "In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "27affbb6-098c-4605-a8b3-e9ea7f0cf721", "node_type": "1", "metadata": {"window": "I said on our last call that in \npharma we are focused on two things, further enhancing our core distribution business and fueling sustained \ngrowth in key areas.  \n \n  Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.  ", "original_text": "For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "04f17547530e90ed4d0cd92c0dfca06800aa33afce6050ba1c9829cb3f18fabb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ebe2d54c-cd9f-4432-8e3b-6ed5a5e78a57", "node_type": "1", "metadata": {"window": "We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.  ", "original_text": "Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n "}, "hash": "26e46afbca38234969fa9cf21168950d72b672c6d60a6780b79c6541b917f615", "class_name": "RelatedNodeInfo"}}, "text": "In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.  ", "start_char_idx": 1456, "end_char_idx": 1585, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ebe2d54c-cd9f-4432-8e3b-6ed5a5e78a57": {"__data__": {"id_": "ebe2d54c-cd9f-4432-8e3b-6ed5a5e78a57", "embedding": null, "metadata": {"window": "We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.  ", "original_text": "Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "10df67a1-91fd-4f50-b32d-7de93aa219b1", "node_type": "1", "metadata": {"window": "Regarding our core distribution business we are focused on continuous ly enhancing the customer experience, \nimproving pricing and contract discipline and reducing costs.   We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n ", "original_text": "In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a99e8d46a39e65543d7687e05c79134472a1a7f2532796952f568c9fabaf804f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8facf4f4-9cc1-4fa0-9f5f-2ced3791deb9", "node_type": "1", "metadata": {"window": "For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n ", "original_text": "For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.  "}, "hash": "6bb7230a5cfd700e038c29977470e38c2d987faafa6a3dc452faaf8ea985225b", "class_name": "RelatedNodeInfo"}}, "text": "Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n ", "start_char_idx": 1585, "end_char_idx": 1795, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8facf4f4-9cc1-4fa0-9f5f-2ced3791deb9": {"__data__": {"id_": "8facf4f4-9cc1-4fa0-9f5f-2ced3791deb9", "embedding": null, "metadata": {"window": "For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n ", "original_text": "For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ebe2d54c-cd9f-4432-8e3b-6ed5a5e78a57", "node_type": "1", "metadata": {"window": "We are making significant investments throughout \nthe segment with a longer term view of the business.  \n \n  For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.  ", "original_text": "Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2669ab93f7e7606b83692eb4c8c0a28a4d04af603f13b662f346df32ef1c95f2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "53b1ddba-78bd-44ac-a06d-490de3ca4686", "node_type": "1", "metadata": {"window": "In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.  ", "original_text": "This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n "}, "hash": "976d316172701b6fa302d77a314e688d859cf97c880dc847edb4a81061cdb130", "class_name": "RelatedNodeInfo"}}, "text": "For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.  ", "start_char_idx": 1795, "end_char_idx": 2022, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "53b1ddba-78bd-44ac-a06d-490de3ca4686": {"__data__": {"id_": "53b1ddba-78bd-44ac-a06d-490de3ca4686", "embedding": null, "metadata": {"window": "In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.  ", "original_text": "This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8facf4f4-9cc1-4fa0-9f5f-2ced3791deb9", "node_type": "1", "metadata": {"window": "For example, we are implementing digital technologi es that will improve visibility and enhance our pricing \ncapabilities.  \n \n  In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n ", "original_text": "For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "07cfbd06861c000e1c3149b92e481bdcc8ebaf668f4dffedf3d3eb6ae163ee6b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af2ff3c8-2869-42db-bcd8-79ea4f4921eb", "node_type": "1", "metadata": {"window": "Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.  "}, "hash": "8a791896944bcbccb4e72ec51b7a05211d43bab40e2ffcacc453331e2147b631", "class_name": "RelatedNodeInfo"}}, "text": "This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n ", "start_char_idx": 2022, "end_char_idx": 2249, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "af2ff3c8-2869-42db-bcd8-79ea4f4921eb": {"__data__": {"id_": "af2ff3c8-2869-42db-bcd8-79ea4f4921eb", "embedding": null, "metadata": {"window": "Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "53b1ddba-78bd-44ac-a06d-490de3ca4686", "node_type": "1", "metadata": {"window": "In addition, we recently began a program to improve our e -Commerce capabilities and enhance the experience \nfor our customers.   Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.  ", "original_text": "This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3a8def26facf8d89b706c33086ec42b625f06284009f6b6fb614c47adb4105ad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0d6cefb5-6e09-4ca6-b9ec-41a757e2d05c", "node_type": "1", "metadata": {"window": "For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n "}, "hash": "8a6056285e94b056b567a2f7cda15e218a9a785f7c4c3965471dad6c59bc58aa", "class_name": "RelatedNodeInfo"}}, "text": "We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.  ", "start_char_idx": 2249, "end_char_idx": 2443, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0d6cefb5-6e09-4ca6-b9ec-41a757e2d05c": {"__data__": {"id_": "0d6cefb5-6e09-4ca6-b9ec-41a757e2d05c", "embedding": null, "metadata": {"window": "For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af2ff3c8-2869-42db-bcd8-79ea4f4921eb", "node_type": "1", "metadata": {"window": "Beyond investing in our core businesses we are focused on  investing to drive growth in rapidly \nevolving spaces in healthcare and identifying ways to further differentiate ourselves and shape the future.  \n \n  For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "947f489d14edb7114aa2b23091d29ecdfef41e3380bddcb56ca5f5286df2da47", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "19ff95bc-319f-404e-9658-08b26cbb61b2", "node_type": "1", "metadata": {"window": "This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.  "}, "hash": "a8762a973d1c807426eecef30869801dd53b919ab8068eb43a977206591acd85", "class_name": "RelatedNodeInfo"}}, "text": "We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n ", "start_char_idx": 2443, "end_char_idx": 2549, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "19ff95bc-319f-404e-9658-08b26cbb61b2": {"__data__": {"id_": "19ff95bc-319f-404e-9658-08b26cbb61b2", "embedding": null, "metadata": {"window": "This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0d6cefb5-6e09-4ca6-b9ec-41a757e2d05c", "node_type": "1", "metadata": {"window": "For example, in specialty we recently made a multimillion dollar investment to establish a new Distribution Center \noutside of Nashville, Tennessee with a state -of-the-art cold chain complex including deep frozen technology.   This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "990ef4529bc745848fc1d9ac10d08ef27b9be941191cbec074c014788085e393", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89570014-d9ac-476c-8c1f-cd85b67c49d0", "node_type": "1", "metadata": {"window": "We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n "}, "hash": "6b4c09273adcf01337d732f76dae9a1331bf633e44d12b22d60781b9af76daad", "class_name": "RelatedNodeInfo"}}, "text": "Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.  ", "start_char_idx": 2549, "end_char_idx": 2697, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "89570014-d9ac-476c-8c1f-cd85b67c49d0": {"__data__": {"id_": "89570014-d9ac-476c-8c1f-cd85b67c49d0", "embedding": null, "metadata": {"window": "We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "94070a92-6692-4b76-a49b-08f36bd565df", "node_type": "4", "metadata": {"page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40a8266038e32d5ad2af8a44ce5ac6c1b341b00aeb98c3f52ba5ace7f9d3791a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "19ff95bc-319f-404e-9658-08b26cbb61b2", "node_type": "1", "metadata": {"window": "This \nnew facility will enable us to combine two existing Distribution Centers, streamline technologies to drive \noperational ef ficiencies and support continued growth in rapidly evolving areas of the specialty industry.  \n \n  We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.  ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "48656479d8738c83e3f0644c562a6606140c1eaf647e20151fe8021f237ee0e8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ae8e43b9-e3b7-4b58-b110-f693f15170e4", "node_type": "1", "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n ", "original_text": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.  "}, "hash": "a1c3ea28800cacc7d65275848f132249d35fe510d53af60918e1bf24b4326069", "class_name": "RelatedNodeInfo"}}, "text": "Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "start_char_idx": 2697, "end_char_idx": 2893, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ae8e43b9-e3b7-4b58-b110-f693f15170e4": {"__data__": {"id_": "ae8e43b9-e3b7-4b58-b110-f693f15170e4", "embedding": null, "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n ", "original_text": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "89570014-d9ac-476c-8c1f-cd85b67c49d0", "node_type": "1", "metadata": {"window": "We\u2019re also investing in our higher margin services businesses, which we call our Connected Care offering to build \ngreater connectivity between manufacturers, pay ers, pharmacies and patients.   We will continue to purposely \nredeploy capital in these and other areas that align to our strategy.  \n \n  Moving onto medical, we are building -out our commercial and operational capabilities across the segment and \ncontinuing inve stment in key areas.   Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "original_text": "Dave shared that some of these activities, which include enhancing our \ncommercial approach, streamlining our supply chain, and rationalizing our footprint are showing early signs of \nsuccess.  \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1f1137ae0989985b185c7f110887a3715ead2e776e682772b72f35fbe4b59484", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ad9664bc-4628-41d0-905e-64398ac61d70", "node_type": "1", "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.  ", "original_text": "We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n "}, "hash": "1d308101750aaccb5a6e70aae31f127bde5de473783978449a261c00215f5986", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.  ", "start_char_idx": 0, "end_char_idx": 172, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ad9664bc-4628-41d0-905e-64398ac61d70": {"__data__": {"id_": "ad9664bc-4628-41d0-905e-64398ac61d70", "embedding": null, "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.  ", "original_text": "We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ae8e43b9-e3b7-4b58-b110-f693f15170e4", "node_type": "1", "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n ", "original_text": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "db54ecbe4aeb152e8f0db579c1de264d1397495006e94640bebc8d9aa8403b21", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "269782c5-80d4-4de6-acb1-58d932791550", "node_type": "1", "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n ", "original_text": "As part of our supply chain work we are  reconfiguring our North America network.  "}, "hash": "54a910ca045be4c2c8d42e0b9283fe37da6de6256a44e5abce4ab70455fdfe99", "class_name": "RelatedNodeInfo"}}, "text": "We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n ", "start_char_idx": 172, "end_char_idx": 283, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "269782c5-80d4-4de6-acb1-58d932791550": {"__data__": {"id_": "269782c5-80d4-4de6-acb1-58d932791550", "embedding": null, "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n ", "original_text": "As part of our supply chain work we are  reconfiguring our North America network.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad9664bc-4628-41d0-905e-64398ac61d70", "node_type": "1", "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.  ", "original_text": "We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "88d7e9bc7c086b510104a84283c2e15e6b12ddcd9fe212b19489fefa2e1d45f0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e1715db-9491-421d-b7f7-4d48ee021cd3", "node_type": "1", "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.  ", "original_text": "For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n "}, "hash": "6c27801f68e5ce4031564559197c9f135864810d7ef12e896a05d532f97a12c5", "class_name": "RelatedNodeInfo"}}, "text": "As part of our supply chain work we are  reconfiguring our North America network.  ", "start_char_idx": 283, "end_char_idx": 366, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4e1715db-9491-421d-b7f7-4d48ee021cd3": {"__data__": {"id_": "4e1715db-9491-421d-b7f7-4d48ee021cd3", "embedding": null, "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.  ", "original_text": "For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "269782c5-80d4-4de6-acb1-58d932791550", "node_type": "1", "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n ", "original_text": "As part of our supply chain work we are  reconfiguring our North America network.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "722241ffe8655c13fbbe1d0c1a666c2d1d705c643822601076b0a0dbf1a806e7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab110ce6-202b-45b6-9571-ad1aa52f3221", "node_type": "1", "metadata": {"window": "We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.  ", "original_text": "Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.  "}, "hash": "72c914dd86148a470c8ef4b2674d6adb78cef1dbdc1aa32fd607c4922c7696bf", "class_name": "RelatedNodeInfo"}}, "text": "For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n ", "start_char_idx": 366, "end_char_idx": 585, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ab110ce6-202b-45b6-9571-ad1aa52f3221": {"__data__": {"id_": "ab110ce6-202b-45b6-9571-ad1aa52f3221", "embedding": null, "metadata": {"window": "We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.  ", "original_text": "Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e1715db-9491-421d-b7f7-4d48ee021cd3", "node_type": "1", "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.  ", "original_text": "For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e4e288615ebd427290d93e6d0e6307a246129a20a7bba9688c9ac3e5029601ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ecc469d8-35f7-4a5b-8f3b-8e1b805fab8b", "node_type": "1", "metadata": {"window": "As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n ", "original_text": "We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n "}, "hash": "45f5b72e416bea6236461c263ad238352ba40dce0defdc2d336e2a3271d60eab", "class_name": "RelatedNodeInfo"}}, "text": "Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.  ", "start_char_idx": 585, "end_char_idx": 729, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ecc469d8-35f7-4a5b-8f3b-8e1b805fab8b": {"__data__": {"id_": "ecc469d8-35f7-4a5b-8f3b-8e1b805fab8b", "embedding": null, "metadata": {"window": "As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n ", "original_text": "We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab110ce6-202b-45b6-9571-ad1aa52f3221", "node_type": "1", "metadata": {"window": "We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.  ", "original_text": "Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1106aba32b550aeedc23136b93af1381e03973f4c79b8c1a80d380280d259c7f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a65373f-f6ed-4d7e-ab7e-8fc11f7b8fc8", "node_type": "1", "metadata": {"window": "For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n ", "original_text": "To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.  "}, "hash": "ac61597a0b41a819cfcc571491f5683704abad32e19c7926c82099b81a83c499", "class_name": "RelatedNodeInfo"}}, "text": "We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n ", "start_char_idx": 729, "end_char_idx": 825, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1a65373f-f6ed-4d7e-ab7e-8fc11f7b8fc8": {"__data__": {"id_": "1a65373f-f6ed-4d7e-ab7e-8fc11f7b8fc8", "embedding": null, "metadata": {"window": "For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n ", "original_text": "To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ecc469d8-35f7-4a5b-8f3b-8e1b805fab8b", "node_type": "1", "metadata": {"window": "As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n ", "original_text": "We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "92cab7fcda0f930dfad0a26ba7ad4fb823ee1ac78e729238dd080304b3a9f9ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e783ba55-ad3f-45e7-a4c9-aa96a7ade91b", "node_type": "1", "metadata": {"window": "Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.  ", "original_text": "These plans will take some time to execute.  "}, "hash": "3de9f1de9579a6c017d2e25f1139300855405cdfb34ad9e4d895deab0d7876ca", "class_name": "RelatedNodeInfo"}}, "text": "To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.  ", "start_char_idx": 825, "end_char_idx": 967, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e783ba55-ad3f-45e7-a4c9-aa96a7ade91b": {"__data__": {"id_": "e783ba55-ad3f-45e7-a4c9-aa96a7ade91b", "embedding": null, "metadata": {"window": "Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.  ", "original_text": "These plans will take some time to execute.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a65373f-f6ed-4d7e-ab7e-8fc11f7b8fc8", "node_type": "1", "metadata": {"window": "For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n  Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n ", "original_text": "To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ca57bc282116e4f43e7e8818bd09e6bbf8e7779b37b4e1383ccd7cd70961edc6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fa04aaf8-e60d-40a6-a335-6315e0bb7383", "node_type": "1", "metadata": {"window": "We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n ", "original_text": "So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n "}, "hash": "291af7a57566cfa0e0065ce75809f30555a04808efd49869a40ecda5315a5b50", "class_name": "RelatedNodeInfo"}}, "text": "These plans will take some time to execute.  ", "start_char_idx": 967, "end_char_idx": 1012, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fa04aaf8-e60d-40a6-a335-6315e0bb7383": {"__data__": {"id_": "fa04aaf8-e60d-40a6-a335-6315e0bb7383", "embedding": null, "metadata": {"window": "We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n ", "original_text": "So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e783ba55-ad3f-45e7-a4c9-aa96a7ade91b", "node_type": "1", "metadata": {"window": "Additionally, with respect to our global supply chain we more than doubled our manufacturing footprint with the \nPatient Recovery acquisition.   We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.  ", "original_text": "These plans will take some time to execute.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "acbb0eda4a691964fe1761d62371c442d61821bbda65ac85dfd14b6f63826f4f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "90b02d47-f364-4e8b-844c-08c3950eaf09", "node_type": "1", "metadata": {"window": "To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.  ", "original_text": "As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n "}, "hash": "33a9cf9d6ce7fabde22ddf36e0aa753bba70dea9e2629ccf50b35f33e8154670", "class_name": "RelatedNodeInfo"}}, "text": "So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n ", "start_char_idx": 1012, "end_char_idx": 1164, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "90b02d47-f364-4e8b-844c-08c3950eaf09": {"__data__": {"id_": "90b02d47-f364-4e8b-844c-08c3950eaf09", "embedding": null, "metadata": {"window": "To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.  ", "original_text": "As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fa04aaf8-e60d-40a6-a335-6315e0bb7383", "node_type": "1", "metadata": {"window": "We are already leveraging some synergies but we see a path to capture \nsignificantly more.  \n \n  To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n ", "original_text": "So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ed98a65db81ce3ced1b3b51eddd2baaf8a5211a4d3872938b6f61176edce75d7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3a51a433-375b-44e3-b5ce-7ec2e44b2599", "node_type": "1", "metadata": {"window": "These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n ", "original_text": "For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.  "}, "hash": "bd5986b69a0770a6ac5a4b5f09bc285a6e68c03ad6e382da13cc5be9eefc039f", "class_name": "RelatedNodeInfo"}}, "text": "As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n ", "start_char_idx": 1164, "end_char_idx": 1342, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3a51a433-375b-44e3-b5ce-7ec2e44b2599": {"__data__": {"id_": "3a51a433-375b-44e3-b5ce-7ec2e44b2599", "embedding": null, "metadata": {"window": "These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n ", "original_text": "For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "90b02d47-f364-4e8b-844c-08c3950eaf09", "node_type": "1", "metadata": {"window": "To that end, within the next quarter we will finalize plans to reduce costs and deliver industry leading service \nacross our global network.   These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.  ", "original_text": "As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "eed1bb7eeb343e48342a62bb445cd29e0837df068f94c88d88ffb5eb71bde316", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "416243c0-dc6c-4f72-9241-6453cd306976", "node_type": "1", "metadata": {"window": "So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.  ", "original_text": "We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n "}, "hash": "08c0b49027871843d7175122bac3f0ee2489098d878cc311944bfd0a213713ca", "class_name": "RelatedNodeInfo"}}, "text": "For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.  ", "start_char_idx": 1342, "end_char_idx": 1490, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "416243c0-dc6c-4f72-9241-6453cd306976": {"__data__": {"id_": "416243c0-dc6c-4f72-9241-6453cd306976", "embedding": null, "metadata": {"window": "So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.  ", "original_text": "We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3a51a433-375b-44e3-b5ce-7ec2e44b2599", "node_type": "1", "metadata": {"window": "These plans will take some time to execute.   So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n ", "original_text": "For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e6a69d879f9f970c1b6239378ee12174b3360df913123c97f75d9fab2aae6f7f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0a438360-b1e1-4a31-8f46-c3d27b3da3f3", "node_type": "1", "metadata": {"window": "As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n ", "original_text": "In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.  "}, "hash": "f2b691b2f2ded7eacd2012992659c8dfa876a680e0d8b2120710e59772f5f3c1", "class_name": "RelatedNodeInfo"}}, "text": "We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n ", "start_char_idx": 1490, "end_char_idx": 1690, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0a438360-b1e1-4a31-8f46-c3d27b3da3f3": {"__data__": {"id_": "0a438360-b1e1-4a31-8f46-c3d27b3da3f3", "embedding": null, "metadata": {"window": "As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n ", "original_text": "In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "416243c0-dc6c-4f72-9241-6453cd306976", "node_type": "1", "metadata": {"window": "So we have a strong governance \nstructure in place and are committed to diligently m anaging our costs to realize the greatest long -term benefit.  \n \n  As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.  ", "original_text": "We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5f036a55353a68bbd964297379f92a004ebdaacfcd1255e8e4f78401fdf3246f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9e81f693-9306-4962-88b4-8511b3a0d4d3", "node_type": "1", "metadata": {"window": "For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.  ", "original_text": "This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n "}, "hash": "ee9822f67f347c51c6823b6b3dfb82ae4be037e3118a67bee546678519f742d6", "class_name": "RelatedNodeInfo"}}, "text": "In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.  ", "start_char_idx": 1690, "end_char_idx": 1939, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9e81f693-9306-4962-88b4-8511b3a0d4d3": {"__data__": {"id_": "9e81f693-9306-4962-88b4-8511b3a0d4d3", "embedding": null, "metadata": {"window": "For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.  ", "original_text": "This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0a438360-b1e1-4a31-8f46-c3d27b3da3f3", "node_type": "1", "metadata": {"window": "As in pharma we are making significant investments across the Medical Segment to improve the customer \nexperience and drive growth in both the products and services spaces.  \n \n  For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n ", "original_text": "In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1aed42a14df99a20708c7529b2d77e2438afa0bfc034ea750cb78c138547d8a6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d0237d73-d58b-4066-9635-23e8a04ff174", "node_type": "1", "metadata": {"window": "We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n ", "original_text": "We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.  "}, "hash": "042626a3281817f2e16aa1faf63b5ddf6c4c5cd9ec1963f79538351695d8bf9d", "class_name": "RelatedNodeInfo"}}, "text": "This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n ", "start_char_idx": 1939, "end_char_idx": 2047, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d0237d73-d58b-4066-9635-23e8a04ff174": {"__data__": {"id_": "d0237d73-d58b-4066-9635-23e8a04ff174", "embedding": null, "metadata": {"window": "We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n ", "original_text": "We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9e81f693-9306-4962-88b4-8511b3a0d4d3", "node_type": "1", "metadata": {"window": "For example, as pat ient care shifts more toward the home we continue to capture growth opportunities through \nCardinal Health at -Home solutions.   We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.  ", "original_text": "This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2623d6b93562e98e46c881a98a34e56cdbc20a10c1148c7c58891f5f69441e0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "096ff9ec-d8d2-4952-b1a0-14c9bbec8da0", "node_type": "1", "metadata": {"window": "In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n ", "original_text": "We remain committed to fueling this momentum.  \n \n "}, "hash": "c83d658e91d68ed9b2242919cf6506a9441bb5b938f8465d154c58bcd3d9a7d7", "class_name": "RelatedNodeInfo"}}, "text": "We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.  ", "start_char_idx": 2047, "end_char_idx": 2194, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "096ff9ec-d8d2-4952-b1a0-14c9bbec8da0": {"__data__": {"id_": "096ff9ec-d8d2-4952-b1a0-14c9bbec8da0", "embedding": null, "metadata": {"window": "In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n ", "original_text": "We remain committed to fueling this momentum.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d0237d73-d58b-4066-9635-23e8a04ff174", "node_type": "1", "metadata": {"window": "We are committed to further developing this business and are redeploying \nsome of our cost savings benefit in this area to improve the customer, healthcare professional and patient \nexperiences.  \n \n  In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n ", "original_text": "We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8827aaaac11bfe1ebbd633d7072edf350a50fc01c285475ff528b88cb7e0dc16", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6f6b41c1-3ee1-4de9-a415-e3fc2f7594bb", "node_type": "1", "metadata": {"window": "This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.  "}, "hash": "1dfa8197c6aaaa613ea3d93ca01fd754b8b9fbf3c68efa7defea221f347ce6b9", "class_name": "RelatedNodeInfo"}}, "text": "We remain committed to fueling this momentum.  \n \n ", "start_char_idx": 2194, "end_char_idx": 2245, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6f6b41c1-3ee1-4de9-a415-e3fc2f7594bb": {"__data__": {"id_": "6f6b41c1-3ee1-4de9-a415-e3fc2f7594bb", "embedding": null, "metadata": {"window": "This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "096ff9ec-d8d2-4952-b1a0-14c9bbec8da0", "node_type": "1", "metadata": {"window": "In medical services, another business unit in the segment with sustained growth and strong results, we are \nbuilding additional digital and data capabilities, modernizing our operating systems  and streamlining clinical and \noperational workflows.   This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n ", "original_text": "We remain committed to fueling this momentum.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0cd0a3e2837540d1a8c997562e3a98af2bbc9c4ba935de06293c3b4d047a09ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9b7a1a9-04b8-4f9f-9fe8-9bc7d514aede", "node_type": "1", "metadata": {"window": "We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n "}, "hash": "b7348651172d3dd2147fc24eefcceb9ebb81f258b8250183cd6f2b91b570faaa", "class_name": "RelatedNodeInfo"}}, "text": "On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.  ", "start_char_idx": 2245, "end_char_idx": 2382, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d9b7a1a9-04b8-4f9f-9fe8-9bc7d514aede": {"__data__": {"id_": "d9b7a1a9-04b8-4f9f-9fe8-9bc7d514aede", "embedding": null, "metadata": {"window": "We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6f6b41c1-3ee1-4de9-a415-e3fc2f7594bb", "node_type": "1", "metadata": {"window": "This will reduce costs for both us and for our customers and importantly will improve \npatient safety.  \n \n  We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bb84e287f21df65ca251d08aee602c8bee2b993db002bee129da12d819072608", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "31d0cbee-864d-42c1-a54a-6004b5054a20", "node_type": "1", "metadata": {"window": "We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n "}, "hash": "abb43e358b78963a9f0bb17a0716e9cde30e2a0979c0672bbc3bf2c656d897c9", "class_name": "RelatedNodeInfo"}}, "text": "We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n ", "start_char_idx": 2382, "end_char_idx": 2501, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "31d0cbee-864d-42c1-a54a-6004b5054a20": {"__data__": {"id_": "31d0cbee-864d-42c1-a54a-6004b5054a20", "embedding": null, "metadata": {"window": "We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d9b7a1a9-04b8-4f9f-9fe8-9bc7d514aede", "node_type": "1", "metadata": {"window": "We recognize that components of the work across our products and services spaces will take time t o translate \ninto sustained growth and results.   We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "971b80985d29e683cdf6c0d7242b9765cbf3a5ad1ed866ad3c360d53ac5bd90f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3f2d2c2-19d8-4ffa-9bd1-0bbce9ef12cc", "node_type": "1", "metadata": {"window": "On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n "}, "hash": "a7f70af38d08d754c7c65838fd6171d7044d6b33fe8906541c336df67ac92853", "class_name": "RelatedNodeInfo"}}, "text": "Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n ", "start_char_idx": 2501, "end_char_idx": 2755, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b3f2d2c2-19d8-4ffa-9bd1-0bbce9ef12cc": {"__data__": {"id_": "b3f2d2c2-19d8-4ffa-9bd1-0bbce9ef12cc", "embedding": null, "metadata": {"window": "On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14", "node_type": "4", "metadata": {"page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ee65617656edf9310ffab50bbcb34b9e3fa089d7801abefc117bf58c356f86ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "31d0cbee-864d-42c1-a54a-6004b5054a20", "node_type": "1", "metadata": {"window": "We remain committed to fueling this momentum.  \n \n  On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "403e907929c447834e26a8372334d7d5663d05151a715d248cc82063e32630f1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bfe9cf12-aa72-467e-b162-c2be7530a4d2", "node_type": "1", "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.  ", "original_text": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n "}, "hash": "723cee373c20b4bc98ff0d48a47a3110c85e49d288620d8caa1577f31a1adc07", "class_name": "RelatedNodeInfo"}}, "text": "With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "start_char_idx": 2755, "end_char_idx": 3038, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bfe9cf12-aa72-467e-b162-c2be7530a4d2": {"__data__": {"id_": "bfe9cf12-aa72-467e-b162-c2be7530a4d2", "embedding": null, "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.  ", "original_text": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b3f2d2c2-19d8-4ffa-9bd1-0bbce9ef12cc", "node_type": "1", "metadata": {"window": "On the enterprise level as Dave and I shared earlier, our cost savings initiatives are producing tangible benefits \nacross the company.   We expect to meet or exc eed our $130 million commitment for the year primarily through \nSG&A related activities.  \n \n  Our initiatives to improve gross margin like those in medical to right size our manufacturing and distribution \nfootprint, will contribute more significantly to our fi ve year $500 million savings goal as they will ramp up over the \nnext few years.  \n \n  With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "original_text": "With these initiatives leaders across the company are evaluating internal operating models and identifying \nopportunities to leverage automation, analytics and additional tech nologies that not only drive efficiencies and \ncontribute to our savings goals but to improve insights.  \n ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8616e96150f204b3aa4e640f6720b0deca6fec47de56986bcd942997f6f3e4c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1b2563f4-931b-4a27-9eaf-34ab5cb21e73", "node_type": "1", "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n ", "original_text": "As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.  "}, "hash": "6c369e7ee495de96ac9127dc1770554f7058368e636bbbae1dab3122491233ba", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n ", "start_char_idx": 0, "end_char_idx": 213, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1b2563f4-931b-4a27-9eaf-34ab5cb21e73": {"__data__": {"id_": "1b2563f4-931b-4a27-9eaf-34ab5cb21e73", "embedding": null, "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n ", "original_text": "As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bfe9cf12-aa72-467e-b162-c2be7530a4d2", "node_type": "1", "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.  ", "original_text": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d2d9348c4e317a4a16387048587006312c1758b57fd8a29b892e1f9331a81297", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7630b64d-0fc0-43bf-b18c-19f494b8c3ec", "node_type": "1", "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n", "original_text": "About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n "}, "hash": "91e55d875f142a9505decb0e86458ec3d04f7d089b343a61435ef0a2c00a12c5", "class_name": "RelatedNodeInfo"}}, "text": "As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.  ", "start_char_idx": 213, "end_char_idx": 353, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7630b64d-0fc0-43bf-b18c-19f494b8c3ec": {"__data__": {"id_": "7630b64d-0fc0-43bf-b18c-19f494b8c3ec", "embedding": null, "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n", "original_text": "About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1b2563f4-931b-4a27-9eaf-34ab5cb21e73", "node_type": "1", "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n ", "original_text": "As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f8bb05f673386e6e76cbbaac75e895af6cd90a260cfdf08710df2107d7c11fb9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1176cf93-80c7-4243-a3d3-f53fc0a2c2ad", "node_type": "1", "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.  ", "original_text": "This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.  "}, "hash": "6a4d38136ebca6673ec0b2a773bbb577a1b04a294c04b1bfd79cbd9c815a7a5e", "class_name": "RelatedNodeInfo"}}, "text": "About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n ", "start_char_idx": 353, "end_char_idx": 551, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1176cf93-80c7-4243-a3d3-f53fc0a2c2ad": {"__data__": {"id_": "1176cf93-80c7-4243-a3d3-f53fc0a2c2ad", "embedding": null, "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.  ", "original_text": "This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7630b64d-0fc0-43bf-b18c-19f494b8c3ec", "node_type": "1", "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n", "original_text": "About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "46b308ce47ad2d5a9d2adde73ea6cf0e9698c5b93613111164f6e8cf1d61b2a5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9d24e060-94aa-4179-bff4-a4cfd0bc43d6", "node_type": "1", "metadata": {"window": "As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n ", "original_text": "We will share additional updates on these initiatives as they develop.  \n \n "}, "hash": "f52eba47036764af5ef4fc1cfa6743885eeb8d697a37e111bafecd164b8d745b", "class_name": "RelatedNodeInfo"}}, "text": "This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.  ", "start_char_idx": 551, "end_char_idx": 696, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9d24e060-94aa-4179-bff4-a4cfd0bc43d6": {"__data__": {"id_": "9d24e060-94aa-4179-bff4-a4cfd0bc43d6", "embedding": null, "metadata": {"window": "As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n ", "original_text": "We will share additional updates on these initiatives as they develop.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1176cf93-80c7-4243-a3d3-f53fc0a2c2ad", "node_type": "1", "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.  ", "original_text": "This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3b800c003947bcd24e07b53bdb3a675c46a4577ce94dc7f9e24e62c7a8dac8b6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8ee28bda-0873-4029-96a3-5dd221112f17", "node_type": "1", "metadata": {"window": "About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.  ", "original_text": "As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n"}, "hash": "b4e117b595981d427d8ec0f2ab352ec183f6a4b7c9cbd3d55fbb97efd87c1b45", "class_name": "RelatedNodeInfo"}}, "text": "We will share additional updates on these initiatives as they develop.  \n \n ", "start_char_idx": 696, "end_char_idx": 772, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8ee28bda-0873-4029-96a3-5dd221112f17": {"__data__": {"id_": "8ee28bda-0873-4029-96a3-5dd221112f17", "embedding": null, "metadata": {"window": "About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.  ", "original_text": "As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9d24e060-94aa-4179-bff4-a4cfd0bc43d6", "node_type": "1", "metadata": {"window": "As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n ", "original_text": "We will share additional updates on these initiatives as they develop.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "872e0e10b7bc7a18ad5c4f7f99f4ecafb5fd09decb3085e599850661715fb899", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d054c45a-eca0-4ead-b717-a605d5dfc923", "node_type": "1", "metadata": {"window": "This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.  ", "original_text": "This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.  "}, "hash": "6bfd0b675f79759c938dce604de16f7bf8c0c1427f8692d5bc6af9985a630a09", "class_name": "RelatedNodeInfo"}}, "text": "As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n", "start_char_idx": 772, "end_char_idx": 889, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d054c45a-eca0-4ead-b717-a605d5dfc923": {"__data__": {"id_": "d054c45a-eca0-4ead-b717-a605d5dfc923", "embedding": null, "metadata": {"window": "This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.  ", "original_text": "This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8ee28bda-0873-4029-96a3-5dd221112f17", "node_type": "1", "metadata": {"window": "About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.  ", "original_text": "As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "57d8f85a77c0c2dd4d0ef18048bbad48c11f9a6700a6204fd5665d29e2540add", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ba95085-4058-4329-82d0-595fe7a966a2", "node_type": "1", "metadata": {"window": "We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n", "original_text": "We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n "}, "hash": "acfb3c03bfbf16d49bdf537033221a00dd363225f269eed8b2f391472e4f42a8", "class_name": "RelatedNodeInfo"}}, "text": "This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.  ", "start_char_idx": 889, "end_char_idx": 1053, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6ba95085-4058-4329-82d0-595fe7a966a2": {"__data__": {"id_": "6ba95085-4058-4329-82d0-595fe7a966a2", "embedding": null, "metadata": {"window": "We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n", "original_text": "We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d054c45a-eca0-4ead-b717-a605d5dfc923", "node_type": "1", "metadata": {"window": "This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.   We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.  ", "original_text": "This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "26df3883abd97fff0e685a7f8846bcbaf99e1dd02b69b5ae706975a14bd5627b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d419e426-ff94-49e7-813e-a1d18ddbe90f", "node_type": "1", "metadata": {"window": "As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n ", "original_text": "To close, i n Q1 we generated positive momentum across the company.  "}, "hash": "b778e21c55ebcba58b80faebdd46fe13f76dbb6f18bf068c4edfe8329c627cb6", "class_name": "RelatedNodeInfo"}}, "text": "We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n ", "start_char_idx": 1053, "end_char_idx": 1207, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d419e426-ff94-49e7-813e-a1d18ddbe90f": {"__data__": {"id_": "d419e426-ff94-49e7-813e-a1d18ddbe90f", "embedding": null, "metadata": {"window": "As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n ", "original_text": "To close, i n Q1 we generated positive momentum across the company.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ba95085-4058-4329-82d0-595fe7a966a2", "node_type": "1", "metadata": {"window": "We will share additional updates on these initiatives as they develop.  \n \n  As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n", "original_text": "We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c06b329bff91e57401c175396c8fb819cf98c098481627f3c89478fd55777458", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "75659330-0daf-4bc7-95c9-90d945cbf8f1", "node_type": "1", "metadata": {"window": "This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n", "original_text": "We are pleased with this start to the year \nand recognize that there is more work ahead.  "}, "hash": "bdc1b9c76ac184dcb363a21a27c031f14415a2f3dacd0ae23b0861f04f3f16f1", "class_name": "RelatedNodeInfo"}}, "text": "To close, i n Q1 we generated positive momentum across the company.  ", "start_char_idx": 1207, "end_char_idx": 1276, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "75659330-0daf-4bc7-95c9-90d945cbf8f1": {"__data__": {"id_": "75659330-0daf-4bc7-95c9-90d945cbf8f1", "embedding": null, "metadata": {"window": "This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n", "original_text": "We are pleased with this start to the year \nand recognize that there is more work ahead.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d419e426-ff94-49e7-813e-a1d18ddbe90f", "node_type": "1", "metadata": {"window": "As we drive these type of efficiencies across the company we will fuel growth through balanced capital allocation.  \n This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n ", "original_text": "To close, i n Q1 we generated positive momentum across the company.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ab6ef1e247e08ef388ac76d1b741eca7c884e83c2ee513852fb69f2340a2166a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "35920030-fbf2-4885-b92b-641c544333d6", "node_type": "1", "metadata": {"window": "We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.  ", "original_text": "We have a strong foundation of scale and industry knowledge.  \n"}, "hash": "5583fa484c837a3366681b92b515fbbbd2533054c3405cd0e6618d6df5c6f302", "class_name": "RelatedNodeInfo"}}, "text": "We are pleased with this start to the year \nand recognize that there is more work ahead.  ", "start_char_idx": 1276, "end_char_idx": 1366, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "35920030-fbf2-4885-b92b-641c544333d6": {"__data__": {"id_": "35920030-fbf2-4885-b92b-641c544333d6", "embedding": null, "metadata": {"window": "We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.  ", "original_text": "We have a strong foundation of scale and industry knowledge.  \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75659330-0daf-4bc7-95c9-90d945cbf8f1", "node_type": "1", "metadata": {"window": "This includes reinvesting in the business, returning cash to share holders and improving our financial flexibility \nwhile maintaining our investment grade status.   We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n", "original_text": "We are pleased with this start to the year \nand recognize that there is more work ahead.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "94a976fd4be8ee1e48d7d5ba43ad2a4f93fa142092d067323d68faa95820489c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d9f98b8-d62a-49fc-a53b-8dec7911536b", "node_type": "1", "metadata": {"window": "To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n", "original_text": "With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n "}, "hash": "663acd39f7fcd1fbd5e1d4b32c77cfd77542286605aefe55dec02b2826c25e7b", "class_name": "RelatedNodeInfo"}}, "text": "We have a strong foundation of scale and industry knowledge.  \n", "start_char_idx": 1366, "end_char_idx": 1429, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5d9f98b8-d62a-49fc-a53b-8dec7911536b": {"__data__": {"id_": "5d9f98b8-d62a-49fc-a53b-8dec7911536b", "embedding": null, "metadata": {"window": "To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n", "original_text": "With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "35920030-fbf2-4885-b92b-641c544333d6", "node_type": "1", "metadata": {"window": "We remain committed to paying down at least $1 billion of long -\nterm debt this fiscal year, which includes the $450 million of debt maturing in Q2.  \n \n  To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.  ", "original_text": "We have a strong foundation of scale and industry knowledge.  \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5fcd5985b33edf43446450967d94e8bdbf3187972a68b8075f4b4182d69dcb26", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c7f5266-e575-4eed-b5e1-0920ed67f4a5", "node_type": "1", "metadata": {"window": "We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.  ", "original_text": "With that I\u2019ll now open it up for questions.  \n \n"}, "hash": "e520368098f7229b2763818eb15ab538013ba9eb3e996fa9c6b9cc62bdaeec83", "class_name": "RelatedNodeInfo"}}, "text": "With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n ", "start_char_idx": 1429, "end_char_idx": 1579, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1c7f5266-e575-4eed-b5e1-0920ed67f4a5": {"__data__": {"id_": "1c7f5266-e575-4eed-b5e1-0920ed67f4a5", "embedding": null, "metadata": {"window": "We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.  ", "original_text": "With that I\u2019ll now open it up for questions.  \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d9f98b8-d62a-49fc-a53b-8dec7911536b", "node_type": "1", "metadata": {"window": "To close, i n Q1 we generated positive momentum across the company.   We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n", "original_text": "With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a1168b4c036f4d36ffe506a9f2d64aeaf52077c8be7b00c301e01c882eb40c56", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a29ec611-9097-4915-9cff-e8c0b18368dd", "node_type": "1", "metadata": {"window": "We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?  ", "original_text": "Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.  "}, "hash": "2e7a560e560ea959ec13c2a277092561dc8b8ba23006ce9b761e4681e4393005", "class_name": "RelatedNodeInfo"}}, "text": "With that I\u2019ll now open it up for questions.  \n \n", "start_char_idx": 1579, "end_char_idx": 1628, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a29ec611-9097-4915-9cff-e8c0b18368dd": {"__data__": {"id_": "a29ec611-9097-4915-9cff-e8c0b18368dd", "embedding": null, "metadata": {"window": "We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?  ", "original_text": "Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c7f5266-e575-4eed-b5e1-0920ed67f4a5", "node_type": "1", "metadata": {"window": "We are pleased with this start to the year \nand recognize that there is more work ahead.   We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.  ", "original_text": "With that I\u2019ll now open it up for questions.  \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b4ddaa54a0e4b370a389c9e5fce516fce7efaf95604a3058085f150c90ad69cd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b540a01-8a86-4cfe-88ea-ef84b786faa4", "node_type": "1", "metadata": {"window": "With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n ", "original_text": "Please go ahead.  \n \n"}, "hash": "abc192a9e86fadd333e775e848d80854f813009415f31b93216a7aa709494ee9", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.  ", "start_char_idx": 1628, "end_char_idx": 1737, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5b540a01-8a86-4cfe-88ea-ef84b786faa4": {"__data__": {"id_": "5b540a01-8a86-4cfe-88ea-ef84b786faa4", "embedding": null, "metadata": {"window": "With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n ", "original_text": "Please go ahead.  \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a29ec611-9097-4915-9cff-e8c0b18368dd", "node_type": "1", "metadata": {"window": "We have a strong foundation of scale and industry knowledge.  \n With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?  ", "original_text": "Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4bfebc2831967476d3e98553058a51b0fd9caebf2dd79560cace69bcee918cef", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3b5d423d-b90e-4b26-b20b-aa39f086149e", "node_type": "1", "metadata": {"window": "With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n ", "original_text": "George Hill :  Hey good morning and thanks for taking the questions.  "}, "hash": "6c78047dd9db35215bff754d3f748b904bc47eff77094c0a46d942521c2de67d", "class_name": "RelatedNodeInfo"}}, "text": "Please go ahead.  \n \n", "start_char_idx": 1737, "end_char_idx": 1758, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3b5d423d-b90e-4b26-b20b-aa39f086149e": {"__data__": {"id_": "3b5d423d-b90e-4b26-b20b-aa39f086149e", "embedding": null, "metadata": {"window": "With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n ", "original_text": "George Hill :  Hey good morning and thanks for taking the questions.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b540a01-8a86-4cfe-88ea-ef84b786faa4", "node_type": "1", "metadata": {"window": "With our talented and dedicated employees we are  committed to building on this foundation to adapt, innovate \nand lead as our industry evolves.  \n \n  With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n ", "original_text": "Please go ahead.  \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a7d09c8c54f2f96d62b36298f5168372f6253ab3546550677be26eba5ac7882d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7645b9dd-7fb1-4879-b47a-1a16af71abc7", "node_type": "1", "metadata": {"window": "Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n", "original_text": "Mike I guess can you help me square two things \nhere?  "}, "hash": "2f73966f65ffb98f1238140fecc23473efaec2071d12acfee90f500449320cb2", "class_name": "RelatedNodeInfo"}}, "text": "George Hill :  Hey good morning and thanks for taking the questions.  ", "start_char_idx": 1758, "end_char_idx": 1828, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7645b9dd-7fb1-4879-b47a-1a16af71abc7": {"__data__": {"id_": "7645b9dd-7fb1-4879-b47a-1a16af71abc7", "embedding": null, "metadata": {"window": "Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n", "original_text": "Mike I guess can you help me square two things \nhere?  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3b5d423d-b90e-4b26-b20b-aa39f086149e", "node_type": "1", "metadata": {"window": "With that I\u2019ll now open it up for questions.  \n \n Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n ", "original_text": "George Hill :  Hey good morning and thanks for taking the questions.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e8761e38356463c4cdf9178276882c8772080bef580992c02bb8d775a50225c7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a2f016bd-c533-4ce5-8603-d7565d6aede7", "node_type": "1", "metadata": {"window": "Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n", "original_text": "You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n "}, "hash": "74c5cf9bd9ce930e0a76ee413cc7eb3cabc19e6ace85fdb0b8eb5a9064dbb0ef", "class_name": "RelatedNodeInfo"}}, "text": "Mike I guess can you help me square two things \nhere?  ", "start_char_idx": 1828, "end_char_idx": 1883, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a2f016bd-c533-4ce5-8603-d7565d6aede7": {"__data__": {"id_": "a2f016bd-c533-4ce5-8603-d7565d6aede7", "embedding": null, "metadata": {"window": "Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n", "original_text": "You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7645b9dd-7fb1-4879-b47a-1a16af71abc7", "node_type": "1", "metadata": {"window": "Operator :  (Operator Instructions)  \n \n We will take our first question from George Hill of Deutsche Bank.   Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n", "original_text": "Mike I guess can you help me square two things \nhere?  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "016f9d71837cd26c73dce26d4a98718e7db32e6491d5b857ba33059847099b6f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1ca391aa-9db5-480e-8abf-fdcb06eab3d6", "node_type": "1", "metadata": {"window": "George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n", "original_text": "But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n "}, "hash": "6414abcb4b1617c9740724c260653d459a5bef3d0f332fe590ad053eb265b9f1", "class_name": "RelatedNodeInfo"}}, "text": "You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n ", "start_char_idx": 1883, "end_char_idx": 1991, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1ca391aa-9db5-480e-8abf-fdcb06eab3d6": {"__data__": {"id_": "1ca391aa-9db5-480e-8abf-fdcb06eab3d6", "embedding": null, "metadata": {"window": "George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n", "original_text": "But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a2f016bd-c533-4ce5-8603-d7565d6aede7", "node_type": "1", "metadata": {"window": "Please go ahead.  \n \n George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n", "original_text": "You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "68f507dea3a24469f432c954ac08cb04fb225be6640dd06dcf79a6d02a1f0815", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c2931742-9ecb-49de-b665-23f05522bdf4", "node_type": "1", "metadata": {"window": "Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n"}, "hash": "708eefa563e15b7a041197c7bdcad4b17202882be63731967bb58604b0d579d6", "class_name": "RelatedNodeInfo"}}, "text": "But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n ", "start_char_idx": 1991, "end_char_idx": 2154, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c2931742-9ecb-49de-b665-23f05522bdf4": {"__data__": {"id_": "c2931742-9ecb-49de-b665-23f05522bdf4", "embedding": null, "metadata": {"window": "Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ca391aa-9db5-480e-8abf-fdcb06eab3d6", "node_type": "1", "metadata": {"window": "George Hill :  Hey good morning and thanks for taking the questions.   Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n", "original_text": "But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7280fd0df62d3bdee8c8737b2fa36eb500483837812ced23aa1e345b48af4ef2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f2aacda2-03d1-4b45-ab7d-5edcc778ba91", "node_type": "1", "metadata": {"window": "You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Mike Kaufmann :  Yes. \n \n"}, "hash": "5a5445aefba8cb26fba11f0ffa2bd73240dc7706362b0f9fdb648254c8ed7b7b", "class_name": "RelatedNodeInfo"}}, "text": "So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n", "start_char_idx": 2154, "end_char_idx": 2379, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f2aacda2-03d1-4b45-ab7d-5edcc778ba91": {"__data__": {"id_": "f2aacda2-03d1-4b45-ab7d-5edcc778ba91", "embedding": null, "metadata": {"window": "You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Mike Kaufmann :  Yes. \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c2931742-9ecb-49de-b665-23f05522bdf4", "node_type": "1", "metadata": {"window": "Mike I guess can you help me square two things \nhere?   You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "be67c03f1124f322587956ebf4ecd88ca9a450e3628203b5819ec8547e6866dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5dfc6309-d764-4b6d-9cbf-97ea6ce98671", "node_type": "1", "metadata": {"window": "But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Dave Evans :  Yes. \n \n"}, "hash": "dd5ffa85bcde96e5d2beb5012122ee2fabbd24facc8993b8204dbb3ce5bd417f", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes. \n \n", "start_char_idx": 2379, "end_char_idx": 2404, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5dfc6309-d764-4b6d-9cbf-97ea6ce98671": {"__data__": {"id_": "5dfc6309-d764-4b6d-9cbf-97ea6ce98671", "embedding": null, "metadata": {"window": "But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Dave Evans :  Yes. \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f2aacda2-03d1-4b45-ab7d-5edcc778ba91", "node_type": "1", "metadata": {"window": "You talked about the early signs of positive trends that you\u2019re seeing in the pharmaceutical business.  \n \n  But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Mike Kaufmann :  Yes. \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d153ebd34556c018c5b92425f828e44040c8541ce0b81d6ca7a51c2e0aa97002", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0dbac70c-8865-4e42-a2a2-84dbb1912b87", "node_type": "1", "metadata": {"window": "So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Mike Kaufmann :  And I\u2019ll let Dave start.  "}, "hash": "9719a00a84160479d489096d5342cbbf2d15f81f66ae1eb0d8275445e00bf9d9", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes. \n \n", "start_char_idx": 2404, "end_char_idx": 2426, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0dbac70c-8865-4e42-a2a2-84dbb1912b87": {"__data__": {"id_": "0dbac70c-8865-4e42-a2a2-84dbb1912b87", "embedding": null, "metadata": {"window": "So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Mike Kaufmann :  And I\u2019ll let Dave start.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b", "node_type": "4", "metadata": {"page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c74825e269b340fba496addbc1e707dabb31f77d91ee17ad5d2125791ff90671", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5dfc6309-d764-4b6d-9cbf-97ea6ce98671", "node_type": "1", "metadata": {"window": "But I kind  of want to square that with the guide where it seems like operating earnings deceleration was going to \ncontinue through the balance of the year.  \n \n  So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Dave Evans :  Yes. \n \n", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b848ea6534d363de1bf4a00e0dc2e071826034ec8391b2145ad7ffd715d64521", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "67888d04-cb8d-4eba-8f2e-cafafa920c09", "node_type": "1", "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.  ", "original_text": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.  "}, "hash": "50f02795b2efb87a68c199c7b7165c8cc30937dd6c56bcf4ee0157c44eab7dde", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  And I\u2019ll let Dave start.  ", "start_char_idx": 2426, "end_char_idx": 2469, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "67888d04-cb8d-4eba-8f2e-cafafa920c09": {"__data__": {"id_": "67888d04-cb8d-4eba-8f2e-cafafa920c09", "embedding": null, "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.  ", "original_text": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0dbac70c-8865-4e42-a2a2-84dbb1912b87", "node_type": "1", "metadata": {"window": "So I guess could you put a little more color on the positive trends that you\u2019re seeing and kind of help me s quare \nthat with the guide for operating\u2019s growth or actually operating\u2019s kind of deterioration in the segment?  \n \n Mike Kaufmann :  Yes. \n \n Dave Evans :  Yes. \n \n Mike Kaufmann :  And I\u2019ll let Dave start.  ", "original_text": "Mike Kaufmann :  And I\u2019ll let Dave start.  ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbb7ffdbc491bcd63aa01bf637740c36581f389c8cb173159a61bb0126cef91a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ea37b2de-afe1-46c1-96b9-633b0f2e3ae7", "node_type": "1", "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n ", "original_text": "Thanks for the question.  "}, "hash": "af100f794f70c266b39629efc4b4f238a8c8e7f462d6972261d87d4e8b0a68da", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.  ", "start_char_idx": 0, "end_char_idx": 47, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ea37b2de-afe1-46c1-96b9-633b0f2e3ae7": {"__data__": {"id_": "ea37b2de-afe1-46c1-96b9-633b0f2e3ae7", "embedding": null, "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n ", "original_text": "Thanks for the question.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67888d04-cb8d-4eba-8f2e-cafafa920c09", "node_type": "1", "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.  ", "original_text": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "30558c6fdb33018ea24a7baf2f138ad97874a813413dcd1618b4bfb2b9f39137", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af12a818-6874-41e8-8f62-66c2feab56fa", "node_type": "1", "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.  ", "original_text": "Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.  "}, "hash": "eaf59921d5dad70abf6c1e93fc3644f18772cd473b083f5242e8174f5933e5bd", "class_name": "RelatedNodeInfo"}}, "text": "Thanks for the question.  ", "start_char_idx": 47, "end_char_idx": 73, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "af12a818-6874-41e8-8f62-66c2feab56fa": {"__data__": {"id_": "af12a818-6874-41e8-8f62-66c2feab56fa", "embedding": null, "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.  ", "original_text": "Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ea37b2de-afe1-46c1-96b9-633b0f2e3ae7", "node_type": "1", "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n ", "original_text": "Thanks for the question.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3427514f52dcebb63b636b918a89cc4ca7d17e6a8b35b339ec9ad4e00f5f0df2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1672364d-5323-46d6-9dd3-7d99bad01829", "node_type": "1", "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.  ", "original_text": "I\u2019ll start with that.  "}, "hash": "d61e144a81b3bfcc91b0f648c26e95009df0a129e85646f9c1ce2ec5974e7a54", "class_name": "RelatedNodeInfo"}}, "text": "Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.  ", "start_char_idx": 73, "end_char_idx": 180, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1672364d-5323-46d6-9dd3-7d99bad01829": {"__data__": {"id_": "1672364d-5323-46d6-9dd3-7d99bad01829", "embedding": null, "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.  ", "original_text": "I\u2019ll start with that.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af12a818-6874-41e8-8f62-66c2feab56fa", "node_type": "1", "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.  ", "original_text": "Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0370002cca4901523f0ec5b896849ab5653ee03d2121520a317da3fce86bc603", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "26046145-f26e-4027-a0c5-119e56716eb0", "node_type": "1", "metadata": {"window": "Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n ", "original_text": "And certainly gives us increased confidence in the full year.  \n \n "}, "hash": "077b876cd04101969fac2ff8a84b1df1ed8c6d5ce5ea7019a50aff25e611a9d7", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019ll start with that.  ", "start_char_idx": 180, "end_char_idx": 203, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "26046145-f26e-4027-a0c5-119e56716eb0": {"__data__": {"id_": "26046145-f26e-4027-a0c5-119e56716eb0", "embedding": null, "metadata": {"window": "Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n ", "original_text": "And certainly gives us increased confidence in the full year.  \n \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1672364d-5323-46d6-9dd3-7d99bad01829", "node_type": "1", "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.  ", "original_text": "I\u2019ll start with that.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b1c1a10eef3f61b968c9bc8754446603c1b72d1d02aaab28303ba50ff866e938", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "90c2bd87-4473-4479-b7a2-e381a64b472d", "node_type": "1", "metadata": {"window": "Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.  ", "original_text": "At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.  "}, "hash": "c4291ef8ffccbec6178a1ce7f621f48175c5775f54b2c6fb22cf0b9690b85f87", "class_name": "RelatedNodeInfo"}}, "text": "And certainly gives us increased confidence in the full year.  \n \n ", "start_char_idx": 203, "end_char_idx": 270, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "90c2bd87-4473-4479-b7a2-e381a64b472d": {"__data__": {"id_": "90c2bd87-4473-4479-b7a2-e381a64b472d", "embedding": null, "metadata": {"window": "Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.  ", "original_text": "At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "26046145-f26e-4027-a0c5-119e56716eb0", "node_type": "1", "metadata": {"window": "Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n ", "original_text": "And certainly gives us increased confidence in the full year.  \n \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b4c2e6a8a368cb004bea211fc2b2118fdf141d16ef3634fc30d1b6c959840d71", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "238d4a95-4db3-4f8f-bd15-74f494cc4d0f", "node_type": "1", "metadata": {"window": "I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n", "original_text": "And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.  "}, "hash": "5b6bed778a49604eb583a2486ca637d89f56d66cf169467ae4c0f00043317a16", "class_name": "RelatedNodeInfo"}}, "text": "At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.  ", "start_char_idx": 270, "end_char_idx": 364, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "238d4a95-4db3-4f8f-bd15-74f494cc4d0f": {"__data__": {"id_": "238d4a95-4db3-4f8f-bd15-74f494cc4d0f", "embedding": null, "metadata": {"window": "I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n", "original_text": "And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "90c2bd87-4473-4479-b7a2-e381a64b472d", "node_type": "1", "metadata": {"window": "Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.  ", "original_text": "At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4a10a867b5e03c0b2cdbc8b63896984afd513b8bba0be46aff082e9ca1d73128", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45684b05-af2c-4f76-b25f-da6be3cfc355", "node_type": "1", "metadata": {"window": "And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.  ", "original_text": "And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n "}, "hash": "22ba7a923f8ae7db0c1cd86778e55885ca2b2356ff63edff901d83470468c8a2", "class_name": "RelatedNodeInfo"}}, "text": "And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.  ", "start_char_idx": 364, "end_char_idx": 480, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "45684b05-af2c-4f76-b25f-da6be3cfc355": {"__data__": {"id_": "45684b05-af2c-4f76-b25f-da6be3cfc355", "embedding": null, "metadata": {"window": "And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.  ", "original_text": "And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "238d4a95-4db3-4f8f-bd15-74f494cc4d0f", "node_type": "1", "metadata": {"window": "I\u2019ll start with that.   And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n", "original_text": "And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d357f28eaddc5b9f953395c55fe43dcb4e9d6e3e39edda9caeb09c3954081fab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ae3a7ae8-02ba-409c-b2f9-ac4b9bf1775a", "node_type": "1", "metadata": {"window": "At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n", "original_text": "So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.  "}, "hash": "74b9c41aa708a724500dbba5032fa68510938a7431f9f2a0e0d84f6ff0473a8f", "class_name": "RelatedNodeInfo"}}, "text": "And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n ", "start_char_idx": 480, "end_char_idx": 593, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ae3a7ae8-02ba-409c-b2f9-ac4b9bf1775a": {"__data__": {"id_": "ae3a7ae8-02ba-409c-b2f9-ac4b9bf1775a", "embedding": null, "metadata": {"window": "At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n", "original_text": "So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45684b05-af2c-4f76-b25f-da6be3cfc355", "node_type": "1", "metadata": {"window": "And certainly gives us increased confidence in the full year.  \n \n  At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.  ", "original_text": "And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7f9cc179bf7c2d1f0a2b56519b1ac2d28a7af1c1d4ff6fd6511000ae5f54c026", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "42bfde68-162a-43ea-a86a-9777116fb508", "node_type": "1", "metadata": {"window": "And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.  ", "original_text": "We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n"}, "hash": "7aa3fbd62f855fad647f39fbe4d76e32984c97215109292358166d84ef07c18e", "class_name": "RelatedNodeInfo"}}, "text": "So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.  ", "start_char_idx": 593, "end_char_idx": 703, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "42bfde68-162a-43ea-a86a-9777116fb508": {"__data__": {"id_": "42bfde68-162a-43ea-a86a-9777116fb508", "embedding": null, "metadata": {"window": "And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.  ", "original_text": "We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ae3a7ae8-02ba-409c-b2f9-ac4b9bf1775a", "node_type": "1", "metadata": {"window": "At the same time, I\u2019d say we\u2019re very cautious in that we\u2019re only one quar ter into the year.   And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n", "original_text": "So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "66555baa5fafddd3195739a736599532a5dbcdb7fd8d9582907b96b14e694d64", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8af24bf4-3842-44f7-9254-819e85068a04", "node_type": "1", "metadata": {"window": "And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n", "original_text": "George Hill :  Okay that\u2019s super helpful.  "}, "hash": "7d34d59b741935c0fc84aaa6a348573c472f2f2260bc970b3792c65b8c1a157b", "class_name": "RelatedNodeInfo"}}, "text": "We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n", "start_char_idx": 703, "end_char_idx": 802, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8af24bf4-3842-44f7-9254-819e85068a04": {"__data__": {"id_": "8af24bf4-3842-44f7-9254-819e85068a04", "embedding": null, "metadata": {"window": "And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n", "original_text": "George Hill :  Okay that\u2019s super helpful.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "42bfde68-162a-43ea-a86a-9777116fb508", "node_type": "1", "metadata": {"window": "And we\u2019ve got some \npretty significant assumptions out there that are still left open for example brand inflation.   And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.  ", "original_text": "We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "44ab9a649211fae63b2ee8baddb2a06d8fea044e97a6727324611f36216bbe4c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b59a702a-3f71-4642-b7b1-39ea3fe26cbf", "node_type": "1", "metadata": {"window": "So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n", "original_text": "And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n"}, "hash": "43daa1781e2ab232d666deb29d67a1714976c593886ae50a4f83096f4dc81924", "class_name": "RelatedNodeInfo"}}, "text": "George Hill :  Okay that\u2019s super helpful.  ", "start_char_idx": 802, "end_char_idx": 845, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b59a702a-3f71-4642-b7b1-39ea3fe26cbf": {"__data__": {"id_": "b59a702a-3f71-4642-b7b1-39ea3fe26cbf", "embedding": null, "metadata": {"window": "So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n", "original_text": "And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8af24bf4-3842-44f7-9254-819e85068a04", "node_type": "1", "metadata": {"window": "And there\u2019s also a lot of \nother key kind of environmental assumptions that we\u2019re making that could change.  \n \n  So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n", "original_text": "George Hill :  Okay that\u2019s super helpful.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5e9fddeab98706fcdce1ee2201c4c2a989a068cb26faff6ed1de516a496a31d0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c086de9e-e60f-4b05-9595-fa38d0d15fb4", "node_type": "1", "metadata": {"window": "We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.  ", "original_text": "Dave Evans :  You know we did see a full quarter.  "}, "hash": "71098fcdc30577e4c80d617485a74f152f61a11980f4299b5e614549c38efbcc", "class_name": "RelatedNodeInfo"}}, "text": "And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n", "start_char_idx": 845, "end_char_idx": 1005, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c086de9e-e60f-4b05-9595-fa38d0d15fb4": {"__data__": {"id_": "c086de9e-e60f-4b05-9595-fa38d0d15fb4", "embedding": null, "metadata": {"window": "We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.  ", "original_text": "Dave Evans :  You know we did see a full quarter.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b59a702a-3f71-4642-b7b1-39ea3fe26cbf", "node_type": "1", "metadata": {"window": "So our view is at this early stage in the year there\u2019s just no reason to be changing our full year guidance.   We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n", "original_text": "And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "fd19956b247c2bc10808cd85ae3d9f67a9266fd32db1543d76337853c40cb847", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4eb2f0bd-ff23-43c2-9476-efc29ccb4294", "node_type": "1", "metadata": {"window": "George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n", "original_text": "And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n"}, "hash": "d9e47767f7023fa268683eae2363ab9aeb6646ba332cfce8e9d6f405414bf286", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  You know we did see a full quarter.  ", "start_char_idx": 1005, "end_char_idx": 1056, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4eb2f0bd-ff23-43c2-9476-efc29ccb4294": {"__data__": {"id_": "4eb2f0bd-ff23-43c2-9476-efc29ccb4294", "embedding": null, "metadata": {"window": "George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n", "original_text": "And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c086de9e-e60f-4b05-9595-fa38d0d15fb4", "node_type": "1", "metadata": {"window": "We\u2019ll \ncertainly be in a much better position to do that after our next quarter earnings call.  \n \n George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.  ", "original_text": "Dave Evans :  You know we did see a full quarter.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d68b26d577af22c29d1d8e7382be5a465527de354b6f8dab831cc9d492331769", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5dfef621-bf39-47af-ad8d-dd57dc0f3ca7", "node_type": "1", "metadata": {"window": "And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n", "original_text": "Kevin Moran :  Thanks George.  \n \n"}, "hash": "827c451d1f05a61fafbefb7c0a09a67047b168f500c6c32720c7e604e60cf639", "class_name": "RelatedNodeInfo"}}, "text": "And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n", "start_char_idx": 1056, "end_char_idx": 1157, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5dfef621-bf39-47af-ad8d-dd57dc0f3ca7": {"__data__": {"id_": "5dfef621-bf39-47af-ad8d-dd57dc0f3ca7", "embedding": null, "metadata": {"window": "And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n", "original_text": "Kevin Moran :  Thanks George.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4eb2f0bd-ff23-43c2-9476-efc29ccb4294", "node_type": "1", "metadata": {"window": "George Hill :  Okay that\u2019s super helpful.   And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n", "original_text": "And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "caea6f08d8b3d7c84693b1ef50660d5762e8cfc76a56de93c4e5353d2b9ec8a7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0d410a0e-c79d-4c20-a331-84f18b9d0e38", "node_type": "1", "metadata": {"window": "Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.  ", "original_text": "George Hill :  Okay helpful.  "}, "hash": "c2d4550eeda995f76c6790e105f1575accf1516102369ef20d5848e930e513f2", "class_name": "RelatedNodeInfo"}}, "text": "Kevin Moran :  Thanks George.  \n \n", "start_char_idx": 1157, "end_char_idx": 1191, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0d410a0e-c79d-4c20-a331-84f18b9d0e38": {"__data__": {"id_": "0d410a0e-c79d-4c20-a331-84f18b9d0e38", "embedding": null, "metadata": {"window": "Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.  ", "original_text": "George Hill :  Okay helpful.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5dfef621-bf39-47af-ad8d-dd57dc0f3ca7", "node_type": "1", "metadata": {"window": "And then maybe just a quick follow -up is did we see a full quarter of the CVS \nrepricing this quarter and is there any way to call out the impact to that?  \n \n Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n", "original_text": "Kevin Moran :  Thanks George.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4d6c028641a0a8cb1b5d87c9a499334a6f86f4071f2c7875e1095944ce0eee78", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5e622aeb-cf35-4eed-9d0e-fbf7fc9502fa", "node_type": "1", "metadata": {"window": "And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.  ", "original_text": "Thank you.  \n \n"}, "hash": "090b4a4252a6d20147250d4916f85c536920971c32ad7cf10889a654f27cf957", "class_name": "RelatedNodeInfo"}}, "text": "George Hill :  Okay helpful.  ", "start_char_idx": 1191, "end_char_idx": 1221, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5e622aeb-cf35-4eed-9d0e-fbf7fc9502fa": {"__data__": {"id_": "5e622aeb-cf35-4eed-9d0e-fbf7fc9502fa", "embedding": null, "metadata": {"window": "And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.  ", "original_text": "Thank you.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0d410a0e-c79d-4c20-a331-84f18b9d0e38", "node_type": "1", "metadata": {"window": "Dave Evans :  You know we did see a full quarter.   And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.  ", "original_text": "George Hill :  Okay helpful.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "eceac8d2ec9985e00b0a735114a00d3147b11beb65817f6d89111aecb79c9e39", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1eb192c-f13e-4185-83a9-c1d654bc7e9f", "node_type": "1", "metadata": {"window": "Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n", "original_text": "Kevin Moran :  Operator, next question please.  \n \n"}, "hash": "d8e7f73b95688cda2b6cd7f96b6dee3c0524912278453fad9d5c450acb84ef74", "class_name": "RelatedNodeInfo"}}, "text": "Thank you.  \n \n", "start_char_idx": 1221, "end_char_idx": 1236, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d1eb192c-f13e-4185-83a9-c1d654bc7e9f": {"__data__": {"id_": "d1eb192c-f13e-4185-83a9-c1d654bc7e9f", "embedding": null, "metadata": {"window": "Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n", "original_text": "Kevin Moran :  Operator, next question please.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5e622aeb-cf35-4eed-9d0e-fbf7fc9502fa", "node_type": "1", "metadata": {"window": "And we\u2019ve not provided any specificity in terms of the annual impa ct of \nthat contract renewal.  \n \n Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.  ", "original_text": "Thank you.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c27e116814d8a7bc414623961eea696841fc35c1036aff1e01c33db6e0e17784", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4bbf0b3c-6ea3-4233-84ca-ed94433e0ade", "node_type": "1", "metadata": {"window": "George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.  ", "original_text": "Operator :  Thank you sir.  "}, "hash": "3d1a084db372bd913ab31fa7c3d0850ba2d0e31b2e0a763efc8fb5f89e0b68ef", "class_name": "RelatedNodeInfo"}}, "text": "Kevin Moran :  Operator, next question please.  \n \n", "start_char_idx": 1236, "end_char_idx": 1287, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4bbf0b3c-6ea3-4233-84ca-ed94433e0ade": {"__data__": {"id_": "4bbf0b3c-6ea3-4233-84ca-ed94433e0ade", "embedding": null, "metadata": {"window": "George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.  ", "original_text": "Operator :  Thank you sir.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1eb192c-f13e-4185-83a9-c1d654bc7e9f", "node_type": "1", "metadata": {"window": "Kevin Moran :  Thanks George.  \n \n George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n", "original_text": "Kevin Moran :  Operator, next question please.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "83b75b93f931e9fa984a08207bb81e701b9d0344b0a3f1d18317028251563769", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "00a73d54-ae97-4fc6-8930-e92518b57270", "node_type": "1", "metadata": {"window": "Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n", "original_text": "We will now take our next question from Glen Santangelo of Guggenheim Partners.  "}, "hash": "6e084b61fbb49bfb46d7d595d816c844439d75eda73f2837b8e820843830f805", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you sir.  ", "start_char_idx": 1287, "end_char_idx": 1315, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "00a73d54-ae97-4fc6-8930-e92518b57270": {"__data__": {"id_": "00a73d54-ae97-4fc6-8930-e92518b57270", "embedding": null, "metadata": {"window": "Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n", "original_text": "We will now take our next question from Glen Santangelo of Guggenheim Partners.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4bbf0b3c-6ea3-4233-84ca-ed94433e0ade", "node_type": "1", "metadata": {"window": "George Hill :  Okay helpful.   Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.  ", "original_text": "Operator :  Thank you sir.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "33e6453aff6d5f4c7995ec747c8ad296b7de52e8412487609634cbebc2ae688e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "81cecd95-5f8b-4116-9c7f-07ee4f1bced0", "node_type": "1", "metadata": {"window": "Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n ", "original_text": "Please go \nahead.  \n \n"}, "hash": "c4dea16fc139e99d50efa58873f221de5eae85d84696592a611c88f44960d107", "class_name": "RelatedNodeInfo"}}, "text": "We will now take our next question from Glen Santangelo of Guggenheim Partners.  ", "start_char_idx": 1315, "end_char_idx": 1396, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "81cecd95-5f8b-4116-9c7f-07ee4f1bced0": {"__data__": {"id_": "81cecd95-5f8b-4116-9c7f-07ee4f1bced0", "embedding": null, "metadata": {"window": "Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n ", "original_text": "Please go \nahead.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "00a73d54-ae97-4fc6-8930-e92518b57270", "node_type": "1", "metadata": {"window": "Thank you.  \n \n Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n", "original_text": "We will now take our next question from Glen Santangelo of Guggenheim Partners.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b06da294627d254132945d7c51a16e58cb24bf246f54e0197d2ac9cd8e0d7e9d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6f3f1d59-14e1-4221-904e-32d6f1189884", "node_type": "1", "metadata": {"window": "Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n", "original_text": "Glen Santangelo :  Yes, thanks and good morning.  "}, "hash": "d5860a5b70a89de98120e8a321107d242d3fc5a57fe9b1ad5f1838e67b2cc9cb", "class_name": "RelatedNodeInfo"}}, "text": "Please go \nahead.  \n \n", "start_char_idx": 1396, "end_char_idx": 1418, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6f3f1d59-14e1-4221-904e-32d6f1189884": {"__data__": {"id_": "6f3f1d59-14e1-4221-904e-32d6f1189884", "embedding": null, "metadata": {"window": "Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n", "original_text": "Glen Santangelo :  Yes, thanks and good morning.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "81cecd95-5f8b-4116-9c7f-07ee4f1bced0", "node_type": "1", "metadata": {"window": "Kevin Moran :  Operator, next question please.  \n \n Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n ", "original_text": "Please go \nahead.  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6caa141c566a1bf1179cb08b253c20e15afe4931433df98bb0f6c2311de85600", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d7081f32-363e-42bb-a39a-c56f76149d93", "node_type": "1", "metadata": {"window": "We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "Mike I just wanted to follow -up on the strength in the medical business.  \n"}, "hash": "e6547a14da95a4ef28e878a56e0b3713287b628cd6e5a9f4382b123a00146bad", "class_name": "RelatedNodeInfo"}}, "text": "Glen Santangelo :  Yes, thanks and good morning.  ", "start_char_idx": 1418, "end_char_idx": 1468, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d7081f32-363e-42bb-a39a-c56f76149d93": {"__data__": {"id_": "d7081f32-363e-42bb-a39a-c56f76149d93", "embedding": null, "metadata": {"window": "We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "Mike I just wanted to follow -up on the strength in the medical business.  \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6f3f1d59-14e1-4221-904e-32d6f1189884", "node_type": "1", "metadata": {"window": "Operator :  Thank you sir.   We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n", "original_text": "Glen Santangelo :  Yes, thanks and good morning.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "11fa6d3ec94a2f8f26ecac6d30e006e1541a2f1b119375e3c4421f2a147ffa5c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "88bbb52b-2a99-4d5e-ac89-e42448b4cfda", "node_type": "1", "metadata": {"window": "Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.  ", "original_text": "In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n "}, "hash": "22d790b5a7f755d0b470abe0e640b4ffc4712ade52e4aa398eee566d6d3367bb", "class_name": "RelatedNodeInfo"}}, "text": "Mike I just wanted to follow -up on the strength in the medical business.  \n", "start_char_idx": 1468, "end_char_idx": 1544, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "88bbb52b-2a99-4d5e-ac89-e42448b4cfda": {"__data__": {"id_": "88bbb52b-2a99-4d5e-ac89-e42448b4cfda", "embedding": null, "metadata": {"window": "Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.  ", "original_text": "In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d7081f32-363e-42bb-a39a-c56f76149d93", "node_type": "1", "metadata": {"window": "We will now take our next question from Glen Santangelo of Guggenheim Partners.   Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "Mike I just wanted to follow -up on the strength in the medical business.  \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "599576929bc209534240bca3cb1130106ae9bd6ace59463bee80e16ae352be37", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ada1d1bf-fad8-4f1a-a4b3-c16e46e5c7ce", "node_type": "1", "metadata": {"window": "Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.  ", "original_text": "But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n"}, "hash": "a6e47a756d2eb602e9711dbe2f1b3bebd2e88e0017310977464d1e9a5f1f26ad", "class_name": "RelatedNodeInfo"}}, "text": "In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n ", "start_char_idx": 1544, "end_char_idx": 1733, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ada1d1bf-fad8-4f1a-a4b3-c16e46e5c7ce": {"__data__": {"id_": "ada1d1bf-fad8-4f1a-a4b3-c16e46e5c7ce", "embedding": null, "metadata": {"window": "Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.  ", "original_text": "But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "88bbb52b-2a99-4d5e-ac89-e42448b4cfda", "node_type": "1", "metadata": {"window": "Please go \nahead.  \n \n Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.  ", "original_text": "In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d054ca5657893ca84bda82235b8b2a8cc84d1c452633f9f967579b76c93d284a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6763d7f5-0083-4195-bec3-840a8d3f075f", "node_type": "1", "metadata": {"window": "Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n ", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  "}, "hash": "2d9e17f61efe565517c962be3cc150762c82562a8b9996779f4a40604c71d855", "class_name": "RelatedNodeInfo"}}, "text": "But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n", "start_char_idx": 1733, "end_char_idx": 1893, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6763d7f5-0083-4195-bec3-840a8d3f075f": {"__data__": {"id_": "6763d7f5-0083-4195-bec3-840a8d3f075f", "embedding": null, "metadata": {"window": "Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n ", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ada1d1bf-fad8-4f1a-a4b3-c16e46e5c7ce", "node_type": "1", "metadata": {"window": "Glen Santangelo :  Yes, thanks and good morning.   Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.  ", "original_text": "But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "aa075e8eb6ffa0981346feff4a1fa8661ddf8b1b1138aecb32cfaea0e25879be", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ccf11c6f-aaa3-468e-b47c-34fcd6f50c14", "node_type": "1", "metadata": {"window": "In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.  ", "original_text": "Yes, I feel really good about the Med Segment.  "}, "hash": "1a315e99870e47a8b555b2cbdeb14a21b60bf19de25fa43c5a0642e2bd15aba3", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes, thanks for the question.  ", "start_char_idx": 1893, "end_char_idx": 1941, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ccf11c6f-aaa3-468e-b47c-34fcd6f50c14": {"__data__": {"id_": "ccf11c6f-aaa3-468e-b47c-34fcd6f50c14", "embedding": null, "metadata": {"window": "In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.  ", "original_text": "Yes, I feel really good about the Med Segment.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6763d7f5-0083-4195-bec3-840a8d3f075f", "node_type": "1", "metadata": {"window": "Mike I just wanted to follow -up on the strength in the medical business.  \n In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n ", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "385d3a0b211093a4b18902348c9be9c49dd9c59a055d1f5efc365250f252307f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6889a72b-29fe-4a15-ac78-7424fe34e6ed", "node_type": "1", "metadata": {"window": "But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.  "}, "hash": "5ef15e1fcd03ca62fd2b44152d8a02c79036a3f3e2212111a9cd584f0013928e", "class_name": "RelatedNodeInfo"}}, "text": "Yes, I feel really good about the Med Segment.  ", "start_char_idx": 1941, "end_char_idx": 1989, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6889a72b-29fe-4a15-ac78-7424fe34e6ed": {"__data__": {"id_": "6889a72b-29fe-4a15-ac78-7424fe34e6ed", "embedding": null, "metadata": {"window": "But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ccf11c6f-aaa3-468e-b47c-34fcd6f50c14", "node_type": "1", "metadata": {"window": "In the past few years you talked about the challenging market conditions, some of the supply chain issue s.  It \nsounds like this quarter the company did a great job on the cost side.  \n \n  But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.  ", "original_text": "Yes, I feel really good about the Med Segment.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c1bc36a8117e5187d759cb4d8d4ba994722b3573cb7c7d0dc95ce3a3c87ce688", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "55dfa09d-ff21-4101-b682-303e3a4109b1", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n "}, "hash": "27005b77014a145e5524d424627cfb7a8fffe204aa077e3ec6e7326349c2b33f", "class_name": "RelatedNodeInfo"}}, "text": "They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.  ", "start_char_idx": 1989, "end_char_idx": 2110, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "55dfa09d-ff21-4101-b682-303e3a4109b1": {"__data__": {"id_": "55dfa09d-ff21-4101-b682-303e3a4109b1", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6889a72b-29fe-4a15-ac78-7424fe34e6ed", "node_type": "1", "metadata": {"window": "But what else has changed to help drive that performance so we can, you know, maybe think about the \nsustainability of the results you posted this quarter?  \n \n Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "75ba4161bef9a04616e4f78dc16bd231b29baafdae3ee48deee64bfaac8b17a5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa225c5e-c9fb-4176-9717-301e0bba55d5", "node_type": "1", "metadata": {"window": "Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "SG&A clearly was a component of our performance in the quarter.  "}, "hash": "07e9f7ef1882a31322ba3913326f0fd06dc2dc639278830f5161fa4a532d0d15", "class_name": "RelatedNodeInfo"}}, "text": "He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n ", "start_char_idx": 2110, "end_char_idx": 2223, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "aa225c5e-c9fb-4176-9717-301e0bba55d5": {"__data__": {"id_": "aa225c5e-c9fb-4176-9717-301e0bba55d5", "embedding": null, "metadata": {"window": "Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "SG&A clearly was a component of our performance in the quarter.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "55dfa09d-ff21-4101-b682-303e3a4109b1", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bb1c9d2633edd8224432b1279322b48a6ab20b78909cf5e4afb9dcd225fd96b0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b35ce096-1642-4450-b42f-d907f59daea1", "node_type": "1", "metadata": {"window": "They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "But there are multiple areas where we are \nworking through various performance, you know improvement.  \n "}, "hash": "1e0e8ea5d046645a990a674aae96092d6b31c1031238e7f5f19a3f1610ca780e", "class_name": "RelatedNodeInfo"}}, "text": "SG&A clearly was a component of our performance in the quarter.  ", "start_char_idx": 2223, "end_char_idx": 2288, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b35ce096-1642-4450-b42f-d907f59daea1": {"__data__": {"id_": "b35ce096-1642-4450-b42f-d907f59daea1", "embedding": null, "metadata": {"window": "They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8", "node_type": "4", "metadata": {"page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5956e72d4c6febec42d3e3bbbffea229a00154556404c72b450e4e266b84b4fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa225c5e-c9fb-4176-9717-301e0bba55d5", "node_type": "1", "metadata": {"window": "Yes, I feel really good about the Med Segment.   They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "SG&A clearly was a component of our performance in the quarter.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c18f9f8f626426a4a419a0bf0d5adc55abc20216cbade36d583be66a26320998", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a1fb589-4f83-4b19-a7ee-60a727084426", "node_type": "1", "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.  ", "original_text": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n "}, "hash": "adb64a030fac20c9f35c8d7790ebe032bc7320a1fe0e7343714fb0cb67cbc525", "class_name": "RelatedNodeInfo"}}, "text": "But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "start_char_idx": 2288, "end_char_idx": 2393, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8a1fb589-4f83-4b19-a7ee-60a727084426": {"__data__": {"id_": "8a1fb589-4f83-4b19-a7ee-60a727084426", "embedding": null, "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.  ", "original_text": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b35ce096-1642-4450-b42f-d907f59daea1", "node_type": "1", "metadata": {"window": "They performed a little \nbetter than we expected in Q1 and really happy with the transition of Steve Mason in his role.   He\u2019s done an \nexcellent job of getting up to speed so far and really surrounding himself with a solid team.  \n \n  SG&A clearly was a component of our performance in the quarter.   But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "original_text": "But there are multiple areas where we are \nworking through various performance, you know improvement.  \n ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "de4be2fb957e631c4b1ba84d80f66b8c0504943ce2a58fc8c2be5e4a737f27eb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f880d04c-a401-4c16-b46b-8e21e6ce4f15", "node_type": "1", "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n", "original_text": "So we made a lot of progress in service levels.  "}, "hash": "c31550d1ccdbfb46d237de71a424c305ccc9bf97215c0d8271cf514035092666", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n ", "start_char_idx": 0, "end_char_idx": 221, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f880d04c-a401-4c16-b46b-8e21e6ce4f15": {"__data__": {"id_": "f880d04c-a401-4c16-b46b-8e21e6ce4f15", "embedding": null, "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n", "original_text": "So we made a lot of progress in service levels.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a1fb589-4f83-4b19-a7ee-60a727084426", "node_type": "1", "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.  ", "original_text": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1d9294c0af69f1762d9b89d837d1c9bdb048177a9e38360f8a28b1a734ae9f02", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "147a09bd-10dd-48ab-8578-b4328255655e", "node_type": "1", "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.  ", "original_text": "We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n "}, "hash": "b41479a4212a42aed6c45b7aef54c956003813266aa03447e9141222c827c21e", "class_name": "RelatedNodeInfo"}}, "text": "So we made a lot of progress in service levels.  ", "start_char_idx": 221, "end_char_idx": 270, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "147a09bd-10dd-48ab-8578-b4328255655e": {"__data__": {"id_": "147a09bd-10dd-48ab-8578-b4328255655e", "embedding": null, "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.  ", "original_text": "We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f880d04c-a401-4c16-b46b-8e21e6ce4f15", "node_type": "1", "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n", "original_text": "So we made a lot of progress in service levels.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "350ed8a225de614d8463e12d9beab0bac985c63bacad177d1981e5f71e8cbe55", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9b5185fe-2f6e-4026-afd3-16dd3620cb33", "node_type": "1", "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.  ", "original_text": "And we\u2019re in different innings on each one of those.  "}, "hash": "dc8e3e90e1935160e8e51e8954a36fa6da3b4528ea337915e0a10aadc239c98f", "class_name": "RelatedNodeInfo"}}, "text": "We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n ", "start_char_idx": 270, "end_char_idx": 357, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9b5185fe-2f6e-4026-afd3-16dd3620cb33": {"__data__": {"id_": "9b5185fe-2f6e-4026-afd3-16dd3620cb33", "embedding": null, "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.  ", "original_text": "And we\u2019re in different innings on each one of those.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "147a09bd-10dd-48ab-8578-b4328255655e", "node_type": "1", "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.  ", "original_text": "We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cf45cdba8366097cf4c005ac564bb0cf42ca852f863ed0406696429632e44a2e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a65c5cc1-8a32-4c8e-bd88-24c42b85f81d", "node_type": "1", "metadata": {"window": "So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n", "original_text": "But really happy so far with what we saw in the first quarter \nof medical.  \n \n"}, "hash": "297c9a12274e3e2bfb1ccae902803586659c5a65767014f5e5820118703406e3", "class_name": "RelatedNodeInfo"}}, "text": "And we\u2019re in different innings on each one of those.  ", "start_char_idx": 357, "end_char_idx": 411, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a65c5cc1-8a32-4c8e-bd88-24c42b85f81d": {"__data__": {"id_": "a65c5cc1-8a32-4c8e-bd88-24c42b85f81d", "embedding": null, "metadata": {"window": "So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n", "original_text": "But really happy so far with what we saw in the first quarter \nof medical.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9b5185fe-2f6e-4026-afd3-16dd3620cb33", "node_type": "1", "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.  ", "original_text": "And we\u2019re in different innings on each one of those.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "751cc79442fea56027f18789747cdb89224b46f8d451ece6179b7bab5f3c0afb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c224a1a4-0fa0-47d6-a368-464eb80432f9", "node_type": "1", "metadata": {"window": "We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?  ", "original_text": "Glen Santangelo :  Thanks.  "}, "hash": "b0506f04b6b5fb2f8097168efdeaede1e80c1f09171df4a7844fb74dd4f1b41d", "class_name": "RelatedNodeInfo"}}, "text": "But really happy so far with what we saw in the first quarter \nof medical.  \n \n", "start_char_idx": 411, "end_char_idx": 490, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c224a1a4-0fa0-47d6-a368-464eb80432f9": {"__data__": {"id_": "c224a1a4-0fa0-47d6-a368-464eb80432f9", "embedding": null, "metadata": {"window": "We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?  ", "original_text": "Glen Santangelo :  Thanks.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a65c5cc1-8a32-4c8e-bd88-24c42b85f81d", "node_type": "1", "metadata": {"window": "So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n", "original_text": "But really happy so far with what we saw in the first quarter \nof medical.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a5f93f48d1b74a32dd38ba094326a4a55377b98a3b4a66c673bff261db95b811", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28131108-8de0-4dd7-816f-38e9ee065d25", "node_type": "1", "metadata": {"window": "And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n", "original_text": "You know maybe if I can just have one follow -up for Dave.  "}, "hash": "7e2b00e5d10657de28c9ba9a06915dc408efd476bf09eac2cd72ff8b7c1a598b", "class_name": "RelatedNodeInfo"}}, "text": "Glen Santangelo :  Thanks.  ", "start_char_idx": 490, "end_char_idx": 518, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "28131108-8de0-4dd7-816f-38e9ee065d25": {"__data__": {"id_": "28131108-8de0-4dd7-816f-38e9ee065d25", "embedding": null, "metadata": {"window": "And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n", "original_text": "You know maybe if I can just have one follow -up for Dave.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c224a1a4-0fa0-47d6-a368-464eb80432f9", "node_type": "1", "metadata": {"window": "We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?  ", "original_text": "Glen Santangelo :  Thanks.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6536313709c508c35ca22b3af9edc49ee80e9aa38c9836fba25271ccce291e2b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "53d46441-e00e-427c-b3a2-6dcd49043af8", "node_type": "1", "metadata": {"window": "But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.  ", "original_text": "You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n"}, "hash": "18e95a6046d02e20625befda6c465a97dd4a98ea0f8a2059d095f2d33fb97ce6", "class_name": "RelatedNodeInfo"}}, "text": "You know maybe if I can just have one follow -up for Dave.  ", "start_char_idx": 518, "end_char_idx": 578, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "53d46441-e00e-427c-b3a2-6dcd49043af8": {"__data__": {"id_": "53d46441-e00e-427c-b3a2-6dcd49043af8", "embedding": null, "metadata": {"window": "But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.  ", "original_text": "You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28131108-8de0-4dd7-816f-38e9ee065d25", "node_type": "1", "metadata": {"window": "And we\u2019re in different innings on each one of those.   But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n", "original_text": "You know maybe if I can just have one follow -up for Dave.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "31a0a95dc86e2180d2bf56bc9e902c514e5ec0097335dc8e6028e2991b37aa99", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "777ac3e1-e730-4dbf-9b2d-b18b7b31900f", "node_type": "1", "metadata": {"window": "Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.  ", "original_text": "Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?  "}, "hash": "3db0f76b0a858eaa980d7d4d116fad6b92a01d0f859d03adf349f4e6998ed9e0", "class_name": "RelatedNodeInfo"}}, "text": "You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n", "start_char_idx": 578, "end_char_idx": 730, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "777ac3e1-e730-4dbf-9b2d-b18b7b31900f": {"__data__": {"id_": "777ac3e1-e730-4dbf-9b2d-b18b7b31900f", "embedding": null, "metadata": {"window": "Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.  ", "original_text": "Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "53d46441-e00e-427c-b3a2-6dcd49043af8", "node_type": "1", "metadata": {"window": "But really happy so far with what we saw in the first quarter \nof medical.  \n \n Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.  ", "original_text": "You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "aa74e32431993e9ed48415d921174cc984f4931fb394e7451d22f39d6589270a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c9d09df8-59f1-4946-90c7-0c6bb8221aff", "node_type": "1", "metadata": {"window": "You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.  ", "original_text": "Thanks.  \n \n"}, "hash": "3637d1d5a39dc1cbeb51b123a46f4a77ee22826ceef3c019b5f62da962f4b510", "class_name": "RelatedNodeInfo"}}, "text": "Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?  ", "start_char_idx": 730, "end_char_idx": 916, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c9d09df8-59f1-4946-90c7-0c6bb8221aff": {"__data__": {"id_": "c9d09df8-59f1-4946-90c7-0c6bb8221aff", "embedding": null, "metadata": {"window": "You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.  ", "original_text": "Thanks.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "777ac3e1-e730-4dbf-9b2d-b18b7b31900f", "node_type": "1", "metadata": {"window": "Glen Santangelo :  Thanks.   You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.  ", "original_text": "Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "153c565de0ac0ea911a88cd65b8ce2318c698327fc80c357b00e19c1b389a55b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0cc14c43-fbab-4dfa-a88f-6515de4d9dab", "node_type": "1", "metadata": {"window": "You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.  ", "original_text": "Dave Evans :  Yes, absolutely.  "}, "hash": "2dc599adb210cb2e3f0384798b39323e613987986d8ff6c48efae6f4c31655cc", "class_name": "RelatedNodeInfo"}}, "text": "Thanks.  \n \n", "start_char_idx": 916, "end_char_idx": 928, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0cc14c43-fbab-4dfa-a88f-6515de4d9dab": {"__data__": {"id_": "0cc14c43-fbab-4dfa-a88f-6515de4d9dab", "embedding": null, "metadata": {"window": "You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.  ", "original_text": "Dave Evans :  Yes, absolutely.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c9d09df8-59f1-4946-90c7-0c6bb8221aff", "node_type": "1", "metadata": {"window": "You know maybe if I can just have one follow -up for Dave.   You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.  ", "original_text": "Thanks.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6f9fc99561824ed2226903a6382bbd62cec03813f9077dab274703981346a018", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cb4adb2a-f159-4c8a-b847-07abaf98a1b9", "node_type": "1", "metadata": {"window": "Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.  ", "original_text": "So I\u2019d say, you know, first of all we said modestly lower.  "}, "hash": "a4c8f2f58121e8e475944411cae69126e05b3e47c792aba54710f1f01caf71a3", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes, absolutely.  ", "start_char_idx": 928, "end_char_idx": 960, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cb4adb2a-f159-4c8a-b847-07abaf98a1b9": {"__data__": {"id_": "cb4adb2a-f159-4c8a-b847-07abaf98a1b9", "embedding": null, "metadata": {"window": "Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.  ", "original_text": "So I\u2019d say, you know, first of all we said modestly lower.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0cc14c43-fbab-4dfa-a88f-6515de4d9dab", "node_type": "1", "metadata": {"window": "You know  Dave you maintained \nthe guidance for the full year but you called out specifically that the operating profit in 2Q would be lower than Q1.  \n Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.  ", "original_text": "Dave Evans :  Yes, absolutely.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "434579e5939dd95161ba28011b876966c56e158e009fdd0d27948de6d52fb0e1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c72701e4-d857-4daa-98a3-b0e7ada0d583", "node_type": "1", "metadata": {"window": "Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.  ", "original_text": "And we think about that.  "}, "hash": "e819f820672fbd55e8214949115e4b4d9b8b89be64344993e367c31c24f8a817", "class_name": "RelatedNodeInfo"}}, "text": "So I\u2019d say, you know, first of all we said modestly lower.  ", "start_char_idx": 960, "end_char_idx": 1020, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c72701e4-d857-4daa-98a3-b0e7ada0d583": {"__data__": {"id_": "c72701e4-d857-4daa-98a3-b0e7ada0d583", "embedding": null, "metadata": {"window": "Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.  ", "original_text": "And we think about that.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cb4adb2a-f159-4c8a-b847-07abaf98a1b9", "node_type": "1", "metadata": {"window": "Could you maybe just, you know, help us think about some of the assumptions in that sequential second quarter \nor so me of the seasonal items that are maybe driving that outlook in 2Q?   Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.  ", "original_text": "So I\u2019d say, you know, first of all we said modestly lower.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "28eb8535796aaa3f05c346da201cfeb0d523474761309f1fe62bbe30fa5e8a3f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8d4386c0-20ad-4a0b-9006-e917ff5106f5", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n ", "original_text": "We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.  "}, "hash": "d384d21cf0670c3b1c7dfeccf977b553a5ad4935906a70bdd92223bff293aa34", "class_name": "RelatedNodeInfo"}}, "text": "And we think about that.  ", "start_char_idx": 1020, "end_char_idx": 1046, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8d4386c0-20ad-4a0b-9006-e917ff5106f5": {"__data__": {"id_": "8d4386c0-20ad-4a0b-9006-e917ff5106f5", "embedding": null, "metadata": {"window": "Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n ", "original_text": "We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c72701e4-d857-4daa-98a3-b0e7ada0d583", "node_type": "1", "metadata": {"window": "Thanks.  \n \n Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.  ", "original_text": "And we think about that.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "31f74bf7f33520c9e3cc5996a35de6c0358afaae520ede22e539c893443facf2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d60d4bd8-b9c6-4127-af4b-9419f5c0c213", "node_type": "1", "metadata": {"window": "So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.  ", "original_text": "We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.  "}, "hash": "6db0369bc19fb5d6e15de824810b76b524953d47aaded1470b0fc509fdc9ecd2", "class_name": "RelatedNodeInfo"}}, "text": "We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.  ", "start_char_idx": 1046, "end_char_idx": 1171, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d60d4bd8-b9c6-4127-af4b-9419f5c0c213": {"__data__": {"id_": "d60d4bd8-b9c6-4127-af4b-9419f5c0c213", "embedding": null, "metadata": {"window": "So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.  ", "original_text": "We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8d4386c0-20ad-4a0b-9006-e917ff5106f5", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes, absolutely.   So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n ", "original_text": "We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9180706304bbcab6b81af5a2b7d2e340db79207b9d460cc54defbe03a800db98", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "38805d88-b4e6-466c-aab2-fc068cdf97d2", "node_type": "1", "metadata": {"window": "And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n ", "original_text": "And those are \nramping up.  "}, "hash": "0c00e7116228edf480d048c9be55a2710af6f947e9ffd9bf77ed5d4aacf07c3d", "class_name": "RelatedNodeInfo"}}, "text": "We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.  ", "start_char_idx": 1171, "end_char_idx": 1262, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "38805d88-b4e6-466c-aab2-fc068cdf97d2": {"__data__": {"id_": "38805d88-b4e6-466c-aab2-fc068cdf97d2", "embedding": null, "metadata": {"window": "And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n ", "original_text": "And those are \nramping up.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d60d4bd8-b9c6-4127-af4b-9419f5c0c213", "node_type": "1", "metadata": {"window": "So I\u2019d say, you know, first of all we said modestly lower.   And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.  ", "original_text": "We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e9e23b09f4a3bec7c65e0faac00cbe1f1e63eb89fcfb91f29297095d64869f05", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "897e194d-48da-49aa-97bb-e85562f5cac6", "node_type": "1", "metadata": {"window": "We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n ", "original_text": "And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n "}, "hash": "bd652ed3901a4dc48e222a9085e2d2aadfb7519efb88689c1dc5d5f6b0c10f0c", "class_name": "RelatedNodeInfo"}}, "text": "And those are \nramping up.  ", "start_char_idx": 1262, "end_char_idx": 1290, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "897e194d-48da-49aa-97bb-e85562f5cac6": {"__data__": {"id_": "897e194d-48da-49aa-97bb-e85562f5cac6", "embedding": null, "metadata": {"window": "We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n ", "original_text": "And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "38805d88-b4e6-466c-aab2-fc068cdf97d2", "node_type": "1", "metadata": {"window": "And we think about that.   We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n ", "original_text": "And those are \nramping up.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b4795f190a7bb38a48121539aee3b56ce29b1efbd32f7e31b3d9bc77af88d555", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec3954ae-02f9-408a-9a10-ff522934b8ea", "node_type": "1", "metadata": {"window": "We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.  ", "original_text": "Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.  "}, "hash": "56faf1bc1a9b0485dd0bb0c23ece1e812ebb64f96230e52e24e722ce3f1dee9f", "class_name": "RelatedNodeInfo"}}, "text": "And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n ", "start_char_idx": 1290, "end_char_idx": 1396, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ec3954ae-02f9-408a-9a10-ff522934b8ea": {"__data__": {"id_": "ec3954ae-02f9-408a-9a10-ff522934b8ea", "embedding": null, "metadata": {"window": "We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.  ", "original_text": "Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "897e194d-48da-49aa-97bb-e85562f5cac6", "node_type": "1", "metadata": {"window": "We \nthink about a variety of factors that could change from quarter -to-quarter, one for example, would be our SG&A \nspend.   We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n ", "original_text": "And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0602e493ef3441e662b21e27bf356b6b16d692e0f420f68d8e5b59dc9764eab6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f7ad63c3-9081-4081-940d-a64323315c8d", "node_type": "1", "metadata": {"window": "And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n ", "original_text": "We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n "}, "hash": "fdd7658941848399844456121b28b7b1d6c1c776894ccbdf1323762b9635f026", "class_name": "RelatedNodeInfo"}}, "text": "Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.  ", "start_char_idx": 1396, "end_char_idx": 1517, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f7ad63c3-9081-4081-940d-a64323315c8d": {"__data__": {"id_": "f7ad63c3-9081-4081-940d-a64323315c8d", "embedding": null, "metadata": {"window": "And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n ", "original_text": "We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec3954ae-02f9-408a-9a10-ff522934b8ea", "node_type": "1", "metadata": {"window": "We\u2019ve got a large inventory of investment opportunities to drive long -term improvements.   And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.  ", "original_text": "Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "527442cbc69697c65d1963eeed2a1cf6b91c91e40989b704bf3f5eedb26a7b72", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c6b6c17f-6e6c-41c4-8895-bac614d91b46", "node_type": "1", "metadata": {"window": "And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n", "original_text": "And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n "}, "hash": "9ab66b3a739bec479428f8bdc273216983724c8d1ef0a7325a68344abe2458a3", "class_name": "RelatedNodeInfo"}}, "text": "We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n ", "start_char_idx": 1517, "end_char_idx": 1681, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c6b6c17f-6e6c-41c4-8895-bac614d91b46": {"__data__": {"id_": "c6b6c17f-6e6c-41c4-8895-bac614d91b46", "embedding": null, "metadata": {"window": "And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n", "original_text": "And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f7ad63c3-9081-4081-940d-a64323315c8d", "node_type": "1", "metadata": {"window": "And those are \nramping up.   And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n ", "original_text": "We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40730d402adee5f675c26d0736f885628c781e188ad1667f34c1f20dd72044bc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "abca503a-af37-4ffa-a632-d6995103af18", "node_type": "1", "metadata": {"window": "Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n", "original_text": "And as that volume declines we\u2019ll capture our fair share of that.  "}, "hash": "17f10957c3289cfb98286348020566d8ee91d62caf5c79856db768be2151ae9a", "class_name": "RelatedNodeInfo"}}, "text": "And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n ", "start_char_idx": 1681, "end_char_idx": 1945, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "abca503a-af37-4ffa-a632-d6995103af18": {"__data__": {"id_": "abca503a-af37-4ffa-a632-d6995103af18", "embedding": null, "metadata": {"window": "Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n", "original_text": "And as that volume declines we\u2019ll capture our fair share of that.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c6b6c17f-6e6c-41c4-8895-bac614d91b46", "node_type": "1", "metadata": {"window": "And so the level of the spend, the pace of that spend, we expect to inc rease in our second quarter.  \n \n  Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n", "original_text": "And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5f2d352969ae2c5d414dfaebf3d4ed92db0e82712ef42fdc42a954209ffe47aa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4a770cfa-35ec-4782-b05c-f3c776a325fc", "node_type": "1", "metadata": {"window": "We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n", "original_text": "But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n "}, "hash": "24fe8c27ebe5a7bcdb456a1d9a3e2f181f70bd691c7013435f71ff5ad9eadf2c", "class_name": "RelatedNodeInfo"}}, "text": "And as that volume declines we\u2019ll capture our fair share of that.  ", "start_char_idx": 1945, "end_char_idx": 2012, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4a770cfa-35ec-4782-b05c-f3c776a325fc": {"__data__": {"id_": "4a770cfa-35ec-4782-b05c-f3c776a325fc", "embedding": null, "metadata": {"window": "We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n", "original_text": "But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "abca503a-af37-4ffa-a632-d6995103af18", "node_type": "1", "metadata": {"window": "Further we have, you know, what we\u2019ve talked about the CVS and the Kroger\u2019s contract renewal being effective \nJuly 1st.   We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n", "original_text": "And as that volume declines we\u2019ll capture our fair share of that.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9dc0f2c425d62d08b621b0dd4f9274259e30eeda7e5976dc0576c12cc3810839", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a91be33f-f51d-4297-a92f-1913afa59e49", "node_type": "1", "metadata": {"window": "And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.  ", "original_text": "So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n"}, "hash": "fe7e72f63e2969a7e302b08ac7da2d7fc3d6acef491326ceb3867d278de2b2b7", "class_name": "RelatedNodeInfo"}}, "text": "But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n ", "start_char_idx": 2012, "end_char_idx": 2091, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a91be33f-f51d-4297-a92f-1913afa59e49": {"__data__": {"id_": "a91be33f-f51d-4297-a92f-1913afa59e49", "embedding": null, "metadata": {"window": "And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.  ", "original_text": "So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4a770cfa-35ec-4782-b05c-f3c776a325fc", "node_type": "1", "metadata": {"window": "We do have other contract renewals at much smaller scale but yet other contract renewals that\u2019ll be \noccur ring in the second quarter and throughout the year.  \n \n  And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n", "original_text": "But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6b29e0f54cdfdc3c235ddaec78fbfc7732d66ad67908884d1fb7066d74a4fb28", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b92c75eb-693d-46dc-8e27-d5d5f7d453ac", "node_type": "1", "metadata": {"window": "And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Glen Santangelo :  Okay thank you.  \n \n"}, "hash": "1e771442411d684b70875232f1d271155516ece7d272fa7f690045a39925e283", "class_name": "RelatedNodeInfo"}}, "text": "So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n", "start_char_idx": 2091, "end_char_idx": 2266, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b92c75eb-693d-46dc-8e27-d5d5f7d453ac": {"__data__": {"id_": "b92c75eb-693d-46dc-8e27-d5d5f7d453ac", "embedding": null, "metadata": {"window": "And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Glen Santangelo :  Okay thank you.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a91be33f-f51d-4297-a92f-1913afa59e49", "node_type": "1", "metadata": {"window": "And finally I would also say that we have some customers that we\u2019ve, you know, have experienced difficulty either \nthrough bankruptcy or other financial distress where we\u2019re expecting some modestly lower  volume in the second \nquarter than the first quarter.  \n \n  And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.  ", "original_text": "So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cd0753fda6fdddf8eca2cf8ca3ba4b33f73981ebc34e4ef132b5e1bd641139d0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "95eeb62a-3053-4462-8364-d2e1085c84f6", "node_type": "1", "metadata": {"window": "But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n"}, "hash": "99eb00b05c9aeaf62ffb4c84236013d6f99b59b688a197a714bc219665984c5d", "class_name": "RelatedNodeInfo"}}, "text": "Glen Santangelo :  Okay thank you.  \n \n", "start_char_idx": 2266, "end_char_idx": 2305, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "95eeb62a-3053-4462-8364-d2e1085c84f6": {"__data__": {"id_": "95eeb62a-3053-4462-8364-d2e1085c84f6", "embedding": null, "metadata": {"window": "But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b92c75eb-693d-46dc-8e27-d5d5f7d453ac", "node_type": "1", "metadata": {"window": "And as that volume declines we\u2019ll capture our fair share of that.   But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Glen Santangelo :  Okay thank you.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "97e0d91260a4eb6c4bcf7d25fcdd9796c39cfc5b19d06e80772c284e5d93a9b0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "12bb2d84-77f5-4b26-be73-0d222d40db2c", "node_type": "1", "metadata": {"window": "So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.  "}, "hash": "b52c450e0691ca24750f7a3eda38f0950c22bd9c4dc4761b2eae961e6be25fe2", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n", "start_char_idx": 2305, "end_char_idx": 2369, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "12bb2d84-77f5-4b26-be73-0d222d40db2c": {"__data__": {"id_": "12bb2d84-77f5-4b26-be73-0d222d40db2c", "embedding": null, "metadata": {"window": "So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "95eeb62a-3053-4462-8364-d2e1085c84f6", "node_type": "1", "metadata": {"window": "But we\u2019ll only capture our fair share of that is our \ncurrent assumption.  \n \n  So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "986e232549a2474b9474836c051fb2eb96eb4fef19bfeb122ba4d29545fb2655", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "de5d6e25-f8b5-44b1-b5d9-198c9f076605", "node_type": "1", "metadata": {"window": "Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Please go ahead.  \n "}, "hash": "0b070ca0270b63b2bcbffa0139d286ba704e385359a67bb5b757604cada30196", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.  ", "start_char_idx": 2369, "end_char_idx": 2450, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "de5d6e25-f8b5-44b1-b5d9-198c9f076605": {"__data__": {"id_": "de5d6e25-f8b5-44b1-b5d9-198c9f076605", "embedding": null, "metadata": {"window": "Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Please go ahead.  \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1991a006-e6c6-437c-bd28-649de7e63ba3", "node_type": "4", "metadata": {"page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "780876531b6a18b4e215fc6630edf620ae843770e596176e8bc0a0a614bd796c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "12bb2d84-77f5-4b26-be73-0d222d40db2c", "node_type": "1", "metadata": {"window": "So there\u2019s a lot more depth than that but I\u2019d say those ar e some of the headlines that give us some reason to \nbelieve that Q2 won\u2019t be just simply a mirror image of Q1.  \n \n Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.  ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "eb126629ad801d403004991ba79097762208e11a3d42cebaff5ab87d4b7b3a09", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9b2dd3d3-525d-40b3-9bc0-bc84a6db6343", "node_type": "1", "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?  ", "original_text": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.  "}, "hash": "9bafd565d9e7b4ce0b0dcd63d243ffb561bd75a3445f7efc17a79f14dcfc16ec", "class_name": "RelatedNodeInfo"}}, "text": "Please go ahead.  \n ", "start_char_idx": 2450, "end_char_idx": 2470, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9b2dd3d3-525d-40b3-9bc0-bc84a6db6343": {"__data__": {"id_": "9b2dd3d3-525d-40b3-9bc0-bc84a6db6343", "embedding": null, "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?  ", "original_text": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "de5d6e25-f8b5-44b1-b5d9-198c9f076605", "node_type": "1", "metadata": {"window": "Glen Santangelo :  Okay thank you.  \n \n Operator :  And we will\u2026  \n \nMike Kaufmann:  Next question.  \n \n Operator :  \u2026take our next question from Ricky Goldwa sser from Morgan Stanley.   Please go ahead.  \n ", "original_text": "Please go ahead.  \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f362240cb17f8b071760393be2916620a4906d6a4780eea42d3b4073fe1cad48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8868151e-49cd-4b3e-9d0e-bcaa34dd62b2", "node_type": "1", "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n", "original_text": "Good morning.  "}, "hash": "706a1535252134cfa7c4cf7da21021d4f38bebc9ac9cf91b4f2e265f40309001", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.  ", "start_char_idx": 0, "end_char_idx": 48, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8868151e-49cd-4b3e-9d0e-bcaa34dd62b2": {"__data__": {"id_": "8868151e-49cd-4b3e-9d0e-bcaa34dd62b2", "embedding": null, "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n", "original_text": "Good morning.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9b2dd3d3-525d-40b3-9bc0-bc84a6db6343", "node_type": "1", "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?  ", "original_text": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ff160ed0c03d44425c83be808416a874e873a7f6ae7f0c6211b44f996f242d82", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c6f4c976-ed40-4d52-8f65-5f3c64b7fbf4", "node_type": "1", "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "My question is related to the opioid comments.  "}, "hash": "0024c3f8716ca682a6f63e48de27fad32d7907cd776feb018b5b2c32bae9b08c", "class_name": "RelatedNodeInfo"}}, "text": "Good morning.  ", "start_char_idx": 48, "end_char_idx": 63, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c6f4c976-ed40-4d52-8f65-5f3c64b7fbf4": {"__data__": {"id_": "c6f4c976-ed40-4d52-8f65-5f3c64b7fbf4", "embedding": null, "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "My question is related to the opioid comments.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8868151e-49cd-4b3e-9d0e-bcaa34dd62b2", "node_type": "1", "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n", "original_text": "Good morning.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ef2271f08502af861d7e1ce37c1448954c069018759b27ff707ca41ab0f4ea84", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0dc4c5d1-32cd-41ac-862e-a481ba0a74f9", "node_type": "1", "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n ", "original_text": "When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?  "}, "hash": "2fa8152f80bf92a55a901cb2d584ad4caabc3e7af1a15527b90029477dba6886", "class_name": "RelatedNodeInfo"}}, "text": "My question is related to the opioid comments.  ", "start_char_idx": 63, "end_char_idx": 111, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0dc4c5d1-32cd-41ac-862e-a481ba0a74f9": {"__data__": {"id_": "0dc4c5d1-32cd-41ac-862e-a481ba0a74f9", "embedding": null, "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n ", "original_text": "When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c6f4c976-ed40-4d52-8f65-5f3c64b7fbf4", "node_type": "1", "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "My question is related to the opioid comments.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a90c54e8bb0ee4986f76c3b7a35cfd5a53064e7cd63c282d1a83f215bf9df002", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "360928ff-42b4-441c-90ec-fb6d46834c9a", "node_type": "1", "metadata": {"window": "Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.  ", "original_text": "And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n"}, "hash": "a554f536dfe3faae7b628ecc6e0005d3ee1ecfc60631369d60c2ce63461e4062", "class_name": "RelatedNodeInfo"}}, "text": "When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?  ", "start_char_idx": 111, "end_char_idx": 314, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "360928ff-42b4-441c-90ec-fb6d46834c9a": {"__data__": {"id_": "360928ff-42b4-441c-90ec-fb6d46834c9a", "embedding": null, "metadata": {"window": "Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.  ", "original_text": "And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0dc4c5d1-32cd-41ac-862e-a481ba0a74f9", "node_type": "1", "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n ", "original_text": "When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "945b9d62576b2a5b6a74c0173cd832c41fd1fe4c920d4576884eb81d90de52dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "87ffdf17-3e3f-4635-8bc7-e57d1d597cf2", "node_type": "1", "metadata": {"window": "My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.  ", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  "}, "hash": "68a452e9a86da1e16df75506a42163e4abaa8814eb767c21e9e58204bc07deb4", "class_name": "RelatedNodeInfo"}}, "text": "And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n", "start_char_idx": 314, "end_char_idx": 440, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "87ffdf17-3e3f-4635-8bc7-e57d1d597cf2": {"__data__": {"id_": "87ffdf17-3e3f-4635-8bc7-e57d1d597cf2", "embedding": null, "metadata": {"window": "My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.  ", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "360928ff-42b4-441c-90ec-fb6d46834c9a", "node_type": "1", "metadata": {"window": "Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.  ", "original_text": "And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3588f6689d911ce3ac2e0eda688ed24703969912721f0e56bc539cf6cacde873", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4fc24d6a-3f60-4c04-9af8-8c921c8f1910", "node_type": "1", "metadata": {"window": "When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n ", "original_text": "It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n "}, "hash": "92f21a820caff0ad03fc8ea6decf37aaea42196797245b14fd597d25d789658d", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes, thanks for the question.  ", "start_char_idx": 440, "end_char_idx": 488, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4fc24d6a-3f60-4c04-9af8-8c921c8f1910": {"__data__": {"id_": "4fc24d6a-3f60-4c04-9af8-8c921c8f1910", "embedding": null, "metadata": {"window": "When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n ", "original_text": "It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "87ffdf17-3e3f-4635-8bc7-e57d1d597cf2", "node_type": "1", "metadata": {"window": "My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.  ", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6a5b482667032042be099766234fd4bbf97db5d383a90aa649a4a1c43f943c22", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "362797e8-c96f-4c4a-bbfd-db92263d96d9", "node_type": "1", "metadata": {"window": "And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n ", "original_text": "You know I can\u2019t provide a lot of details on it.  "}, "hash": "8e7baf20c55e88d570e30e49e1ffb49d78b2a1ced19b9df67c7244f60a6601fc", "class_name": "RelatedNodeInfo"}}, "text": "It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n ", "start_char_idx": 488, "end_char_idx": 617, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "362797e8-c96f-4c4a-bbfd-db92263d96d9": {"__data__": {"id_": "362797e8-c96f-4c4a-bbfd-db92263d96d9", "embedding": null, "metadata": {"window": "And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n ", "original_text": "You know I can\u2019t provide a lot of details on it.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4fc24d6a-3f60-4c04-9af8-8c921c8f1910", "node_type": "1", "metadata": {"window": "When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?   And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n ", "original_text": "It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ec1a4c90d5fd3dea183f5a5ffc2e8ec3763993c7a21a916683c6101b8626d610", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3327ebba-0b00-4547-9cdb-2107734f2ada", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.  ", "original_text": "But first of all, the settlement is spread over 18 years.  "}, "hash": "1a065cf85c5c04c92a8f86b8f4412e840a045c3cc1e9b47bd3fd9d34ec47b21b", "class_name": "RelatedNodeInfo"}}, "text": "You know I can\u2019t provide a lot of details on it.  ", "start_char_idx": 617, "end_char_idx": 667, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3327ebba-0b00-4547-9cdb-2107734f2ada": {"__data__": {"id_": "3327ebba-0b00-4547-9cdb-2107734f2ada", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.  ", "original_text": "But first of all, the settlement is spread over 18 years.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "362797e8-c96f-4c4a-bbfd-db92263d96d9", "node_type": "1", "metadata": {"window": "And if so, do you have the \u2013 what degree of freedom \ndo you have to offset that with additional streamlining initiatives?  \n \n Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n ", "original_text": "You know I can\u2019t provide a lot of details on it.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3432b74c78403519ac96820c7ec5c870dfab4447131dd3e5940f30ac84482a73", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e298aafd-a317-4eb0-82bd-80e8bc6dce80", "node_type": "1", "metadata": {"window": "It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n ", "original_text": "And so that\u2019s \nimportant to know . \n \n "}, "hash": "281c94bb2514dee0000d6af25d099fc2807d305560ebfeef375c0759540e6e33", "class_name": "RelatedNodeInfo"}}, "text": "But first of all, the settlement is spread over 18 years.  ", "start_char_idx": 667, "end_char_idx": 726, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e298aafd-a317-4eb0-82bd-80e8bc6dce80": {"__data__": {"id_": "e298aafd-a317-4eb0-82bd-80e8bc6dce80", "embedding": null, "metadata": {"window": "It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n ", "original_text": "And so that\u2019s \nimportant to know . \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3327ebba-0b00-4547-9cdb-2107734f2ada", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.  ", "original_text": "But first of all, the settlement is spread over 18 years.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1c923da971b0c496d6e1c4f2bdcee2df7707a29e9423e319a4db8021a328f787", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "78f60df7-4014-4594-9c8d-b94b61c3c548", "node_type": "1", "metadata": {"window": "You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n", "original_text": "We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n "}, "hash": "8ba28b463eacc3b7681fbcc511f7a446f8d08937522f7b171c8810629da8375d", "class_name": "RelatedNodeInfo"}}, "text": "And so that\u2019s \nimportant to know . \n \n ", "start_char_idx": 726, "end_char_idx": 765, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "78f60df7-4014-4594-9c8d-b94b61c3c548": {"__data__": {"id_": "78f60df7-4014-4594-9c8d-b94b61c3c548", "embedding": null, "metadata": {"window": "You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n", "original_text": "We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e298aafd-a317-4eb0-82bd-80e8bc6dce80", "node_type": "1", "metadata": {"window": "It brok e up a little bit Ricky so if I don\u2019t quite get the answer right, feel free \nto follow -up on that in particularly.  \n \n  You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n ", "original_text": "And so that\u2019s \nimportant to know . \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "83a7a79b98397aae3529e35346c56e5e6b771e2db4ab6389fd816a5cf1bfca5b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "058cbb97-b577-4ba9-a6c9-47271ecb0c29", "node_type": "1", "metadata": {"window": "But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.  ", "original_text": "We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.  "}, "hash": "1232a2d8fe357003ce85d6a7c1540c231df3f53e416ebb6bdfb54a570ec2d37b", "class_name": "RelatedNodeInfo"}}, "text": "We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n ", "start_char_idx": 765, "end_char_idx": 968, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "058cbb97-b577-4ba9-a6c9-47271ecb0c29": {"__data__": {"id_": "058cbb97-b577-4ba9-a6c9-47271ecb0c29", "embedding": null, "metadata": {"window": "But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.  ", "original_text": "We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "78f60df7-4014-4594-9c8d-b94b61c3c548", "node_type": "1", "metadata": {"window": "You know I can\u2019t provide a lot of details on it.   But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n", "original_text": "We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f90f4ab713eab6e159dbd609cf601ba6337402797d5c77a5470973294e26dd77", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "99e69b82-dd21-4e56-8da5-4619e98d5a2c", "node_type": "1", "metadata": {"window": "And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.  ", "original_text": "Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n "}, "hash": "e7223c08d6448a842d0b74a1c526756442e20d144c78e94f39afedd56fa6499c", "class_name": "RelatedNodeInfo"}}, "text": "We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.  ", "start_char_idx": 968, "end_char_idx": 1261, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "99e69b82-dd21-4e56-8da5-4619e98d5a2c": {"__data__": {"id_": "99e69b82-dd21-4e56-8da5-4619e98d5a2c", "embedding": null, "metadata": {"window": "And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.  ", "original_text": "Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "058cbb97-b577-4ba9-a6c9-47271ecb0c29", "node_type": "1", "metadata": {"window": "But first of all, the settlement is spread over 18 years.   And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.  ", "original_text": "We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a85f7420550edde82ab9b4b435202352bab324e487519c0863d5720b47794d24", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8ad03270-b485-4117-b86c-3b5b3f0e5209", "node_type": "1", "metadata": {"window": "We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.  ", "original_text": "So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n"}, "hash": "e3dd311f7f57ae5aa421ee7525d078c829fdd57aebad1dce2730c7d0859a17bb", "class_name": "RelatedNodeInfo"}}, "text": "Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n ", "start_char_idx": 1261, "end_char_idx": 1452, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8ad03270-b485-4117-b86c-3b5b3f0e5209": {"__data__": {"id_": "8ad03270-b485-4117-b86c-3b5b3f0e5209", "embedding": null, "metadata": {"window": "We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.  ", "original_text": "So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99e69b82-dd21-4e56-8da5-4619e98d5a2c", "node_type": "1", "metadata": {"window": "And so that\u2019s \nimportant to know . \n \n  We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.  ", "original_text": "Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "37fd7c03affa29b243868854b91489655fa3f935cc34c5dfa33174cba1aeedde", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2a97f385-1248-4107-bc90-97042fd39a0a", "node_type": "1", "metadata": {"window": "We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.  ", "original_text": "Ricky Goldwasser :  No you did.  "}, "hash": "8b499f810358b699cb2b647def2e65ac6b774336b19bec199dc2d6b6416c6b5e", "class_name": "RelatedNodeInfo"}}, "text": "So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n", "start_char_idx": 1452, "end_char_idx": 1535, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2a97f385-1248-4107-bc90-97042fd39a0a": {"__data__": {"id_": "2a97f385-1248-4107-bc90-97042fd39a0a", "embedding": null, "metadata": {"window": "We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.  ", "original_text": "Ricky Goldwasser :  No you did.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8ad03270-b485-4117-b86c-3b5b3f0e5209", "node_type": "1", "metadata": {"window": "We continue to believe that that settlement is something that will be a consideration as we look at capital \ndeployment but not a limitation as to when we look at capital deployment or investments.  \n \n  We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.  ", "original_text": "So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "85af7c289fb2d9bd7525dad66cfde41f3213301e581858f5b84fe2c5f0749742", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "895e65ae-182c-464c-a7fe-ecb136d77734", "node_type": "1", "metadata": {"window": "Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.  ", "original_text": "Thank you.  "}, "hash": "d4170245f7794811c4d4f8045d8912f0b96c03847ddd25471e560ce85b3d7bad", "class_name": "RelatedNodeInfo"}}, "text": "Ricky Goldwasser :  No you did.  ", "start_char_idx": 1535, "end_char_idx": 1568, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "895e65ae-182c-464c-a7fe-ecb136d77734": {"__data__": {"id_": "895e65ae-182c-464c-a7fe-ecb136d77734", "embedding": null, "metadata": {"window": "Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.  ", "original_text": "Thank you.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2a97f385-1248-4107-bc90-97042fd39a0a", "node_type": "1", "metadata": {"window": "We do believe that the overall settlement framework is something that is supported by a bipartisan group of state \nattorneys general and is \u2013 does provide a framework by which hopefully we can continue to not only get this \nbehind us but also get meaningful funds to the people that need it.   Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.  ", "original_text": "Ricky Goldwasser :  No you did.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c64aa2599ed79a2d0373abbe293ee1822f41b2c84da076926ba38f154e987fa5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bd2ce9ef-ef59-4c9d-9a52-ddb3e220430e", "node_type": "1", "metadata": {"window": "So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n ", "original_text": "Thank you much.  "}, "hash": "1eac667e6f9916a0758e5fec9bc128dee2c9c7089b3677d76f51ae9a8e28f6d2", "class_name": "RelatedNodeInfo"}}, "text": "Thank you.  ", "start_char_idx": 1568, "end_char_idx": 1580, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bd2ce9ef-ef59-4c9d-9a52-ddb3e220430e": {"__data__": {"id_": "bd2ce9ef-ef59-4c9d-9a52-ddb3e220430e", "embedding": null, "metadata": {"window": "So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n ", "original_text": "Thank you much.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "895e65ae-182c-464c-a7fe-ecb136d77734", "node_type": "1", "metadata": {"window": "Begin l ooking at the distribution of the free \ngoods so they\u2019re out there and also look at other ways that the industry can work together to improve the overall \nmonitoring of opioids.  \n \n  So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.  ", "original_text": "Thank you.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b7cf3ff13c53ed45667d8dbdba56b6f2b54be5399896fdc4f8ccb48c35712f48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2d0bbdce-27ab-4b0d-8c6c-05d2e328e6f7", "node_type": "1", "metadata": {"window": "Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n", "original_text": "And I may just have a quick follow -up or maybe not so \nquick.  "}, "hash": "c134f2fd0be2be65fa89fd8ccf32bc9be3ee09fe04aa1860c25914faa9c9d25c", "class_name": "RelatedNodeInfo"}}, "text": "Thank you much.  ", "start_char_idx": 1580, "end_char_idx": 1597, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2d0bbdce-27ab-4b0d-8c6c-05d2e328e6f7": {"__data__": {"id_": "2d0bbdce-27ab-4b0d-8c6c-05d2e328e6f7", "embedding": null, "metadata": {"window": "Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n", "original_text": "And I may just have a quick follow -up or maybe not so \nquick.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bd2ce9ef-ef59-4c9d-9a52-ddb3e220430e", "node_type": "1", "metadata": {"window": "So I\u2019ll stop right there and see if I was able to answer your question or not.  \n \n Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n ", "original_text": "Thank you much.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ef36ddf4c98c0f1131db548e9c4fe4eb4f8cd79b77a865725a878f0e2668f140", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "491fb161-5fd6-488e-a5e6-f338b7385f13", "node_type": "1", "metadata": {"window": "Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.  ", "original_text": "But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.  "}, "hash": "d766f80a5d0280bebf9f45e3204106ffcb0ab0b774af9ae2c27b766fa7900ed2", "class_name": "RelatedNodeInfo"}}, "text": "And I may just have a quick follow -up or maybe not so \nquick.  ", "start_char_idx": 1597, "end_char_idx": 1661, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "491fb161-5fd6-488e-a5e6-f338b7385f13": {"__data__": {"id_": "491fb161-5fd6-488e-a5e6-f338b7385f13", "embedding": null, "metadata": {"window": "Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.  ", "original_text": "But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2d0bbdce-27ab-4b0d-8c6c-05d2e328e6f7", "node_type": "1", "metadata": {"window": "Ricky Goldwasser :  No you did.   Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n", "original_text": "And I may just have a quick follow -up or maybe not so \nquick.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f241ed581b51c8f28673f61e219a38a7cdf37ec87de7ce229423378d7d17d390", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8cd03806-12fe-42e8-a0cc-41fd5c773aef", "node_type": "1", "metadata": {"window": "Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.  ", "original_text": "I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n "}, "hash": "23f57e374a7738d599fdbc34b03f7d65b87a9fdfefa83653ec5039d4ad052b01", "class_name": "RelatedNodeInfo"}}, "text": "But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.  ", "start_char_idx": 1661, "end_char_idx": 1767, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8cd03806-12fe-42e8-a0cc-41fd5c773aef": {"__data__": {"id_": "8cd03806-12fe-42e8-a0cc-41fd5c773aef", "embedding": null, "metadata": {"window": "Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.  ", "original_text": "I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "491fb161-5fd6-488e-a5e6-f338b7385f13", "node_type": "1", "metadata": {"window": "Thank you.   Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.  ", "original_text": "But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1d45e147792290bd349dd4175d3c74080a03134a03227035765158bff45dad63", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9a0b3448-d74e-4fd8-8db9-4aa683515147", "node_type": "1", "metadata": {"window": "And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n ", "original_text": "But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n"}, "hash": "adc49256ded57c2d6b1af60bcb9a9e3d24dd2749e16a5369815e6f0cc6b27ede", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n ", "start_char_idx": 1767, "end_char_idx": 1901, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9a0b3448-d74e-4fd8-8db9-4aa683515147": {"__data__": {"id_": "9a0b3448-d74e-4fd8-8db9-4aa683515147", "embedding": null, "metadata": {"window": "And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n ", "original_text": "But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8cd03806-12fe-42e8-a0cc-41fd5c773aef", "node_type": "1", "metadata": {"window": "Thank you much.   And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.  ", "original_text": "I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "57e24b4b87a4a164996a2afb5adad1750fe64a0d47c1cd468c93dcff927d3551", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "38db24d8-e014-4573-82ae-9ddab47c7038", "node_type": "1", "metadata": {"window": "But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.  ", "original_text": "Mike Kaufmann :  Yes, thanks for th e question.  "}, "hash": "3ce5e61b40b754d7f4a99ff30928e343bcfeb49fc7a19df783466e35eeac97b9", "class_name": "RelatedNodeInfo"}}, "text": "But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n", "start_char_idx": 1901, "end_char_idx": 2285, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "38db24d8-e014-4573-82ae-9ddab47c7038": {"__data__": {"id_": "38db24d8-e014-4573-82ae-9ddab47c7038", "embedding": null, "metadata": {"window": "But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.  ", "original_text": "Mike Kaufmann :  Yes, thanks for th e question.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9a0b3448-d74e-4fd8-8db9-4aa683515147", "node_type": "1", "metadata": {"window": "And I may just have a quick follow -up or maybe not so \nquick.   But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n ", "original_text": "But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6e940e18b91a5b239e18f1ed59a60ced9ec992f1a0eedd67f2152a361437e57d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d8cde7d-1174-44ea-b069-cc77571677ec", "node_type": "1", "metadata": {"window": "I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.   ", "original_text": "You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.  "}, "hash": "4e03608a11cc5a8807dcb8ac66bb8b3ced0f3c2612bc6e90219cbd3e91754359", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes, thanks for th e question.  ", "start_char_idx": 2285, "end_char_idx": 2334, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5d8cde7d-1174-44ea-b069-cc77571677ec": {"__data__": {"id_": "5d8cde7d-1174-44ea-b069-cc77571677ec", "embedding": null, "metadata": {"window": "I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.   ", "original_text": "You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "38db24d8-e014-4573-82ae-9ddab47c7038", "node_type": "1", "metadata": {"window": "But when we think about the long -term financial profile, you know, obviously in the quarter revenue up.   I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.  ", "original_text": "Mike Kaufmann :  Yes, thanks for th e question.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f8cd19d70be6e9a1a3aa5a6b038e25b2e7035ac30f9944f3db9de47a0a0e496e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "976f0db3-cf55-46c5-8f31-e9e7654764e8", "node_type": "1", "metadata": {"window": "But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.  ", "original_text": "I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n "}, "hash": "76a3136c90d917d1548b74eccee0c961d28ee7e1df7cf772b6f793691daff7c8", "class_name": "RelatedNodeInfo"}}, "text": "You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.  ", "start_char_idx": 2334, "end_char_idx": 2414, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "976f0db3-cf55-46c5-8f31-e9e7654764e8": {"__data__": {"id_": "976f0db3-cf55-46c5-8f31-e9e7654764e8", "embedding": null, "metadata": {"window": "But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.  ", "original_text": "I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d8cde7d-1174-44ea-b069-cc77571677ec", "node_type": "1", "metadata": {"window": "I\u2019ll \nmention the dividend and profit were down because of the renewals that you talked about as we\u2019ll see throughout \nthe year.  \n \n  But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.   ", "original_text": "You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0e84687cc61544d699bc0033edcc594d7e0b3b41aed8d3e54e6caae581100147", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "03ca86e7-eb57-403a-9f5e-12c24d83cac6", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n ", "original_text": "I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.  "}, "hash": "2f18e112b51e95ca67c529065f7fe41c517be036d8a80e32ef3fd101a9144b38", "class_name": "RelatedNodeInfo"}}, "text": "I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n ", "start_char_idx": 2414, "end_char_idx": 2674, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "03ca86e7-eb57-403a-9f5e-12c24d83cac6": {"__data__": {"id_": "03ca86e7-eb57-403a-9f5e-12c24d83cac6", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n ", "original_text": "I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "976f0db3-cf55-46c5-8f31-e9e7654764e8", "node_type": "1", "metadata": {"window": "But when we step back and we think about the industry and the steady -state in your assets and once you \nnormalize for the renewals and taking into account  all the streamlining and efficiencies that you talked about in \nyour prepared comments, what type of operating profit growth do you believe the business can support long -term \nwithin the single digit type top line growth?  \n \n Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.  ", "original_text": "I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d1199f40a88b3fffeac01eed3667faaa403544d8a82945566d5dbc1b83200da3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0cee6ea7-af82-4c27-98dd-83a1eb6fbf4a", "node_type": "1", "metadata": {"window": "You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "This is taking entire cost \nstructures out in a way that they won\u2019t come back.   "}, "hash": "c0dccf8b407fbdff7548acee1f396bc9cc312aaf1fa27a377bb2f6d08095c6b0", "class_name": "RelatedNodeInfo"}}, "text": "I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.  ", "start_char_idx": 2674, "end_char_idx": 2764, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0cee6ea7-af82-4c27-98dd-83a1eb6fbf4a": {"__data__": {"id_": "0cee6ea7-af82-4c27-98dd-83a1eb6fbf4a", "embedding": null, "metadata": {"window": "You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "This is taking entire cost \nstructures out in a way that they won\u2019t come back.   ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "03ca86e7-eb57-403a-9f5e-12c24d83cac6", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, thanks for th e question.   You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n ", "original_text": "I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "93c93b671b08f42915c93bcf92826da56a2061402697c7326f30b3a71055ff1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "13cde9c9-c561-4801-9876-6562e55ac219", "node_type": "1", "metadata": {"window": "I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.  "}, "hash": "34ab007f52f97aac392f277535a2c0b40883a2a4fcf12c90f1d83b0fd200d872", "class_name": "RelatedNodeInfo"}}, "text": "This is taking entire cost \nstructures out in a way that they won\u2019t come back.   ", "start_char_idx": 2764, "end_char_idx": 2845, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "13cde9c9-c561-4801-9876-6562e55ac219": {"__data__": {"id_": "13cde9c9-c561-4801-9876-6562e55ac219", "embedding": null, "metadata": {"window": "I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0cee6ea7-af82-4c27-98dd-83a1eb6fbf4a", "node_type": "1", "metadata": {"window": "You know it\u2019s too early for us to give any really comments on \u201921 and \nbeyond.   I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "This is taking entire cost \nstructures out in a way that they won\u2019t come back.   ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "968698a373062aaba50dd576d54f65b590f914801498774f49aa7e9e56973534", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4324e8fc-3add-405a-871e-4d005963b071", "node_type": "1", "metadata": {"window": "I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n "}, "hash": "05fcc05e8ac0a9f4c8b8e7724b03ed6fab1d4cca69c0af095b64a653123d3d6c", "class_name": "RelatedNodeInfo"}}, "text": "That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.  ", "start_char_idx": 2845, "end_char_idx": 3018, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4324e8fc-3add-405a-871e-4d005963b071": {"__data__": {"id_": "4324e8fc-3add-405a-871e-4d005963b071", "embedding": null, "metadata": {"window": "I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "13cde9c9-c561-4801-9876-6562e55ac219", "node_type": "1", "metadata": {"window": "I would just say that, you know, we feel really good about the progress that we made this quarter both in \ninvesting in the growth areas that we\u2019ve talked about, spe cialty, at -Home and our services businesses but also \ngetting after our cost structure.  \n \n  I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b71f485bd7080f18ff2d3f64a13cf0e16e949180d3b38da8d8bcd9936876dcc7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b947b54-9147-41ad-a471-d8b1f21defd0", "node_type": "1", "metadata": {"window": "This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n "}, "hash": "713243586a40b1d2d047d5abd44c01e3fa0c6c9c232f1e946aa5cf7aa0fcfcd3", "class_name": "RelatedNodeInfo"}}, "text": "Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n ", "start_char_idx": 3018, "end_char_idx": 3151, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5b947b54-9147-41ad-a471-d8b1f21defd0": {"__data__": {"id_": "5b947b54-9147-41ad-a471-d8b1f21defd0", "embedding": null, "metadata": {"window": "This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "68b47fc5-3328-49ec-9e35-e84845d5882b", "node_type": "4", "metadata": {"page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55e0fabaa081de4fb260e773c3d485c93c956826d69baf450a1e3b1e3e17d727", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4324e8fc-3add-405a-871e-4d005963b071", "node_type": "1", "metadata": {"window": "I think Dave made a comment that\u2019s really important is this isn\u2019t just a cost reduction.   This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "22adda6eadc01bf0acd490d7ba91a47b698f9e4a1ede2728e912f6fa0e1275d6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "702c0d9b-9144-47fe-b5c8-3c3255fba23f", "node_type": "1", "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n", "original_text": " \nPage 11 of 22 \n \n And really have this built into our overall culture.  "}, "hash": "c2cc99621ce049c3136b20d4643d6c6b9292c632e412dc9ed5b9cbe10934559c", "class_name": "RelatedNodeInfo"}}, "text": "So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "start_char_idx": 3151, "end_char_idx": 3265, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "702c0d9b-9144-47fe-b5c8-3c3255fba23f": {"__data__": {"id_": "702c0d9b-9144-47fe-b5c8-3c3255fba23f", "embedding": null, "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n", "original_text": " \nPage 11 of 22 \n \n And really have this built into our overall culture.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b947b54-9147-41ad-a471-d8b1f21defd0", "node_type": "1", "metadata": {"window": "This is taking entire cost \nstructures out in a way that they won\u2019t come back.    That the culture and the way the leadership is working is really \ndriving and prioritizing and focusing us on the right thing so we\u2019re spending dollars in the right space.   Taking \nadvantage of digital technologies, robotic automation, AI, etcetera, in ord er to really drive our cost structure down.  \n \n  So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "original_text": "So we feel really good about achieving our overall $500 million number, our $130 million number for this year.  \n ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e25f6ed23ef029df70d1441114514491fe77af9e23c62ee26d1318fe52375959", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8c32223-de46-417e-9cbc-b21ea4e94658", "node_type": "1", "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.  ", "original_text": "And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.  "}, "hash": "72fad33ca461f8eff6613cda433a91a2c41a7e9fc0539ca09f8302be8b551d47", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 11 of 22 \n \n And really have this built into our overall culture.  ", "start_char_idx": 0, "end_char_idx": 74, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e8c32223-de46-417e-9cbc-b21ea4e94658": {"__data__": {"id_": "e8c32223-de46-417e-9cbc-b21ea4e94658", "embedding": null, "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.  ", "original_text": "And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "702c0d9b-9144-47fe-b5c8-3c3255fba23f", "node_type": "1", "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n", "original_text": " \nPage 11 of 22 \n \n And really have this built into our overall culture.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2a74d14e4b5789c7f9b8d0b2ca2deddef9a48db31713ad21d641193845187f46", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "292b4b4f-2e89-4d93-80c8-5735d13b03db", "node_type": "1", "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.  ", "original_text": "But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n "}, "hash": "003d683c781976846fbaa06c6550d958e877b3060ac2f7898aa680dd9c1ef986", "class_name": "RelatedNodeInfo"}}, "text": "And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.  ", "start_char_idx": 74, "end_char_idx": 154, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "292b4b4f-2e89-4d93-80c8-5735d13b03db": {"__data__": {"id_": "292b4b4f-2e89-4d93-80c8-5735d13b03db", "embedding": null, "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.  ", "original_text": "But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e8c32223-de46-417e-9cbc-b21ea4e94658", "node_type": "1", "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.  ", "original_text": "And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ddedbd50a33a7ff7ab50245a5c6af4621a586cb0ca45f53d67e84122c51994e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c9d0ff23-d164-4c8e-a03a-ca4e15f654b0", "node_type": "1", "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n", "original_text": "Next question.  \n \n"}, "hash": "868a035715ab3b8cf1f557f77f92e3f977ac9924d1e10e4c617440393deac0f8", "class_name": "RelatedNodeInfo"}}, "text": "But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n ", "start_char_idx": 154, "end_char_idx": 278, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c9d0ff23-d164-4c8e-a03a-ca4e15f654b0": {"__data__": {"id_": "c9d0ff23-d164-4c8e-a03a-ca4e15f654b0", "embedding": null, "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n", "original_text": "Next question.  \n \n", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "292b4b4f-2e89-4d93-80c8-5735d13b03db", "node_type": "1", "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.  ", "original_text": "But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4d645ad2f8b1b1c51e3d76b3bbeaf1df876dd034871b259d035b40bb4bcd4e19", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25393370-ca28-46d4-96f3-efcc6cedd41a", "node_type": "1", "metadata": {"window": "And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.  ", "original_text": "Operator :  Thank you sir.  "}, "hash": "fc103c925e11265b939493e5f741f3333e7fa6b4685d50d2ba12f10f596a0c28", "class_name": "RelatedNodeInfo"}}, "text": "Next question.  \n \n", "start_char_idx": 278, "end_char_idx": 297, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "25393370-ca28-46d4-96f3-efcc6cedd41a": {"__data__": {"id_": "25393370-ca28-46d4-96f3-efcc6cedd41a", "embedding": null, "metadata": {"window": "And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.  ", "original_text": "Operator :  Thank you sir.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c9d0ff23-d164-4c8e-a03a-ca4e15f654b0", "node_type": "1", "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n", "original_text": "Next question.  \n \n", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bf4b6f85491626e58d25c3b6eac4e33e12feb348fcb73fa9554f00586b1604d6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "74bbe277-56b7-4c7c-b52d-39c09ae8d6b1", "node_type": "1", "metadata": {"window": "But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.  ", "original_text": "Our next question comes from Charles Rhyee of Cowen.  "}, "hash": "c28e669d2430762d54e1795dc69e04ce3681d7c866476c1264be58068ddc67a4", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you sir.  ", "start_char_idx": 297, "end_char_idx": 325, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "74bbe277-56b7-4c7c-b52d-39c09ae8d6b1": {"__data__": {"id_": "74bbe277-56b7-4c7c-b52d-39c09ae8d6b1", "embedding": null, "metadata": {"window": "But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.  ", "original_text": "Our next question comes from Charles Rhyee of Cowen.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "25393370-ca28-46d4-96f3-efcc6cedd41a", "node_type": "1", "metadata": {"window": "And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.  ", "original_text": "Operator :  Thank you sir.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b6eb90658a0eae648e66291bbd44dd234562f6dc74f70bf6266c44ad6d84761e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b078d91c-1f51-493d-ac05-5a9b3998e054", "node_type": "1", "metadata": {"window": "Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n ", "original_text": "Plea se go ahead.  \n \n"}, "hash": "0442f70f936c0d19a7548e3dacabfe0ca8f25642394b57a255da5799b38e22b9", "class_name": "RelatedNodeInfo"}}, "text": "Our next question comes from Charles Rhyee of Cowen.  ", "start_char_idx": 325, "end_char_idx": 379, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b078d91c-1f51-493d-ac05-5a9b3998e054": {"__data__": {"id_": "b078d91c-1f51-493d-ac05-5a9b3998e054", "embedding": null, "metadata": {"window": "Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n ", "original_text": "Plea se go ahead.  \n \n", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "74bbe277-56b7-4c7c-b52d-39c09ae8d6b1", "node_type": "1", "metadata": {"window": "But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.  ", "original_text": "Our next question comes from Charles Rhyee of Cowen.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "02e4418644728659adc98b7cafdf3b54aaa374c3f54610f8b271fe4995c72aa0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "35e4913a-b03f-4732-814d-10e64a30ab52", "node_type": "1", "metadata": {"window": "Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n", "original_text": "Charles Rhyee :  Of Cowen.  "}, "hash": "189ca2b45852e5393f29001e0e72fcf372049c9fb2e7a99da85d0c445819311e", "class_name": "RelatedNodeInfo"}}, "text": "Plea se go ahead.  \n \n", "start_char_idx": 379, "end_char_idx": 401, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "35e4913a-b03f-4732-814d-10e64a30ab52": {"__data__": {"id_": "35e4913a-b03f-4732-814d-10e64a30ab52", "embedding": null, "metadata": {"window": "Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n", "original_text": "Charles Rhyee :  Of Cowen.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b078d91c-1f51-493d-ac05-5a9b3998e054", "node_type": "1", "metadata": {"window": "Next question.  \n \n Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n ", "original_text": "Plea se go ahead.  \n \n", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b0c22966771185e62221a7bcd8164c33bd230cadb167b001562f4dd18e92dd3f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "16e7baa4-cc76-47e7-a69e-d17db7c3946f", "node_type": "1", "metadata": {"window": "Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.  ", "original_text": "Yes, hey thanks for taking the questions Mike.  "}, "hash": "47caf9ab174bf97407c460789c11245577d60741661b862d416bdf7abbc26e60", "class_name": "RelatedNodeInfo"}}, "text": "Charles Rhyee :  Of Cowen.  ", "start_char_idx": 401, "end_char_idx": 429, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "16e7baa4-cc76-47e7-a69e-d17db7c3946f": {"__data__": {"id_": "16e7baa4-cc76-47e7-a69e-d17db7c3946f", "embedding": null, "metadata": {"window": "Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.  ", "original_text": "Yes, hey thanks for taking the questions Mike.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "35e4913a-b03f-4732-814d-10e64a30ab52", "node_type": "1", "metadata": {"window": "Operator :  Thank you sir.   Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n", "original_text": "Charles Rhyee :  Of Cowen.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "62f2653ba22c13129c3257a071675dcbb1b08eb0b34db58772b015280869fa4d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "574df1e0-4dab-4298-ae0c-6620afe9e628", "node_type": "1", "metadata": {"window": "Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.  ", "original_text": "Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n "}, "hash": "1380f3282107935758fa9b9b1d90816f7e25046999bc13429429c5f94174e9f7", "class_name": "RelatedNodeInfo"}}, "text": "Yes, hey thanks for taking the questions Mike.  ", "start_char_idx": 429, "end_char_idx": 477, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "574df1e0-4dab-4298-ae0c-6620afe9e628": {"__data__": {"id_": "574df1e0-4dab-4298-ae0c-6620afe9e628", "embedding": null, "metadata": {"window": "Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.  ", "original_text": "Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16e7baa4-cc76-47e7-a69e-d17db7c3946f", "node_type": "1", "metadata": {"window": "Our next question comes from Charles Rhyee of Cowen.   Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.  ", "original_text": "Yes, hey thanks for taking the questions Mike.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2960974b17c3d835e849f24634e9c09661b9e9a613bfacf328a6adb0601e437d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "42348b3f-9dc4-41aa-9fca-487fe1e6a176", "node_type": "1", "metadata": {"window": "Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.  ", "original_text": "Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n"}, "hash": "ca20af9ef3cb9c0ac8ae7915bcab158dc88a1cfbc77320b55c15b0d00821a20f", "class_name": "RelatedNodeInfo"}}, "text": "Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n ", "start_char_idx": 477, "end_char_idx": 721, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "42348b3f-9dc4-41aa-9fca-487fe1e6a176": {"__data__": {"id_": "42348b3f-9dc4-41aa-9fca-487fe1e6a176", "embedding": null, "metadata": {"window": "Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.  ", "original_text": "Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "574df1e0-4dab-4298-ae0c-6620afe9e628", "node_type": "1", "metadata": {"window": "Plea se go ahead.  \n \n Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.  ", "original_text": "Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d8b4515b2a0bf207df5ef890f8759ccecb56343f281594625b4107729ceee96e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "edf3584f-df5d-4cba-a2be-b4fbeb555c9b", "node_type": "1", "metadata": {"window": "Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n ", "original_text": "Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.  "}, "hash": "e4dfb82498f0c0d1107af5628bc54ed7740a38e70a7f3431baa421bd7659f644", "class_name": "RelatedNodeInfo"}}, "text": "Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n", "start_char_idx": 721, "end_char_idx": 905, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "edf3584f-df5d-4cba-a2be-b4fbeb555c9b": {"__data__": {"id_": "edf3584f-df5d-4cba-a2be-b4fbeb555c9b", "embedding": null, "metadata": {"window": "Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n ", "original_text": "Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "42348b3f-9dc4-41aa-9fca-487fe1e6a176", "node_type": "1", "metadata": {"window": "Charles Rhyee :  Of Cowen.   Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.  ", "original_text": "Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "dbe759e98777d1566905868dc0dbf85c190941781a91cff2ce57930f8af99c08", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "86e62ba4-45a4-463e-8d63-e7901a5aaa9a", "node_type": "1", "metadata": {"window": "Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.  ", "original_text": "But let me just step back and make sure that, you know, we\u2019re on the \nsame page.  "}, "hash": "a7530f584d4aa378c35e5b3c324bdc766e248c9354bc01d0076123fd9a17b625", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.  ", "start_char_idx": 905, "end_char_idx": 957, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "86e62ba4-45a4-463e-8d63-e7901a5aaa9a": {"__data__": {"id_": "86e62ba4-45a4-463e-8d63-e7901a5aaa9a", "embedding": null, "metadata": {"window": "Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.  ", "original_text": "But let me just step back and make sure that, you know, we\u2019re on the \nsame page.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "edf3584f-df5d-4cba-a2be-b4fbeb555c9b", "node_type": "1", "metadata": {"window": "Yes, hey thanks for taking the questions Mike.   Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n ", "original_text": "Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "14ac28b2eb8def4d04ec028cfce82ec22ea09319e6f2039b202c52c0a0ed7724", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "10093179-9d6b-4099-9f1f-f5a0c4240eb4", "node_type": "1", "metadata": {"window": "Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.  ", "original_text": "As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.  "}, "hash": "c6294aabb06d6889d617e7018cbd95d468becccb0c28c6cb60a87dc4e360f98d", "class_name": "RelatedNodeInfo"}}, "text": "But let me just step back and make sure that, you know, we\u2019re on the \nsame page.  ", "start_char_idx": 957, "end_char_idx": 1039, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "10093179-9d6b-4099-9f1f-f5a0c4240eb4": {"__data__": {"id_": "10093179-9d6b-4099-9f1f-f5a0c4240eb4", "embedding": null, "metadata": {"window": "Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.  ", "original_text": "As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "86e62ba4-45a4-463e-8d63-e7901a5aaa9a", "node_type": "1", "metadata": {"window": "Just going back to the opioids really quickly, \nyou know your comments and, you know, one of your peers today, you know, sounds a lot more positive I would \nsay maybe than the comments, you know, fro m one of the companies the other week.  \n \n  Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.  ", "original_text": "But let me just step back and make sure that, you know, we\u2019re on the \nsame page.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "23a01281c6aa75269d7ba8577a260c181206d96698fd1f2623858c7e56ff6732", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bb431036-2dd5-4d00-aa24-51e613670e1a", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.  ", "original_text": "That was an important compo nent of being able to get that behind us.  \n \n "}, "hash": "c7680c9ecfc936c044473d0c2f301332d2d54b53bd426d8528657c09e71f41ea", "class_name": "RelatedNodeInfo"}}, "text": "As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.  ", "start_char_idx": 1039, "end_char_idx": 1173, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bb431036-2dd5-4d00-aa24-51e613670e1a": {"__data__": {"id_": "bb431036-2dd5-4d00-aa24-51e613670e1a", "embedding": null, "metadata": {"window": "Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.  ", "original_text": "That was an important compo nent of being able to get that behind us.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "10093179-9d6b-4099-9f1f-f5a0c4240eb4", "node_type": "1", "metadata": {"window": "Anything kind of changed in the last week or two that kind of increases sort of the optimism here in terms of \ngetting, you know, sort of getting towards a global settlement here?  \n \n Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.  ", "original_text": "As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "318f79756fa066c01da0c72ad6d00c6217810bcede3f136f97a241fe5a7d8fdc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f578b07f-070a-4db5-b839-7b8a3844fb18", "node_type": "1", "metadata": {"window": "But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n ", "original_text": "So all of the parties involved in the global framework could move forward and begin working on it.  "}, "hash": "f8468a29543a1e152fe12270c304f52a986f4ba8d9d4f49841154ac0cc4d7fcc", "class_name": "RelatedNodeInfo"}}, "text": "That was an important compo nent of being able to get that behind us.  \n \n ", "start_char_idx": 1173, "end_char_idx": 1248, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f578b07f-070a-4db5-b839-7b8a3844fb18": {"__data__": {"id_": "f578b07f-070a-4db5-b839-7b8a3844fb18", "embedding": null, "metadata": {"window": "But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n ", "original_text": "So all of the parties involved in the global framework could move forward and begin working on it.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bb431036-2dd5-4d00-aa24-51e613670e1a", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  I wouldn\u2019t say anyt hing changed.   But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.  ", "original_text": "That was an important compo nent of being able to get that behind us.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3a4eea15a4b857a8f54d1728ac74dc16e877bcf2555818308771392072e866b7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f015e915-c269-4880-9487-2c6de252b0a8", "node_type": "1", "metadata": {"window": "As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n ", "original_text": "So that\u2019s an \nimportant thing to know.  "}, "hash": "5c5bfc653605687f643d706d42d116d8f7442a35f751f99f2fcf0b83608ea6d9", "class_name": "RelatedNodeInfo"}}, "text": "So all of the parties involved in the global framework could move forward and begin working on it.  ", "start_char_idx": 1248, "end_char_idx": 1348, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f015e915-c269-4880-9487-2c6de252b0a8": {"__data__": {"id_": "f015e915-c269-4880-9487-2c6de252b0a8", "embedding": null, "metadata": {"window": "As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n ", "original_text": "So that\u2019s an \nimportant thing to know.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f578b07f-070a-4db5-b839-7b8a3844fb18", "node_type": "1", "metadata": {"window": "But let me just step back and make sure that, you know, we\u2019re on the \nsame page.   As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n ", "original_text": "So all of the parties involved in the global framework could move forward and begin working on it.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "583d0012b953f4857b5110762319c95c2a65723ab1ce2c4361e6934a9e4eadd6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f8f3f987-b23d-473e-9337-ef8b44efe6ce", "node_type": "1", "metadata": {"window": "That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n ", "original_text": "We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.  "}, "hash": "fb6ad7941b547c30c316ecb34b9be9a6b539a3908728477d136d4bfdb5ee902f", "class_name": "RelatedNodeInfo"}}, "text": "So that\u2019s an \nimportant thing to know.  ", "start_char_idx": 1348, "end_char_idx": 1388, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f8f3f987-b23d-473e-9337-ef8b44efe6ce": {"__data__": {"id_": "f8f3f987-b23d-473e-9337-ef8b44efe6ce", "embedding": null, "metadata": {"window": "That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n ", "original_text": "We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f015e915-c269-4880-9487-2c6de252b0a8", "node_type": "1", "metadata": {"window": "As you know, a few weeks ago we settled with two Ohio counties, which by doing that enabled us to \nmove forward with this framework.   That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n ", "original_text": "So that\u2019s an \nimportant thing to know.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2c6551cda0daeb3b4b9cb5e85e2e261d5d14d79e37df20900c7fd4796945f00b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f39cfa14-a63c-4b77-acc4-f054121af9a9", "node_type": "1", "metadata": {"window": "So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.  ", "original_text": "We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n "}, "hash": "6f48d4d426d490d901386162afe82b90df79109ed2fb77ec41a4d9ea339bb165", "class_name": "RelatedNodeInfo"}}, "text": "We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.  ", "start_char_idx": 1388, "end_char_idx": 1524, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f39cfa14-a63c-4b77-acc4-f054121af9a9": {"__data__": {"id_": "f39cfa14-a63c-4b77-acc4-f054121af9a9", "embedding": null, "metadata": {"window": "So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.  ", "original_text": "We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f8f3f987-b23d-473e-9337-ef8b44efe6ce", "node_type": "1", "metadata": {"window": "That was an important compo nent of being able to get that behind us.  \n \n  So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n ", "original_text": "We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d05c1b4d9282bce80ffcda2994bbfa1419e3a5ac3da877c1cba05c378085b9bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d5fd13bb-f375-49ce-a38a-67716e194193", "node_type": "1", "metadata": {"window": "So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n", "original_text": "And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n "}, "hash": "9c06f210dee624bbeb0bf693d1878e2ac51a78eb09a804939f1251edd4c25d59", "class_name": "RelatedNodeInfo"}}, "text": "We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n ", "start_char_idx": 1524, "end_char_idx": 1612, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d5fd13bb-f375-49ce-a38a-67716e194193": {"__data__": {"id_": "d5fd13bb-f375-49ce-a38a-67716e194193", "embedding": null, "metadata": {"window": "So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n", "original_text": "And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f39cfa14-a63c-4b77-acc4-f054121af9a9", "node_type": "1", "metadata": {"window": "So all of the parties involved in the global framework could move forward and begin working on it.   So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.  ", "original_text": "We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c1ea88a6fd4edeb3f1d92acadd4bbbddfd088991a5f3ab832e660b63822e55ef", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6de58eaf-a095-4979-951b-93901687e5fb", "node_type": "1", "metadata": {"window": "We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.  ", "original_text": "We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n "}, "hash": "492f8cef5870c75384ea88547d23646cfca894a100fc02edba38f42339c5ab4a", "class_name": "RelatedNodeInfo"}}, "text": "And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n ", "start_char_idx": 1612, "end_char_idx": 1845, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6de58eaf-a095-4979-951b-93901687e5fb": {"__data__": {"id_": "6de58eaf-a095-4979-951b-93901687e5fb", "embedding": null, "metadata": {"window": "We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.  ", "original_text": "We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d5fd13bb-f375-49ce-a38a-67716e194193", "node_type": "1", "metadata": {"window": "So that\u2019s an \nimportant thing to know.   We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n", "original_text": "And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b3d299351cf292427e655177745dfea2336f7903b8007ff5667112f362e944c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "83654659-13b1-46b3-883f-0f96b96b3d78", "node_type": "1", "metadata": {"window": "We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.  ", "original_text": "And so we feel positive that folks will work hard on this to get this going.  "}, "hash": "040cae4dee64bcad00f8d73ccfec41d99d24c4b9921e0df44de97a8aa336b963", "class_name": "RelatedNodeInfo"}}, "text": "We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n ", "start_char_idx": 1845, "end_char_idx": 2042, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "83654659-13b1-46b3-883f-0f96b96b3d78": {"__data__": {"id_": "83654659-13b1-46b3-883f-0f96b96b3d78", "embedding": null, "metadata": {"window": "We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.  ", "original_text": "And so we feel positive that folks will work hard on this to get this going.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6de58eaf-a095-4979-951b-93901687e5fb", "node_type": "1", "metadata": {"window": "We clearly have a global settlement framework and structure with the $18 billion over 18 \nyears with our component being $5.6 billion.   We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.  ", "original_text": "We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7e51b0fa87df1ee4ee7f5a34db4b5ff13fe0ed5d95ffd507e11e309a2927e6f5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5cb73bd5-5efe-46db-95a5-bea125aa4b42", "node_type": "1", "metadata": {"window": "And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n ", "original_text": "So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n"}, "hash": "46a3bb608f56cd27217c2a9e4fb7188cb7cc9e033d89b2255444ce111b68d8e0", "class_name": "RelatedNodeInfo"}}, "text": "And so we feel positive that folks will work hard on this to get this going.  ", "start_char_idx": 2042, "end_char_idx": 2120, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5cb73bd5-5efe-46db-95a5-bea125aa4b42": {"__data__": {"id_": "5cb73bd5-5efe-46db-95a5-bea125aa4b42", "embedding": null, "metadata": {"window": "And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n ", "original_text": "So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "83654659-13b1-46b3-883f-0f96b96b3d78", "node_type": "1", "metadata": {"window": "We\u2019ve also agreed upon distributing the free treatment medications \nfor ten years.  \n \n  And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.  ", "original_text": "And so we feel positive that folks will work hard on this to get this going.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d89f6d88238fb25f18a88e2d6af98c3469be0530ba8334f6182de27dcfca4cac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5f09fd7a-8996-4453-b29a-03b3b174735b", "node_type": "1", "metadata": {"window": "We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?  ", "original_text": "Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.  "}, "hash": "e068fe7b2861dfe4c3d1f1bab28dd874e53a5bbdc96f80275d08b9413c387333", "class_name": "RelatedNodeInfo"}}, "text": "So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n", "start_char_idx": 2120, "end_char_idx": 2267, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5f09fd7a-8996-4453-b29a-03b3b174735b": {"__data__": {"id_": "5f09fd7a-8996-4453-b29a-03b3b174735b", "embedding": null, "metadata": {"window": "We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?  ", "original_text": "Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5cb73bd5-5efe-46db-95a5-bea125aa4b42", "node_type": "1", "metadata": {"window": "And we\u2019ve agreed that when we get this behind us we can all work together to look at the way states, federal \ngovernment, distributors, everybody work together to monitor opioid shipments and uses so that we can work \ntogether.  \n \n  We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n ", "original_text": "So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "25f21964070728d54193d93b8a2a6aed536117d008ddb201c78e429cffa393c8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "56b99b5f-27f3-41d2-802f-474e1277da10", "node_type": "1", "metadata": {"window": "And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.  "}, "hash": "31203dd5ef61e66afb573eaa5f17f82c9432b0d9aee233e46695d0151c9a23c4", "class_name": "RelatedNodeInfo"}}, "text": "Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.  ", "start_char_idx": 2267, "end_char_idx": 2460, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "56b99b5f-27f3-41d2-802f-474e1277da10": {"__data__": {"id_": "56b99b5f-27f3-41d2-802f-474e1277da10", "embedding": null, "metadata": {"window": "And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5f09fd7a-8996-4453-b29a-03b3b174735b", "node_type": "1", "metadata": {"window": "We think the desire and how \u2013 if we can get this behind us how it will bring meaningful relief in both funds and \ndistribution of treatment medication to the people that need it is important.  \n \n  And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?  ", "original_text": "Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a841284988397b10a2bf246e535d6eb6e62615c569948fa7e5028942928adcdb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c7db9c0-2367-481b-a891-3ff370f13beb", "node_type": "1", "metadata": {"window": "So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n "}, "hash": "c902509be4e506ee4242298e0ad5ab49ede3978034eab77986e7fb0f123b3796", "class_name": "RelatedNodeInfo"}}, "text": "Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.  ", "start_char_idx": 2460, "end_char_idx": 2554, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7c7db9c0-2367-481b-a891-3ff370f13beb": {"__data__": {"id_": "7c7db9c0-2367-481b-a891-3ff370f13beb", "embedding": null, "metadata": {"window": "So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "56b99b5f-27f3-41d2-802f-474e1277da10", "node_type": "1", "metadata": {"window": "And so we feel positive that folks will work hard on this to get this going.   So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6e81dc9fae56d6e97220c4ed4167468e11b4d865e2266b492fcb137df417d959", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd05510c-92cb-48e0-9991-449192233aa5", "node_type": "1", "metadata": {"window": "Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?  "}, "hash": "4799754ad01a4de19e4c194e1b78e9349ada7804bf06d2357f5a39c3c5eb46ba", "class_name": "RelatedNodeInfo"}}, "text": "I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n ", "start_char_idx": 2554, "end_char_idx": 2773, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cd05510c-92cb-48e0-9991-449192233aa5": {"__data__": {"id_": "cd05510c-92cb-48e0-9991-449192233aa5", "embedding": null, "metadata": {"window": "Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c7db9c0-2367-481b-a891-3ff370f13beb", "node_type": "1", "metadata": {"window": "So again, nothing specific but our belief \nis that the way this is structured that this is the right accounting for  us at this point in time.  \n \n Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "42d0d6bb9a256232b748cc5eb92c8f96b1e2b08772522ced100f5da5a39c5cdf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1b805b31-db05-40b9-a820-fa645b274696", "node_type": "1", "metadata": {"window": "Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, "}, "hash": "cd006660bf781d0344e36e69a46050596c008cba8cfef38523fb4d9925400ec8", "class_name": "RelatedNodeInfo"}}, "text": "You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?  ", "start_char_idx": 2773, "end_char_idx": 2899, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1b805b31-db05-40b9-a820-fa645b274696": {"__data__": {"id_": "1b805b31-db05-40b9-a820-fa645b274696", "embedding": null, "metadata": {"window": "Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd", "node_type": "4", "metadata": {"page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7880c797dfc7430ebea879ca3ddfddfabffa7dbb22b6bdc6e999c8444b88c592", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cd05510c-92cb-48e0-9991-449192233aa5", "node_type": "1", "metadata": {"window": "Charles Rhyee :  And if I could just follow -up, right, obviously if you look at the number of plaintiffs, I mean I forget the last \ncount, right, it\u2019s, you know, upwards of what, 2000 or so.   Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f57e7ca3915de9c30c1bb9b5a47271aa2101d89d1e80c6810f74ba55ffcc8a4e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a612e260-f1e2-4bf7-8753-fd64183dc256", "node_type": "1", "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.  ", "original_text": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n"}, "hash": "ebf62896642e0cf8d13e6e6d6e05cf952178b29ed8e440414e255f8215b35ef3", "class_name": "RelatedNodeInfo"}}, "text": "In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "start_char_idx": 2899, "end_char_idx": 3011, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a612e260-f1e2-4bf7-8753-fd64183dc256": {"__data__": {"id_": "a612e260-f1e2-4bf7-8753-fd64183dc256", "embedding": null, "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.  ", "original_text": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1b805b31-db05-40b9-a820-fa645b274696", "node_type": "1", "metadata": {"window": "Obviously these states are a big compo nent of it but you \nhave a lot of smaller plaintiffs.   I mean, you know, as I read some of the comments, you know, from Amerisource \nas well as who speaks to it, it\u2019s, you know, it kind of suggests that not only state agencies but also a lot of the \nother pla intiffs.  \n \n  You know can you kind of discuss like sort of the participation of, you know, sort of the smaller entities kind of in \nthis?   In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "original_text": "In other words, if you get this framework done do we still have a long tail of small plaintiffs kind of coming, ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a1d5dd144a15fd6b126d2874602dd0f96ad90ded74ffb3ac9b7dbc854218b9d7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1ddcedd0-7330-41ac-99b0-bf5ae37f6912", "node_type": "1", "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.  ", "original_text": "Mike Kaufmann :  Yes good question.  "}, "hash": "f9294d911cc737c0cf197b26882fd27a8d047271667b4f2927a8c420aefcc3c1", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n", "start_char_idx": 0, "end_char_idx": 195, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1ddcedd0-7330-41ac-99b0-bf5ae37f6912": {"__data__": {"id_": "1ddcedd0-7330-41ac-99b0-bf5ae37f6912", "embedding": null, "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.  ", "original_text": "Mike Kaufmann :  Yes good question.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a612e260-f1e2-4bf7-8753-fd64183dc256", "node_type": "1", "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.  ", "original_text": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bc58c2481ebb3537b2936ca79cc83c6ab34bbc54ca7bdbd11bd40b9265bd6474", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0c9d43cf-2ed0-4297-9983-7adba5e4e459", "node_type": "1", "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n ", "original_text": "I would say this.  "}, "hash": "c1b838b620ed19a4d03ff62bebfd37b3ea0a019813e7c80bfaeb17c21811b79b", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes good question.  ", "start_char_idx": 195, "end_char_idx": 232, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0c9d43cf-2ed0-4297-9983-7adba5e4e459": {"__data__": {"id_": "0c9d43cf-2ed0-4297-9983-7adba5e4e459", "embedding": null, "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n ", "original_text": "I would say this.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ddcedd0-7330-41ac-99b0-bf5ae37f6912", "node_type": "1", "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.  ", "original_text": "Mike Kaufmann :  Yes good question.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "74a584b74e298c4fd133aefe6ca62641153dc0117ef57563d6c81ecf300bdf8b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "499a37ed-ffcd-4ab8-997a-31e56e3a1c0e", "node_type": "1", "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n ", "original_text": "I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.  "}, "hash": "11a16e900b7aa4de5af2ff53eccf3e7e0a00fa90b2d3d76537c3c7b6a1bc4d56", "class_name": "RelatedNodeInfo"}}, "text": "I would say this.  ", "start_char_idx": 232, "end_char_idx": 251, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "499a37ed-ffcd-4ab8-997a-31e56e3a1c0e": {"__data__": {"id_": "499a37ed-ffcd-4ab8-997a-31e56e3a1c0e", "embedding": null, "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n ", "original_text": "I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0c9d43cf-2ed0-4297-9983-7adba5e4e459", "node_type": "1", "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n ", "original_text": "I would say this.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f61fbac7664af9f315434a6d0e73ac7ed36b845c493ea0896cfacbfc0c7943fe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "54d082da-93c8-49aa-98cc-67f035174c0b", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n", "original_text": "Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.  "}, "hash": "211afbafa5ae6142be53f173609a18a8d7ca638edff8d28bd04583d406b10f04", "class_name": "RelatedNodeInfo"}}, "text": "I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.  ", "start_char_idx": 251, "end_char_idx": 337, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "54d082da-93c8-49aa-98cc-67f035174c0b": {"__data__": {"id_": "54d082da-93c8-49aa-98cc-67f035174c0b", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n", "original_text": "Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "499a37ed-ffcd-4ab8-997a-31e56e3a1c0e", "node_type": "1", "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n ", "original_text": "I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2ae148f56e9c792900f7ca3be9ff661f8e18481cc63677e08941fa881d6388d4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9185e736-a9e5-4153-8067-6c65855048b1", "node_type": "1", "metadata": {"window": "I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n", "original_text": "And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n "}, "hash": "029863827864445da3749fe62df28d70284dbbd7b04e2c905024ecea9d6d5667", "class_name": "RelatedNodeInfo"}}, "text": "Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.  ", "start_char_idx": 337, "end_char_idx": 457, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9185e736-a9e5-4153-8067-6c65855048b1": {"__data__": {"id_": "9185e736-a9e5-4153-8067-6c65855048b1", "embedding": null, "metadata": {"window": "I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n", "original_text": "And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "54d082da-93c8-49aa-98cc-67f035174c0b", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n", "original_text": "Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3538fc0ea8feac4d0a6c88a0f5a6097474ba42bb3e389bd028d54a07e1c766dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e81a0b09-effd-4b71-a563-81d271569916", "node_type": "1", "metadata": {"window": "I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n ", "original_text": "This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n "}, "hash": "eeee73471a701e219ea3a2860cae2375ef12b32c35652dcc5bdeef2447457a87", "class_name": "RelatedNodeInfo"}}, "text": "And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n ", "start_char_idx": 457, "end_char_idx": 583, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e81a0b09-effd-4b71-a563-81d271569916": {"__data__": {"id_": "e81a0b09-effd-4b71-a563-81d271569916", "embedding": null, "metadata": {"window": "I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n ", "original_text": "This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9185e736-a9e5-4153-8067-6c65855048b1", "node_type": "1", "metadata": {"window": "I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n", "original_text": "And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "64c16aaee2d3d8cb678388a406b2b85ec0f1ed9b59b5afe6dacec1a335402b5c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c035b526-5d77-40fc-be29-ff852f77418e", "node_type": "1", "metadata": {"window": "Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n", "original_text": "And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n"}, "hash": "59cff67ac1a2ec99d4d80402c72ff394655609de18dead7b790983d9d52cad12", "class_name": "RelatedNodeInfo"}}, "text": "This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n ", "start_char_idx": 583, "end_char_idx": 750, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c035b526-5d77-40fc-be29-ff852f77418e": {"__data__": {"id_": "c035b526-5d77-40fc-be29-ff852f77418e", "embedding": null, "metadata": {"window": "Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n", "original_text": "And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e81a0b09-effd-4b71-a563-81d271569916", "node_type": "1", "metadata": {"window": "I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.   Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n ", "original_text": "This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "077e8dc27fd330651944193d3d9eaced69654b0bcca3410604448b4accf1d1ae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7b28894a-9a6a-4d2f-a87c-8c03a3f694e1", "node_type": "1", "metadata": {"window": "And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.  ", "original_text": "That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n"}, "hash": "bfeaccdf8db6287d09d052ebaf132b0428b2d0e701ff7ef1c6ffe1117e8926bd", "class_name": "RelatedNodeInfo"}}, "text": "And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n", "start_char_idx": 750, "end_char_idx": 867, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7b28894a-9a6a-4d2f-a87c-8c03a3f694e1": {"__data__": {"id_": "7b28894a-9a6a-4d2f-a87c-8c03a3f694e1", "embedding": null, "metadata": {"window": "And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.  ", "original_text": "That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c035b526-5d77-40fc-be29-ff852f77418e", "node_type": "1", "metadata": {"window": "Let me put them in three broad buckets, there\u2019s states, there\u2019s the political subdivisions, \nthe counties, the cities.   And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n", "original_text": "And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6b5ac2f7034dd5628a7c960f625543350b982779fd5afc6f2eee812ffd64ed01", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7de08c09-c456-4d2c-9028-0cb6a0bc1415", "node_type": "1", "metadata": {"window": "This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.  ", "original_text": "And those are still out there and will be things that we will have to address goi ng forward.  \n \n "}, "hash": "6fc21201a5d8322225ebad31335191cdd8d6ce7d0aae0f53a9d486113ed9a036", "class_name": "RelatedNodeInfo"}}, "text": "That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n", "start_char_idx": 867, "end_char_idx": 990, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7de08c09-c456-4d2c-9028-0cb6a0bc1415": {"__data__": {"id_": "7de08c09-c456-4d2c-9028-0cb6a0bc1415", "embedding": null, "metadata": {"window": "This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.  ", "original_text": "And those are still out there and will be things that we will have to address goi ng forward.  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7b28894a-9a6a-4d2f-a87c-8c03a3f694e1", "node_type": "1", "metadata": {"window": "And then there\u2019s what we\u2019ll call more private plaintiffs, which might be pension funds or \nindividuals and those things.  \n \n  This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.  ", "original_text": "That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8f74dbd3b289e24c24bb3fc7bfc96ab8a61f843f924dba1ff150498eab6c6eb3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc061452-80a8-4327-aa72-cea0c88971ea", "node_type": "1", "metadata": {"window": "And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n", "original_text": "Next question.  \n \n"}, "hash": "da4bb8d8f6bca97dcb1d237083843655a3b870d5b76ca8ce205cbdbeef2f708c", "class_name": "RelatedNodeInfo"}}, "text": "And those are still out there and will be things that we will have to address goi ng forward.  \n \n ", "start_char_idx": 990, "end_char_idx": 1089, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "dc061452-80a8-4327-aa72-cea0c88971ea": {"__data__": {"id_": "dc061452-80a8-4327-aa72-cea0c88971ea", "embedding": null, "metadata": {"window": "And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n", "original_text": "Next question.  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7de08c09-c456-4d2c-9028-0cb6a0bc1415", "node_type": "1", "metadata": {"window": "This global framework is put together to settle the first two, all of the state claims as well as the cities and political \nsub \u2013 all the political subdivisions.  \n \n  And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.  ", "original_text": "And those are still out there and will be things that we will have to address goi ng forward.  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "99054f99ce5fd35beab903d8ee891cad14db4127752f62f3b072e6cdb04da380", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "93dad029-21b4-44b7-b0a5-7cc5038c77ec", "node_type": "1", "metadata": {"window": "That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.  ", "original_text": "Operator :  Thank you.  "}, "hash": "f06cd41467549d408fba74c25a5756a85462dcac98823cdc479278047bc96153", "class_name": "RelatedNodeInfo"}}, "text": "Next question.  \n \n", "start_char_idx": 1089, "end_char_idx": 1108, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "93dad029-21b4-44b7-b0a5-7cc5038c77ec": {"__data__": {"id_": "93dad029-21b4-44b7-b0a5-7cc5038c77ec", "embedding": null, "metadata": {"window": "That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.  ", "original_text": "Operator :  Thank you.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc061452-80a8-4327-aa72-cea0c88971ea", "node_type": "1", "metadata": {"window": "And the accrual that we put on the books is to represent the g lobal framework we did for those first two buckets.  \n That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n", "original_text": "Next question.  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "939d39820abd5e39f19e69a2d2cfe2112336a4eb7ef258c370122f050821f25c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b93e118b-1368-43ad-8b34-ae72cd780194", "node_type": "1", "metadata": {"window": "And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.  ", "original_text": "We will take our next question from Steven Valiquette at Barclays.  "}, "hash": "2dba631c0bede550f1d6f429f52546675fed5395c9e2f971016369acbb0a29bf", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you.  ", "start_char_idx": 1108, "end_char_idx": 1132, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b93e118b-1368-43ad-8b34-ae72cd780194": {"__data__": {"id_": "b93e118b-1368-43ad-8b34-ae72cd780194", "embedding": null, "metadata": {"window": "And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.  ", "original_text": "We will take our next question from Steven Valiquette at Barclays.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "93dad029-21b4-44b7-b0a5-7cc5038c77ec", "node_type": "1", "metadata": {"window": "That third bucket, which there is also still suits out there, are very different and it\u2019s a mixture of different things.  \n And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.  ", "original_text": "Operator :  Thank you.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d17cfece1f5d3226fa2794bca0bfbc098fc0df65a195abee8046cfb827c6e6ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9713c4b5-1b22-4c64-8c68-6538df6416fa", "node_type": "1", "metadata": {"window": "Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n ", "original_text": "Please go ahead.  \n \n"}, "hash": "1c35e5e00431efe9d591f2447d323a7f9a3ae9b19ae6516966087f035dbc000c", "class_name": "RelatedNodeInfo"}}, "text": "We will take our next question from Steven Valiquette at Barclays.  ", "start_char_idx": 1132, "end_char_idx": 1200, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9713c4b5-1b22-4c64-8c68-6538df6416fa": {"__data__": {"id_": "9713c4b5-1b22-4c64-8c68-6538df6416fa", "embedding": null, "metadata": {"window": "Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n ", "original_text": "Please go ahead.  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b93e118b-1368-43ad-8b34-ae72cd780194", "node_type": "1", "metadata": {"window": "And those are still out there and will be things that we will have to address goi ng forward.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.  ", "original_text": "We will take our next question from Steven Valiquette at Barclays.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bea2e7c5570a9b8eee2bd241cb8d518bbc907cbfe78279a5d74c2d25dc3eefd7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8205edd-220d-4c3c-a084-a5496ae5adc1", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n ", "original_text": "Steven Valiquette :  Great, thanks.  "}, "hash": "f2ccf589d2183da7cb95d6b7d95692fa05adf860b86120551863d0a04776ace4", "class_name": "RelatedNodeInfo"}}, "text": "Please go ahead.  \n \n", "start_char_idx": 1200, "end_char_idx": 1221, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e8205edd-220d-4c3c-a084-a5496ae5adc1": {"__data__": {"id_": "e8205edd-220d-4c3c-a084-a5496ae5adc1", "embedding": null, "metadata": {"window": "Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n ", "original_text": "Steven Valiquette :  Great, thanks.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9713c4b5-1b22-4c64-8c68-6538df6416fa", "node_type": "1", "metadata": {"window": "Next question.  \n \n Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n ", "original_text": "Please go ahead.  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6ce2c207a941967ee337f7b2ac6e7ed5800afaee4e5889e81146c9a22d9b174e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d4f9b472-0d98-4dbc-adec-76a5fc9a03a4", "node_type": "1", "metadata": {"window": "We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.  ", "original_text": "Good morning Mike and Dave.  "}, "hash": "d2cfbe6523d1c14098ea5cbcc2cceb1ece1adca7a6b8f9da13dad8ee658548f8", "class_name": "RelatedNodeInfo"}}, "text": "Steven Valiquette :  Great, thanks.  ", "start_char_idx": 1221, "end_char_idx": 1258, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d4f9b472-0d98-4dbc-adec-76a5fc9a03a4": {"__data__": {"id_": "d4f9b472-0d98-4dbc-adec-76a5fc9a03a4", "embedding": null, "metadata": {"window": "We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.  ", "original_text": "Good morning Mike and Dave.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e8205edd-220d-4c3c-a084-a5496ae5adc1", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n ", "original_text": "Steven Valiquette :  Great, thanks.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5f1622269f2bdad36338fa52c08da1415a5a047e3ea9c329c3ad08df730aad82", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1669748f-873f-4877-88eb-c18338129c03", "node_type": "1", "metadata": {"window": "Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n", "original_text": "So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n "}, "hash": "d834a337e9c5f8a0f65b4a1633f1e663cf6aa645acad1c795dc2d40f96f72b68", "class_name": "RelatedNodeInfo"}}, "text": "Good morning Mike and Dave.  ", "start_char_idx": 1258, "end_char_idx": 1287, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1669748f-873f-4877-88eb-c18338129c03": {"__data__": {"id_": "1669748f-873f-4877-88eb-c18338129c03", "embedding": null, "metadata": {"window": "Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n", "original_text": "So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d4f9b472-0d98-4dbc-adec-76a5fc9a03a4", "node_type": "1", "metadata": {"window": "We will take our next question from Steven Valiquette at Barclays.   Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.  ", "original_text": "Good morning Mike and Dave.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "fc9b6037619ad6bf0bd6955fdaf13f67231502e9653f9d3c1615e873e4abaddf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "77278770-7ec0-45ca-bd31-ad5006865216", "node_type": "1", "metadata": {"window": "Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n "}, "hash": "30db96f9a6cf0eff976a6681a7b7cf9b8ed71a30b394dfcb2027a73aace78cda", "class_name": "RelatedNodeInfo"}}, "text": "So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n ", "start_char_idx": 1287, "end_char_idx": 1514, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "77278770-7ec0-45ca-bd31-ad5006865216": {"__data__": {"id_": "77278770-7ec0-45ca-bd31-ad5006865216", "embedding": null, "metadata": {"window": "Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1669748f-873f-4877-88eb-c18338129c03", "node_type": "1", "metadata": {"window": "Please go ahead.  \n \n Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n", "original_text": "So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4fbfb81343f8e20ec98bb74f8d2d66ee085cb434bfd86afc02888b15f03e2c74", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d3540ba-8b8f-49cb-9f83-66fbdef07c94", "node_type": "1", "metadata": {"window": "Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No. ", "original_text": "And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.  "}, "hash": "8ef76a6d78db563b9261b7b384d34017d9f31b3ca05022ae1c3a8dbbe764ba21", "class_name": "RelatedNodeInfo"}}, "text": "But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n ", "start_char_idx": 1514, "end_char_idx": 1745, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6d3540ba-8b8f-49cb-9f83-66fbdef07c94": {"__data__": {"id_": "6d3540ba-8b8f-49cb-9f83-66fbdef07c94", "embedding": null, "metadata": {"window": "Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No. ", "original_text": "And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "77278770-7ec0-45ca-bd31-ad5006865216", "node_type": "1", "metadata": {"window": "Steven Valiquette :  Great, thanks.   Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.  ", "original_text": "But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b7d4caefce8f0196adf1ae69162d673a5b2aceb643038bd44cb951cffec8e677", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a842546f-5116-4226-b322-cb956e76c9de", "node_type": "1", "metadata": {"window": "So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.  ", "original_text": "Thanks.  \n \n"}, "hash": "5e3472c7b333ce35fe22a372a4afc9c8983f72b4f9846a80b3bc1b50412dba08", "class_name": "RelatedNodeInfo"}}, "text": "And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.  ", "start_char_idx": 1745, "end_char_idx": 1967, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a842546f-5116-4226-b322-cb956e76c9de": {"__data__": {"id_": "a842546f-5116-4226-b322-cb956e76c9de", "embedding": null, "metadata": {"window": "So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.  ", "original_text": "Thanks.  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6d3540ba-8b8f-49cb-9f83-66fbdef07c94", "node_type": "1", "metadata": {"window": "Good morning Mike and Dave.   So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No. ", "original_text": "And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ef7b7686d3deb0d944c4ad52f54d3fc6569babf68e6598a4c3d69b382fac7b59", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8071422a-2753-4599-9f05-a499dc346b37", "node_type": "1", "metadata": {"window": "But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  "}, "hash": "440ea9f4151fd0f663eb487fa6abcb26c20d6c93c2e839a9d8168eb11492a2b1", "class_name": "RelatedNodeInfo"}}, "text": "Thanks.  \n \n", "start_char_idx": 1967, "end_char_idx": 1979, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8071422a-2753-4599-9f05-a499dc346b37": {"__data__": {"id_": "8071422a-2753-4599-9f05-a499dc346b37", "embedding": null, "metadata": {"window": "But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a842546f-5116-4226-b322-cb956e76c9de", "node_type": "1", "metadata": {"window": "So, you know, kind of following up a little bit on t hat \nlast question, you know, one of your peers had some very different language in their press release this morning \nabout when they make accruals and when they don\u2019t.  \n \n  But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.  ", "original_text": "Thanks.  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f4ffc7daee04ef59807a42dc272c99bf3a5cd49a0f57c9286e1c41e1f658c525", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a19bc29a-3e5f-46e3-915d-20cd3167daf3", "node_type": "1", "metadata": {"window": "And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.  ", "original_text": "No. "}, "hash": "0508012ae648babb1d07fabe7f8611ff0922237f69e93a08e2a0e2ef55857cc3", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes, thanks for the question.  ", "start_char_idx": 1979, "end_char_idx": 2027, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a19bc29a-3e5f-46e3-915d-20cd3167daf3": {"__data__": {"id_": "a19bc29a-3e5f-46e3-915d-20cd3167daf3", "embedding": null, "metadata": {"window": "And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.  ", "original_text": "No. ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8071422a-2753-4599-9f05-a499dc346b37", "node_type": "1", "metadata": {"window": "But, you know, without getting too much into that I guess the question is, you know, is  there any possibility that, \nyou know, Cardinal\u2019s further along or closer to a Settlement Agreement than some of your distributor peers?  \n \n  And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n", "original_text": "Mike Kaufmann :  Yes, thanks for the question.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "dab0c2264595a4fb2cee48dd1dc1b1bc3b19f1dfcff5772224db52f51e3fba8a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "815450e4-e30c-40b9-a2b1-00e86a2d1731", "node_type": "1", "metadata": {"window": "Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.  ", "original_text": "I would say that Cardinal is not doing anything different.  "}, "hash": "0f3a93db47621acec5cb6b2008e0898b30e88c7e86943337891403c025e20ba9", "class_name": "RelatedNodeInfo"}}, "text": "No. ", "start_char_idx": 2027, "end_char_idx": 2031, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "815450e4-e30c-40b9-a2b1-00e86a2d1731": {"__data__": {"id_": "815450e4-e30c-40b9-a2b1-00e86a2d1731", "embedding": null, "metadata": {"window": "Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.  ", "original_text": "I would say that Cardinal is not doing anything different.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a19bc29a-3e5f-46e3-915d-20cd3167daf3", "node_type": "1", "metadata": {"window": "And is there any scenario where Cardinal may reach a global settlement but your peers may not or is it kind of, \nyou k now, all three or none around the global settlement, just curious to get your extra thoughts on that.   Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.  ", "original_text": "No. ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5dbf75996b9947ccb93657118130705217cb30c1364139bb07ed0ac8298ecca1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "88db782f-6cbb-4ab4-bc82-d9b2a33db909", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.  ", "original_text": "This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n"}, "hash": "03d7385f447119030bbd7f16c7784f2b6f2a3e8ea1a8211661a475f7bb926870", "class_name": "RelatedNodeInfo"}}, "text": "I would say that Cardinal is not doing anything different.  ", "start_char_idx": 2031, "end_char_idx": 2091, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "88db782f-6cbb-4ab4-bc82-d9b2a33db909": {"__data__": {"id_": "88db782f-6cbb-4ab4-bc82-d9b2a33db909", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.  ", "original_text": "This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "815450e4-e30c-40b9-a2b1-00e86a2d1731", "node_type": "1", "metadata": {"window": "Thanks.  \n \n Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.  ", "original_text": "I would say that Cardinal is not doing anything different.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6347a36c5bf2789183fce0d1d63d17a793dddced56973561943174dad0f82dcf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ba599a9-503b-48ea-a08c-a7679c154ab5", "node_type": "1", "metadata": {"window": "No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n", "original_text": "Steven Valiquette :  Yes.  "}, "hash": "7d699218fa861f0eda0c3f4d4f346c2029f0cf3cec40aa15ffcd9f5a5ee4f271", "class_name": "RelatedNodeInfo"}}, "text": "This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n", "start_char_idx": 2091, "end_char_idx": 2283, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7ba599a9-503b-48ea-a08c-a7679c154ab5": {"__data__": {"id_": "7ba599a9-503b-48ea-a08c-a7679c154ab5", "embedding": null, "metadata": {"window": "No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n", "original_text": "Steven Valiquette :  Yes.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "88db782f-6cbb-4ab4-bc82-d9b2a33db909", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, thanks for the question.   No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.  ", "original_text": "This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f8de1d9d11fe46f871e9eb83ea2aa14613c992317d5015d10ee57513aa0e609a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e5725bc8-5447-4bfc-b316-afbe63d87564", "node_type": "1", "metadata": {"window": "I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.  ", "original_text": "And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.  "}, "hash": "927d0f27b52c4dc79438e26d13934893a3f09c2266d45425e9ca3fd5027d73da", "class_name": "RelatedNodeInfo"}}, "text": "Steven Valiquette :  Yes.  ", "start_char_idx": 2283, "end_char_idx": 2310, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e5725bc8-5447-4bfc-b316-afbe63d87564": {"__data__": {"id_": "e5725bc8-5447-4bfc-b316-afbe63d87564", "embedding": null, "metadata": {"window": "I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.  ", "original_text": "And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7ba599a9-503b-48ea-a08c-a7679c154ab5", "node_type": "1", "metadata": {"window": "No.  I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n", "original_text": "Steven Valiquette :  Yes.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9d5205a01b302cab943d02f87566e761714750593a8c0aa75fbdf6ef61e62795", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "850b66c5-c251-4335-942e-9a4863485609", "node_type": "1", "metadata": {"window": "This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.  ", "original_text": "And that seemed, you know, be different than what some investors were thinking.  "}, "hash": "3e5c14211a350f53b9190ed9dde2ec84bea681c1dc1a9da007604133fae92805", "class_name": "RelatedNodeInfo"}}, "text": "And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.  ", "start_char_idx": 2310, "end_char_idx": 2414, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "850b66c5-c251-4335-942e-9a4863485609": {"__data__": {"id_": "850b66c5-c251-4335-942e-9a4863485609", "embedding": null, "metadata": {"window": "This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.  ", "original_text": "And that seemed, you know, be different than what some investors were thinking.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e5725bc8-5447-4bfc-b316-afbe63d87564", "node_type": "1", "metadata": {"window": "I would say that Cardinal is not doing anything different.   This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.  ", "original_text": "And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ba7b8d7750a3952b850c42d7b08eeffaa39f3491f49774c13351d9c492f79d2d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e470d086-869e-41df-95f2-f62bcae0764f", "node_type": "1", "metadata": {"window": "Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.  ", "original_text": "You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n"}, "hash": "89e0eb00d0b57eefced0a50a68e92e081f26e990ee7fd671dd2ba9e5d16d4997", "class_name": "RelatedNodeInfo"}}, "text": "And that seemed, you know, be different than what some investors were thinking.  ", "start_char_idx": 2414, "end_char_idx": 2495, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e470d086-869e-41df-95f2-f62bcae0764f": {"__data__": {"id_": "e470d086-869e-41df-95f2-f62bcae0764f", "embedding": null, "metadata": {"window": "Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.  ", "original_text": "You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "850b66c5-c251-4335-942e-9a4863485609", "node_type": "1", "metadata": {"window": "This is just \nour understanding and belief of the way the global framework is set up that we believe the accounting that we\u2019ve \ndone is appropriate for the circumstances in our \u2013 in that.  \n \n Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.  ", "original_text": "And that seemed, you know, be different than what some investors were thinking.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "dc0bec7d3ea1cbd3616e4b76a592d50159d3102ac9adc74b29da82cd471633fc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "311db5b6-4611-4644-870d-8d862973603a", "node_type": "1", "metadata": {"window": "And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "Mike Kaufmann :  Yes.  "}, "hash": "9464d0f4d90daacddaf27454de3df1dfd8dd6846327cddaeeb4331ca034b950c", "class_name": "RelatedNodeInfo"}}, "text": "You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n", "start_char_idx": 2495, "end_char_idx": 2725, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "311db5b6-4611-4644-870d-8d862973603a": {"__data__": {"id_": "311db5b6-4611-4644-870d-8d862973603a", "embedding": null, "metadata": {"window": "And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "Mike Kaufmann :  Yes.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e470d086-869e-41df-95f2-f62bcae0764f", "node_type": "1", "metadata": {"window": "Steven Valiquette :  Yes.   And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.  ", "original_text": "You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "257aa2efc55a5a3eb3041d2756df20e7b8ef913c72a74db646ef9bda516ea9d8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a1263259-caa8-4520-b520-441ea7f5a153", "node_type": "1", "metadata": {"window": "And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "It\u2019s really hard to actually predict timing.  "}, "hash": "3fa077562b0725b7d9e69ecff642351e08a1eddc5deb3c683855698725e7158f", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes.  ", "start_char_idx": 2725, "end_char_idx": 2748, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a1263259-caa8-4520-b520-441ea7f5a153": {"__data__": {"id_": "a1263259-caa8-4520-b520-441ea7f5a153", "embedding": null, "metadata": {"window": "And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "It\u2019s really hard to actually predict timing.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "311db5b6-4611-4644-870d-8d862973603a", "node_type": "1", "metadata": {"window": "And, you know, one of your peers talked about a settlement m aybe still being, you know, months \naway.   And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "Mike Kaufmann :  Yes.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b5579b536f9f913adda9750bd56bf1802c1ec3e0d562dc99963eefae9c553d64", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1bb7a877-41f8-4045-b263-8ecd4ccce4a5", "node_type": "1", "metadata": {"window": "You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "But it\u2019s not something that we think is going to get done \ntomorrow.  "}, "hash": "42794436fa133e2243ffe921e3f20f9d9ffbeade5383c2c85b0085c497e4a61b", "class_name": "RelatedNodeInfo"}}, "text": "It\u2019s really hard to actually predict timing.  ", "start_char_idx": 2748, "end_char_idx": 2794, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1bb7a877-41f8-4045-b263-8ecd4ccce4a5": {"__data__": {"id_": "1bb7a877-41f8-4045-b263-8ecd4ccce4a5", "embedding": null, "metadata": {"window": "You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "But it\u2019s not something that we think is going to get done \ntomorrow.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a1263259-caa8-4520-b520-441ea7f5a153", "node_type": "1", "metadata": {"window": "And that seemed, you know, be different than what some investors were thinking.   You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "It\u2019s really hard to actually predict timing.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1bf267e771faa5077d9c63dee945320521f389a21d3ab9ad7568f165338fffc1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b52809ae-ecd1-4add-bb22-e6f4c4330a67", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "There is work to be done.  \n "}, "hash": "23932c997d196fd30b23a41d23ec0fe58d0fcbe37e17629a68c00a1b0b532a76", "class_name": "RelatedNodeInfo"}}, "text": "But it\u2019s not something that we think is going to get done \ntomorrow.  ", "start_char_idx": 2794, "end_char_idx": 2864, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b52809ae-ecd1-4add-bb22-e6f4c4330a67": {"__data__": {"id_": "b52809ae-ecd1-4add-bb22-e6f4c4330a67", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "There is work to be done.  \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "27c9be5c-48c1-4788-a349-5276dbc93e27", "node_type": "4", "metadata": {"page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a656ad2937eeebd91a39d5dbb5fae3e09d5f764a1e93527a903b3f2d05589c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1bb7a877-41f8-4045-b263-8ecd4ccce4a5", "node_type": "1", "metadata": {"window": "You know to me I think \nand that\u2019s still a pretty short time horizon given the number of parties involved but is there any extra color  around, \nyou know, when you think, you know, timing could be nailed down on a settlement?  \n \n Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "But it\u2019s not something that we think is going to get done \ntomorrow.  ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ff454f4fc70fb1949d1dd6c312577b776f98f3ffd709fc9069fd90e19ba65500", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6f4615ee-4303-4194-b68d-de0eae3cc143", "node_type": "1", "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n", "original_text": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.  "}, "hash": "be84eb416978419e5f776871678dbb615586ca4b2c8ac096817783de48a2791a", "class_name": "RelatedNodeInfo"}}, "text": "There is work to be done.  \n ", "start_char_idx": 2864, "end_char_idx": 2893, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6f4615ee-4303-4194-b68d-de0eae3cc143": {"__data__": {"id_": "6f4615ee-4303-4194-b68d-de0eae3cc143", "embedding": null, "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n", "original_text": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b52809ae-ecd1-4add-bb22-e6f4c4330a67", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes.   It\u2019s really hard to actually predict timing.   But it\u2019s not something that we think is going to get done \ntomorrow.   There is work to be done.  \n ", "original_text": "There is work to be done.  \n ", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9f0c416a7825b94a7ba1363d0878bd206806bb2f5f78190738099e0afec1c2d4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1db30304-0634-4aa5-bc43-341ebf61689a", "node_type": "1", "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n", "original_text": "And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n "}, "hash": "6019cc7c1862179d8f7f7562f978089fe50a4e74fc62a75c5143ab3a3bce26df", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.  ", "start_char_idx": 0, "end_char_idx": 257, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1db30304-0634-4aa5-bc43-341ebf61689a": {"__data__": {"id_": "1db30304-0634-4aa5-bc43-341ebf61689a", "embedding": null, "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n", "original_text": "And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6f4615ee-4303-4194-b68d-de0eae3cc143", "node_type": "1", "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n", "original_text": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "41f3a539b351eec91f877fba58fc323dc80b24aa5823b2f3ba078c4992dc24f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "616aeb05-f465-45fc-99ee-53f6e7b387ec", "node_type": "1", "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.  ", "original_text": "And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n "}, "hash": "286f73b0c61137bc80f67fa8fe218c71768156328ea24ecf15cfc060424c40dd", "class_name": "RelatedNodeInfo"}}, "text": "And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n ", "start_char_idx": 257, "end_char_idx": 340, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "616aeb05-f465-45fc-99ee-53f6e7b387ec": {"__data__": {"id_": "616aeb05-f465-45fc-99ee-53f6e7b387ec", "embedding": null, "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.  ", "original_text": "And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1db30304-0634-4aa5-bc43-341ebf61689a", "node_type": "1", "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n", "original_text": "And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0d41c2a614feddf1809dd67bbfdbd98e67501e9ae0e644d3b636a19c01292d53", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a745bd9b-2141-43b6-992e-f8c4382667a7", "node_type": "1", "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.  ", "original_text": "Next question.  \n \n"}, "hash": "8c4a542fb76b7db1b57184dc22385d1f7d90b2e028efa80b08f49e301fe0341d", "class_name": "RelatedNodeInfo"}}, "text": "And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n ", "start_char_idx": 340, "end_char_idx": 433, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a745bd9b-2141-43b6-992e-f8c4382667a7": {"__data__": {"id_": "a745bd9b-2141-43b6-992e-f8c4382667a7", "embedding": null, "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.  ", "original_text": "Next question.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "616aeb05-f465-45fc-99ee-53f6e7b387ec", "node_type": "1", "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.  ", "original_text": "And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8a1626187b25eb2f39f2cd3ea7858f8683511e78ad48fca77f0db2005d8edd1b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "024d01d4-b053-4374-8d15-a7c84ee006cc", "node_type": "1", "metadata": {"window": "And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?  ", "original_text": "Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n"}, "hash": "2c8bdd42917f69d9f9af31e8a53e5202a212be60ba855b69001ce6d60208132f", "class_name": "RelatedNodeInfo"}}, "text": "Next question.  \n \n", "start_char_idx": 433, "end_char_idx": 452, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "024d01d4-b053-4374-8d15-a7c84ee006cc": {"__data__": {"id_": "024d01d4-b053-4374-8d15-a7c84ee006cc", "embedding": null, "metadata": {"window": "And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?  ", "original_text": "Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a745bd9b-2141-43b6-992e-f8c4382667a7", "node_type": "1", "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.  ", "original_text": "Next question.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c1058d5966c2aa0c5987e68e2542c8d06426c4e508ac051012b6967f268edf5d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "33999732-411f-4df5-af69-9d57a55b7164", "node_type": "1", "metadata": {"window": "And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.  ", "original_text": "Lisa Gill :  Thanks very much.  "}, "hash": "c12e88d1fc0f8866013cd734ab7b6847315b4a8ffc2d698fb0953009108cd82f", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n", "start_char_idx": 452, "end_char_idx": 529, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "33999732-411f-4df5-af69-9d57a55b7164": {"__data__": {"id_": "33999732-411f-4df5-af69-9d57a55b7164", "embedding": null, "metadata": {"window": "And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.  ", "original_text": "Lisa Gill :  Thanks very much.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "024d01d4-b053-4374-8d15-a7c84ee006cc", "node_type": "1", "metadata": {"window": "And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?  ", "original_text": "Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8b6a5a68ecaa28932d5dc0b20bd0fdb4b7d509fe991390c1f1703eb6985c2f04", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "643242a6-f397-4100-8161-eba606ccf083", "node_type": "1", "metadata": {"window": "Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .  ", "original_text": "Good morning Mike.  "}, "hash": "8b28b1e20be2d3755fc51be2f9ddf59cff4c9437e3aa8930c15741083e5115c1", "class_name": "RelatedNodeInfo"}}, "text": "Lisa Gill :  Thanks very much.  ", "start_char_idx": 529, "end_char_idx": 561, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "643242a6-f397-4100-8161-eba606ccf083": {"__data__": {"id_": "643242a6-f397-4100-8161-eba606ccf083", "embedding": null, "metadata": {"window": "Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .  ", "original_text": "Good morning Mike.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "33999732-411f-4df5-af69-9d57a55b7164", "node_type": "1", "metadata": {"window": "And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.  ", "original_text": "Lisa Gill :  Thanks very much.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "44746231ae4ed7a6773e71946f76b4877746ab03ee4a2da732c7c8e3598fe46e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2856df6f-b598-49b9-9b69-ba750083c843", "node_type": "1", "metadata": {"window": "Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.  ", "original_text": "As we think about the global settlement how do we think about it from \na tax perspective?  "}, "hash": "374ca37a3d1c54d77c12d75a9560d9da4940789d85fc6d9344f00c4bdbc365ae", "class_name": "RelatedNodeInfo"}}, "text": "Good morning Mike.  ", "start_char_idx": 561, "end_char_idx": 581, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2856df6f-b598-49b9-9b69-ba750083c843": {"__data__": {"id_": "2856df6f-b598-49b9-9b69-ba750083c843", "embedding": null, "metadata": {"window": "Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.  ", "original_text": "As we think about the global settlement how do we think about it from \na tax perspective?  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "643242a6-f397-4100-8161-eba606ccf083", "node_type": "1", "metadata": {"window": "Next question.  \n \n Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .  ", "original_text": "Good morning Mike.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ecb425b4cbca9598911288c3c2571585012966780a8342d703870b120de9f580", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "999a48a5-348f-4512-9b46-46ba44982493", "node_type": "1", "metadata": {"window": "Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n", "original_text": "I\u2019m just trying to figure out what the impact will be to cash flow.  "}, "hash": "f5c70b051072b8e63c21020567ae92225faf19d89aa5e84ee6c0a333aee8a958", "class_name": "RelatedNodeInfo"}}, "text": "As we think about the global settlement how do we think about it from \na tax perspective?  ", "start_char_idx": 581, "end_char_idx": 672, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "999a48a5-348f-4512-9b46-46ba44982493": {"__data__": {"id_": "999a48a5-348f-4512-9b46-46ba44982493", "embedding": null, "metadata": {"window": "Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n", "original_text": "I\u2019m just trying to figure out what the impact will be to cash flow.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2856df6f-b598-49b9-9b69-ba750083c843", "node_type": "1", "metadata": {"window": "Operator :  We will take our next question from Lisa Gill from JPMorgan.  \n \n Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.  ", "original_text": "As we think about the global settlement how do we think about it from \na tax perspective?  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "90b59bee1be8bebefeff1808739ffa5f8c004ced1bfe47cc336ffc2ff2e002da", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "308980b3-9149-48a8-b3c6-35a119771c6d", "node_type": "1", "metadata": {"window": "Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.  ", "original_text": "You talked about the fact that, \nyou know, there\u2019ll be some impact .  "}, "hash": "049e3ec7dd69f941d866ebf7c94d7cd17b32d31ab31933f3d5194d47fb8d16cf", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019m just trying to figure out what the impact will be to cash flow.  ", "start_char_idx": 672, "end_char_idx": 741, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "308980b3-9149-48a8-b3c6-35a119771c6d": {"__data__": {"id_": "308980b3-9149-48a8-b3c6-35a119771c6d", "embedding": null, "metadata": {"window": "Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.  ", "original_text": "You talked about the fact that, \nyou know, there\u2019ll be some impact .  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "999a48a5-348f-4512-9b46-46ba44982493", "node_type": "1", "metadata": {"window": "Lisa Gill :  Thanks very much.   Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n", "original_text": "I\u2019m just trying to figure out what the impact will be to cash flow.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2092493489e709a9b077fa01e7a8a3a1bd311e158a208da776f042ddc64eaa90", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "840747cb-9318-4749-b45d-1dec02b43f7b", "node_type": "1", "metadata": {"window": "As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.  ", "original_text": "But really shouldn\u2019t change how you think about capital deployment.  "}, "hash": "3f618c52a300ea0cdee9e631ccfb52134e95f24796282a509cf080b17e18ff93", "class_name": "RelatedNodeInfo"}}, "text": "You talked about the fact that, \nyou know, there\u2019ll be some impact .  ", "start_char_idx": 741, "end_char_idx": 811, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "840747cb-9318-4749-b45d-1dec02b43f7b": {"__data__": {"id_": "840747cb-9318-4749-b45d-1dec02b43f7b", "embedding": null, "metadata": {"window": "As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.  ", "original_text": "But really shouldn\u2019t change how you think about capital deployment.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "308980b3-9149-48a8-b3c6-35a119771c6d", "node_type": "1", "metadata": {"window": "Good morning Mike.   As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.  ", "original_text": "You talked about the fact that, \nyou know, there\u2019ll be some impact .  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e9958a87f29f3d16747f4777ab05a5821c181b0c5d59ebddc9d8c05e917163c1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "646b5965-51ae-41b6-b48d-f120bcdb3239", "node_type": "1", "metadata": {"window": "I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n ", "original_text": "So that \nwould be just my first question was how do we think about the tax implications?  \n \n"}, "hash": "8c9dd652902dae921afe644b799e0a4a0eb7fd688a329627d745c13d3a09bba6", "class_name": "RelatedNodeInfo"}}, "text": "But really shouldn\u2019t change how you think about capital deployment.  ", "start_char_idx": 811, "end_char_idx": 880, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "646b5965-51ae-41b6-b48d-f120bcdb3239": {"__data__": {"id_": "646b5965-51ae-41b6-b48d-f120bcdb3239", "embedding": null, "metadata": {"window": "I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n ", "original_text": "So that \nwould be just my first question was how do we think about the tax implications?  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "840747cb-9318-4749-b45d-1dec02b43f7b", "node_type": "1", "metadata": {"window": "As we think about the global settlement how do we think about it from \na tax perspective?   I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.  ", "original_text": "But really shouldn\u2019t change how you think about capital deployment.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a10b83a8af1dc01858713975c10cde88638d9ed31b0b5d5b851d5d69dd6fde07", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "478b4e90-a81c-42c6-9f5b-55879b37485f", "node_type": "1", "metadata": {"window": "You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n ", "original_text": "Dave Evans :  Yes Lisa, this is Dave.  "}, "hash": "aff26fb67292f09851b5d0438893ed4cbcccba498b90353752b63af008e3ba53", "class_name": "RelatedNodeInfo"}}, "text": "So that \nwould be just my first question was how do we think about the tax implications?  \n \n", "start_char_idx": 880, "end_char_idx": 973, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "478b4e90-a81c-42c6-9f5b-55879b37485f": {"__data__": {"id_": "478b4e90-a81c-42c6-9f5b-55879b37485f", "embedding": null, "metadata": {"window": "You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n ", "original_text": "Dave Evans :  Yes Lisa, this is Dave.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "646b5965-51ae-41b6-b48d-f120bcdb3239", "node_type": "1", "metadata": {"window": "I\u2019m just trying to figure out what the impact will be to cash flow.   You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n ", "original_text": "So that \nwould be just my first question was how do we think about the tax implications?  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3a6b302d13b44ff53f5af7d4127f461a55c3e1bf10a3bda23fd83fe5c9379bcd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a8ba5d39-7bec-41d4-ac81-ccddc75ff029", "node_type": "1", "metadata": {"window": "But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n", "original_text": "Thanks for the question.  "}, "hash": "a3a5d3e72632a369672c1f2d0ea99b1bb508c9431b1cc01cd19f41c5cff823a0", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes Lisa, this is Dave.  ", "start_char_idx": 973, "end_char_idx": 1012, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a8ba5d39-7bec-41d4-ac81-ccddc75ff029": {"__data__": {"id_": "a8ba5d39-7bec-41d4-ac81-ccddc75ff029", "embedding": null, "metadata": {"window": "But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n", "original_text": "Thanks for the question.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "478b4e90-a81c-42c6-9f5b-55879b37485f", "node_type": "1", "metadata": {"window": "You talked about the fact that, \nyou know, there\u2019ll be some impact .   But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n ", "original_text": "Dave Evans :  Yes Lisa, this is Dave.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "653d4f4656a52cf8e6f43f7b3bda86fe20423af45570592f63955d15816f9896", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3ac127cd-1033-43ac-a3f9-16b4ea42a7a8", "node_type": "1", "metadata": {"window": "So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.  ", "original_text": "Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n "}, "hash": "ea88f97eb8e5f59680b323e8026809b4204818263c06405f8298da58512f8d72", "class_name": "RelatedNodeInfo"}}, "text": "Thanks for the question.  ", "start_char_idx": 1012, "end_char_idx": 1038, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3ac127cd-1033-43ac-a3f9-16b4ea42a7a8": {"__data__": {"id_": "3ac127cd-1033-43ac-a3f9-16b4ea42a7a8", "embedding": null, "metadata": {"window": "So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.  ", "original_text": "Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a8ba5d39-7bec-41d4-ac81-ccddc75ff029", "node_type": "1", "metadata": {"window": "But really shouldn\u2019t change how you think about capital deployment.   So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n", "original_text": "Thanks for the question.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c6d5dd9f9d221bf3cd4f656b8346492d60ed567f89628b60ac53e4e2b40d4f61", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7c0a3ee7-1aa2-4756-8e06-386cb7e649b2", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n ", "original_text": "Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n "}, "hash": "8c6ae0222500a3b4f18db1a66e3f29f4a6514f9192d4d309d0132f550368d503", "class_name": "RelatedNodeInfo"}}, "text": "Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n ", "start_char_idx": 1038, "end_char_idx": 1192, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7c0a3ee7-1aa2-4756-8e06-386cb7e649b2": {"__data__": {"id_": "7c0a3ee7-1aa2-4756-8e06-386cb7e649b2", "embedding": null, "metadata": {"window": "Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n ", "original_text": "Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3ac127cd-1033-43ac-a3f9-16b4ea42a7a8", "node_type": "1", "metadata": {"window": "So that \nwould be just my first question was how do we think about the tax implications?  \n \n Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.  ", "original_text": "Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b9d6bfdbeabaec8d2681830b65cad132b444a278109ad393a2164c377a32a167", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "526dc107-27b1-4b99-ae8c-0bb4d574a43d", "node_type": "1", "metadata": {"window": "Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n", "original_text": "With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n"}, "hash": "7d827264c67331ab1ad193733111b18cdf24adbad17a37b54cd5d378df7c8c83", "class_name": "RelatedNodeInfo"}}, "text": "Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n ", "start_char_idx": 1192, "end_char_idx": 1584, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "526dc107-27b1-4b99-ae8c-0bb4d574a43d": {"__data__": {"id_": "526dc107-27b1-4b99-ae8c-0bb4d574a43d", "embedding": null, "metadata": {"window": "Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n", "original_text": "With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c0a3ee7-1aa2-4756-8e06-386cb7e649b2", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes Lisa, this is Dave.   Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n ", "original_text": "Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "82135ea661625673a861b93e6449f4485e5b8cd57d0805a1b66a3400467f9528", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9683f90a-b39e-454b-8ddd-c35f4db60c54", "node_type": "1", "metadata": {"window": "Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n", "original_text": "Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.  "}, "hash": "85eb65dabd5303ab7cfa0d2b7c2aefff379b15e15d10479124dffe0579acc4c2", "class_name": "RelatedNodeInfo"}}, "text": "With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n", "start_char_idx": 1584, "end_char_idx": 1746, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9683f90a-b39e-454b-8ddd-c35f4db60c54": {"__data__": {"id_": "9683f90a-b39e-454b-8ddd-c35f4db60c54", "embedding": null, "metadata": {"window": "Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n", "original_text": "Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "526dc107-27b1-4b99-ae8c-0bb4d574a43d", "node_type": "1", "metadata": {"window": "Thanks for the question.   Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n", "original_text": "With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "212efa2f76aa8d2c08559331f9f717ca94c70f219f7fe4889ba6aed3f4855a6c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bbb6ee6d-36db-4811-b2e7-a6aafaf74a30", "node_type": "1", "metadata": {"window": "Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.  ", "original_text": "So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n "}, "hash": "8b0a350546819db900f9db99d1fce9ccdf730ff9ec78f70971649031b1bcf484", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.  ", "start_char_idx": 1746, "end_char_idx": 1937, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bbb6ee6d-36db-4811-b2e7-a6aafaf74a30": {"__data__": {"id_": "bbb6ee6d-36db-4811-b2e7-a6aafaf74a30", "embedding": null, "metadata": {"window": "Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.  ", "original_text": "So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9683f90a-b39e-454b-8ddd-c35f4db60c54", "node_type": "1", "metadata": {"window": "Look, the intent of this is con sistent with the public policy \nand guidelines of the IRS and the state tax authorities to make this tax deductible.  \n \n  Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n", "original_text": "Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1b0d35268c1fc14d1cef3cc2eecde93f447ea3ac5ead498da4393f4094682501", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a6f268c-a465-46c0-844e-fe2ecc116c9a", "node_type": "1", "metadata": {"window": "With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.  ", "original_text": "But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n"}, "hash": "d333aebc8571c4de64031d94e77f0c6e60df34bc3488f1ced20db5fef9853bdf", "class_name": "RelatedNodeInfo"}}, "text": "So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n ", "start_char_idx": 1937, "end_char_idx": 2032, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1a6f268c-a465-46c0-844e-fe2ecc116c9a": {"__data__": {"id_": "1a6f268c-a465-46c0-844e-fe2ecc116c9a", "embedding": null, "metadata": {"window": "With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.  ", "original_text": "But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bbb6ee6d-36db-4811-b2e7-a6aafaf74a30", "node_type": "1", "metadata": {"window": "Having said that the details and specifics of this agreement really just aren\u2019t there right now to provide the level of \nprecision that ult imately we\u2019ll have nor is the complete clarity of the tax code there at this stage so from an \naccounting perspective we just followed accounting guidance and established what we believe is an appropriate \nreserve for what will be tax deductible.  \n \n  With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.  ", "original_text": "So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "88e44960da69751efda8d469fbce2c21c55c18149131aac8db2a400f3c4c6299", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "afe02bdf-8f2d-4824-9555-26bccbbb1a4f", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.  ", "original_text": "Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n"}, "hash": "360250975ad0f3311679ce29a10e6201811b0a2d8c1a53d8678424b115d3f1f1", "class_name": "RelatedNodeInfo"}}, "text": "But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n", "start_char_idx": 2032, "end_char_idx": 2164, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "afe02bdf-8f2d-4824-9555-26bccbbb1a4f": {"__data__": {"id_": "afe02bdf-8f2d-4824-9555-26bccbbb1a4f", "embedding": null, "metadata": {"window": "Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.  ", "original_text": "Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a6f268c-a465-46c0-844e-fe2ecc116c9a", "node_type": "1", "metadata": {"window": "With that  I\u2019d say we\u2019ll continue to become more clear as time marches on and the specifics of both the tax code \nand the settlement offer become more clear.  \n \n Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.  ", "original_text": "But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f4e3d2f37cc267242b01d864dade204e4f063bf6e61cd2420ee5f5777738194a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "236b44bd-d75f-41b1-8b50-386e597d3342", "node_type": "1", "metadata": {"window": "So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "Mike Kaufmann :  Yes.  "}, "hash": "507b842c343a52764533eca09e928259a6ee2e2a6892ba71dc0849633ec8fd77", "class_name": "RelatedNodeInfo"}}, "text": "Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n", "start_char_idx": 2164, "end_char_idx": 2379, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "236b44bd-d75f-41b1-8b50-386e597d3342": {"__data__": {"id_": "236b44bd-d75f-41b1-8b50-386e597d3342", "embedding": null, "metadata": {"window": "So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "Mike Kaufmann :  Yes.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "afe02bdf-8f2d-4824-9555-26bccbbb1a4f", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  And as far as the cash flow impact goes Lisa, as you said while it\u2019s spread over 18 years sp ecifically \nhow it will be paid and funded each year is still being worked out.   So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.  ", "original_text": "Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e8b901e332eb48d066ce96d5538b7a7c91a73a8fbff2ca70cf3c55d1464c6990", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f9b012a0-5602-4fe5-9891-f68a9068a5cc", "node_type": "1", "metadata": {"window": "But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "It\u2019s an interesting question.  "}, "hash": "50bdb170dc266b62ec3e7e61635c02dcde2a17a4bc249ef8da1d842da7f1e14d", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes.  ", "start_char_idx": 2379, "end_char_idx": 2402, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f9b012a0-5602-4fe5-9891-f68a9068a5cc": {"__data__": {"id_": "f9b012a0-5602-4fe5-9891-f68a9068a5cc", "embedding": null, "metadata": {"window": "But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "It\u2019s an interesting question.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "236b44bd-d75f-41b1-8b50-386e597d3342", "node_type": "1", "metadata": {"window": "So it\u2019s hard for us to give you any real color on \nexact timing and impact of cash flows.  \n \n  But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "Mike Kaufmann :  Yes.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e519961bc44a5ee04393a17971082504ac00e9915e725db26d75c104d545a390", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f098a2af-ff9d-448f-bd88-71706f9eca28", "node_type": "1", "metadata": {"window": "Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.  "}, "hash": "ad0c9ea153ddfa88294eeb59354d3f3caf1e63b4eae4f69c18574c0237528c09", "class_name": "RelatedNodeInfo"}}, "text": "It\u2019s an interesting question.  ", "start_char_idx": 2402, "end_char_idx": 2433, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f098a2af-ff9d-448f-bd88-71706f9eca28": {"__data__": {"id_": "f098a2af-ff9d-448f-bd88-71706f9eca28", "embedding": null, "metadata": {"window": "Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f9b012a0-5602-4fe5-9891-f68a9068a5cc", "node_type": "1", "metadata": {"window": "But as you can imagine we spread it out over time in order to be able to still manage  our business effectively \ngoing forward.  \n \n Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "It\u2019s an interesting question.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7c156bb187fef96204f00413f275f2e7078a3ea1e2c29e9bb5adc7340ee04b6e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28812504-5519-4aea-8f49-2f7caa3d8500", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n "}, "hash": "1ee0833de38053712a713c8b3d13b6338ac03bc7f9322c459fb7212dd21f691a", "class_name": "RelatedNodeInfo"}}, "text": "You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.  ", "start_char_idx": 2433, "end_char_idx": 2536, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "28812504-5519-4aea-8f49-2f7caa3d8500": {"__data__": {"id_": "28812504-5519-4aea-8f49-2f7caa3d8500", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "b47e77b5-32a4-490a-895d-4d71a61511e8", "node_type": "4", "metadata": {"page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bbcdc4fb9875f844344e38b7b0e3902d6792ae0518a2f79a865fe08238133e7c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f098a2af-ff9d-448f-bd88-71706f9eca28", "node_type": "1", "metadata": {"window": "Lisa Gill :  And then Mike if I can just sneak one, you know, policy today, you know, thoughts around re -importation and the \npotential impact that that could have to Cardinal and drug distribution in general.  \n \n Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2f6ee083ccf1ffd997d87e63d3a9c67909eb6feac48469cd738f52f98c21aae1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5ea73402-9713-4c41-941a-79e384b424f2", "node_type": "1", "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n ", "original_text": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.  "}, "hash": "2aa285771aca0a30eef0ad8857d5d52d738793fffc6c251b375c6053aa57243f", "class_name": "RelatedNodeInfo"}}, "text": "This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "start_char_idx": 2536, "end_char_idx": 2783, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5ea73402-9713-4c41-941a-79e384b424f2": {"__data__": {"id_": "5ea73402-9713-4c41-941a-79e384b424f2", "embedding": null, "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n ", "original_text": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28812504-5519-4aea-8f49-2f7caa3d8500", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes.   It\u2019s an interesting question.   You know it\u2019s one of those things that it\u2019s probably a little too early to \nget into a lot of detail.   This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "original_text": "This is something that I can remember working on 15 years ago when we thought it was \ngoing to be eminent and working on setting up all of the capabilities internally to help make sure that if it did \nhappen there would be a safe supply chain.  \n ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0372dad712ed3c02d27721bb74dc99614d1cd83a0027b2e35a1fae2f740b253f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c1e2bcbc-20f5-4695-b220-d8324bb8fe9a", "node_type": "1", "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n", "original_text": "And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n "}, "hash": "116135f9c4b53ce468415860c66c38d9ad0ec58d7d76cb2d382e0f8b09963057", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.  ", "start_char_idx": 0, "end_char_idx": 91, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c1e2bcbc-20f5-4695-b220-d8324bb8fe9a": {"__data__": {"id_": "c1e2bcbc-20f5-4695-b220-d8324bb8fe9a", "embedding": null, "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n", "original_text": "And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5ea73402-9713-4c41-941a-79e384b424f2", "node_type": "1", "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n ", "original_text": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "05488be272ac1134c38210a56c6e90fd7584cc5c48c0a8bdb81cd2374d89fced", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a587e070-23c3-4e39-be76-e01bc5cbe643", "node_type": "1", "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.  ", "original_text": "It\u2019s hard to imagine that it could be material in any way to affect our businesses.  "}, "hash": "73eecef5d7dfeb26086f9b0b6111d547f3c3fb0bab8839ff7b0594271bfe7c74", "class_name": "RelatedNodeInfo"}}, "text": "And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n ", "start_char_idx": 91, "end_char_idx": 302, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a587e070-23c3-4e39-be76-e01bc5cbe643": {"__data__": {"id_": "a587e070-23c3-4e39-be76-e01bc5cbe643", "embedding": null, "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.  ", "original_text": "It\u2019s hard to imagine that it could be material in any way to affect our businesses.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1e2bcbc-20f5-4695-b220-d8324bb8fe9a", "node_type": "1", "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n", "original_text": "And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f6409ff63f6ed716068d5e93c4f08d1041cfcfacc5183712fa9397414abe51d6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "939e1e98-f059-44c6-9582-8c335a181593", "node_type": "1", "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n", "original_text": "But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n "}, "hash": "806ac38909eb90d207f251d3dc90184ebc3ab502460be9f71075bcad1cdecf72", "class_name": "RelatedNodeInfo"}}, "text": "It\u2019s hard to imagine that it could be material in any way to affect our businesses.  ", "start_char_idx": 302, "end_char_idx": 387, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "939e1e98-f059-44c6-9582-8c335a181593": {"__data__": {"id_": "939e1e98-f059-44c6-9582-8c335a181593", "embedding": null, "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n", "original_text": "But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a587e070-23c3-4e39-be76-e01bc5cbe643", "node_type": "1", "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.  ", "original_text": "It\u2019s hard to imagine that it could be material in any way to affect our businesses.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "31b6a8de51118d197a00469e9dc36eda7a66249367fecb80e9532ca75037d5ab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "11fbf32f-e37f-4678-9220-5666b0bca92f", "node_type": "1", "metadata": {"window": "And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.  ", "original_text": "Next question.  \n \n"}, "hash": "d2ab156d3b3df15e6ad179843c9851db48f29ff0262f10916866c0a527789c49", "class_name": "RelatedNodeInfo"}}, "text": "But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n ", "start_char_idx": 387, "end_char_idx": 497, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "11fbf32f-e37f-4678-9220-5666b0bca92f": {"__data__": {"id_": "11fbf32f-e37f-4678-9220-5666b0bca92f", "embedding": null, "metadata": {"window": "And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.  ", "original_text": "Next question.  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "939e1e98-f059-44c6-9582-8c335a181593", "node_type": "1", "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n", "original_text": "But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f86ad046145bc386c9790c8f2a4e7eaa74e945bec92539130ae8d4008266e472", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3f386601-d873-4ac2-aebf-6e6b0f223774", "node_type": "1", "metadata": {"window": "It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .  ", "original_text": "Operator :  Thank you.  "}, "hash": "880cf265a9eddc820a0af308fa671a2d6eff012935ee8cfdbd1ee9bd4b57a997", "class_name": "RelatedNodeInfo"}}, "text": "Next question.  \n \n", "start_char_idx": 497, "end_char_idx": 516, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3f386601-d873-4ac2-aebf-6e6b0f223774": {"__data__": {"id_": "3f386601-d873-4ac2-aebf-6e6b0f223774", "embedding": null, "metadata": {"window": "It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .  ", "original_text": "Operator :  Thank you.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "11fbf32f-e37f-4678-9220-5666b0bca92f", "node_type": "1", "metadata": {"window": "And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.  ", "original_text": "Next question.  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ac994362e39a9cb81a7df66139992266dea4054daf4ea4d2c6d6879862d1fb7b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb886d4b-87a2-489b-96f9-061e6dd0e75b", "node_type": "1", "metadata": {"window": "But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.  ", "original_text": "We will take our next question from Robert Jones from Goldman Sachs.  \n \n"}, "hash": "51a6d190effd5dc778b71c656e753f91a54c98fce1bd3a56252804a28341f737", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you.  ", "start_char_idx": 516, "end_char_idx": 540, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "eb886d4b-87a2-489b-96f9-061e6dd0e75b": {"__data__": {"id_": "eb886d4b-87a2-489b-96f9-061e6dd0e75b", "embedding": null, "metadata": {"window": "But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.  ", "original_text": "We will take our next question from Robert Jones from Goldman Sachs.  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3f386601-d873-4ac2-aebf-6e6b0f223774", "node_type": "1", "metadata": {"window": "It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .  ", "original_text": "Operator :  Thank you.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f24707d92e9947f4f5dbe47974a5ef83c27a460cc3111888e9dc869c1ee356ad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "72cf6f03-7ad3-4c3c-88f9-c2f60e3bed72", "node_type": "1", "metadata": {"window": "Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n ", "original_text": "Robert Jones :  Great.  "}, "hash": "75c9d9f37ef056cd8f5d25d0723fed41ab65429bfb14b33344a3c97e25e33d41", "class_name": "RelatedNodeInfo"}}, "text": "We will take our next question from Robert Jones from Goldman Sachs.  \n \n", "start_char_idx": 540, "end_char_idx": 613, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "72cf6f03-7ad3-4c3c-88f9-c2f60e3bed72": {"__data__": {"id_": "72cf6f03-7ad3-4c3c-88f9-c2f60e3bed72", "embedding": null, "metadata": {"window": "Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n ", "original_text": "Robert Jones :  Great.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb886d4b-87a2-489b-96f9-061e6dd0e75b", "node_type": "1", "metadata": {"window": "But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n  Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.  ", "original_text": "We will take our next question from Robert Jones from Goldman Sachs.  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "92829ae65ec89749e3f9a99e75ca2835b9dc93f04a9f32a1a0a3f3ae1e5977d8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0e36ef52-4593-4935-94ef-d24d49fe25ca", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?  ", "original_text": "Thanks for the questions .  "}, "hash": "68a1995a0ad4c9aaa138480400699e3877ba6e403068aea521a7e173086756d3", "class_name": "RelatedNodeInfo"}}, "text": "Robert Jones :  Great.  ", "start_char_idx": 613, "end_char_idx": 637, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0e36ef52-4593-4935-94ef-d24d49fe25ca": {"__data__": {"id_": "0e36ef52-4593-4935-94ef-d24d49fe25ca", "embedding": null, "metadata": {"window": "Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?  ", "original_text": "Thanks for the questions .  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "72cf6f03-7ad3-4c3c-88f9-c2f60e3bed72", "node_type": "1", "metadata": {"window": "Next question.  \n \n Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n ", "original_text": "Robert Jones :  Great.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f6c2495396edeed871e29f2f76221062c13ad4dcfd6e3dff7374a54c0f942d30", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ea92f815-a353-4a43-9fc3-34e7df3b0e7f", "node_type": "1", "metadata": {"window": "We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n", "original_text": "You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.  "}, "hash": "50d4b6634a9f7cf8fb49a53413d948d9b6e4008032ae17ec1ffca2a349a35403", "class_name": "RelatedNodeInfo"}}, "text": "Thanks for the questions .  ", "start_char_idx": 637, "end_char_idx": 665, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ea92f815-a353-4a43-9fc3-34e7df3b0e7f": {"__data__": {"id_": "ea92f815-a353-4a43-9fc3-34e7df3b0e7f", "embedding": null, "metadata": {"window": "We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n", "original_text": "You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0e36ef52-4593-4935-94ef-d24d49fe25ca", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?  ", "original_text": "Thanks for the questions .  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "232e0a891e84e26cc2e9d9a6140332b85575e60ee028f241436d963d21e20d9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "046ade57-bdf2-453e-9d74-4bf48c9c1828", "node_type": "1", "metadata": {"window": "Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.  ", "original_text": "I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n "}, "hash": "dcae8cac469aa6f86e3930c8550fb48b85df8d311bd7f324e4621d7665259caa", "class_name": "RelatedNodeInfo"}}, "text": "You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.  ", "start_char_idx": 665, "end_char_idx": 801, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "046ade57-bdf2-453e-9d74-4bf48c9c1828": {"__data__": {"id_": "046ade57-bdf2-453e-9d74-4bf48c9c1828", "embedding": null, "metadata": {"window": "Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.  ", "original_text": "I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ea92f815-a353-4a43-9fc3-34e7df3b0e7f", "node_type": "1", "metadata": {"window": "We will take our next question from Robert Jones from Goldman Sachs.  \n \n Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n", "original_text": "You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b510d2245d48e804270ec04e21d591e998519d6a88968c44a5f3960427b90575", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "51fd04ff-bb8d-4459-937a-ca742340d943", "node_type": "1", "metadata": {"window": "Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.  ", "original_text": "And then could you tal k a little bit about, you know, what you think is driving this?  "}, "hash": "8561e3604f8d48112bfedf88623cf744002d9dfd0a0fb21e432479c5e2ff796f", "class_name": "RelatedNodeInfo"}}, "text": "I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n ", "start_char_idx": 801, "end_char_idx": 901, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "51fd04ff-bb8d-4459-937a-ca742340d943": {"__data__": {"id_": "51fd04ff-bb8d-4459-937a-ca742340d943", "embedding": null, "metadata": {"window": "Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.  ", "original_text": "And then could you tal k a little bit about, you know, what you think is driving this?  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "046ade57-bdf2-453e-9d74-4bf48c9c1828", "node_type": "1", "metadata": {"window": "Robert Jones :  Great.   Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.  ", "original_text": "I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4e8c1b229875b774df4c14a8bc960a23c057db98aa39c4b2ae8d0e7f4f5e0deb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fccb6151-0cd0-4b8b-9800-9efa9a2e3da3", "node_type": "1", "metadata": {"window": "You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.  ", "original_text": "Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n"}, "hash": "23e8e91da82112af7c9b3c37b9cdcfa12dd478f95fb817cb63e4a70f094dd9df", "class_name": "RelatedNodeInfo"}}, "text": "And then could you tal k a little bit about, you know, what you think is driving this?  ", "start_char_idx": 901, "end_char_idx": 989, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fccb6151-0cd0-4b8b-9800-9efa9a2e3da3": {"__data__": {"id_": "fccb6151-0cd0-4b8b-9800-9efa9a2e3da3", "embedding": null, "metadata": {"window": "You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.  ", "original_text": "Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "51fd04ff-bb8d-4459-937a-ca742340d943", "node_type": "1", "metadata": {"window": "Thanks for the questions .   You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.  ", "original_text": "And then could you tal k a little bit about, you know, what you think is driving this?  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2b5f59ede3eb4eaddd0375d4e7192b755369f4bdfb4fb42e8c4896b3ba3cc0a2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab991b2f-2cd7-4656-84c7-ff6f0c19eb9c", "node_type": "1", "metadata": {"window": "I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n ", "original_text": "Mike Kaufmann :  No.  "}, "hash": "5f7644be6a3c55a3e0a67a8e46e9a40253f86d7b161dcef8edbd1a433945361e", "class_name": "RelatedNodeInfo"}}, "text": "Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n", "start_char_idx": 989, "end_char_idx": 1208, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ab991b2f-2cd7-4656-84c7-ff6f0c19eb9c": {"__data__": {"id_": "ab991b2f-2cd7-4656-84c7-ff6f0c19eb9c", "embedding": null, "metadata": {"window": "I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n ", "original_text": "Mike Kaufmann :  No.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fccb6151-0cd0-4b8b-9800-9efa9a2e3da3", "node_type": "1", "metadata": {"window": "You know Mike I just wanted to go back to some comments from the \nprepared remarks around the financial distress of certain customers.   I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.  ", "original_text": "Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "25970420a454a3566b216142ea5315adb861afd7d8dc84b98964035c52674182", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "70518751-c6fa-4514-beb5-b8a3fa28c498", "node_type": "1", "metadata": {"window": "And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n", "original_text": "This is \u2013 those comments were not meant.  "}, "hash": "5ab228a4ef0f845e2c55bcd2652c2a5f17107954555514d93aeff258b1788023", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  No.  ", "start_char_idx": 1208, "end_char_idx": 1230, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "70518751-c6fa-4514-beb5-b8a3fa28c498": {"__data__": {"id_": "70518751-c6fa-4514-beb5-b8a3fa28c498", "embedding": null, "metadata": {"window": "And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n", "original_text": "This is \u2013 those comments were not meant.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab991b2f-2cd7-4656-84c7-ff6f0c19eb9c", "node_type": "1", "metadata": {"window": "I guess first, I\u2019m assuming that\u2019s the \u2013 some \nretail independents but wanted to confirm that.  \n \n  And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n ", "original_text": "Mike Kaufmann :  No.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4d7b56e513cf5961b8c25034414b51b08e69f9f23a75abd56a9fa84ff37a002e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "962f6fcf-7d6f-44c4-ae76-9cad7493a257", "node_type": "1", "metadata": {"window": "Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.  ", "original_text": "So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.  "}, "hash": "48673d349d4ce0900ff9d2de57a3b4d3286bd3a116cd3d5987a9af1ace8b3302", "class_name": "RelatedNodeInfo"}}, "text": "This is \u2013 those comments were not meant.  ", "start_char_idx": 1230, "end_char_idx": 1272, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "962f6fcf-7d6f-44c4-ae76-9cad7493a257": {"__data__": {"id_": "962f6fcf-7d6f-44c4-ae76-9cad7493a257", "embedding": null, "metadata": {"window": "Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.  ", "original_text": "So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "70518751-c6fa-4514-beb5-b8a3fa28c498", "node_type": "1", "metadata": {"window": "And then could you tal k a little bit about, you know, what you think is driving this?   Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n", "original_text": "This is \u2013 those comments were not meant.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b95986d4f1fde58fa923a15810701deffd1d0f11f9b54338ccadb312de76c7bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20256c4d-a688-4b56-be86-47674f79e462", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.  ", "original_text": "This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n "}, "hash": "045e2beecc7fd692052f765577fdd5c2f2a504f7ec3f5ef517132c45c31c7c7b", "class_name": "RelatedNodeInfo"}}, "text": "So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.  ", "start_char_idx": 1272, "end_char_idx": 1354, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "20256c4d-a688-4b56-be86-47674f79e462": {"__data__": {"id_": "20256c4d-a688-4b56-be86-47674f79e462", "embedding": null, "metadata": {"window": "Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.  ", "original_text": "This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "962f6fcf-7d6f-44c4-ae76-9cad7493a257", "node_type": "1", "metadata": {"window": "Was it, you know, kind of a \none-off related to a certain pocket of customers or is there anything more systemic you\u2019re seeing in the \nmarketplace around the health of some of your maybe perhap s smaller customers?  \n \n Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.  ", "original_text": "So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "132cad879b2a3761397170824d9005faa7e9689c49fc66b3c74f65b3d28bb0e2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20726868-bc28-4d2e-a7f7-d58e79481ea9", "node_type": "1", "metadata": {"window": "This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.  ", "original_text": "And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n"}, "hash": "14c8b68926ecf3951de16e0fc6dfd9291fb829e7f914ce70bd86efc0d10f4b18", "class_name": "RelatedNodeInfo"}}, "text": "This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n ", "start_char_idx": 1354, "end_char_idx": 1580, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "20726868-bc28-4d2e-a7f7-d58e79481ea9": {"__data__": {"id_": "20726868-bc28-4d2e-a7f7-d58e79481ea9", "embedding": null, "metadata": {"window": "This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.  ", "original_text": "And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20256c4d-a688-4b56-be86-47674f79e462", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  No.   This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.  ", "original_text": "This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cd5ad4d5f5c3081e02ec89faf7ed617be42aaab71b0e50a3be3052367cd4775b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c718ccc-3eb9-4b6a-a4ab-d22b79f64df6", "node_type": "1", "metadata": {"window": "So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n", "original_text": "Robert Jones :  Got it, got it.  "}, "hash": "14256a5421c582fe6e2a11714321ead1683b89b2437119564c3792a8b02a44d4", "class_name": "RelatedNodeInfo"}}, "text": "And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n", "start_char_idx": 1580, "end_char_idx": 1754, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1c718ccc-3eb9-4b6a-a4ab-d22b79f64df6": {"__data__": {"id_": "1c718ccc-3eb9-4b6a-a4ab-d22b79f64df6", "embedding": null, "metadata": {"window": "So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n", "original_text": "Robert Jones :  Got it, got it.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20726868-bc28-4d2e-a7f7-d58e79481ea9", "node_type": "1", "metadata": {"window": "This is \u2013 those comments were not meant.   So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.  ", "original_text": "And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cd05145fd9b58a9fc27fe48c51d791c02d1db6506a36c1c74bab7642a5a37d0d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ae51b47f-2680-4edf-af06-0e0bbb8af605", "node_type": "1", "metadata": {"window": "This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n ", "original_text": "No.  "}, "hash": "a0b342c1d16222a63ff222fbeca0d7cb446e6365e38842fdde1d6b81ee9c9461", "class_name": "RelatedNodeInfo"}}, "text": "Robert Jones :  Got it, got it.  ", "start_char_idx": 1754, "end_char_idx": 1787, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ae51b47f-2680-4edf-af06-0e0bbb8af605": {"__data__": {"id_": "ae51b47f-2680-4edf-af06-0e0bbb8af605", "embedding": null, "metadata": {"window": "This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n ", "original_text": "No.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c718ccc-3eb9-4b6a-a4ab-d22b79f64df6", "node_type": "1", "metadata": {"window": "So I\u2019m really glad you asked, were not meant to talk \nabout the small customers.   This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n", "original_text": "Robert Jones :  Got it, got it.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6d24df95fe49927adaae1a212c1c05fca9d12e8294d39ec65c0e94f3c207d9ca", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8831708-fb48-4478-81ba-0018b39582cf", "node_type": "1", "metadata": {"window": "And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n ", "original_text": "Thanks for the clarification.  "}, "hash": "e780b3a7e2ae1dadf39b8d3591a515fab50aba8b531dabf4ff9781eb044f2785", "class_name": "RelatedNodeInfo"}}, "text": "No.  ", "start_char_idx": 1225, "end_char_idx": 1230, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e8831708-fb48-4478-81ba-0018b39582cf": {"__data__": {"id_": "e8831708-fb48-4478-81ba-0018b39582cf", "embedding": null, "metadata": {"window": "And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n ", "original_text": "Thanks for the clarification.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ae51b47f-2680-4edf-af06-0e0bbb8af605", "node_type": "1", "metadata": {"window": "This was really about the bankruptcy of Fred\u2019s and the continuing, you know, \nrestructuring  of the Kmart account and two accounts that we\u2019ve had that we\u2019ve been managing over time that \nwere both generic buyers of ours.  \n \n  And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n ", "original_text": "No.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8521ee945bf7265bf6a5f725c7782b7db67b1b56402b87affd295b8f9f2aa2d9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "98fda166-d1ec-4d81-b453-aea6804c2bde", "node_type": "1", "metadata": {"window": "Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n ", "original_text": "And I guess just one follow -up on the medical guidance.  \n"}, "hash": "5ea690fbc8ceed5ecfeb081af0559974b89d44112710a7ffceec37ef88bae4a7", "class_name": "RelatedNodeInfo"}}, "text": "Thanks for the clarification.  ", "start_char_idx": 1792, "end_char_idx": 1823, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "98fda166-d1ec-4d81-b453-aea6804c2bde": {"__data__": {"id_": "98fda166-d1ec-4d81-b453-aea6804c2bde", "embedding": null, "metadata": {"window": "Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n ", "original_text": "And I guess just one follow -up on the medical guidance.  \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e8831708-fb48-4478-81ba-0018b39582cf", "node_type": "1", "metadata": {"window": "And as those volumes \u2013 as you \u2013 declined due to their financial situation that has had some impact on us but \nthat\u2019s really wha t we were referring to in those comments.  \n \n Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n ", "original_text": "Thanks for the clarification.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "912edc10db3eff70b0b93daf8b09d8f3065ba0ba42baae9570f58f01c5c1b0fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "75230058-30a1-4908-afc6-c5e078227e1b", "node_type": "1", "metadata": {"window": "No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.  ", "original_text": "You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n "}, "hash": "56b580fd0fa369900677b20dbcfeaee6bbed6ce5f6fb6343d7c27c95d8e94853", "class_name": "RelatedNodeInfo"}}, "text": "And I guess just one follow -up on the medical guidance.  \n", "start_char_idx": 1823, "end_char_idx": 1882, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "75230058-30a1-4908-afc6-c5e078227e1b": {"__data__": {"id_": "75230058-30a1-4908-afc6-c5e078227e1b", "embedding": null, "metadata": {"window": "No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.  ", "original_text": "You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "98fda166-d1ec-4d81-b453-aea6804c2bde", "node_type": "1", "metadata": {"window": "Robert Jones :  Got it, got it.   No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n ", "original_text": "And I guess just one follow -up on the medical guidance.  \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c0dd787cbb064e6d4122948434b9e362f17ea877e700010b446b59fd16a42c7a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "409b38e6-68a1-40d2-acaf-6f918a991479", "node_type": "1", "metadata": {"window": "Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n", "original_text": "And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n "}, "hash": "20470149bd5c9720a84dc7f5fe28f05e87a28cf500b39262087876d733cf374b", "class_name": "RelatedNodeInfo"}}, "text": "You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n ", "start_char_idx": 1882, "end_char_idx": 2023, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "409b38e6-68a1-40d2-acaf-6f918a991479": {"__data__": {"id_": "409b38e6-68a1-40d2-acaf-6f918a991479", "embedding": null, "metadata": {"window": "Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n", "original_text": "And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75230058-30a1-4908-afc6-c5e078227e1b", "node_type": "1", "metadata": {"window": "No.   Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.  ", "original_text": "You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a870575a3819237a8535394d7ac26fd9e9c1c71f5ab1f53c58a21125c65e10b5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a3a4d410-8b8d-4ed5-884a-49312e967bfb", "node_type": "1", "metadata": {"window": "And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.  ", "original_text": "So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n "}, "hash": "c2daa9ffae8c3552171ae5ee73816b00bef240074431cdbb1b08c414725728b0", "class_name": "RelatedNodeInfo"}}, "text": "And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n ", "start_char_idx": 2023, "end_char_idx": 2131, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a3a4d410-8b8d-4ed5-884a-49312e967bfb": {"__data__": {"id_": "a3a4d410-8b8d-4ed5-884a-49312e967bfb", "embedding": null, "metadata": {"window": "And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.  ", "original_text": "So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "409b38e6-68a1-40d2-acaf-6f918a991479", "node_type": "1", "metadata": {"window": "Thanks for the clarification.   And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n", "original_text": "And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "00e5b6bf220e5997362a0f644bad62e9dd43b2ee5e22e4f6fe7cf38f84893d2f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a6cc63a-89f3-4789-9f46-82be58dc2fb0", "node_type": "1", "metadata": {"window": "You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "And just one point related to medical, I wanted to make sure I was thinking about this right.  "}, "hash": "b8abbfedb2a3ede9363699369a4f0b1bf0cebbee81e82dbe0474a81a0f5a9004", "class_name": "RelatedNodeInfo"}}, "text": "So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n ", "start_char_idx": 2131, "end_char_idx": 2292, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8a6cc63a-89f3-4789-9f46-82be58dc2fb0": {"__data__": {"id_": "8a6cc63a-89f3-4789-9f46-82be58dc2fb0", "embedding": null, "metadata": {"window": "You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "And just one point related to medical, I wanted to make sure I was thinking about this right.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a3a4d410-8b8d-4ed5-884a-49312e967bfb", "node_type": "1", "metadata": {"window": "And I guess just one follow -up on the medical guidance.  \n You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.  ", "original_text": "So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f8adf2d1ebc380d23618acd36ed437ff8f0692cea82fec70caeea18e6801f480", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fd1efa7c-2739-482e-8f08-424099a49e42", "node_type": "1", "metadata": {"window": "And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n"}, "hash": "6d0847ee8c566e32d5a39f705fdd4375ed95d40b71efda0284c3366e34e14ae9", "class_name": "RelatedNodeInfo"}}, "text": "And just one point related to medical, I wanted to make sure I was thinking about this right.  ", "start_char_idx": 2292, "end_char_idx": 2387, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fd1efa7c-2739-482e-8f08-424099a49e42": {"__data__": {"id_": "fd1efa7c-2739-482e-8f08-424099a49e42", "embedding": null, "metadata": {"window": "And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a6cc63a-89f3-4789-9f46-82be58dc2fb0", "node_type": "1", "metadata": {"window": "You know you guys mentioned that you\u2019re monitoring, you know, the med t ax, the med devic e tax and tariffs as it \nrelates to guidance.  \n \n  And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "And just one point related to medical, I wanted to make sure I was thinking about this right.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9df4a2573b0f9def9945a01976ea886dcb52d3c3f8720f413b5151d99f2e46fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "370843e0-cddd-4486-b64a-2801a0b80832", "node_type": "1", "metadata": {"window": "So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.  "}, "hash": "c9a515c51e69abe5ae93b7535347b8cd7fb780df7ea91ef458f8029357ed1037", "class_name": "RelatedNodeInfo"}}, "text": "I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n", "start_char_idx": 2387, "end_char_idx": 2602, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "370843e0-cddd-4486-b64a-2801a0b80832": {"__data__": {"id_": "370843e0-cddd-4486-b64a-2801a0b80832", "embedding": null, "metadata": {"window": "So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fd1efa7c-2739-482e-8f08-424099a49e42", "node_type": "1", "metadata": {"window": "And, you know, clearly the guidance would imply, you know, a deceleration over the course of the year.  \n \n  So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c3fd2050bde9bd12d97dea9818abc8706be610a5428475a221bad3b0b02dcd63", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "225287ce-5b47-4adc-834b-86d9ea22210b", "node_type": "1", "metadata": {"window": "And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  "}, "hash": "86c4e0e8ba22492426dbe0058c7dff09a2572b102808377ebcd324bd93a7b9ca", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.  ", "start_char_idx": 2602, "end_char_idx": 2698, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "225287ce-5b47-4adc-834b-86d9ea22210b": {"__data__": {"id_": "225287ce-5b47-4adc-834b-86d9ea22210b", "embedding": null, "metadata": {"window": "And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11", "node_type": "4", "metadata": {"page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f867374123fa54a4ddc8a0c05f8d2ff89b2981b4fbbd416ddc1a1550f4fba41c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "370843e0-cddd-4486-b64a-2801a0b80832", "node_type": "1", "metadata": {"window": "So I just wanted to maybe get a better sense of what, you know, what maybe the guidance looks like if in  fact \nthose items don\u2019t in fact come to fruition.  \n \n  And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "597885df8a53f0b22634c4dca5800df95c384d6fced06a729183e47dee63ad10", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c872664b-a508-4911-b0d0-584cd5eec9f5", "node_type": "1", "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n ", "original_text": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.  "}, "hash": "837748fdbeb17d1579162c8fdd4db105f2d11410169fdb0b9739374575c087cf", "class_name": "RelatedNodeInfo"}}, "text": "We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "start_char_idx": 2698, "end_char_idx": 2799, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c872664b-a508-4911-b0d0-584cd5eec9f5": {"__data__": {"id_": "c872664b-a508-4911-b0d0-584cd5eec9f5", "embedding": null, "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n ", "original_text": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "225287ce-5b47-4adc-834b-86d9ea22210b", "node_type": "1", "metadata": {"window": "And just one point related to medical, I wanted to make sure I was thinking about this right.   I believe you\u2019re \nlapping a fairly meaningful headwind from a supplier charge in 4Q, wanted to confirm that th at was right as we \njust think about the cadence around the medical guide for the rest of the year.  \n \n Dave Evans :  Yes Bob that\u2019s absolutely correct in terms of the second half of your statement.   We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "original_text": "We will be lapping in the \nfourth quarter, you know, reasonable charge that should be nonrecurring.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cff248318b24168da8074f5f6b3ac9ce78d4e2cf5603c9a500a43ce97349caab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "712fa1db-3680-426c-9e5e-5acb827b28de", "node_type": "1", "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n ", "original_text": "We\u2019ve \nbuilt-in nothing with respect to the med device tax.  "}, "hash": "6f5b7008d5072d1b5cf904a69b19034ac1b8d4ed9d42dc31f0b0348a2921058c", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.  ", "start_char_idx": 0, "end_char_idx": 135, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "712fa1db-3680-426c-9e5e-5acb827b28de": {"__data__": {"id_": "712fa1db-3680-426c-9e5e-5acb827b28de", "embedding": null, "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n ", "original_text": "We\u2019ve \nbuilt-in nothing with respect to the med device tax.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c872664b-a508-4911-b0d0-584cd5eec9f5", "node_type": "1", "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n ", "original_text": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6c41c521ae815bcaac04e3c2f759191d470837ce560e036f78e4b1dae6bc600b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e747e56-91fa-4c40-b509-6a1846d7154d", "node_type": "1", "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.  ", "original_text": "So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n "}, "hash": "2376d2c0186462d566cd32a0a3a94b905f07176cd7e56b24184c53f2001b027f", "class_name": "RelatedNodeInfo"}}, "text": "We\u2019ve \nbuilt-in nothing with respect to the med device tax.  ", "start_char_idx": 135, "end_char_idx": 196, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4e747e56-91fa-4c40-b509-6a1846d7154d": {"__data__": {"id_": "4e747e56-91fa-4c40-b509-6a1846d7154d", "embedding": null, "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.  ", "original_text": "So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "712fa1db-3680-426c-9e5e-5acb827b28de", "node_type": "1", "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n ", "original_text": "We\u2019ve \nbuilt-in nothing with respect to the med device tax.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "940a4c261756b6ebc5fd36149a75a12774589eebe6874d7c05137cbc90d1ba0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bb60e733-3d30-4700-b466-809ad3ecb5e9", "node_type": "1", "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n ", "original_text": "And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n "}, "hash": "98aeb24b10c5a64c94bc54606085e86ab991e6528831962b18ee75325d30d7b6", "class_name": "RelatedNodeInfo"}}, "text": "So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n ", "start_char_idx": 196, "end_char_idx": 291, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bb60e733-3d30-4700-b466-809ad3ecb5e9": {"__data__": {"id_": "bb60e733-3d30-4700-b466-809ad3ecb5e9", "embedding": null, "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n ", "original_text": "And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e747e56-91fa-4c40-b509-6a1846d7154d", "node_type": "1", "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.  ", "original_text": "So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e1ebd30c845d3db66f34e6f3a4d03c3cb8057fd6018439e7b287d815cf060973", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3a6b9eb3-78b4-4928-9959-9c04e84b9af9", "node_type": "1", "metadata": {"window": "We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.  ", "original_text": "Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n "}, "hash": "bd9ac321b3110302d8f5c45677c22c0ed58f4710b76ee7a1cab0be31fb3f365f", "class_name": "RelatedNodeInfo"}}, "text": "And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n ", "start_char_idx": 291, "end_char_idx": 393, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3a6b9eb3-78b4-4928-9959-9c04e84b9af9": {"__data__": {"id_": "3a6b9eb3-78b4-4928-9959-9c04e84b9af9", "embedding": null, "metadata": {"window": "We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.  ", "original_text": "Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bb60e733-3d30-4700-b466-809ad3ecb5e9", "node_type": "1", "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n ", "original_text": "And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2052f37aa650359b1758e7f3949f0967d21e7d0337cb2d6ab6b52c5ca147111e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a34c1ad6-8c15-4b1d-8e8d-85f74e127917", "node_type": "1", "metadata": {"window": "So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n ", "original_text": "But that again is changing.  "}, "hash": "8312f339929bf4ddce441acfedd995a200e52107ccdbca2fba1dac5080762c06", "class_name": "RelatedNodeInfo"}}, "text": "Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n ", "start_char_idx": 393, "end_char_idx": 508, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a34c1ad6-8c15-4b1d-8e8d-85f74e127917": {"__data__": {"id_": "a34c1ad6-8c15-4b1d-8e8d-85f74e127917", "embedding": null, "metadata": {"window": "So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n ", "original_text": "But that again is changing.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3a6b9eb3-78b4-4928-9959-9c04e84b9af9", "node_type": "1", "metadata": {"window": "We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.  ", "original_text": "Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "663e1e4f1021f8ae747beaf0accd9060b881c2d59ec286b843754bf2ef83df0d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ae139f29-0ddc-4e54-bddd-fa84f1803e3d", "node_type": "1", "metadata": {"window": "And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.  ", "original_text": "So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n "}, "hash": "883df206a3793d27ac8268f9df99364764a383b1a535c7d64bf8d947a7c977ad", "class_name": "RelatedNodeInfo"}}, "text": "But that again is changing.  ", "start_char_idx": 508, "end_char_idx": 537, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ae139f29-0ddc-4e54-bddd-fa84f1803e3d": {"__data__": {"id_": "ae139f29-0ddc-4e54-bddd-fa84f1803e3d", "embedding": null, "metadata": {"window": "And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.  ", "original_text": "So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a34c1ad6-8c15-4b1d-8e8d-85f74e127917", "node_type": "1", "metadata": {"window": "So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n ", "original_text": "But that again is changing.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1558f72da97c65acb0952e5821d94c98b844c780f09c6af946137ac64397c285", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0190391f-0fe0-4e58-8475-395b25b06352", "node_type": "1", "metadata": {"window": "Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n ", "original_text": "What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.  "}, "hash": "da0d1c60f73ed0b9f378eadfe57c0d96ef599b1d5a1aff9a83eaa67378a404fc", "class_name": "RelatedNodeInfo"}}, "text": "So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n ", "start_char_idx": 537, "end_char_idx": 732, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0190391f-0fe0-4e58-8475-395b25b06352": {"__data__": {"id_": "0190391f-0fe0-4e58-8475-395b25b06352", "embedding": null, "metadata": {"window": "Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n ", "original_text": "What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ae139f29-0ddc-4e54-bddd-fa84f1803e3d", "node_type": "1", "metadata": {"window": "And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n  Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.  ", "original_text": "So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "34e315cdff47d60d068e26c7eed1fe757d06294c86bb543babe46606ce55b12a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b6ba3e24-8301-436c-97d3-299becae3a16", "node_type": "1", "metadata": {"window": "But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.  ", "original_text": "And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n "}, "hash": "db68b5c55a6acb8e7b599a7a479557e6a73558dddcb8a59576516450b34699f7", "class_name": "RelatedNodeInfo"}}, "text": "What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.  ", "start_char_idx": 732, "end_char_idx": 856, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b6ba3e24-8301-436c-97d3-299becae3a16": {"__data__": {"id_": "b6ba3e24-8301-436c-97d3-299becae3a16", "embedding": null, "metadata": {"window": "But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.  ", "original_text": "And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0190391f-0fe0-4e58-8475-395b25b06352", "node_type": "1", "metadata": {"window": "Tariffs are just such a dynamic topic that we\u2019ve done our best to offset the tariffs that are in effec t now.  \n \n  But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n ", "original_text": "What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5a3f4a124eac84815a458af6edd39b3957d6064212420278ad41ebc0e9a64d8d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8b3f722a-adce-4b40-a1a1-b070a33a0ad7", "node_type": "1", "metadata": {"window": "So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n ", "original_text": "I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.  "}, "hash": "33684e0b88e23afb8304e676c3a16a0c4972d96c27938743d8c88d83e31bc522", "class_name": "RelatedNodeInfo"}}, "text": "And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n ", "start_char_idx": 856, "end_char_idx": 976, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8b3f722a-adce-4b40-a1a1-b070a33a0ad7": {"__data__": {"id_": "8b3f722a-adce-4b40-a1a1-b070a33a0ad7", "embedding": null, "metadata": {"window": "So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n ", "original_text": "I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b6ba3e24-8301-436c-97d3-299becae3a16", "node_type": "1", "metadata": {"window": "But that again is changing.   So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.  ", "original_text": "And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ab4b153f6f2918758d051a6d5e64292e9dc6f41f94e4c875f66b26de0ab3a1ce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "98bfca33-4524-4d1a-9c19-982d3cd9d8a9", "node_type": "1", "metadata": {"window": "What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.  ", "original_text": "But we are incurring cost to begin to plan for those this year.  \n \n "}, "hash": "cbcf0055fe4faca6491985ce7978c23c4834ec4c9013280b406dba68feb70bec", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.  ", "start_char_idx": 976, "end_char_idx": 1141, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "98bfca33-4524-4d1a-9c19-982d3cd9d8a9": {"__data__": {"id_": "98bfca33-4524-4d1a-9c19-982d3cd9d8a9", "embedding": null, "metadata": {"window": "What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.  ", "original_text": "But we are incurring cost to begin to plan for those this year.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8b3f722a-adce-4b40-a1a1-b070a33a0ad7", "node_type": "1", "metadata": {"window": "So I\u2019d say if that would completely, you know, cease any further dialogue around \ntariffs, then what we\u2019ve \u2013 what\u2019s been announced today we\u2019ve more or less been able to manage through that.  \n \n  What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n ", "original_text": "I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "407ee6173255fdf1cd67c4d5d8359718f69c1378d60fca7d25e1443c18141c1e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0849ac87-bc71-4a9a-91d2-27cb7cb055ed", "node_type": "1", "metadata": {"window": "And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n", "original_text": "And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.  "}, "hash": "44236efb77871b06a8d689f34b397690460c54871035020980060db075859f78", "class_name": "RelatedNodeInfo"}}, "text": "But we are incurring cost to begin to plan for those this year.  \n \n ", "start_char_idx": 1141, "end_char_idx": 1210, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0849ac87-bc71-4a9a-91d2-27cb7cb055ed": {"__data__": {"id_": "0849ac87-bc71-4a9a-91d2-27cb7cb055ed", "embedding": null, "metadata": {"window": "And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n", "original_text": "And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "98bfca33-4524-4d1a-9c19-982d3cd9d8a9", "node_type": "1", "metadata": {"window": "What I would say is there a re still a lot of other SG&A initiatives that Mike talked about that do have a longer \nrunway.   And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.  ", "original_text": "But we are incurring cost to begin to plan for those this year.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7d1f993353bd9115cb8fd92997ee79e8a22e2e82055f6ed2e35ff55cecc8d944", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0daf13da-257d-49b2-bc71-d3022ab6b96c", "node_type": "1", "metadata": {"window": "I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.  ", "original_text": "So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n "}, "hash": "90398be44f9b3d45aabe8fea3199407022b5ca004612c9ea1d2eb0970ffc6561", "class_name": "RelatedNodeInfo"}}, "text": "And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.  ", "start_char_idx": 1210, "end_char_idx": 1336, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0daf13da-257d-49b2-bc71-d3022ab6b96c": {"__data__": {"id_": "0daf13da-257d-49b2-bc71-d3022ab6b96c", "embedding": null, "metadata": {"window": "I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.  ", "original_text": "So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0849ac87-bc71-4a9a-91d2-27cb7cb055ed", "node_type": "1", "metadata": {"window": "And therefore they aren\u2019t necessarily all, you know, the cadence isn\u2019t equally distributed amongst four \nquarters.  \n \n  I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n", "original_text": "And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7cbecb2c862a332d7dcb4e8b106e43bc2a022943be26dfc2ec1d27450814f92d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "971356d8-67e6-46d1-81e9-51c936424a9a", "node_type": "1", "metadata": {"window": "But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n", "original_text": "So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.  "}, "hash": "78f1b3e0fcc4818a7b690fc00583719394635ca2dd16c406deac5f9f4dfc661d", "class_name": "RelatedNodeInfo"}}, "text": "So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n ", "start_char_idx": 1336, "end_char_idx": 1476, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "971356d8-67e6-46d1-81e9-51c936424a9a": {"__data__": {"id_": "971356d8-67e6-46d1-81e9-51c936424a9a", "embedding": null, "metadata": {"window": "But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n", "original_text": "So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0daf13da-257d-49b2-bc71-d3022ab6b96c", "node_type": "1", "metadata": {"window": "I\u2019d really highlight some of the supply chain  initiatives that have a long runway and won\u2019t necessarily bear fruit for \n\u2013 it could be, you know, two, three years.   But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.  ", "original_text": "So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ad5cc254516e51462a86de31a76dfc0bdcf2e7f26479b8dc109379991a0c8c94", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa05ded3-e7cf-44bb-9178-abbe6d007116", "node_type": "1", "metadata": {"window": "And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.  ", "original_text": "But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n"}, "hash": "090d4507b16c68c999099dc10e68a43002cf6fb76e49240331a31d9f1d07c3fb", "class_name": "RelatedNodeInfo"}}, "text": "So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.  ", "start_char_idx": 1476, "end_char_idx": 1618, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "aa05ded3-e7cf-44bb-9178-abbe6d007116": {"__data__": {"id_": "aa05ded3-e7cf-44bb-9178-abbe6d007116", "embedding": null, "metadata": {"window": "And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.  ", "original_text": "But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "971356d8-67e6-46d1-81e9-51c936424a9a", "node_type": "1", "metadata": {"window": "But we are incurring cost to begin to plan for those this year.  \n \n  And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n", "original_text": "So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d032216de04f4f6caf7acaded1dde3ac2215acd72eada2257aac25659004856e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "885c3bb3-44ac-49f0-ad57-aef9af2d72b8", "node_type": "1", "metadata": {"window": "So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.  ", "original_text": "Operator :  Thank you.  "}, "hash": "8529d3066067af7df6b2721c50abb6dc004f8b97bdd6ec99486e4b798fdc5d8c", "class_name": "RelatedNodeInfo"}}, "text": "But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n", "start_char_idx": 1618, "end_char_idx": 1842, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "885c3bb3-44ac-49f0-ad57-aef9af2d72b8": {"__data__": {"id_": "885c3bb3-44ac-49f0-ad57-aef9af2d72b8", "embedding": null, "metadata": {"window": "So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.  ", "original_text": "Operator :  Thank you.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa05ded3-e7cf-44bb-9178-abbe6d007116", "node_type": "1", "metadata": {"window": "And as well the salesforce restructuring that we\u2019ve discussed as well is  kind of in flight through the course of the \nyear.   So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.  ", "original_text": "But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cd650314b52b807ca8a4686c274653c07ec374bede3d28fd2e65b154eb448e0f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "672db77e-ee80-456d-8168-a925006d7593", "node_type": "1", "metadata": {"window": "So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?  ", "original_text": "We will take our next question from Eric Percher from Nephron Research.  \n \n"}, "hash": "4cd6b72d23fa0e14c14e4cc5fd4388159f91dc8bbd84094a6f6e019b1620d917", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you.  ", "start_char_idx": 1842, "end_char_idx": 1866, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "672db77e-ee80-456d-8168-a925006d7593": {"__data__": {"id_": "672db77e-ee80-456d-8168-a925006d7593", "embedding": null, "metadata": {"window": "So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?  ", "original_text": "We will take our next question from Eric Percher from Nephron Research.  \n \n", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "885c3bb3-44ac-49f0-ad57-aef9af2d72b8", "node_type": "1", "metadata": {"window": "So that\u2019s not something you can just kind of ratably divide by 4 and say it\u2019s going to be equal in terms of the \ncost or the benefits.  \n \n  So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.  ", "original_text": "Operator :  Thank you.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f19869ea4c727d7781977e3cc6c105196a4f0d0b084805fd21a5d852a573d453", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a70b1a7f-4e08-461f-b154-e2ea1c1e7934", "node_type": "1", "metadata": {"window": "But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n", "original_text": "Dolph Warburton :  Hi.  "}, "hash": "7dce0d4e1ad6c79a07abcab5f5eebc672252dde596ba6a42d88614f336cf5580", "class_name": "RelatedNodeInfo"}}, "text": "We will take our next question from Eric Percher from Nephron Research.  \n \n", "start_char_idx": 1866, "end_char_idx": 1942, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a70b1a7f-4e08-461f-b154-e2ea1c1e7934": {"__data__": {"id_": "a70b1a7f-4e08-461f-b154-e2ea1c1e7934", "embedding": null, "metadata": {"window": "But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n", "original_text": "Dolph Warburton :  Hi.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "672db77e-ee80-456d-8168-a925006d7593", "node_type": "1", "metadata": {"window": "So look, you\u2019re right in that the fourth quarter does have a tailwin d this year and the fact that there\u2019s a non -\nrecurrence of the charge.   But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?  ", "original_text": "We will take our next question from Eric Percher from Nephron Research.  \n \n", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9179b9cb1605e3ac74bfa89f9865d4b289707a5a09901a8aa538c5a0558a5a07", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a1c53aea-561c-4863-940c-20bf49c53be1", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.  ", "original_text": "This is Dolph on for Eric.  "}, "hash": "36c288ab84e5e81dc9a57d2da44479310ba752bb8d82c012f82e7248ceff7428", "class_name": "RelatedNodeInfo"}}, "text": "Dolph Warburton :  Hi.  ", "start_char_idx": 1942, "end_char_idx": 1966, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a1c53aea-561c-4863-940c-20bf49c53be1": {"__data__": {"id_": "a1c53aea-561c-4863-940c-20bf49c53be1", "embedding": null, "metadata": {"window": "Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.  ", "original_text": "This is Dolph on for Eric.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a70b1a7f-4e08-461f-b154-e2ea1c1e7934", "node_type": "1", "metadata": {"window": "But we just \u2013 we feel I guess I\u2019d say cautiously optimistic for the year based on the first \nquarter but it feels too early to stage given all these variables that are out there to call anything up at this early \nstage.  \n \n Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n", "original_text": "Dolph Warburton :  Hi.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "30b8c85f890959541c939a49009058c820457ab2b4f84dcb56e2888e92e47523", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bf638cbf-35a9-43c1-8f16-9285c833de46", "node_type": "1", "metadata": {"window": "We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n ", "original_text": "A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?  "}, "hash": "f070f80170ad4c84932309af78080e20dbfb1fbde2de773ece573456270dd938", "class_name": "RelatedNodeInfo"}}, "text": "This is Dolph on for Eric.  ", "start_char_idx": 1966, "end_char_idx": 1994, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bf638cbf-35a9-43c1-8f16-9285c833de46": {"__data__": {"id_": "bf638cbf-35a9-43c1-8f16-9285c833de46", "embedding": null, "metadata": {"window": "We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n ", "original_text": "A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a1c53aea-561c-4863-940c-20bf49c53be1", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.  ", "original_text": "This is Dolph on for Eric.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b8722b57cc6876fa6c9fff88568de545d63e056ed161ee9f97146b779d69ebe3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "30d187d7-3495-4f45-8349-25df2bc7172f", "node_type": "1", "metadata": {"window": "Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.  ", "original_text": "And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n"}, "hash": "39923781cce0736ce176a8456ca2416aace6e56997dad2134f9b950969719ec9", "class_name": "RelatedNodeInfo"}}, "text": "A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?  ", "start_char_idx": 1994, "end_char_idx": 2152, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "30d187d7-3495-4f45-8349-25df2bc7172f": {"__data__": {"id_": "30d187d7-3495-4f45-8349-25df2bc7172f", "embedding": null, "metadata": {"window": "Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.  ", "original_text": "And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bf638cbf-35a9-43c1-8f16-9285c833de46", "node_type": "1", "metadata": {"window": "We will take our next question from Eric Percher from Nephron Research.  \n \n Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n ", "original_text": "A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d77fd6d98d0ffb9653e0be7dea81765d27e00c234dd6953c0b4b9ece356e2df7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e192b5e4-8199-4c14-854f-d331c0021d84", "node_type": "1", "metadata": {"window": "This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.  ", "original_text": "Mike Kaufmann :  Yes, it\u2019s a great question.  "}, "hash": "d2941ee1d8df73652d9161ce90d4c23c338d91a778c931fdb63299bc91ba1ef8", "class_name": "RelatedNodeInfo"}}, "text": "And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n", "start_char_idx": 2152, "end_char_idx": 2318, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e192b5e4-8199-4c14-854f-d331c0021d84": {"__data__": {"id_": "e192b5e4-8199-4c14-854f-d331c0021d84", "embedding": null, "metadata": {"window": "This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.  ", "original_text": "Mike Kaufmann :  Yes, it\u2019s a great question.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30d187d7-3495-4f45-8349-25df2bc7172f", "node_type": "1", "metadata": {"window": "Dolph Warburton :  Hi.   This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.  ", "original_text": "And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6987b8eade6d66e47877003c065edb9491e3ace9d3b814305c97dfb3035b0bb7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "37228113-eb2a-4730-b65e-7631f569e7a2", "node_type": "1", "metadata": {"window": "A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "That would be an area that is still looking to be defined yet.  \n \n "}, "hash": "dbcbd050fa83d92dfefd9b7406ece726ea0de6b1c4cc1f525ae871f1d0ad6b35", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes, it\u2019s a great question.  ", "start_char_idx": 2318, "end_char_idx": 2364, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "37228113-eb2a-4730-b65e-7631f569e7a2": {"__data__": {"id_": "37228113-eb2a-4730-b65e-7631f569e7a2", "embedding": null, "metadata": {"window": "A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "That would be an area that is still looking to be defined yet.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e192b5e4-8199-4c14-854f-d331c0021d84", "node_type": "1", "metadata": {"window": "This is Dolph on for Eric.   A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.  ", "original_text": "Mike Kaufmann :  Yes, it\u2019s a great question.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4fda891715ab3a3200a8347cbb4231b570a4d4a9e52e30611b23f75652df5597", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "edb0ca46-d8a4-4a35-b0c9-988d2a1054ac", "node_type": "1", "metadata": {"window": "And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.  "}, "hash": "555d376caae426f93f7a038dfbc81bbe41bf6117b4216d559399728133d55bba", "class_name": "RelatedNodeInfo"}}, "text": "That would be an area that is still looking to be defined yet.  \n \n ", "start_char_idx": 2364, "end_char_idx": 2432, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "edb0ca46-d8a4-4a35-b0c9-988d2a1054ac": {"__data__": {"id_": "edb0ca46-d8a4-4a35-b0c9-988d2a1054ac", "embedding": null, "metadata": {"window": "And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "37228113-eb2a-4730-b65e-7631f569e7a2", "node_type": "1", "metadata": {"window": "A question about the in kind portion of the potential settlement, if the \u2013 \nlet\u2019s just take \u2013 if we take $1 billion of value, is that $1 billion of revenue?   And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "That would be an area that is still looking to be defined yet.  \n \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "716dd47c7bab91bf60e914ac626568b0ad6ff76a3a8035d0f556f1442edeb837", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cff9d501-7854-4cf7-b7cb-4e257579d73e", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.  "}, "hash": "e88548f2af3fd453b57a6fe37d8ee5e9672721361d9beadf4d411f5c6d47455f", "class_name": "RelatedNodeInfo"}}, "text": "But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.  ", "start_char_idx": 2432, "end_char_idx": 2560, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cff9d501-7854-4cf7-b7cb-4e257579d73e": {"__data__": {"id_": "cff9d501-7854-4cf7-b7cb-4e257579d73e", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "edb0ca46-d8a4-4a35-b0c9-988d2a1054ac", "node_type": "1", "metadata": {"window": "And if so, is there \u2013 are you able to \ndetermine kind of the costs or I guess the better question is what does an in kind service really look like for \nCardinal?  \n \n Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0622832c368a421e1cd808abecaf9c1170b11f4cfcc392679705e73bfc4f0370", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a9496e4-29de-4642-86d9-bbd688e36b30", "node_type": "1", "metadata": {"window": "That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n "}, "hash": "bef255a4a5e0ce7990c6c8e9f5965eec13ff7ec261971256d6a8c68cedebdaf5", "class_name": "RelatedNodeInfo"}}, "text": "And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.  ", "start_char_idx": 2560, "end_char_idx": 2681, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8a9496e4-29de-4642-86d9-bbd688e36b30": {"__data__": {"id_": "8a9496e4-29de-4642-86d9-bbd688e36b30", "embedding": null, "metadata": {"window": "That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "88c91c57-d901-4d1d-a762-8e2940612333", "node_type": "4", "metadata": {"page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5491cc1dd8d0dcc6193ef723f141619c7d6c0e316799e07c361b9b26d217fec3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cff9d501-7854-4cf7-b7cb-4e257579d73e", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes, it\u2019s a great question.   That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4ac17c82ab749075f652117b422a87c80f667f66fcd2d9f4475171bae42664df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b96bfe4f-35d5-44c1-a268-f8baaacd1bd2", "node_type": "1", "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.  ", "original_text": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n "}, "hash": "c50fe1f7ab73ebc930d2d7d3445b8c27567a86a734d62b15f55919dbc888ceec", "class_name": "RelatedNodeInfo"}}, "text": "None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "start_char_idx": 2681, "end_char_idx": 2829, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b96bfe4f-35d5-44c1-a268-f8baaacd1bd2": {"__data__": {"id_": "b96bfe4f-35d5-44c1-a268-f8baaacd1bd2", "embedding": null, "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.  ", "original_text": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a9496e4-29de-4642-86d9-bbd688e36b30", "node_type": "1", "metadata": {"window": "That would be an area that is still looking to be defined yet.  \n \n  But essentially they\u2019re - one of the folks that\u2019s settling in the case is contributing free goods is the essential idea \nhere.   And the thought is that the thre e distributors would agree to distribute those free goods to the people that \nneed it.   None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "original_text": "None of the actual costs of distributing those free goods because we don\u2019t have enough information on \nthat are included in our overall accrual.  \n ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "dca091bf0829c5461352f52ce95f19f7aa4567a9cea7946a2d978cae618716ae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "41911e82-df2d-4be9-944e-c006b88f32dd", "node_type": "1", "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n", "original_text": "But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n"}, "hash": "1bad520e1b3375147df85206945dab330ae4a10c80a33542c5518a79f486ab67", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n ", "start_char_idx": 0, "end_char_idx": 136, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "41911e82-df2d-4be9-944e-c006b88f32dd": {"__data__": {"id_": "41911e82-df2d-4be9-944e-c006b88f32dd", "embedding": null, "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n", "original_text": "But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b96bfe4f-35d5-44c1-a268-f8baaacd1bd2", "node_type": "1", "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.  ", "original_text": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d7542530a18976d504bce9784ce00ccdce9003457376e5d16062baf7c362cb72", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5f9f014d-4d9e-4394-8247-be5e01b0819b", "node_type": "1", "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.  ", "original_text": "Dolph Warburton :  Great thank you.  "}, "hash": "be679df0cc1c682920a7f387460425accd0c32ca160384aaa2db58e6fd91971a", "class_name": "RelatedNodeInfo"}}, "text": "But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n", "start_char_idx": 136, "end_char_idx": 324, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5f9f014d-4d9e-4394-8247-be5e01b0819b": {"__data__": {"id_": "5f9f014d-4d9e-4394-8247-be5e01b0819b", "embedding": null, "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.  ", "original_text": "Dolph Warburton :  Great thank you.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "41911e82-df2d-4be9-944e-c006b88f32dd", "node_type": "1", "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n", "original_text": "But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cdb8f1579f4b9fe8d592aa708d4a96be9a33dfe222869d8b267833c4264109a3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "be9c4aff-3957-4cfd-859c-619e2db5c82d", "node_type": "1", "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n", "original_text": "And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.  "}, "hash": "3b9bef4e3d9c3ab0a7d9b915fe12b4d6a836902c3dcabcf73076b0e836042897", "class_name": "RelatedNodeInfo"}}, "text": "Dolph Warburton :  Great thank you.  ", "start_char_idx": 324, "end_char_idx": 361, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "be9c4aff-3957-4cfd-859c-619e2db5c82d": {"__data__": {"id_": "be9c4aff-3957-4cfd-859c-619e2db5c82d", "embedding": null, "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n", "original_text": "And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5f9f014d-4d9e-4394-8247-be5e01b0819b", "node_type": "1", "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.  ", "original_text": "Dolph Warburton :  Great thank you.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ff81f8084a6335928664e23f15508ec4b181d9c67696a732950721cf6e7b63a6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5f12fc62-1029-42a7-93be-15f7ccf71247", "node_type": "1", "metadata": {"window": "But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.  ", "original_text": "Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n"}, "hash": "77d9809a4f450f358a5a3c3e31bf25dc9d8c1e42ecd99897501b241c3ad2cd81", "class_name": "RelatedNodeInfo"}}, "text": "And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.  ", "start_char_idx": 361, "end_char_idx": 529, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5f12fc62-1029-42a7-93be-15f7ccf71247": {"__data__": {"id_": "5f12fc62-1029-42a7-93be-15f7ccf71247", "embedding": null, "metadata": {"window": "But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.  ", "original_text": "Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "be9c4aff-3957-4cfd-859c-619e2db5c82d", "node_type": "1", "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n", "original_text": "And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ef742e7f8f1f90b2921a271094af6fb9bc6869d3f90b60aa049b8cdc810de602", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c824db30-5958-4f3c-81eb-978b5a2e5c32", "node_type": "1", "metadata": {"window": "Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.  ", "original_text": "Mike Kaufmann :  No.  "}, "hash": "8eb85c547b793599b11029b1643d20065038fa3ee0e389da5e16453d88cf5c56", "class_name": "RelatedNodeInfo"}}, "text": "Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n", "start_char_idx": 529, "end_char_idx": 638, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c824db30-5958-4f3c-81eb-978b5a2e5c32": {"__data__": {"id_": "c824db30-5958-4f3c-81eb-978b5a2e5c32", "embedding": null, "metadata": {"window": "Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.  ", "original_text": "Mike Kaufmann :  No.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5f12fc62-1029-42a7-93be-15f7ccf71247", "node_type": "1", "metadata": {"window": "But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.  ", "original_text": "Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "03f83370a80512cc7c558a6d726018ec1aa3610dd0a165c9bb2056c3b0081cfe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e0ee4c4f-07ec-4c12-8a3f-dd88ca4cbe11", "node_type": "1", "metadata": {"window": "And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.  ", "original_text": "The breakdown.  \n \n"}, "hash": "e4766afd6ddbeded0b9e2bfcca03490e9edd71d2b799b9a115034733dd74e3dd", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  No.  ", "start_char_idx": 638, "end_char_idx": 660, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e0ee4c4f-07ec-4c12-8a3f-dd88ca4cbe11": {"__data__": {"id_": "e0ee4c4f-07ec-4c12-8a3f-dd88ca4cbe11", "embedding": null, "metadata": {"window": "And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.  ", "original_text": "The breakdown.  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c824db30-5958-4f3c-81eb-978b5a2e5c32", "node_type": "1", "metadata": {"window": "Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.  ", "original_text": "Mike Kaufmann :  No.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "19acf300d27f5d8288056d860689f47c0fdc7daba98d30ce9b86001cbe55341c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "25a2c693-7ab1-4d2c-9d9e-9d1722fe0569", "node_type": "1", "metadata": {"window": "Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n", "original_text": "Dave Evans :  Yes.  "}, "hash": "a54d2be9e4689b52a742d11abd9253d46a7e503e857ccae1e9f04bbd2399c486", "class_name": "RelatedNodeInfo"}}, "text": "The breakdown.  \n \n", "start_char_idx": 660, "end_char_idx": 679, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "25a2c693-7ab1-4d2c-9d9e-9d1722fe0569": {"__data__": {"id_": "25a2c693-7ab1-4d2c-9d9e-9d1722fe0569", "embedding": null, "metadata": {"window": "Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n", "original_text": "Dave Evans :  Yes.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e0ee4c4f-07ec-4c12-8a3f-dd88ca4cbe11", "node_type": "1", "metadata": {"window": "And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.   Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.  ", "original_text": "The breakdown.  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "abda3b3c89f5273e97a0cc7ea3be15fd7c23fb12a161f3f1f39d12346cd1fc00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6dd40e66-899d-4b91-9be3-53d9bf4664cf", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.  ", "original_text": "You got two components.  "}, "hash": "7ae48903dbae0f06baf3f52681ecc18543288a1a10262c33ca5ad64e0526cfc6", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes.  ", "start_char_idx": 679, "end_char_idx": 699, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6dd40e66-899d-4b91-9be3-53d9bf4664cf": {"__data__": {"id_": "6dd40e66-899d-4b91-9be3-53d9bf4664cf", "embedding": null, "metadata": {"window": "Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.  ", "original_text": "You got two components.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "25a2c693-7ab1-4d2c-9d9e-9d1722fe0569", "node_type": "1", "metadata": {"window": "Should I assume that\u2019s legal \nservices in the quarter or is there something else causing the difference?  \n \n Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n", "original_text": "Dave Evans :  Yes.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6ff2e0ba6634d1c5c499680400770c6a5da6ec3856907b6026ff9a9f233f9cb7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a2a3991-6bb0-4921-94b3-8505df2db096", "node_type": "1", "metadata": {"window": "The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n", "original_text": "The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.  "}, "hash": "28c24882f9ea82799daa92dba650eaf5de2ccfeaed0bffbf5571466a48a25481", "class_name": "RelatedNodeInfo"}}, "text": "You got two components.  ", "start_char_idx": 699, "end_char_idx": 724, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7a2a3991-6bb0-4921-94b3-8505df2db096": {"__data__": {"id_": "7a2a3991-6bb0-4921-94b3-8505df2db096", "embedding": null, "metadata": {"window": "The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n", "original_text": "The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6dd40e66-899d-4b91-9be3-53d9bf4664cf", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  No.   The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.  ", "original_text": "You got two components.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "179a8689d6bb2828f61c0beb813cf72fb6be7b1348e9ff6b6aa127515550d9db", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08b9ca72-46a6-4521-b57a-b1ad47e09fd5", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n", "original_text": "The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n"}, "hash": "654fd190db4f0312e7173b47324ff807f907bf061b30c724d8848c154e049e45", "class_name": "RelatedNodeInfo"}}, "text": "The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.  ", "start_char_idx": 724, "end_char_idx": 882, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "08b9ca72-46a6-4521-b57a-b1ad47e09fd5": {"__data__": {"id_": "08b9ca72-46a6-4521-b57a-b1ad47e09fd5", "embedding": null, "metadata": {"window": "Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n", "original_text": "The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a2a3991-6bb0-4921-94b3-8505df2db096", "node_type": "1", "metadata": {"window": "The breakdown.  \n \n Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n", "original_text": "The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "00147642a257df59ca034d938759723bed94834c62aa77758a77ae7e74b5e107", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a7f96fb8-b578-4039-aed6-262f4a199e86", "node_type": "1", "metadata": {"window": "You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n", "original_text": "Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.  "}, "hash": "d2bc4b916c3f5f658db58606346c20c76c320314f680a28980e1f459a5376f45", "class_name": "RelatedNodeInfo"}}, "text": "The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n", "start_char_idx": 882, "end_char_idx": 1012, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a7f96fb8-b578-4039-aed6-262f4a199e86": {"__data__": {"id_": "a7f96fb8-b578-4039-aed6-262f4a199e86", "embedding": null, "metadata": {"window": "You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n", "original_text": "Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08b9ca72-46a6-4521-b57a-b1ad47e09fd5", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n", "original_text": "The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "dca6d20b49115a28447bb6f3fac7dff1685ba7891e759664f09e55fa4d9337b2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6311f47f-951e-4fcc-b3bc-12c19ff976b8", "node_type": "1", "metadata": {"window": "The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.  ", "original_text": "It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n"}, "hash": "c7de7da4d23eacedddd14db1090ddfd00b5afe3efee83df805d82a4d2a54e5a6", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.  ", "start_char_idx": 1012, "end_char_idx": 1175, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6311f47f-951e-4fcc-b3bc-12c19ff976b8": {"__data__": {"id_": "6311f47f-951e-4fcc-b3bc-12c19ff976b8", "embedding": null, "metadata": {"window": "The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.  ", "original_text": "It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a7f96fb8-b578-4039-aed6-262f4a199e86", "node_type": "1", "metadata": {"window": "You got two components.   The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n", "original_text": "Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9462db64986806a0b7c7d3010814158d24e869ad590bbd584047a16ed993a7f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "22e0680d-c820-4156-bc7d-ae035b4bb95c", "node_type": "1", "metadata": {"window": "The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.  ", "original_text": "Mike Kaufmann :  Yes. \n \n"}, "hash": "b86fdb0911839c7198cee43cf1e8fb879734b70bbac4a4e9fa49eb105e9e8c99", "class_name": "RelatedNodeInfo"}}, "text": "It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n", "start_char_idx": 1175, "end_char_idx": 1311, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "22e0680d-c820-4156-bc7d-ae035b4bb95c": {"__data__": {"id_": "22e0680d-c820-4156-bc7d-ae035b4bb95c", "embedding": null, "metadata": {"window": "The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.  ", "original_text": "Mike Kaufmann :  Yes. \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6311f47f-951e-4fcc-b3bc-12c19ff976b8", "node_type": "1", "metadata": {"window": "The primary two components of course, you know, our prorate share of the \n$18 billion and then there\u2019s the prorate share of the two Ohio county settlements.   The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.  ", "original_text": "It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "02bf3a32a8c3640f3e0f18b6775997de2c09569b90ba5f7155a1b19b50fc0ae4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "913ae25b-52a3-4a26-adf9-ad54492c719b", "node_type": "1", "metadata": {"window": "Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n", "original_text": "Kevin Moran :  Next question please.  \n \n"}, "hash": "08d714e1ece5a49f799cf951eb04c29b1c635dbfae7e8b476130fcf7bf4c79bb", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes. \n \n", "start_char_idx": 987, "end_char_idx": 1012, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "913ae25b-52a3-4a26-adf9-ad54492c719b": {"__data__": {"id_": "913ae25b-52a3-4a26-adf9-ad54492c719b", "embedding": null, "metadata": {"window": "Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n", "original_text": "Kevin Moran :  Next question please.  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "22e0680d-c820-4156-bc7d-ae035b4bb95c", "node_type": "1", "metadata": {"window": "The remaining small difference \nrelates to something I believe we may have spoken in the past about\u2026  \n \nMike Kaufmann :  Yes. \n \n Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.  ", "original_text": "Mike Kaufmann :  Yes. \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7d842ca329be7a64cd49069fef4bc239208c221d3f86d0aab8daf80d3d5bb528", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1c54f018-909e-455f-be27-874fd1f12292", "node_type": "1", "metadata": {"window": "It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.  ", "original_text": "Operator :  Thank you.  "}, "hash": "6402b4d40adfb214a24f2e0ac1137656c88f029588d6658609cd257d32d5b2dc", "class_name": "RelatedNodeInfo"}}, "text": "Kevin Moran :  Next question please.  \n \n", "start_char_idx": 1336, "end_char_idx": 1377, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1c54f018-909e-455f-be27-874fd1f12292": {"__data__": {"id_": "1c54f018-909e-455f-be27-874fd1f12292", "embedding": null, "metadata": {"window": "It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.  ", "original_text": "Operator :  Thank you.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "913ae25b-52a3-4a26-adf9-ad54492c719b", "node_type": "1", "metadata": {"window": "Dave Evans :  \u2026which is in our med supply business, our Cordis business, the (IV C) product, which we continue to accrue \nfor a lost contingency on that as well.   It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n", "original_text": "Kevin Moran :  Next question please.  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "871e3948e3b172b78ed4ef7934d173b91698dd4d7d5cae8d1a18ed609c2a46a4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f5e16df8-b5e9-4b4e-b01c-9f90ae59090e", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.  ", "original_text": "Thank you, sir.  "}, "hash": "e695c585c33a3382b78ccb06f0220f8c0c8eea5fa81759eaca00fd7d6ab29220", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you.  ", "start_char_idx": 1377, "end_char_idx": 1401, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f5e16df8-b5e9-4b4e-b01c-9f90ae59090e": {"__data__": {"id_": "f5e16df8-b5e9-4b4e-b01c-9f90ae59090e", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.  ", "original_text": "Thank you, sir.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c54f018-909e-455f-be27-874fd1f12292", "node_type": "1", "metadata": {"window": "It\u2019s a fairly small number but that \u2013 if you\u2019re getting to the third decimal digit, \nthat\u2019s what you\u2019re going to find is the (IVC).  \n \n Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.  ", "original_text": "Operator :  Thank you.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a60440776ea7213ffd389a8be47a5bae4a5dd35d0a2d641c74194d035484f977", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b95e35e-9cbb-460d-86df-b28f6835dfe9", "node_type": "1", "metadata": {"window": "Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.  ", "original_text": "We will take our next question from Stephen Baxter from Wolfe Research.  \n \n"}, "hash": "783ac40a4f47ffda48693861c3f5d3ef507c999fc63c2ba3d1eb41e783cd5156", "class_name": "RelatedNodeInfo"}}, "text": "Thank you, sir.  ", "start_char_idx": 1401, "end_char_idx": 1418, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2b95e35e-9cbb-460d-86df-b28f6835dfe9": {"__data__": {"id_": "2b95e35e-9cbb-460d-86df-b28f6835dfe9", "embedding": null, "metadata": {"window": "Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.  ", "original_text": "We will take our next question from Stephen Baxter from Wolfe Research.  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f5e16df8-b5e9-4b4e-b01c-9f90ae59090e", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes. \n \n Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.  ", "original_text": "Thank you, sir.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a3b933761ef735a96bacf8d88075130890b38d4dde4ee0614bbc6c1c1c5a1039", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8089135d-1d44-4b82-9d30-96f51cf3e0a3", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n ", "original_text": "Stephen Baxter :  Okay, thanks for the question.  "}, "hash": "37589b3cbfdc6f18ac3e32976b159ee4a88e2fac76bc39a598b637a3fc927bac", "class_name": "RelatedNodeInfo"}}, "text": "We will take our next question from Stephen Baxter from Wolfe Research.  \n \n", "start_char_idx": 1418, "end_char_idx": 1494, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8089135d-1d44-4b82-9d30-96f51cf3e0a3": {"__data__": {"id_": "8089135d-1d44-4b82-9d30-96f51cf3e0a3", "embedding": null, "metadata": {"window": "Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n ", "original_text": "Stephen Baxter :  Okay, thanks for the question.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2b95e35e-9cbb-460d-86df-b28f6835dfe9", "node_type": "1", "metadata": {"window": "Kevin Moran :  Next question please.  \n \n Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.  ", "original_text": "We will take our next question from Stephen Baxter from Wolfe Research.  \n \n", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ca16af6ca7f6ae9b0f6606f28425ccca1e89602725d814611e2b56a75a39b598", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c96955ca-5c0d-423b-952b-944e7d53c7c7", "node_type": "1", "metadata": {"window": "Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n ", "original_text": "I wanted to follow -up on the opioid discussion.  "}, "hash": "96e818809c5ea00ffe4e8eb3628caf127fb5dbba0a4f80820086160b320a67ca", "class_name": "RelatedNodeInfo"}}, "text": "Stephen Baxter :  Okay, thanks for the question.  ", "start_char_idx": 1494, "end_char_idx": 1544, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c96955ca-5c0d-423b-952b-944e7d53c7c7": {"__data__": {"id_": "c96955ca-5c0d-423b-952b-944e7d53c7c7", "embedding": null, "metadata": {"window": "Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n ", "original_text": "I wanted to follow -up on the opioid discussion.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8089135d-1d44-4b82-9d30-96f51cf3e0a3", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n ", "original_text": "Stephen Baxter :  Okay, thanks for the question.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "29734827c8bc151f18d657b1b7e8a73658cea2e0052d7da5bac6e54ff775fe1a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6bda9280-95cb-4c6e-a8b5-ffdfbb1aa65e", "node_type": "1", "metadata": {"window": "We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n ", "original_text": "Really appre ciate all the \ncolor and insight you provided thus far.  "}, "hash": "7b9aa45cf0d6a463b65b2c5dc5d4098df7cf84b1ec970c8749054e41cdae4b3c", "class_name": "RelatedNodeInfo"}}, "text": "I wanted to follow -up on the opioid discussion.  ", "start_char_idx": 1544, "end_char_idx": 1594, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6bda9280-95cb-4c6e-a8b5-ffdfbb1aa65e": {"__data__": {"id_": "6bda9280-95cb-4c6e-a8b5-ffdfbb1aa65e", "embedding": null, "metadata": {"window": "We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n ", "original_text": "Really appre ciate all the \ncolor and insight you provided thus far.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c96955ca-5c0d-423b-952b-944e7d53c7c7", "node_type": "1", "metadata": {"window": "Thank you, sir.   We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n ", "original_text": "I wanted to follow -up on the opioid discussion.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5e782c21f8b00c50307432f5b9f46ea35db42a549038ad4a8ce252b55c6a4be9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cc2a4062-f1ee-43ef-98aa-013f43808b01", "node_type": "1", "metadata": {"window": "Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.  ", "original_text": "I wanted to come back to the outlook for share purchase.  \n \n "}, "hash": "8e8dfa464b49941b0fe64e68cfe12da32a4881d9cbe2ea5de1e8aba3592842a7", "class_name": "RelatedNodeInfo"}}, "text": "Really appre ciate all the \ncolor and insight you provided thus far.  ", "start_char_idx": 1594, "end_char_idx": 1664, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cc2a4062-f1ee-43ef-98aa-013f43808b01": {"__data__": {"id_": "cc2a4062-f1ee-43ef-98aa-013f43808b01", "embedding": null, "metadata": {"window": "Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.  ", "original_text": "I wanted to come back to the outlook for share purchase.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6bda9280-95cb-4c6e-a8b5-ffdfbb1aa65e", "node_type": "1", "metadata": {"window": "We will take our next question from Stephen Baxter from Wolfe Research.  \n \n Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n ", "original_text": "Really appre ciate all the \ncolor and insight you provided thus far.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "728e08593ec396ce1b6bf4b0e266f9e2d2eb68ec20cc0ffa1ceb845c88d9608e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "37b1646a-c13e-4d47-85f1-d3501d0b20b1", "node_type": "1", "metadata": {"window": "I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n "}, "hash": "0a78c8b51931438fa6c2d5b7dd57901190dc02cde632635c2c5cdcfb1071ed1c", "class_name": "RelatedNodeInfo"}}, "text": "I wanted to come back to the outlook for share purchase.  \n \n ", "start_char_idx": 1664, "end_char_idx": 1726, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "37b1646a-c13e-4d47-85f1-d3501d0b20b1": {"__data__": {"id_": "37b1646a-c13e-4d47-85f1-d3501d0b20b1", "embedding": null, "metadata": {"window": "I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cc2a4062-f1ee-43ef-98aa-013f43808b01", "node_type": "1", "metadata": {"window": "Stephen Baxter :  Okay, thanks for the question.   I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.  ", "original_text": "I wanted to come back to the outlook for share purchase.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "118553d4dc0bdbad432795ee71c8a0c2b47a42baa21e2802da84887f0269c552", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3870efa9-6d78-4d63-a3e5-9c55a1a11749", "node_type": "1", "metadata": {"window": "Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n "}, "hash": "f73173131e474aeb51ae942e8ab6562b7e0c2892e4f810c037f82e13f3ccd9f7", "class_name": "RelatedNodeInfo"}}, "text": "So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n ", "start_char_idx": 1726, "end_char_idx": 1863, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3870efa9-6d78-4d63-a3e5-9c55a1a11749": {"__data__": {"id_": "3870efa9-6d78-4d63-a3e5-9c55a1a11749", "embedding": null, "metadata": {"window": "Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "37b1646a-c13e-4d47-85f1-d3501d0b20b1", "node_type": "1", "metadata": {"window": "I wanted to follow -up on the opioid discussion.   Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "54be651924ad36b2d3c0c0f4ec8da9c7fbc8645a630036b82b019e3d31712ff6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "edbd3b93-3fe4-49d4-890b-abb75bbe1044", "node_type": "1", "metadata": {"window": "I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.  "}, "hash": "a946ad24bf2599ab0ea3145f267565bae80dc268881e823d754fad5e0af53e9f", "class_name": "RelatedNodeInfo"}}, "text": "So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n ", "start_char_idx": 1863, "end_char_idx": 2003, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "edbd3b93-3fe4-49d4-890b-abb75bbe1044": {"__data__": {"id_": "edbd3b93-3fe4-49d4-890b-abb75bbe1044", "embedding": null, "metadata": {"window": "I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3870efa9-6d78-4d63-a3e5-9c55a1a11749", "node_type": "1", "metadata": {"window": "Really appre ciate all the \ncolor and insight you provided thus far.   I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84a1356c5a9092cd0504fe91136500fd5425cfc817931741a09464af0ef780a3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "10cfea86-aa07-40ea-abb5-638e6af14800", "node_type": "1", "metadata": {"window": "So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "Thanks.  \n "}, "hash": "a74c800217490bccd170b88e238de7ee1141c12b3dcd101a954b773f1ae54e8f", "class_name": "RelatedNodeInfo"}}, "text": "So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.  ", "start_char_idx": 2003, "end_char_idx": 2248, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "10cfea86-aa07-40ea-abb5-638e6af14800": {"__data__": {"id_": "10cfea86-aa07-40ea-abb5-638e6af14800", "embedding": null, "metadata": {"window": "So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "Thanks.  \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354", "node_type": "4", "metadata": {"page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a985c53631fb58531edb4df68b2ff5e07878b2e3d81ceda346b1bd297801e22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "edbd3b93-3fe4-49d4-890b-abb75bbe1044", "node_type": "1", "metadata": {"window": "I wanted to come back to the outlook for share purchase.  \n \n  So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.  ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0ca5c11550e427882eedb296379b020886a386f6fcc738803ca8e849d2cb6233", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "295830c3-153a-4ff7-a6be-5f2eb8e38857", "node_type": "1", "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n ", "original_text": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.  "}, "hash": "64eb953ec714e08c1c4639d1d8b0c78ee2e587bd8fea91faab871fbcd51a18b4", "class_name": "RelatedNodeInfo"}}, "text": "Thanks.  \n ", "start_char_idx": 2248, "end_char_idx": 2259, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "295830c3-153a-4ff7-a6be-5f2eb8e38857": {"__data__": {"id_": "295830c3-153a-4ff7-a6be-5f2eb8e38857", "embedding": null, "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n ", "original_text": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "10cfea86-aa07-40ea-abb5-638e6af14800", "node_type": "1", "metadata": {"window": "So if we were to treat the settlement like debt this settlement would point to trailing leverage approaching, you \nknow, 4.5 times.  \n \n  So it so unds like you\u2019re saying that the settlement framework as currently proposed would not be a limitation on \ncapital deployment.  \n \n  So I\u2019m hoping you can help us square your comfort level with this implied leverage, how you think that debt rating \nagencies are g oing to look at this issue and the importance of, you know, maintaining investment grade rating to \nthe company.   Thanks.  \n ", "original_text": "Thanks.  \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1666dc83ce5b0b897cdf834d233d5f971c672af4d3bdeaff99f3eb64790140a7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "19cb1164-e9fc-4432-8a35-89afb7d1dd49", "node_type": "1", "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n", "original_text": "First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.  "}, "hash": "b7bcaad79c6d7f6f1f928e161365d676ee72d62590831407f0a34028d44a2395", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.  ", "start_char_idx": 0, "end_char_idx": 42, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "19cb1164-e9fc-4432-8a35-89afb7d1dd49": {"__data__": {"id_": "19cb1164-e9fc-4432-8a35-89afb7d1dd49", "embedding": null, "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n", "original_text": "First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "295830c3-153a-4ff7-a6be-5f2eb8e38857", "node_type": "1", "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n ", "original_text": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2095b8df48d7a68492f8dfd9244f7bebe267e8228b9732a7ec7abd922e5864f0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fd753d8c-7ede-4882-9796-bae2c6f2fea7", "node_type": "1", "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.  ", "original_text": "We said \nwe don\u2019t see it necessarily as a limitation.  \n \n "}, "hash": "b7ac0822f61e7c3e394c537dbfd926f3aafb063ad31b3d2083a907cdf28e02ce", "class_name": "RelatedNodeInfo"}}, "text": "First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.  ", "start_char_idx": 42, "end_char_idx": 135, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fd753d8c-7ede-4882-9796-bae2c6f2fea7": {"__data__": {"id_": "fd753d8c-7ede-4882-9796-bae2c6f2fea7", "embedding": null, "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.  ", "original_text": "We said \nwe don\u2019t see it necessarily as a limitation.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "19cb1164-e9fc-4432-8a35-89afb7d1dd49", "node_type": "1", "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n", "original_text": "First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "077fcbfb1a1ddc0ff94030c206aa2e00d1a251e277f1e9a83792196c974daf77", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "22508794-275a-4332-a5a0-100f994d38d1", "node_type": "1", "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n ", "original_text": "But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n "}, "hash": "8d670d822634c6bd63e445e12412281fce69ff5657cc03921e0cee8c357eccb2", "class_name": "RelatedNodeInfo"}}, "text": "We said \nwe don\u2019t see it necessarily as a limitation.  \n \n ", "start_char_idx": 135, "end_char_idx": 194, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "22508794-275a-4332-a5a0-100f994d38d1": {"__data__": {"id_": "22508794-275a-4332-a5a0-100f994d38d1", "embedding": null, "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n ", "original_text": "But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fd753d8c-7ede-4882-9796-bae2c6f2fea7", "node_type": "1", "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.  ", "original_text": "We said \nwe don\u2019t see it necessarily as a limitation.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "00cfb9fb73a96c0d2cf387f382eb1eb1c9f91da69f310b73cde7ee2c5ba1ee81", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20c6504f-3fc5-43aa-ba8a-1e5502831bcb", "node_type": "1", "metadata": {"window": "First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.  ", "original_text": "But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n"}, "hash": "912fe4c4c33554fd1b357419cf645aa1fac7239d65c07284e3b7e05c824bcf9c", "class_name": "RelatedNodeInfo"}}, "text": "But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n ", "start_char_idx": 194, "end_char_idx": 370, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "20c6504f-3fc5-43aa-ba8a-1e5502831bcb": {"__data__": {"id_": "20c6504f-3fc5-43aa-ba8a-1e5502831bcb", "embedding": null, "metadata": {"window": "First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.  ", "original_text": "But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "22508794-275a-4332-a5a0-100f994d38d1", "node_type": "1", "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n ", "original_text": "But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4ac48eb30a11619f645b14e193e038de96780f0c8f8902632bd36c158b12048f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "43cbd5a3-3b85-4dc9-a76e-e8de507d6655", "node_type": "1", "metadata": {"window": "We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n ", "original_text": "Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.  "}, "hash": "62250be289b285e1c8c3a2fef2120167e6de2fb9b6bbef2b72695eef81684c5d", "class_name": "RelatedNodeInfo"}}, "text": "But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n", "start_char_idx": 370, "end_char_idx": 507, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "43cbd5a3-3b85-4dc9-a76e-e8de507d6655": {"__data__": {"id_": "43cbd5a3-3b85-4dc9-a76e-e8de507d6655", "embedding": null, "metadata": {"window": "We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n ", "original_text": "Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20c6504f-3fc5-43aa-ba8a-1e5502831bcb", "node_type": "1", "metadata": {"window": "First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.  ", "original_text": "But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "09190fa65a17396293950288289ee8c0269a08866d3fcc853c91021c9988f1ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d7a5332-e1dc-419d-8df6-9bd829a7581d", "node_type": "1", "metadata": {"window": "But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.  ", "original_text": "So there\u2019s continuous dialogue . \n \n "}, "hash": "1cc83d08cc23b9d5cc8d2a312c2f2f47fbefa238d290839e8e41c3d4332b28e9", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.  ", "start_char_idx": 507, "end_char_idx": 642, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7d7a5332-e1dc-419d-8df6-9bd829a7581d": {"__data__": {"id_": "7d7a5332-e1dc-419d-8df6-9bd829a7581d", "embedding": null, "metadata": {"window": "But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.  ", "original_text": "So there\u2019s continuous dialogue . \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "43cbd5a3-3b85-4dc9-a76e-e8de507d6655", "node_type": "1", "metadata": {"window": "We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n ", "original_text": "Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40c948d1dc4a7f2b3cd35fd429f93023bca7d26fc1521b150da84fda1c3bd1e8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b95dd5c7-3de6-4629-b734-4e5da2c1688f", "node_type": "1", "metadata": {"window": "But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.  ", "original_text": "Second, our investment grade credit rating is very important to us.  "}, "hash": "6cb618c611bfa7380c4641d56388254d283e865cebf7e0eae413f751018521b3", "class_name": "RelatedNodeInfo"}}, "text": "So there\u2019s continuous dialogue . \n \n ", "start_char_idx": 642, "end_char_idx": 679, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b95dd5c7-3de6-4629-b734-4e5da2c1688f": {"__data__": {"id_": "b95dd5c7-3de6-4629-b734-4e5da2c1688f", "embedding": null, "metadata": {"window": "But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.  ", "original_text": "Second, our investment grade credit rating is very important to us.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7d7a5332-e1dc-419d-8df6-9bd829a7581d", "node_type": "1", "metadata": {"window": "But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n  But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.  ", "original_text": "So there\u2019s continuous dialogue . \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c96d99a631a37b26f2f78a47dbadcbd787fff773fc7cc174fed0bddae634b7a9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d148ed3f-ff48-466f-8267-5131d6741bc3", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n ", "original_text": "So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n "}, "hash": "3a98019b683d9d315fcf120783a0d5fc97b90f03c3eb706e6ee988bb70ec1820", "class_name": "RelatedNodeInfo"}}, "text": "Second, our investment grade credit rating is very important to us.  ", "start_char_idx": 679, "end_char_idx": 748, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d148ed3f-ff48-466f-8267-5131d6741bc3": {"__data__": {"id_": "d148ed3f-ff48-466f-8267-5131d6741bc3", "embedding": null, "metadata": {"window": "Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n ", "original_text": "So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b95dd5c7-3de6-4629-b734-4e5da2c1688f", "node_type": "1", "metadata": {"window": "But let me turn it over to Dave to give you a little color on our thoughts around the rating agencies and what we \ncould talk about.  \n \n Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.  ", "original_text": "Second, our investment grade credit rating is very important to us.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3d1256565fd40239c0068cdbc9536255848c9d3234408e7353bcc3d68865f304", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d289994f-836f-420d-af08-feb6eec8ff70", "node_type": "1", "metadata": {"window": "So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n ", "original_text": "What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.  "}, "hash": "f9d641cbd1d16d13505e3f6845a3df778f7ea13d558256255e332f7f28a26f51", "class_name": "RelatedNodeInfo"}}, "text": "So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n ", "start_char_idx": 748, "end_char_idx": 847, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d289994f-836f-420d-af08-feb6eec8ff70": {"__data__": {"id_": "d289994f-836f-420d-af08-feb6eec8ff70", "embedding": null, "metadata": {"window": "So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n ", "original_text": "What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d148ed3f-ff48-466f-8267-5131d6741bc3", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes, look, first of all, we\u2019ve got good relationships with the rating agencies and we stay in close contact with \nthem.   So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n ", "original_text": "So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "888237c4ae05b18e198011bba08859104d6c0b556505af6ad317142a3dd1019a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bcbc4a65-4364-4dac-8597-84a4a2bdff13", "node_type": "1", "metadata": {"window": "Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.  ", "original_text": "One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.  "}, "hash": "9e852485a170016df5a3a65b8c0b70719a2efed839d3e8e3fc06b1b46a2ba469", "class_name": "RelatedNodeInfo"}}, "text": "What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.  ", "start_char_idx": 847, "end_char_idx": 945, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bcbc4a65-4364-4dac-8597-84a4a2bdff13": {"__data__": {"id_": "bcbc4a65-4364-4dac-8597-84a4a2bdff13", "embedding": null, "metadata": {"window": "Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.  ", "original_text": "One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d289994f-836f-420d-af08-feb6eec8ff70", "node_type": "1", "metadata": {"window": "So there\u2019s continuous dialogue . \n \n  Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n ", "original_text": "What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9b5e5aa56b7c8e88b525ef052dbf23d52a0be780f7e3f2da8b4e872a0b0f18a5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "03744e1d-e7e1-45ab-b073-0385182ec76c", "node_type": "1", "metadata": {"window": "So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n ", "original_text": "So as we look forward on this that number \nwill be coming down.  \n \n "}, "hash": "bffaa93a1cc5a1011e6ae9c7a6730cbd1d60f5aa625f328fb9ec989cd3fcb74b", "class_name": "RelatedNodeInfo"}}, "text": "One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.  ", "start_char_idx": 945, "end_char_idx": 1036, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "03744e1d-e7e1-45ab-b073-0385182ec76c": {"__data__": {"id_": "03744e1d-e7e1-45ab-b073-0385182ec76c", "embedding": null, "metadata": {"window": "So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n ", "original_text": "So as we look forward on this that number \nwill be coming down.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bcbc4a65-4364-4dac-8597-84a4a2bdff13", "node_type": "1", "metadata": {"window": "Second, our investment grade credit rating is very important to us.   So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.  ", "original_text": "One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3f74917574f626f6be379688ce0bb34b1284cf41dc5aa4a1f1ecd51e93da89c0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08d16d59-6a2a-4089-906c-1cb8ab277005", "node_type": "1", "metadata": {"window": "What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.  ", "original_text": "And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n "}, "hash": "a0275f3d7b476f55ebb88aa23efe2cee6684f8dc28366afc3f2f5de537c3e1c5", "class_name": "RelatedNodeInfo"}}, "text": "So as we look forward on this that number \nwill be coming down.  \n \n ", "start_char_idx": 1036, "end_char_idx": 1105, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "08d16d59-6a2a-4089-906c-1cb8ab277005": {"__data__": {"id_": "08d16d59-6a2a-4089-906c-1cb8ab277005", "embedding": null, "metadata": {"window": "What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.  ", "original_text": "And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "03744e1d-e7e1-45ab-b073-0385182ec76c", "node_type": "1", "metadata": {"window": "So that\u2019s something that we value and we\u2019ll \ncontinue to monitor and manage to maintain that.  \n \n  What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n ", "original_text": "So as we look forward on this that number \nwill be coming down.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e86bb21f4c7dc91c39a6c7cfbe211c7d1a1c5d561b06589ddf9ab03e544d840b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0744b941-95fb-43ae-8a48-0660521bbdf3", "node_type": "1", "metadata": {"window": "One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.  ", "original_text": "But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.  "}, "hash": "f196bace1d8a794d2dea47e5ed0ef776a06705e031be9e9585914926cc8b84b4", "class_name": "RelatedNodeInfo"}}, "text": "And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n ", "start_char_idx": 1105, "end_char_idx": 1253, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0744b941-95fb-43ae-8a48-0660521bbdf3": {"__data__": {"id_": "0744b941-95fb-43ae-8a48-0660521bbdf3", "embedding": null, "metadata": {"window": "One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.  ", "original_text": "But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08d16d59-6a2a-4089-906c-1cb8ab277005", "node_type": "1", "metadata": {"window": "What I\u2019d say, when you look at the leverage, the numbers that you were citing, a couple factors.   One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.  ", "original_text": "And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "05ec3b088dff8f1a2339312d1e76d74eff7b73f3aeee5e349ef6aef65d4105c7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "06fc5140-4cab-4070-968d-f47afe1fd517", "node_type": "1", "metadata": {"window": "So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n", "original_text": "For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n "}, "hash": "7a3117bb5a2e84521085eb59c746d43a8f94a0c8c1ade30d137f78c5aaef06c4", "class_name": "RelatedNodeInfo"}}, "text": "But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.  ", "start_char_idx": 1253, "end_char_idx": 1379, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "06fc5140-4cab-4070-968d-f47afe1fd517": {"__data__": {"id_": "06fc5140-4cab-4070-968d-f47afe1fd517", "embedding": null, "metadata": {"window": "So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n", "original_text": "For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0744b941-95fb-43ae-8a48-0660521bbdf3", "node_type": "1", "metadata": {"window": "One, recall this \nyear we\u2019ve committed externally to de -levering by at least $1 billion.   So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.  ", "original_text": "But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "afde9ddaa3f419689a900a14e9dce00f858759c198076c10d1037b95cf423c00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "95c8f207-9cee-41c4-8e32-eae6624e6376", "node_type": "1", "metadata": {"window": "And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.  ", "original_text": "So we\u2019ll see how the credit rating agencies opine on this, where they land.  "}, "hash": "4aff2ce433be1de72344b962fa90ce31401f811d8e2615abe571d222d0588eb0", "class_name": "RelatedNodeInfo"}}, "text": "For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n ", "start_char_idx": 1379, "end_char_idx": 1587, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "95c8f207-9cee-41c4-8e32-eae6624e6376": {"__data__": {"id_": "95c8f207-9cee-41c4-8e32-eae6624e6376", "embedding": null, "metadata": {"window": "And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.  ", "original_text": "So we\u2019ll see how the credit rating agencies opine on this, where they land.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "06fc5140-4cab-4070-968d-f47afe1fd517", "node_type": "1", "metadata": {"window": "So as we look forward on this that number \nwill be coming down.  \n \n  And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n", "original_text": "For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "48ce2b139c119a808771a8bc40eedc137fab4d2a0e82672f52d1b395bccb6f04", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "32ed7e7d-2982-4e62-9a97-86b284c30c7c", "node_type": "1", "metadata": {"window": "But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.  ", "original_text": "But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.  "}, "hash": "88c0c00ccac1efee2ff81f497723f196be3b410479049b1d7b33514c42aa7eb4", "class_name": "RelatedNodeInfo"}}, "text": "So we\u2019ll see how the credit rating agencies opine on this, where they land.  ", "start_char_idx": 1587, "end_char_idx": 1664, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "32ed7e7d-2982-4e62-9a97-86b284c30c7c": {"__data__": {"id_": "32ed7e7d-2982-4e62-9a97-86b284c30c7c", "embedding": null, "metadata": {"window": "But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.  ", "original_text": "But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "95c8f207-9cee-41c4-8e32-eae6624e6376", "node_type": "1", "metadata": {"window": "And second of all, I\u2019m not sure, you know, I\u2019m not going to speculate on the credit rating a gencies or opine on \nwhere they\u2019re going to land.  \n \n  But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.  ", "original_text": "So we\u2019ll see how the credit rating agencies opine on this, where they land.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "83ed675eaa18537d5f1230a07677f979e0135f9330563b087e658905203af6f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d023bd02-947d-4982-832c-363ea87705c3", "node_type": "1", "metadata": {"window": "For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?  ", "original_text": "We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n"}, "hash": "70de6d4184f1f1715bf4f8fbef5c5bd5f29a7007eea83d2f03e41f391a4feb83", "class_name": "RelatedNodeInfo"}}, "text": "But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.  ", "start_char_idx": 1664, "end_char_idx": 1741, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d023bd02-947d-4982-832c-363ea87705c3": {"__data__": {"id_": "d023bd02-947d-4982-832c-363ea87705c3", "embedding": null, "metadata": {"window": "For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?  ", "original_text": "We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "32ed7e7d-2982-4e62-9a97-86b284c30c7c", "node_type": "1", "metadata": {"window": "But I think there\u2019s multiple scenarios between saying this is zero liability or it\u2019s the book accounting accrual \nliability.   For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.  ", "original_text": "But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "aa30aedd79b8df4b21ba2347df178fdcd7603211a13201488a8cb0c97d04fc7b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "646a7789-e121-49cc-be94-77bb2c6e60c6", "node_type": "1", "metadata": {"window": "So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n", "original_text": "Stephen Baxter :  Great.  "}, "hash": "476aaf8aaf35743b2d3ed01ac7583e8521fd1ac2ef647a3df3bb99143c08071b", "class_name": "RelatedNodeInfo"}}, "text": "We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n", "start_char_idx": 1741, "end_char_idx": 1913, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "646a7789-e121-49cc-be94-77bb2c6e60c6": {"__data__": {"id_": "646a7789-e121-49cc-be94-77bb2c6e60c6", "embedding": null, "metadata": {"window": "So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n", "original_text": "Stephen Baxter :  Great.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d023bd02-947d-4982-832c-363ea87705c3", "node_type": "1", "metadata": {"window": "For example, you could look at it\u2019s just the discounting future cash flow of all  the future years payments \nwhich gets you a number that\u2019s, you know, quite a bit smaller than the headline $5.6 billion.  \n \n  So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?  ", "original_text": "We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4e6109f7ed5b06e7ac2da1642d985af722904ef1656adaad32005b9d9140a333", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "097057cd-ff5c-42f7-9c53-a42be87e92a3", "node_type": "1", "metadata": {"window": "But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.  ", "original_text": "Thanks.  "}, "hash": "054d5e7360d7b90d6deba6484a8269a70d59063b0ae8c36f9484f191e13f5e1a", "class_name": "RelatedNodeInfo"}}, "text": "Stephen Baxter :  Great.  ", "start_char_idx": 1913, "end_char_idx": 1939, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "097057cd-ff5c-42f7-9c53-a42be87e92a3": {"__data__": {"id_": "097057cd-ff5c-42f7-9c53-a42be87e92a3", "embedding": null, "metadata": {"window": "But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.  ", "original_text": "Thanks.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "646a7789-e121-49cc-be94-77bb2c6e60c6", "node_type": "1", "metadata": {"window": "So we\u2019ll see how the credit rating agencies opine on this, where they land.   But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n", "original_text": "Stephen Baxter :  Great.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "defba77dc6315a5f352196a002e085e3544b7c374322355d3e8c37e6f3bdb294", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40e1c169-7d51-46d9-9f5f-ccc5913d0797", "node_type": "1", "metadata": {"window": "We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.  ", "original_text": "One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?  "}, "hash": "e0f5198d1768384771fa9c3df250c1ba35c262b07a247ec56922bce291bbc41d", "class_name": "RelatedNodeInfo"}}, "text": "Thanks.  ", "start_char_idx": 1939, "end_char_idx": 1948, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "40e1c169-7d51-46d9-9f5f-ccc5913d0797": {"__data__": {"id_": "40e1c169-7d51-46d9-9f5f-ccc5913d0797", "embedding": null, "metadata": {"window": "We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.  ", "original_text": "One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "097057cd-ff5c-42f7-9c53-a42be87e92a3", "node_type": "1", "metadata": {"window": "But at this point, you know, I\u2019d say, \nyou know, we\u2019ll be  focused on this.   We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.  ", "original_text": "Thanks.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0c8d8a280240f76f18f66f4b509a311d47a0a3739afc67aae8d6ab6d2c365dd8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "be5e8613-0d16-4b02-b719-d8622548e631", "node_type": "1", "metadata": {"window": "Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n ", "original_text": "Thanks.  \n \n"}, "hash": "387741a75ee0d31911236bd0f62ad2364f3e5b07729fd55af6322f279ffbde4c", "class_name": "RelatedNodeInfo"}}, "text": "One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?  ", "start_char_idx": 1948, "end_char_idx": 2184, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "be5e8613-0d16-4b02-b719-d8622548e631": {"__data__": {"id_": "be5e8613-0d16-4b02-b719-d8622548e631", "embedding": null, "metadata": {"window": "Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n ", "original_text": "Thanks.  \n \n", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40e1c169-7d51-46d9-9f5f-ccc5913d0797", "node_type": "1", "metadata": {"window": "We will make the substantial bite of the apple this year and we\u2019ll continue to \nmonitor this in the broader scheme of our capital allocation policy in the years ahead.  \n \n Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.  ", "original_text": "One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3f3c342c7064fed7f69891ae49bb9a963662aefbdb55671097d03bbbcb8d21f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d55b7ea5-cdb3-4329-90b7-56c499ad9c4d", "node_type": "1", "metadata": {"window": "Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.  ", "original_text": "Dave Evans :  Yes.  "}, "hash": "85d9b497264f6990a8be0c51807faf15aaa1b12854ecfbb28c68342bd1d9e935", "class_name": "RelatedNodeInfo"}}, "text": "Thanks.  \n \n", "start_char_idx": 2184, "end_char_idx": 2196, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d55b7ea5-cdb3-4329-90b7-56c499ad9c4d": {"__data__": {"id_": "d55b7ea5-cdb3-4329-90b7-56c499ad9c4d", "embedding": null, "metadata": {"window": "Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.  ", "original_text": "Dave Evans :  Yes.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "be5e8613-0d16-4b02-b719-d8622548e631", "node_type": "1", "metadata": {"window": "Stephen Baxter :  Great.   Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n ", "original_text": "Thanks.  \n \n", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9719e9749d11f2c0794d1cca0e516a2afa53c5acb950ac2917dc8dc380c60e5e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f2b6cd62-41db-400e-b55b-40dafd6627e5", "node_type": "1", "metadata": {"window": "One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.  ", "original_text": "So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.  "}, "hash": "b603e95081c4b9e857342768264faca498043fb51de08e0befc6e3fe6639c44c", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes.  ", "start_char_idx": 2196, "end_char_idx": 2216, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f2b6cd62-41db-400e-b55b-40dafd6627e5": {"__data__": {"id_": "f2b6cd62-41db-400e-b55b-40dafd6627e5", "embedding": null, "metadata": {"window": "One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.  ", "original_text": "So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d55b7ea5-cdb3-4329-90b7-56c499ad9c4d", "node_type": "1", "metadata": {"window": "Thanks.   One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.  ", "original_text": "Dave Evans :  Yes.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "da128adf107a9b1b62273105b2eb592c7fdd1c462300b864b4f038919d3294bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8f23b26a-821d-4c8b-9b36-444c99eda683", "node_type": "1", "metadata": {"window": "Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n", "original_text": "So \nI\u2019m not going to speak to that.  \n \n "}, "hash": "9eef9e82f1e1b3bc159ba191cbd44b3737009be3d2af7627dad38cee19ab15d7", "class_name": "RelatedNodeInfo"}}, "text": "So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.  ", "start_char_idx": 2216, "end_char_idx": 2315, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8f23b26a-821d-4c8b-9b36-444c99eda683": {"__data__": {"id_": "8f23b26a-821d-4c8b-9b36-444c99eda683", "embedding": null, "metadata": {"window": "Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n", "original_text": "So \nI\u2019m not going to speak to that.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f2b6cd62-41db-400e-b55b-40dafd6627e5", "node_type": "1", "metadata": {"window": "One quick follow -up, just given how  you started out the year on cash flow can you \nremind us what you\u2019re expecting for the full year for operating cash flow or at least some directional context \nrelative to the past couple of years?   Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.  ", "original_text": "So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3839c4d8e6c092ba867e7460bf133128feea1de7a4dcc09344bd34ebc2750c56", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6abe3f27-2007-4214-a94f-09392a00419e", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.  "}, "hash": "7bf6a3276e16e650f3726132195b4fd2fc0ae540bbeb24a05b510a205621e9c1", "class_name": "RelatedNodeInfo"}}, "text": "So \nI\u2019m not going to speak to that.  \n \n ", "start_char_idx": 2315, "end_char_idx": 2356, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6abe3f27-2007-4214-a94f-09392a00419e": {"__data__": {"id_": "6abe3f27-2007-4214-a94f-09392a00419e", "embedding": null, "metadata": {"window": "Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8f23b26a-821d-4c8b-9b36-444c99eda683", "node_type": "1", "metadata": {"window": "Thanks.  \n \n Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n", "original_text": "So \nI\u2019m not going to speak to that.  \n \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "85b178e3246d3b8becbd6356b042e471a986c3ccb86d4f7aaed3ae0e8ae3d87c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aa6cae09-622a-4c68-882f-4a2986e6e76b", "node_type": "1", "metadata": {"window": "So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "We continue to work on o ur working capital efficiency initiatives.  "}, "hash": "4a7276e95c18e3481466f74220b1a05c9a229a0ba0b12fbba6cead06cf54d826", "class_name": "RelatedNodeInfo"}}, "text": "It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.  ", "start_char_idx": 2356, "end_char_idx": 2485, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "aa6cae09-622a-4c68-882f-4a2986e6e76b": {"__data__": {"id_": "aa6cae09-622a-4c68-882f-4a2986e6e76b", "embedding": null, "metadata": {"window": "So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "We continue to work on o ur working capital efficiency initiatives.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6abe3f27-2007-4214-a94f-09392a00419e", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2d72d57bae2cd15e4e7ec957fe0339266121e75eb636a15ec8766bc3a7c5a0e3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "11eafe58-27fd-4faf-b909-ade3bc0a8755", "node_type": "1", "metadata": {"window": "So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "We continue to drive strong cash flow.  \n"}, "hash": "87dca34f52384bd977677fd1b6e4015a1bbe6f6c8b6ae5c1c19d37b0c36ac7de", "class_name": "RelatedNodeInfo"}}, "text": "We continue to work on o ur working capital efficiency initiatives.  ", "start_char_idx": 2485, "end_char_idx": 2554, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "11eafe58-27fd-4faf-b909-ade3bc0a8755": {"__data__": {"id_": "11eafe58-27fd-4faf-b909-ade3bc0a8755", "embedding": null, "metadata": {"window": "So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "We continue to drive strong cash flow.  \n", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa6cae09-622a-4c68-882f-4a2986e6e76b", "node_type": "1", "metadata": {"window": "So look, we have not provided c ash flow guidance in the past and we didn\u2019t provide it this year.   So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "We continue to work on o ur working capital efficiency initiatives.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6a98c282723185530dec882fdcbdcdbc0a479fe02b7c9b15ddbf8678eb16542b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cfb090fe-1bd1-4adb-ab6d-acc3b10be4d1", "node_type": "1", "metadata": {"window": "It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "You will see anomalies based on a point and time.  \n "}, "hash": "0ffbdf1213b826deff9cb0e47a3cd3a3f43a34ed3d523483706a1460c24f8c03", "class_name": "RelatedNodeInfo"}}, "text": "We continue to drive strong cash flow.  \n", "start_char_idx": 2554, "end_char_idx": 2595, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cfb090fe-1bd1-4adb-ab6d-acc3b10be4d1": {"__data__": {"id_": "cfb090fe-1bd1-4adb-ab6d-acc3b10be4d1", "embedding": null, "metadata": {"window": "It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "You will see anomalies based on a point and time.  \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "80ed3866-65df-4bc9-896b-dfea17911a75", "node_type": "4", "metadata": {"page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "84cfca8d7afa4d45bd859173fe703990f4b0349e0f69974f3ba5723f88fd7f8a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "11eafe58-27fd-4faf-b909-ade3bc0a8755", "node_type": "1", "metadata": {"window": "So \nI\u2019m not going to speak to that.  \n \n  It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "We continue to drive strong cash flow.  \n", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55c8817e57d839fdcafe4899fad2a52b03479bd54065f6e69c54b5b679d461be", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7774d7f9-d4ae-4f8d-a777-477f4d0d9132", "node_type": "1", "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.  ", "original_text": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n"}, "hash": "851a70f24be78970c24ce002d22bf2ac2aa49e94296823bc9b0e91011354d715", "class_name": "RelatedNodeInfo"}}, "text": "You will see anomalies based on a point and time.  \n ", "start_char_idx": 2595, "end_char_idx": 2648, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7774d7f9-d4ae-4f8d-a777-477f4d0d9132": {"__data__": {"id_": "7774d7f9-d4ae-4f8d-a777-477f4d0d9132", "embedding": null, "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.  ", "original_text": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cfb090fe-1bd1-4adb-ab6d-acc3b10be4d1", "node_type": "1", "metadata": {"window": "It\u2019s just \u2013 I\u2019d say, you know, if you look at the fundamentals the fundamentals are not structurally different than \nlast year.   We continue to work on o ur working capital efficiency initiatives.   We continue to drive strong cash flow.  \n You will see anomalies based on a point and time.  \n ", "original_text": "You will see anomalies based on a point and time.  \n ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "dfd309bb0e4f73b68f7a253b186d740da64c53d19faf111cf9363571c09ba1d9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f3bc6a48-101d-4db9-8e59-5ffa9ac7aaea", "node_type": "1", "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n", "original_text": "Mike Kaufmann :  Next question.  \n \n"}, "hash": "ab1a44ac8f2907d619f6356271c433ad7ebe9491eeebf9048ed4f5c4d0f90a05", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n", "start_char_idx": 0, "end_char_idx": 195, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f3bc6a48-101d-4db9-8e59-5ffa9ac7aaea": {"__data__": {"id_": "f3bc6a48-101d-4db9-8e59-5ffa9ac7aaea", "embedding": null, "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n", "original_text": "Mike Kaufmann :  Next question.  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7774d7f9-d4ae-4f8d-a777-477f4d0d9132", "node_type": "1", "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.  ", "original_text": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "86e5dd7e0d3f394270fae7af4b3a1834b4b8fb50fb0794a69930fc9d72ce1e73", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fdf871bd-3afe-4b6f-a066-8344a846bb5a", "node_type": "1", "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.  ", "original_text": "Operator :  Thank you.  "}, "hash": "7bdefa718b2c7b1904f0822e557a7c1d8631cc88dd56c4cfd45e5adbf2e24400", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Next question.  \n \n", "start_char_idx": 195, "end_char_idx": 231, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "fdf871bd-3afe-4b6f-a066-8344a846bb5a": {"__data__": {"id_": "fdf871bd-3afe-4b6f-a066-8344a846bb5a", "embedding": null, "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.  ", "original_text": "Operator :  Thank you.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f3bc6a48-101d-4db9-8e59-5ffa9ac7aaea", "node_type": "1", "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n", "original_text": "Mike Kaufmann :  Next question.  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "34f1c7800898a906dbd71b566de73d0e38bfe3a397f4c0a5f25315c93dc3e196", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "782dd7ab-8a16-44c1-94a2-e3a3c6795ed8", "node_type": "1", "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n ", "original_text": "Thank you.  "}, "hash": "0dab0845d4bc940718f38c50e263dfd4330ac60b5b53221cc7b5866b5b1c873e", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you.  ", "start_char_idx": 231, "end_char_idx": 255, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "782dd7ab-8a16-44c1-94a2-e3a3c6795ed8": {"__data__": {"id_": "782dd7ab-8a16-44c1-94a2-e3a3c6795ed8", "embedding": null, "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n ", "original_text": "Thank you.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fdf871bd-3afe-4b6f-a066-8344a846bb5a", "node_type": "1", "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.  ", "original_text": "Operator :  Thank you.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b4fb66c5edda595ad57c846f10adb3d528d51494640a42ca894b4bae9066f510", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d624812e-18a5-4a02-9e02-e2fbbc60d9b4", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.  ", "original_text": "We will take our next question from John Ransom from Raymond James.  \n \n"}, "hash": "dd004680cf1e04e69c33273ac9a5888ff780cb4b4348d157a8e2e7461a6c2775", "class_name": "RelatedNodeInfo"}}, "text": "Thank you.  ", "start_char_idx": 243, "end_char_idx": 255, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d624812e-18a5-4a02-9e02-e2fbbc60d9b4": {"__data__": {"id_": "d624812e-18a5-4a02-9e02-e2fbbc60d9b4", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.  ", "original_text": "We will take our next question from John Ransom from Raymond James.  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "782dd7ab-8a16-44c1-94a2-e3a3c6795ed8", "node_type": "1", "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n ", "original_text": "Thank you.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "55cb587e6c96801c7cc4fd78ac938464f32f868fc230832cc0056b4cfffe1b38", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40b6cc09-934a-462e-a424-eed0bc7e7f15", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.  ", "original_text": "John Ransom :  Hey good morning.  "}, "hash": "56c54bef8481cf1a46f9d1b45a28b1252038cebbd6e2dae53fc80ea1acf96db6", "class_name": "RelatedNodeInfo"}}, "text": "We will take our next question from John Ransom from Raymond James.  \n \n", "start_char_idx": 267, "end_char_idx": 339, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "40b6cc09-934a-462e-a424-eed0bc7e7f15": {"__data__": {"id_": "40b6cc09-934a-462e-a424-eed0bc7e7f15", "embedding": null, "metadata": {"window": "Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.  ", "original_text": "John Ransom :  Hey good morning.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d624812e-18a5-4a02-9e02-e2fbbc60d9b4", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.  ", "original_text": "We will take our next question from John Ransom from Raymond James.  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5c0503f903e88e375c627145ec6c20def824768e579314c22d34290563238ca6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "06f7e4c5-237a-48d6-bfc8-d4eac5e39b4a", "node_type": "1", "metadata": {"window": "Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n ", "original_text": "Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n "}, "hash": "6a8a43749c9eac70f118e2f895e2d967724d3c63b1c6895496d7718b8b531106", "class_name": "RelatedNodeInfo"}}, "text": "John Ransom :  Hey good morning.  ", "start_char_idx": 339, "end_char_idx": 373, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "06f7e4c5-237a-48d6-bfc8-d4eac5e39b4a": {"__data__": {"id_": "06f7e4c5-237a-48d6-bfc8-d4eac5e39b4a", "embedding": null, "metadata": {"window": "Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n ", "original_text": "Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40b6cc09-934a-462e-a424-eed0bc7e7f15", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.  ", "original_text": "John Ransom :  Hey good morning.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "da3b955cd013b3c2c0bb14e43646a801b9e886a1ccbb8ff5e17c061e2617c0bd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f6f1f507-f1cd-4a71-92dc-605f10604d61", "node_type": "1", "metadata": {"window": "We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.  ", "original_text": "But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.  "}, "hash": "d6280a6810284368ac62e422d48bf2fcb9b7a69493f4edb3004f4c8e84233e76", "class_name": "RelatedNodeInfo"}}, "text": "Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n ", "start_char_idx": 373, "end_char_idx": 520, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f6f1f507-f1cd-4a71-92dc-605f10604d61": {"__data__": {"id_": "f6f1f507-f1cd-4a71-92dc-605f10604d61", "embedding": null, "metadata": {"window": "We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.  ", "original_text": "But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "06f7e4c5-237a-48d6-bfc8-d4eac5e39b4a", "node_type": "1", "metadata": {"window": "Thank you.   We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n ", "original_text": "Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6e9b96727fd44e43d6c85561c783ef78158576ea8cc3fba11419b694d9bc0494", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd95685a-880e-418d-ae23-752e9d3edec9", "node_type": "1", "metadata": {"window": "John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n", "original_text": "So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.  "}, "hash": "513769ca5fc18cbd0c6fdaeb3bc5589eeb2a888758e15c502b5bfd2e42e09fda", "class_name": "RelatedNodeInfo"}}, "text": "But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.  ", "start_char_idx": 520, "end_char_idx": 656, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cd95685a-880e-418d-ae23-752e9d3edec9": {"__data__": {"id_": "cd95685a-880e-418d-ae23-752e9d3edec9", "embedding": null, "metadata": {"window": "John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n", "original_text": "So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f6f1f507-f1cd-4a71-92dc-605f10604d61", "node_type": "1", "metadata": {"window": "We will take our next question from John Ransom from Raymond James.  \n \n John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.  ", "original_text": "But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9f0955c9d55b10273959f415802b16fd98c9869e9c9d2559353d91982eb87b00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "67ffef54-0e07-4b38-8a44-5a7fccfb6c89", "node_type": "1", "metadata": {"window": "Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.  ", "original_text": "Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n "}, "hash": "ffe4f1d6bc7743e0e8bfd269d002898f6ecd28a5edb0deac193413af53632d9d", "class_name": "RelatedNodeInfo"}}, "text": "So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.  ", "start_char_idx": 656, "end_char_idx": 772, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "67ffef54-0e07-4b38-8a44-5a7fccfb6c89": {"__data__": {"id_": "67ffef54-0e07-4b38-8a44-5a7fccfb6c89", "embedding": null, "metadata": {"window": "Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.  ", "original_text": "Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cd95685a-880e-418d-ae23-752e9d3edec9", "node_type": "1", "metadata": {"window": "John Ransom :  Hey good morning.   Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n", "original_text": "So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cc540ab3240f6816337d2d63d09109fc3c87c906cf7cde235d03f6f4528a1a5e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "512f83fe-0191-44d4-b367-c9fb4729d0e0", "node_type": "1", "metadata": {"window": "But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n ", "original_text": "So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.  "}, "hash": "e8643002824fe9d77690b1d0b67125586d2f44553ae8c130353182be1084b45c", "class_name": "RelatedNodeInfo"}}, "text": "Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n ", "start_char_idx": 772, "end_char_idx": 920, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "512f83fe-0191-44d4-b367-c9fb4729d0e0": {"__data__": {"id_": "512f83fe-0191-44d4-b367-c9fb4729d0e0", "embedding": null, "metadata": {"window": "But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n ", "original_text": "So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67ffef54-0e07-4b38-8a44-5a7fccfb6c89", "node_type": "1", "metadata": {"window": "Just going back to the stuff we used to talk about a lot Mike and I know you\u2019ve \nprobably answer this question 18,000 times over your career.  \n \n  But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.  ", "original_text": "Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c85eaf540a17336eb74ed2036a8a86e49e7ae13dd881be1bae6fd835424e8556", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3a7785c4-135c-46df-9a75-c0e83006b65c", "node_type": "1", "metadata": {"window": "So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n", "original_text": "How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n"}, "hash": "c9afe3039864500e4e9cda6156ba596ccdcb3f6ba57f857bbd38f56b3687cfda", "class_name": "RelatedNodeInfo"}}, "text": "So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.  ", "start_char_idx": 920, "end_char_idx": 1039, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3a7785c4-135c-46df-9a75-c0e83006b65c": {"__data__": {"id_": "3a7785c4-135c-46df-9a75-c0e83006b65c", "embedding": null, "metadata": {"window": "So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n", "original_text": "How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "512f83fe-0191-44d4-b367-c9fb4729d0e0", "node_type": "1", "metadata": {"window": "But it\u2019s interesting to us what\u2019s happening with the generic cycle and that the pricing at a manufacturer level has \ncertainly firmed.   So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n ", "original_text": "So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1a315b85ed60bbc436eff06e2500a910ea17cf2ff9dcee26295343861a627a7c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28078d6b-a2f2-47b5-acbf-65683859a17d", "node_type": "1", "metadata": {"window": "Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.  ", "original_text": "Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.  "}, "hash": "cf687f81a135fda6fe74407a47a5c01a63154c1c6c5519d40f52734c6a71b7e8", "class_name": "RelatedNodeInfo"}}, "text": "How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n", "start_char_idx": 1039, "end_char_idx": 1144, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "28078d6b-a2f2-47b5-acbf-65683859a17d": {"__data__": {"id_": "28078d6b-a2f2-47b5-acbf-65683859a17d", "embedding": null, "metadata": {"window": "Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.  ", "original_text": "Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3a7785c4-135c-46df-9a75-c0e83006b65c", "node_type": "1", "metadata": {"window": "So we calc ulate deflation having dropped, you know, from the high teens to something like the \nmid-single digits.   Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n", "original_text": "How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d0488367da8d5f1053a488bd926dc746e65bbd89b32d35999e37ec9fb93046ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a637dc0-4abd-4ef5-abcb-cd0223385a9e", "node_type": "1", "metadata": {"window": "So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n ", "original_text": "I\u2019ll talk about it from both sides, you know.  \n \n "}, "hash": "e787463943fc88d5865fe56c54a9cbe925d0d6963e01bcdf9d927d9c04bdca1f", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.  ", "start_char_idx": 1144, "end_char_idx": 1280, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1a637dc0-4abd-4ef5-abcb-cd0223385a9e": {"__data__": {"id_": "1a637dc0-4abd-4ef5-abcb-cd0223385a9e", "embedding": null, "metadata": {"window": "So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n ", "original_text": "I\u2019ll talk about it from both sides, you know.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28078d6b-a2f2-47b5-acbf-65683859a17d", "node_type": "1", "metadata": {"window": "Whereas the \u2013 at the pharmacy level reimbursement pressure, you know, just continues so \nyou\u2019re seeing an accelerated squeeze at the pharmacy.  \n \n  So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.  ", "original_text": "Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "50fb2587c63711583b47b7d387a8f1b6b8c43688efa5fdef9746b915ccb9a6ad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c3d4c6ac-f16d-4236-a83a-9c73df0012de", "node_type": "1", "metadata": {"window": "How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n ", "original_text": "First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n"}, "hash": "8ca198de51f5b1ed293f03edc821a10ede690bc2fcd262d40108545d9cce9277", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019ll talk about it from both sides, you know.  \n \n ", "start_char_idx": 1280, "end_char_idx": 1331, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c3d4c6ac-f16d-4236-a83a-9c73df0012de": {"__data__": {"id_": "c3d4c6ac-f16d-4236-a83a-9c73df0012de", "embedding": null, "metadata": {"window": "How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n ", "original_text": "First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a637dc0-4abd-4ef5-abcb-cd0223385a9e", "node_type": "1", "metadata": {"window": "So I jus t wonder, you know, you guys being a student of the pharmacy and you already talked about Fred\u2019s and \nKmart.   How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n ", "original_text": "I\u2019ll talk about it from both sides, you know.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f80fec96f56cb4dbd0a5acf81bb961b07d37e6d915948ce2a2e18d8f78f4c404", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2fdf1548-0296-4272-9937-f68783487426", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n ", "original_text": "But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.  "}, "hash": "7c53c26d14417c2ce3de4cb870690bab5e19a870f4192b96faca0f7cd4ca414b", "class_name": "RelatedNodeInfo"}}, "text": "First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n", "start_char_idx": 1331, "end_char_idx": 1451, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2fdf1548-0296-4272-9937-f68783487426": {"__data__": {"id_": "2fdf1548-0296-4272-9937-f68783487426", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n ", "original_text": "But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c3d4c6ac-f16d-4236-a83a-9c73df0012de", "node_type": "1", "metadata": {"window": "How long can this go on without, you know, just continued chaos in the independent pharmacy channel?  \n \n Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n ", "original_text": "First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1baceb0c31769e3b9866c8d596ba51d3f61ecd2953ae7f67e4cfdcb89ab40289", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "375b54c5-08ed-42a2-9318-264a655db803", "node_type": "1", "metadata": {"window": "I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.  ", "original_text": "They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n "}, "hash": "e665a059941686b864dded554e8319be85a588224ee69faf9c3ab18732e6bafa", "class_name": "RelatedNodeInfo"}}, "text": "But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.  ", "start_char_idx": 1451, "end_char_idx": 1589, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "375b54c5-08ed-42a2-9318-264a655db803": {"__data__": {"id_": "375b54c5-08ed-42a2-9318-264a655db803", "embedding": null, "metadata": {"window": "I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.  ", "original_text": "They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2fdf1548-0296-4272-9937-f68783487426", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Well that\u2019s a tough question to really talk about so I\u2019ll give you a little bit of color, a few things come to \nmind.   I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n ", "original_text": "But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6dc0f0835f56ee2ed70b172e2ac55418343010305fa43d917001e263c5010c3a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "765d0509-5c00-4d7f-90a3-7d6c05c1e5f9", "node_type": "1", "metadata": {"window": "First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.  ", "original_text": "And I think the chains continue to do the same through automation and other programs  themselves.  \n \n "}, "hash": "e268b190eafdb8fc29db6df0712749262230948caeb34be9034c11ee3140eb07", "class_name": "RelatedNodeInfo"}}, "text": "They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n ", "start_char_idx": 1589, "end_char_idx": 1887, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "765d0509-5c00-4d7f-90a3-7d6c05c1e5f9": {"__data__": {"id_": "765d0509-5c00-4d7f-90a3-7d6c05c1e5f9", "embedding": null, "metadata": {"window": "First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.  ", "original_text": "And I think the chains continue to do the same through automation and other programs  themselves.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "375b54c5-08ed-42a2-9318-264a655db803", "node_type": "1", "metadata": {"window": "I\u2019ll talk about it from both sides, you know.  \n \n  First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.  ", "original_text": "They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "04343a7ff650b8da39287e4c23382d43ceb922fec52791b584884ce9a9ed1fd4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8450ef67-c432-46f7-84a1-1f7bd8ed4f70", "node_type": "1", "metadata": {"window": "But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n ", "original_text": "So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n "}, "hash": "31ed54c37aa28eacdd2d8c322e13c335f889ea5d9501a602f445ef98edd35599", "class_name": "RelatedNodeInfo"}}, "text": "And I think the chains continue to do the same through automation and other programs  themselves.  \n \n ", "start_char_idx": 1887, "end_char_idx": 1990, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8450ef67-c432-46f7-84a1-1f7bd8ed4f70": {"__data__": {"id_": "8450ef67-c432-46f7-84a1-1f7bd8ed4f70", "embedding": null, "metadata": {"window": "But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n ", "original_text": "So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "765d0509-5c00-4d7f-90a3-7d6c05c1e5f9", "node_type": "1", "metadata": {"window": "First of all, I think our \u2013 all of our customers, you know, are there a few one -offs like a Fred\u2019s and a Kmart, yes.  \n But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.  ", "original_text": "And I think the chains continue to do the same through automation and other programs  themselves.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a699011f69d1cd037f65b4030002cb047b924171697fdbcb29d0652a6a944435", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f5401a1a-d916-499e-88b4-638a3546eeae", "node_type": "1", "metadata": {"window": "They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.  ", "original_text": "And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.  "}, "hash": "16f6c973d7960522f7f548507e723f2e232a2da4afb31a662953b5224608a4a7", "class_name": "RelatedNodeInfo"}}, "text": "So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n ", "start_char_idx": 1990, "end_char_idx": 2159, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f5401a1a-d916-499e-88b4-638a3546eeae": {"__data__": {"id_": "f5401a1a-d916-499e-88b4-638a3546eeae", "embedding": null, "metadata": {"window": "They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.  ", "original_text": "And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8450ef67-c432-46f7-84a1-1f7bd8ed4f70", "node_type": "1", "metadata": {"window": "But as we look our retail independent and retail independents in general have stayed at roughly the same number \nover several years now.   They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n ", "original_text": "So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "bff334ce9ac34434ac99c448fc285eeac1d1ae1c975c58189fdb17d112f4c254", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "97e655b2-3e90-44b5-929b-98971769c548", "node_type": "1", "metadata": {"window": "And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.  ", "original_text": "Bu t I think they\u2019ve learned how to \ncompete in this marketplace.  "}, "hash": "a38073648cec12ab7c598ecb384065de4e6f8c72c8f930a245d83d32df121411", "class_name": "RelatedNodeInfo"}}, "text": "And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.  ", "start_char_idx": 2159, "end_char_idx": 2233, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "97e655b2-3e90-44b5-929b-98971769c548": {"__data__": {"id_": "97e655b2-3e90-44b5-929b-98971769c548", "embedding": null, "metadata": {"window": "And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.  ", "original_text": "Bu t I think they\u2019ve learned how to \ncompete in this marketplace.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f5401a1a-d916-499e-88b4-638a3546eeae", "node_type": "1", "metadata": {"window": "They continue to find not only ways to work through the reimbursement challenges but to \ncontinue to find other ways to c ompete in the marketplace whether it be through packaging, through additional \nservices, through frontend, through just the high quality service that they give every day.  \n \n  And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.  ", "original_text": "And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c85de5c217cb0db0bdb5da3a94d3fbffa6b53f10c68663bfe5cada922cb3c079", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2791ad2f-1049-433e-afaa-0bdd442c78ab", "node_type": "1", "metadata": {"window": "So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n ", "original_text": "As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n "}, "hash": "e30c8a85e62a93c2a7a06ec973eb8c768f3d57f19c8277417842cf3814d1da29", "class_name": "RelatedNodeInfo"}}, "text": "Bu t I think they\u2019ve learned how to \ncompete in this marketplace.  ", "start_char_idx": 2233, "end_char_idx": 2300, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2791ad2f-1049-433e-afaa-0bdd442c78ab": {"__data__": {"id_": "2791ad2f-1049-433e-afaa-0bdd442c78ab", "embedding": null, "metadata": {"window": "So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n ", "original_text": "As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "97e655b2-3e90-44b5-929b-98971769c548", "node_type": "1", "metadata": {"window": "And I think the chains continue to do the same through automation and other programs  themselves.  \n \n  So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.  ", "original_text": "Bu t I think they\u2019ve learned how to \ncompete in this marketplace.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "97ae0d935ff51a6b366e1ac520b619cafc9f4f033d7d1af4aa728047b7499139", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a82b6d8c-9898-4af0-bccf-00e418120f64", "node_type": "1", "metadata": {"window": "And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.  "}, "hash": "d5d7156e79f82b4d46d204bc94d432d0ae1b8a8ce180c35813b075765eb5e760", "class_name": "RelatedNodeInfo"}}, "text": "As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n ", "start_char_idx": 2300, "end_char_idx": 2429, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a82b6d8c-9898-4af0-bccf-00e418120f64": {"__data__": {"id_": "a82b6d8c-9898-4af0-bccf-00e418120f64", "embedding": null, "metadata": {"window": "And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2791ad2f-1049-433e-afaa-0bdd442c78ab", "node_type": "1", "metadata": {"window": "So I think that the chains including the independents, all of the retail pharmacies, continue to be an important \ncomponent of getting pharmaceuticals to patients.  \n \n  And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n ", "original_text": "As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a7b35d710d154642b1cc8918c4223b10054177e65df51819c2db9cef7c3e2bb4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "30eb2648-3f6e-4a75-b904-678857038704", "node_type": "1", "metadata": {"window": "Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.  "}, "hash": "176b465f541d1889e62ccc9649ee93dfbec337b1d0a58c23b36e0082a554ba04", "class_name": "RelatedNodeInfo"}}, "text": "But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.  ", "start_char_idx": 2429, "end_char_idx": 2595, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "30eb2648-3f6e-4a75-b904-678857038704": {"__data__": {"id_": "30eb2648-3f6e-4a75-b904-678857038704", "embedding": null, "metadata": {"window": "Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a82b6d8c-9898-4af0-bccf-00e418120f64", "node_type": "1", "metadata": {"window": "And so, you know, it\u2019s something we\u2019re always going to keep our eyes on.   Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2d2b61b8a98b65811e6f16c38a05234a09a8e20ed1997467866c25b2525d75d1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d927ba6-a372-4cef-b648-2aaedd659e08", "node_type": "1", "metadata": {"window": "As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "That\u2019s been a little less than we expected so far this year.  \n \n "}, "hash": "5b138318d253aeced0ebc0b73c6390d21ae2f315a70dc9c2288bec88bbec5adf", "class_name": "RelatedNodeInfo"}}, "text": "Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.  ", "start_char_idx": 2595, "end_char_idx": 2799, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1d927ba6-a372-4cef-b648-2aaedd659e08": {"__data__": {"id_": "1d927ba6-a372-4cef-b648-2aaedd659e08", "embedding": null, "metadata": {"window": "As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "That\u2019s been a little less than we expected so far this year.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30eb2648-3f6e-4a75-b904-678857038704", "node_type": "1", "metadata": {"window": "Bu t I think they\u2019ve learned how to \ncompete in this marketplace.   As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e25cb3a9c0adf52d15c3fbb9f5cbf4c4e2d74918c23b539d0579fa41a373cbeb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bc37b18c-d69d-419c-8c6d-fe024d81907c", "node_type": "1", "metadata": {"window": "But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "And all that netting together, our Generics Program came in about as expected.  "}, "hash": "2d7ee7f32a133b8ecb90a34a47bdd739a1ed7e64cd1c19edb98ba8aa249c56cf", "class_name": "RelatedNodeInfo"}}, "text": "That\u2019s been a little less than we expected so far this year.  \n \n ", "start_char_idx": 2799, "end_char_idx": 2865, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bc37b18c-d69d-419c-8c6d-fe024d81907c": {"__data__": {"id_": "bc37b18c-d69d-419c-8c6d-fe024d81907c", "embedding": null, "metadata": {"window": "But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "And all that netting together, our Generics Program came in about as expected.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4", "node_type": "4", "metadata": {"page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "181ac5a2f09304959cdbf738dd39f287b5c154ce6b55c3e347c8b7f3eed09232", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d927ba6-a372-4cef-b648-2aaedd659e08", "node_type": "1", "metadata": {"window": "As far as on our side, we have seen some improvement as we said in the market \ndynamics around the sell -side pricing side.  \n \n  But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "That\u2019s been a little less than we expected so far this year.  \n \n ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c986da705b4d36cbf8a3a67ec05583a822c5f17306dfc5bb6826b0199270a923", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "871d5f0c-4bd6-441c-99c6-94527a6c5457", "node_type": "1", "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?  ", "original_text": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.  "}, "hash": "0245f7227ffa53d60e07711989ffc8b04c48121cfbdfbee6fe03bf8cb4d6cc3f", "class_name": "RelatedNodeInfo"}}, "text": "And all that netting together, our Generics Program came in about as expected.  ", "start_char_idx": 2865, "end_char_idx": 2945, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "871d5f0c-4bd6-441c-99c6-94527a6c5457": {"__data__": {"id_": "871d5f0c-4bd6-441c-99c6-94527a6c5457", "embedding": null, "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?  ", "original_text": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bc37b18c-d69d-419c-8c6d-fe024d81907c", "node_type": "1", "metadata": {"window": "But remember our Generics Program is made up of four components and w e\u2019ve always said it\u2019s sell -side, buy -\nside, launches and overall volumes with our customers.   Because some of the customers we mentioned, we\u2019ve \nseen a little bit of weakness on the volume side than we expected and the new item launches as you know are \nalway s highly fluctuating and can change.   That\u2019s been a little less than we expected so far this year.  \n \n  And all that netting together, our Generics Program came in about as expected.  ", "original_text": "And all that netting together, our Generics Program came in about as expected.  ", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3de8316f20dd4bf40e2bca526cbb9a45be279f07f9c12574b710c50d4cb6b940", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "68b21a74-869b-4ae5-8cf4-1a59fb5fd985", "node_type": "1", "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n", "original_text": "You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n "}, "hash": "31870870818dd4bdc76b11b7ea831efd90dc2f84e658abf25a151164e08effc3", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.  ", "start_char_idx": 0, "end_char_idx": 94, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "68b21a74-869b-4ae5-8cf4-1a59fb5fd985": {"__data__": {"id_": "68b21a74-869b-4ae5-8cf4-1a59fb5fd985", "embedding": null, "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n", "original_text": "You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "871d5f0c-4bd6-441c-99c6-94527a6c5457", "node_type": "1", "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?  ", "original_text": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e40ad169ef4eb0aaa27e07cd0e097ed5e35e89753702fec8b51a7eab88b43816", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac2d93da-82db-44f8-ae8d-91c714f2192f", "node_type": "1", "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.  ", "original_text": "But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?  "}, "hash": "3c54da384adf203e2621bc665596e79f286c8db21fb30355994364d5f6bd486f", "class_name": "RelatedNodeInfo"}}, "text": "You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n ", "start_char_idx": 94, "end_char_idx": 184, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ac2d93da-82db-44f8-ae8d-91c714f2192f": {"__data__": {"id_": "ac2d93da-82db-44f8-ae8d-91c714f2192f", "embedding": null, "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.  ", "original_text": "But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "68b21a74-869b-4ae5-8cf4-1a59fb5fd985", "node_type": "1", "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n", "original_text": "You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5ddb5101084ae967fb481058b34ac32dc5facd6cd29c1904e378152fbe82a850", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e16c2fec-2b49-439c-8c89-62c70081b5b5", "node_type": "1", "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.  ", "original_text": "I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?  "}, "hash": "dca676c1319a7d72334e933931f6806a47472e1ea7b5483e43fabc9a3067853c", "class_name": "RelatedNodeInfo"}}, "text": "But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?  ", "start_char_idx": 184, "end_char_idx": 339, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e16c2fec-2b49-439c-8c89-62c70081b5b5": {"__data__": {"id_": "e16c2fec-2b49-439c-8c89-62c70081b5b5", "embedding": null, "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.  ", "original_text": "I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ac2d93da-82db-44f8-ae8d-91c714f2192f", "node_type": "1", "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.  ", "original_text": "But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e0eb5052b3e6b384c7798d2a0a70f7109bd49c630b59fad2fb28ce0a8f66d140", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7887eed6-4b10-4f58-95c0-0ca32ff89332", "node_type": "1", "metadata": {"window": "You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n ", "original_text": "Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n"}, "hash": "33c2e3b8e8d10cfd32924ab0fa3b1817fd49ac6384a15adf37aaf475d3deaba1", "class_name": "RelatedNodeInfo"}}, "text": "I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?  ", "start_char_idx": 339, "end_char_idx": 434, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7887eed6-4b10-4f58-95c0-0ca32ff89332": {"__data__": {"id_": "7887eed6-4b10-4f58-95c0-0ca32ff89332", "embedding": null, "metadata": {"window": "You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n ", "original_text": "Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e16c2fec-2b49-439c-8c89-62c70081b5b5", "node_type": "1", "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.  ", "original_text": "I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6673873f89b3a9a89becfbfce5757d5789f7a77eeb3dadde0aa17764406e880e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dd0c7442-6fe9-47b1-bf85-e330e9a599d5", "node_type": "1", "metadata": {"window": "But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n ", "original_text": "Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.  "}, "hash": "0ed6acab5f48b6b35fd2259af55373743a4194628c0b9786ef5c6111d684b1b6", "class_name": "RelatedNodeInfo"}}, "text": "Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n", "start_char_idx": 434, "end_char_idx": 574, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "dd0c7442-6fe9-47b1-bf85-e330e9a599d5": {"__data__": {"id_": "dd0c7442-6fe9-47b1-bf85-e330e9a599d5", "embedding": null, "metadata": {"window": "But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n ", "original_text": "Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7887eed6-4b10-4f58-95c0-0ca32ff89332", "node_type": "1", "metadata": {"window": "You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n ", "original_text": "Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c10b2f05152d63696b90ac6966a1874ef058dee6e36cebd5a1650edcba6656d3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "073e984e-7a16-45b1-b77f-e367cbe0dd3d", "node_type": "1", "metadata": {"window": "I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.  ", "original_text": "It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.  "}, "hash": "c2e6e80fdd176ebfe913fd2a31a54dd72573e4a46b5ba6ca65d0ff8d01dafd37", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.  ", "start_char_idx": 574, "end_char_idx": 678, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "073e984e-7a16-45b1-b77f-e367cbe0dd3d": {"__data__": {"id_": "073e984e-7a16-45b1-b77f-e367cbe0dd3d", "embedding": null, "metadata": {"window": "I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.  ", "original_text": "It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dd0c7442-6fe9-47b1-bf85-e330e9a599d5", "node_type": "1", "metadata": {"window": "But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n ", "original_text": "Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6b18eee0446f08241fa0d94440787c292e6364f45143fb70ce4647906bef5ebb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9175580d-c96f-4e16-8401-67eed8e050d8", "node_type": "1", "metadata": {"window": "Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n", "original_text": "And that\u2019s what you \nsaw reported this quarter.  \n \n "}, "hash": "87e4f053593749b778d366f7fb2cd346852ef9bee8800eea32f2c26fd614bea6", "class_name": "RelatedNodeInfo"}}, "text": "It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.  ", "start_char_idx": 678, "end_char_idx": 789, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9175580d-c96f-4e16-8401-67eed8e050d8": {"__data__": {"id_": "9175580d-c96f-4e16-8401-67eed8e050d8", "embedding": null, "metadata": {"window": "Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n", "original_text": "And that\u2019s what you \nsaw reported this quarter.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "073e984e-7a16-45b1-b77f-e367cbe0dd3d", "node_type": "1", "metadata": {"window": "I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?   Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.  ", "original_text": "It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1b03147e3eab508421121e802327b64d38232af31af630f16e56aeed1288df33", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d3526242-993b-4e5f-867c-5dbe0b4d696b", "node_type": "1", "metadata": {"window": "Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.  ", "original_text": "And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n "}, "hash": "6b426e8a3b26a69813cee0d39eb80b524fd3aea83f348875b617eaf6137bdde5", "class_name": "RelatedNodeInfo"}}, "text": "And that\u2019s what you \nsaw reported this quarter.  \n \n ", "start_char_idx": 789, "end_char_idx": 842, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d3526242-993b-4e5f-867c-5dbe0b4d696b": {"__data__": {"id_": "d3526242-993b-4e5f-867c-5dbe0b4d696b", "embedding": null, "metadata": {"window": "Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.  ", "original_text": "And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9175580d-c96f-4e16-8401-67eed8e050d8", "node_type": "1", "metadata": {"window": "Isn\u2019t this just best thought of as a reduction in adjusted earnings for, you know, almost 20 years, I \nmean why would we add this back?  \n \n Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n", "original_text": "And that\u2019s what you \nsaw reported this quarter.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ce47993d81a7b4f62fd64bc3e90e3122174779691aa3c74fb69d9f50876188bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "09956537-c95e-4e16-8b3e-fa1c975e8de4", "node_type": "1", "metadata": {"window": "It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.  ", "original_text": "So I think we might be mixing and matching cash and expense charges.  "}, "hash": "1bca05e65f9cfb6d61d215a77e41c028f6fd986616d6b35e1ea7ca0536edf3d8", "class_name": "RelatedNodeInfo"}}, "text": "And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n ", "start_char_idx": 842, "end_char_idx": 954, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "09956537-c95e-4e16-8b3e-fa1c975e8de4": {"__data__": {"id_": "09956537-c95e-4e16-8b3e-fa1c975e8de4", "embedding": null, "metadata": {"window": "It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.  ", "original_text": "So I think we might be mixing and matching cash and expense charges.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d3526242-993b-4e5f-867c-5dbe0b4d696b", "node_type": "1", "metadata": {"window": "Dave Evans :  Well so the way I\u2019d answer that is this isn\u2019t going to be a charge to P&L over 18 years.   It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.  ", "original_text": "And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9989626645ab1e06f5c053403fedf50b72430fc0f96e18828c2b028b66519157", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dce83d00-6059-496b-9d1f-88e92e927573", "node_type": "1", "metadata": {"window": "And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n ", "original_text": "Does that answer your question?  \n \n"}, "hash": "fda9bf92c557369dad88abe5f16440df233d46d600248d31fccd2adf6f40c731", "class_name": "RelatedNodeInfo"}}, "text": "So I think we might be mixing and matching cash and expense charges.  ", "start_char_idx": 954, "end_char_idx": 1024, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "dce83d00-6059-496b-9d1f-88e92e927573": {"__data__": {"id_": "dce83d00-6059-496b-9d1f-88e92e927573", "embedding": null, "metadata": {"window": "And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n ", "original_text": "Does that answer your question?  \n \n", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "09956537-c95e-4e16-8b3e-fa1c975e8de4", "node_type": "1", "metadata": {"window": "It\u2019s a cash cost but \nfrom a GAAP accounting P&L expense perspective the charge is recognized initially once.   And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.  ", "original_text": "So I think we might be mixing and matching cash and expense charges.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cd4b03a71cb29a2c00ba7e9f4243f443d047db472c8fdf8c7d2c2db6a9b370e0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "010eb556-bcd8-49d1-acd0-b663fb2608ff", "node_type": "1", "metadata": {"window": "And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.  ", "original_text": "John Ransom :  I mean if I could just push back on that.  "}, "hash": "f235434567497bb24ff2ed32efc713f60c5fbd65e1fdd831132be0eac2fc9681", "class_name": "RelatedNodeInfo"}}, "text": "Does that answer your question?  \n \n", "start_char_idx": 1024, "end_char_idx": 1060, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "010eb556-bcd8-49d1-acd0-b663fb2608ff": {"__data__": {"id_": "010eb556-bcd8-49d1-acd0-b663fb2608ff", "embedding": null, "metadata": {"window": "And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.  ", "original_text": "John Ransom :  I mean if I could just push back on that.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dce83d00-6059-496b-9d1f-88e92e927573", "node_type": "1", "metadata": {"window": "And that\u2019s what you \nsaw reported this quarter.  \n \n  And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n ", "original_text": "Does that answer your question?  \n \n", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d0c500b963d486210c03ca568bef319dee6ebf2877f33cef43d7451c349017a4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b6cec0e1-ec2f-4952-afe1-044a6d06ef13", "node_type": "1", "metadata": {"window": "So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.  ", "original_text": "It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.  "}, "hash": "6517b1a9dbe5785314a4628a9bb5e4b6851a5070cbc9f6fc2d4c9655c529fe18", "class_name": "RelatedNodeInfo"}}, "text": "John Ransom :  I mean if I could just push back on that.  ", "start_char_idx": 1060, "end_char_idx": 1118, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b6cec0e1-ec2f-4952-afe1-044a6d06ef13": {"__data__": {"id_": "b6cec0e1-ec2f-4952-afe1-044a6d06ef13", "embedding": null, "metadata": {"window": "So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.  ", "original_text": "It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "010eb556-bcd8-49d1-acd0-b663fb2608ff", "node_type": "1", "metadata": {"window": "And so recognizing 18 y ear charge we did call out as a GAAP to non -GAAP adjustment and appropriately so.  \n \n  So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.  ", "original_text": "John Ransom :  I mean if I could just push back on that.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a2242a845d01d8dd2c35217cd925a624b4c1568b37e83c61150782ef52ee8425", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b614e4be-0ca3-49eb-8e67-09bc434d0686", "node_type": "1", "metadata": {"window": "Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n ", "original_text": "I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n "}, "hash": "299712a9aba59fd71a2ced37d71fce5c932b5b1f0b86ef157699004d273370d3", "class_name": "RelatedNodeInfo"}}, "text": "It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.  ", "start_char_idx": 1118, "end_char_idx": 1208, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b614e4be-0ca3-49eb-8e67-09bc434d0686": {"__data__": {"id_": "b614e4be-0ca3-49eb-8e67-09bc434d0686", "embedding": null, "metadata": {"window": "Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n ", "original_text": "I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b6cec0e1-ec2f-4952-afe1-044a6d06ef13", "node_type": "1", "metadata": {"window": "So I think we might be mixing and matching cash and expense charges.   Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.  ", "original_text": "It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "890ddcc2c62283b2e2440a9581cb00bd9a8ab390f8f8e22e1efcabe786bc41c4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "438e3852-9f4a-4a9e-81a0-4d28382d2f3f", "node_type": "1", "metadata": {"window": "John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n", "original_text": "And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.  "}, "hash": "b6968c52e0b5116c2b2b10dfc03056ed0ee01d768feaf9edd09813aee5d0108c", "class_name": "RelatedNodeInfo"}}, "text": "I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n ", "start_char_idx": 1208, "end_char_idx": 1338, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "438e3852-9f4a-4a9e-81a0-4d28382d2f3f": {"__data__": {"id_": "438e3852-9f4a-4a9e-81a0-4d28382d2f3f", "embedding": null, "metadata": {"window": "John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n", "original_text": "And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b614e4be-0ca3-49eb-8e67-09bc434d0686", "node_type": "1", "metadata": {"window": "Does that answer your question?  \n \n John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n ", "original_text": "I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "36d28330a3bc1796f4b0652188293c219d3f02bf5a9e3d8b15160ad4f330468e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "13d671f9-e5fa-4ee3-9230-61d27ee9c698", "node_type": "1", "metadata": {"window": "It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n", "original_text": "But this is an actual reduction.  "}, "hash": "0894422651940c931db83fb73c3cf108ceb4c3587e5cd12691bb5d0772b5f5a3", "class_name": "RelatedNodeInfo"}}, "text": "And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.  ", "start_char_idx": 1338, "end_char_idx": 1418, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "13d671f9-e5fa-4ee3-9230-61d27ee9c698": {"__data__": {"id_": "13d671f9-e5fa-4ee3-9230-61d27ee9c698", "embedding": null, "metadata": {"window": "It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n", "original_text": "But this is an actual reduction.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "438e3852-9f4a-4a9e-81a0-4d28382d2f3f", "node_type": "1", "metadata": {"window": "John Ransom :  I mean if I could just push back on that.   It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n", "original_text": "And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "71c44abbcbfc62ca3f1b0cf7b2476c0369d8876983818514b719596bab4588e5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "159f271f-016b-427d-a31d-d0827bbf8a3f", "node_type": "1", "metadata": {"window": "I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.  ", "original_text": "So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n "}, "hash": "e56cb5a03e261d717abacdcd9b5b532e08f9ccd197589faaca8e5bd799c9f2f4", "class_name": "RelatedNodeInfo"}}, "text": "But this is an actual reduction.  ", "start_char_idx": 1418, "end_char_idx": 1452, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "159f271f-016b-427d-a31d-d0827bbf8a3f": {"__data__": {"id_": "159f271f-016b-427d-a31d-d0827bbf8a3f", "embedding": null, "metadata": {"window": "I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.  ", "original_text": "So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "13d671f9-e5fa-4ee3-9230-61d27ee9c698", "node_type": "1", "metadata": {"window": "It seems lik e we want to have it both ways in terms of if it\u2019s helpful \nwe add it back.   I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n", "original_text": "But this is an actual reduction.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4f2f868aa65e38c1e206c190c8ae746cfe6c39a2cb21a44f3f5f2a0e7fef4a9d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2fa3fc1a-6a7d-4245-98c5-0a1e8d6b5ac3", "node_type": "1", "metadata": {"window": "And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.  ", "original_text": "So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n"}, "hash": "788afc31eb2cc8ddc39919bb5d21594bea10e29804151450e481819d33a45982", "class_name": "RelatedNodeInfo"}}, "text": "So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n ", "start_char_idx": 1452, "end_char_idx": 1585, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2fa3fc1a-6a7d-4245-98c5-0a1e8d6b5ac3": {"__data__": {"id_": "2fa3fc1a-6a7d-4245-98c5-0a1e8d6b5ac3", "embedding": null, "metadata": {"window": "And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.  ", "original_text": "So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "159f271f-016b-427d-a31d-d0827bbf8a3f", "node_type": "1", "metadata": {"window": "I mean yes, I get you can take the charge year one and but it\u2019s going to be a reduction of what I \nwould call cash earnings.  \n \n  And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.  ", "original_text": "So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8b7f7ebc52ae234278a4357645e3f07f8da27b25ba817f608d661e5d19780036", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0216dbe6-ad6e-436e-bf1c-a9f277163add", "node_type": "1", "metadata": {"window": "But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.  ", "original_text": "John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n"}, "hash": "6257655e505d50e09a636fdb94187b7840ac4a89db876a7bfdde8a95500b8509", "class_name": "RelatedNodeInfo"}}, "text": "So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n", "start_char_idx": 1585, "end_char_idx": 1652, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0216dbe6-ad6e-436e-bf1c-a9f277163add": {"__data__": {"id_": "0216dbe6-ad6e-436e-bf1c-a9f277163add", "embedding": null, "metadata": {"window": "But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.  ", "original_text": "John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2fa3fc1a-6a7d-4245-98c5-0a1e8d6b5ac3", "node_type": "1", "metadata": {"window": "And so yes, addback amortization and it\u2019s not cash, I get that or a one -time.   But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.  ", "original_text": "So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d24a894dc7596dd636d5eef97321a5649bb553b2a0ac178c043ef0a109e29558", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "72b74c30-aa55-48dc-a1b0-5842e768cda5", "node_type": "1", "metadata": {"window": "So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n ", "original_text": "Dave Evans :  Yes.  "}, "hash": "a8006908c66c7e70b330c0eb164a70fa16c835ac07c5ff4d4726db63a0c0e890", "class_name": "RelatedNodeInfo"}}, "text": "John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n", "start_char_idx": 1652, "end_char_idx": 1720, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "72b74c30-aa55-48dc-a1b0-5842e768cda5": {"__data__": {"id_": "72b74c30-aa55-48dc-a1b0-5842e768cda5", "embedding": null, "metadata": {"window": "So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n ", "original_text": "Dave Evans :  Yes.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0216dbe6-ad6e-436e-bf1c-a9f277163add", "node_type": "1", "metadata": {"window": "But this is an actual reduction.   So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.  ", "original_text": "John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "89e685825cb25153014faae3bee4cb1e9b98792aded5222eccbfc01a73ea5b33", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d5aa8cda-0082-4f52-bb10-45f198361adb", "node_type": "1", "metadata": {"window": "So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n ", "original_text": "No.  "}, "hash": "2540e8f3dd21597620482e526a48770492956a2bd0a64980cbd39481249797b1", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes.  ", "start_char_idx": 1720, "end_char_idx": 1740, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d5aa8cda-0082-4f52-bb10-45f198361adb": {"__data__": {"id_": "d5aa8cda-0082-4f52-bb10-45f198361adb", "embedding": null, "metadata": {"window": "So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n ", "original_text": "No.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "72b74c30-aa55-48dc-a1b0-5842e768cda5", "node_type": "1", "metadata": {"window": "So it \njust seems like we\u2019re having it both ways to take this big accounting charge but then add it back to adjusted \nearnings.  \n \n  So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n ", "original_text": "Dave Evans :  Yes.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "562f2eb6032d70d96e9806623a41ee6bd2f9e167f69ea01ad47a07da7d2af5dd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "48e666fe-03a0-4064-98e9-32dd5414bb5b", "node_type": "1", "metadata": {"window": "John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.  ", "original_text": "I understand your question.  "}, "hash": "f72f6fd182646bd0aead3d53762be70b203ad7a9ae076843342f66b253fdb269", "class_name": "RelatedNodeInfo"}}, "text": "No.  ", "start_char_idx": 1740, "end_char_idx": 1745, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "48e666fe-03a0-4064-98e9-32dd5414bb5b": {"__data__": {"id_": "48e666fe-03a0-4064-98e9-32dd5414bb5b", "embedding": null, "metadata": {"window": "John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.  ", "original_text": "I understand your question.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d5aa8cda-0082-4f52-bb10-45f198361adb", "node_type": "1", "metadata": {"window": "So yes, the mismatch seems like we\u2019re\u2026  \n \nDave Evans :  Well.  \n \n John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n ", "original_text": "No.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0122f838d2eb11a5be016eca996f845d1800d1a1e8056596208202df7879d09b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bd97adbe-4ebc-4ba4-8d95-44e0f2e5ad65", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n "}, "hash": "cfb4722a5ff094cbe946dcaaa9b0060f5bf855680aca196020fc6fe9df29def0", "class_name": "RelatedNodeInfo"}}, "text": "I understand your question.  ", "start_char_idx": 1745, "end_char_idx": 1774, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bd97adbe-4ebc-4ba4-8d95-44e0f2e5ad65": {"__data__": {"id_": "bd97adbe-4ebc-4ba4-8d95-44e0f2e5ad65", "embedding": null, "metadata": {"window": "Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "48e666fe-03a0-4064-98e9-32dd5414bb5b", "node_type": "1", "metadata": {"window": "John Rans om:  \u2026a little bit having it both ways so that\u2019s all.  \n \n Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.  ", "original_text": "I understand your question.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "47d072d0f9ee1625ddb238797787d7775fc87d7b6326ba0b7dce9f9358b13072", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7209d633-68c1-4d38-851a-383694da7154", "node_type": "1", "metadata": {"window": "No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n "}, "hash": "0619fbe734c028bc66380987a0b7987f1c8ffcef8441007904d94b0c5539dd22", "class_name": "RelatedNodeInfo"}}, "text": "I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n ", "start_char_idx": 1774, "end_char_idx": 1970, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7209d633-68c1-4d38-851a-383694da7154": {"__data__": {"id_": "7209d633-68c1-4d38-851a-383694da7154", "embedding": null, "metadata": {"window": "No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bd97adbe-4ebc-4ba4-8d95-44e0f2e5ad65", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "183dc036c4efae8c076fb1854876d0a457c5fadc43ab165f1ee053f36b1f38f8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "302a9883-7627-40b6-9ccd-83ca4bad4a4d", "node_type": "1", "metadata": {"window": "I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "Now, you know, I suppose, you know, I think you will look at this from a cash perspective.  "}, "hash": "5480635325ef3a837e04f04f8bf7c873383d296d356030d83983d4a49ba8bac4", "class_name": "RelatedNodeInfo"}}, "text": "In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n ", "start_char_idx": 1970, "end_char_idx": 2125, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "302a9883-7627-40b6-9ccd-83ca4bad4a4d": {"__data__": {"id_": "302a9883-7627-40b6-9ccd-83ca4bad4a4d", "embedding": null, "metadata": {"window": "I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "Now, you know, I suppose, you know, I think you will look at this from a cash perspective.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7209d633-68c1-4d38-851a-383694da7154", "node_type": "1", "metadata": {"window": "No.   I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6dae4da0d136849eacbd7d8a7358e52a3cbf7eb8c38a61cc25f056972ecbfcb8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e21f178d-ba41-4362-bec0-9c627e80266b", "node_type": "1", "metadata": {"window": "I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n "}, "hash": "f9d359ed1f5137b50e57ff8a00296b41fb4f35fa51824d4285967ba21194efea", "class_name": "RelatedNodeInfo"}}, "text": "Now, you know, I suppose, you know, I think you will look at this from a cash perspective.  ", "start_char_idx": 2125, "end_char_idx": 2217, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e21f178d-ba41-4362-bec0-9c627e80266b": {"__data__": {"id_": "e21f178d-ba41-4362-bec0-9c627e80266b", "embedding": null, "metadata": {"window": "I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "c8dbda70-76e8-4883-857e-5a79d45705b2", "node_type": "4", "metadata": {"page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "955b1d2b61ca252e46ea9d497d76cb35ff3dc17005fb0cc4986f718551636f40", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "302a9883-7627-40b6-9ccd-83ca4bad4a4d", "node_type": "1", "metadata": {"window": "I understand your question.   I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "Now, you know, I suppose, you know, I think you will look at this from a cash perspective.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c2c8bde0f5e1e83642e39352db30595ba2814d69e947b3283fc5c9edef3d3efb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "40d73317-d6b2-4086-b079-461e19906f34", "node_type": "1", "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.  ", "original_text": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.  "}, "hash": "31f2c11056d253b131306f3e520180d437bb76f0e4b59831a7923a966467dd8e", "class_name": "RelatedNodeInfo"}}, "text": "And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "start_char_idx": 2217, "end_char_idx": 2298, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "40d73317-d6b2-4086-b079-461e19906f34": {"__data__": {"id_": "40d73317-d6b2-4086-b079-461e19906f34", "embedding": null, "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.  ", "original_text": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e21f178d-ba41-4362-bec0-9c627e80266b", "node_type": "1", "metadata": {"window": "I think what \u2013 look, when we make GAAP/non -GAAP adjustments \nthat\u2019s for when we have an expense or a credit in the current period P&L that we add bac k or subtract out to get \nto non -GAAP.  \n \n  In the case of this opioid accrual we won\u2019t have a P&L charge in future periods so there won\u2019t be anything to add \nback to get to non -GAAP earnings.  \n \n  Now, you know, I suppose, you know, I think you will look at this from a cash perspective.   And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "original_text": "And certainly everyone \ncan model the cash flow impact for the next 18 years.  \n ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ad631059841d882c90d1c16aebbaef5fc56c17a241ff0f8b7a1b2457a284e478", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "20173cba-abee-4146-a4aa-9668a686eb54", "node_type": "1", "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.  ", "original_text": "So there won\u2019t be anything to add back.  \n \n"}, "hash": "ebaf877d142d73c6c9e01b2c1d958a0ecfcc9e901e4195335a42c594f4368413", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.  ", "start_char_idx": 0, "end_char_idx": 199, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "20173cba-abee-4146-a4aa-9668a686eb54": {"__data__": {"id_": "20173cba-abee-4146-a4aa-9668a686eb54", "embedding": null, "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.  ", "original_text": "So there won\u2019t be anything to add back.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40d73317-d6b2-4086-b079-461e19906f34", "node_type": "1", "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.  ", "original_text": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "0c4f7c679126bc9e795224722584ff54a80c2ed37c6393bdce19b5402f5591db", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "952dce95-3d44-439e-b9f5-eaddfd1373c7", "node_type": "1", "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n", "original_text": "Mike Kaufmann:  Next question.  \n \n"}, "hash": "2b4d46b93a73ffa84057cbaa3b434f4daf81b87744c3a0d5b8134f89566430b6", "class_name": "RelatedNodeInfo"}}, "text": "So there won\u2019t be anything to add back.  \n \n", "start_char_idx": 199, "end_char_idx": 243, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "952dce95-3d44-439e-b9f5-eaddfd1373c7": {"__data__": {"id_": "952dce95-3d44-439e-b9f5-eaddfd1373c7", "embedding": null, "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n", "original_text": "Mike Kaufmann:  Next question.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20173cba-abee-4146-a4aa-9668a686eb54", "node_type": "1", "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.  ", "original_text": "So there won\u2019t be anything to add back.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3a9533c31bb5519ad7cf53644c1434fe60fded9172f7ff7de166736f2157bc4d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5694d8c8-cb69-4c67-be9b-cd31c8f52c35", "node_type": "1", "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.  ", "original_text": "Operator :  Thank you.  "}, "hash": "071ea2730b53f86c2875f8d13cea776e5b916ef20fe62314c96bc69cbbc5aaab", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann:  Next question.  \n \n", "start_char_idx": 243, "end_char_idx": 278, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5694d8c8-cb69-4c67-be9b-cd31c8f52c35": {"__data__": {"id_": "5694d8c8-cb69-4c67-be9b-cd31c8f52c35", "embedding": null, "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.  ", "original_text": "Operator :  Thank you.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "952dce95-3d44-439e-b9f5-eaddfd1373c7", "node_type": "1", "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n", "original_text": "Mike Kaufmann:  Next question.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b8c01d286037fc9132d84a53a242529bb723373ce8df029f88e75848239ccd0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ff7c0d70-d304-4dc2-8d53-d17c3a53ac30", "node_type": "1", "metadata": {"window": "So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.  ", "original_text": "We will take our next question from Eric Coldwell of Baird.  "}, "hash": "f4b620a7db7aff7999b0d389751e6caa057542ebe13bbb04eb8e2829a71fc80d", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you.  ", "start_char_idx": 278, "end_char_idx": 302, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ff7c0d70-d304-4dc2-8d53-d17c3a53ac30": {"__data__": {"id_": "ff7c0d70-d304-4dc2-8d53-d17c3a53ac30", "embedding": null, "metadata": {"window": "So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.  ", "original_text": "We will take our next question from Eric Coldwell of Baird.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5694d8c8-cb69-4c67-be9b-cd31c8f52c35", "node_type": "1", "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.  ", "original_text": "Operator :  Thank you.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "30c9455de0ae7415374d9c4616fe5523796a6fe36ccfa767ad0ce98f1add696e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c092c063-f606-45e1-b1d6-4ce9911d78ca", "node_type": "1", "metadata": {"window": "Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.  ", "original_text": "Please go ahead.  \n \n"}, "hash": "fead2a171c5202ca1618295c763e07213ade5e82120b4759254fc12d5a51d2e7", "class_name": "RelatedNodeInfo"}}, "text": "We will take our next question from Eric Coldwell of Baird.  ", "start_char_idx": 302, "end_char_idx": 363, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c092c063-f606-45e1-b1d6-4ce9911d78ca": {"__data__": {"id_": "c092c063-f606-45e1-b1d6-4ce9911d78ca", "embedding": null, "metadata": {"window": "Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.  ", "original_text": "Please go ahead.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ff7c0d70-d304-4dc2-8d53-d17c3a53ac30", "node_type": "1", "metadata": {"window": "So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.  ", "original_text": "We will take our next question from Eric Coldwell of Baird.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "17b3ec4c69cefc04c001593d5e5f3cf9946f898ce546486f241943b7dda97f3b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d1710972-d74c-4ff1-ba2c-025747f22447", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.  ", "original_text": "Eric Coldwell :  Thanks.  "}, "hash": "a1561c2e54e95a833c784b01a60518a316baeb810952d247217c9cc99b84e5ef", "class_name": "RelatedNodeInfo"}}, "text": "Please go ahead.  \n \n", "start_char_idx": 363, "end_char_idx": 384, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d1710972-d74c-4ff1-ba2c-025747f22447": {"__data__": {"id_": "d1710972-d74c-4ff1-ba2c-025747f22447", "embedding": null, "metadata": {"window": "Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.  ", "original_text": "Eric Coldwell :  Thanks.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c092c063-f606-45e1-b1d6-4ce9911d78ca", "node_type": "1", "metadata": {"window": "Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.  ", "original_text": "Please go ahead.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e2ae13041fd39cc7d9569ab924af9e7ca389bc7c891ce2d566db41f061abca0d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a52851b9-3e7d-482a-a301-216df11c6744", "node_type": "1", "metadata": {"window": "We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.  ", "original_text": "Good morning.  "}, "hash": "bfe32dd24d770bb2a3d6e5d123519f431135ac319ffe731ff4807562804e2841", "class_name": "RelatedNodeInfo"}}, "text": "Eric Coldwell :  Thanks.  ", "start_char_idx": 384, "end_char_idx": 410, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a52851b9-3e7d-482a-a301-216df11c6744": {"__data__": {"id_": "a52851b9-3e7d-482a-a301-216df11c6744", "embedding": null, "metadata": {"window": "We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.  ", "original_text": "Good morning.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1710972-d74c-4ff1-ba2c-025747f22447", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.  ", "original_text": "Eric Coldwell :  Thanks.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "27ddaa5480d13b2749108f33d5d6b0a2a206c809095f1ee9fff51a385050547e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a4a6e976-887f-47ae-8752-89d1456ae07f", "node_type": "1", "metadata": {"window": "Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n ", "original_text": "All of my snazzy questions have been asked already.  "}, "hash": "1bda28def7264b689accc2757a2cb758c0f614126c68466fcb69d88d5b06374c", "class_name": "RelatedNodeInfo"}}, "text": "Good morning.  ", "start_char_idx": 410, "end_char_idx": 425, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a4a6e976-887f-47ae-8752-89d1456ae07f": {"__data__": {"id_": "a4a6e976-887f-47ae-8752-89d1456ae07f", "embedding": null, "metadata": {"window": "Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n ", "original_text": "All of my snazzy questions have been asked already.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a52851b9-3e7d-482a-a301-216df11c6744", "node_type": "1", "metadata": {"window": "We will take our next question from Eric Coldwell of Baird.   Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.  ", "original_text": "Good morning.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1c2a4132f12fb8e6b6f0ec3533c7e79834a890036adeec0a4eaad371472eb2b1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4b6eafd5-eb1e-44b9-9d17-aa5d4cf71527", "node_type": "1", "metadata": {"window": "Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n ", "original_text": "But I have a couple of \ntechnical ones.  "}, "hash": "ad7bbc9397ac4d88d6a9597e6772306fc579e2af878f42a2102f706fb8dba6a6", "class_name": "RelatedNodeInfo"}}, "text": "All of my snazzy questions have been asked already.  ", "start_char_idx": 425, "end_char_idx": 478, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4b6eafd5-eb1e-44b9-9d17-aa5d4cf71527": {"__data__": {"id_": "4b6eafd5-eb1e-44b9-9d17-aa5d4cf71527", "embedding": null, "metadata": {"window": "Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n ", "original_text": "But I have a couple of \ntechnical ones.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a4a6e976-887f-47ae-8752-89d1456ae07f", "node_type": "1", "metadata": {"window": "Please go ahead.  \n \n Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n ", "original_text": "All of my snazzy questions have been asked already.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a4463faf1af0af4b0effbb4935da8270a8c7a4e4c2147e603999775092323e15", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "705d6b24-92fa-4f60-bf27-f76dde3da774", "node_type": "1", "metadata": {"window": "Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.  ", "original_text": "I think it was Bob that asked about the medical device tax.  "}, "hash": "d56d671df9988c09e8e1c4e828bd916af9e6c543df3127579d6bf2e79e8fa452", "class_name": "RelatedNodeInfo"}}, "text": "But I have a couple of \ntechnical ones.  ", "start_char_idx": 478, "end_char_idx": 519, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "705d6b24-92fa-4f60-bf27-f76dde3da774": {"__data__": {"id_": "705d6b24-92fa-4f60-bf27-f76dde3da774", "embedding": null, "metadata": {"window": "Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.  ", "original_text": "I think it was Bob that asked about the medical device tax.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4b6eafd5-eb1e-44b9-9d17-aa5d4cf71527", "node_type": "1", "metadata": {"window": "Eric Coldwell :  Thanks.   Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n ", "original_text": "But I have a couple of \ntechnical ones.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "10ffefded1e0d2c0bee336a69606bbf710edd5f9bb81e8918c93e5f4e8c60d2f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2006df42-ed71-4e46-8b60-9dcdb0b1b54f", "node_type": "1", "metadata": {"window": "All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.  ", "original_text": "You admitted it\u2019s not in guidance, it \ncould come back.  \n \n "}, "hash": "b7cb2085019f1ca0d7489af200d935c8ee9cacaac9686e158c3e7b004f3b11a2", "class_name": "RelatedNodeInfo"}}, "text": "I think it was Bob that asked about the medical device tax.  ", "start_char_idx": 519, "end_char_idx": 580, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2006df42-ed71-4e46-8b60-9dcdb0b1b54f": {"__data__": {"id_": "2006df42-ed71-4e46-8b60-9dcdb0b1b54f", "embedding": null, "metadata": {"window": "All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.  ", "original_text": "You admitted it\u2019s not in guidance, it \ncould come back.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "705d6b24-92fa-4f60-bf27-f76dde3da774", "node_type": "1", "metadata": {"window": "Good morning.   All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.  ", "original_text": "I think it was Bob that asked about the medical device tax.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "4d509d019ef93ab405b5c3c9369fc216467217e72055c7b0c332f02779bc58a4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "72765fed-930d-42e2-8d43-5c2789a24b53", "node_type": "1", "metadata": {"window": "But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n", "original_text": "What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n "}, "hash": "1f436e17469e26d47ac197a423f88592490494ce454c656041132bb2c0f61a2a", "class_name": "RelatedNodeInfo"}}, "text": "You admitted it\u2019s not in guidance, it \ncould come back.  \n \n ", "start_char_idx": 580, "end_char_idx": 641, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "72765fed-930d-42e2-8d43-5c2789a24b53": {"__data__": {"id_": "72765fed-930d-42e2-8d43-5c2789a24b53", "embedding": null, "metadata": {"window": "But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n", "original_text": "What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2006df42-ed71-4e46-8b60-9dcdb0b1b54f", "node_type": "1", "metadata": {"window": "All of my snazzy questions have been asked already.   But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.  ", "original_text": "You admitted it\u2019s not in guidance, it \ncould come back.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "64f9c2c40f7d08754d30aee9eb81f6066f242a1e3e27bc884d32bbd9762e7937", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82567661-b2c9-4918-b9d0-3f84c8a904b2", "node_type": "1", "metadata": {"window": "I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.  ", "original_text": "Secondarily, commodity cost inputs and FX in the Medical Segment.  "}, "hash": "e3ad3d09c95fd66a7cd16449c1078bc0c104537c117aca391f9787d234fdfa90", "class_name": "RelatedNodeInfo"}}, "text": "What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n ", "start_char_idx": 641, "end_char_idx": 748, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "82567661-b2c9-4918-b9d0-3f84c8a904b2": {"__data__": {"id_": "82567661-b2c9-4918-b9d0-3f84c8a904b2", "embedding": null, "metadata": {"window": "I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.  ", "original_text": "Secondarily, commodity cost inputs and FX in the Medical Segment.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "72765fed-930d-42e2-8d43-5c2789a24b53", "node_type": "1", "metadata": {"window": "But I have a couple of \ntechnical ones.   I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n", "original_text": "What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "b15ba35e8a6995bab7ebd91f1192d168bd02d7b8a531aa9dd48fec38197a3194", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a45b802b-e69f-42f5-ac0b-28e3ac63d084", "node_type": "1", "metadata": {"window": "You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n", "original_text": "I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.  "}, "hash": "3633d65074c9a28884f9a9817e61f16f495da26d7eda5f9bffc967cd86474ea0", "class_name": "RelatedNodeInfo"}}, "text": "Secondarily, commodity cost inputs and FX in the Medical Segment.  ", "start_char_idx": 748, "end_char_idx": 815, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a45b802b-e69f-42f5-ac0b-28e3ac63d084": {"__data__": {"id_": "a45b802b-e69f-42f5-ac0b-28e3ac63d084", "embedding": null, "metadata": {"window": "You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n", "original_text": "I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "82567661-b2c9-4918-b9d0-3f84c8a904b2", "node_type": "1", "metadata": {"window": "I think it was Bob that asked about the medical device tax.   You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.  ", "original_text": "Secondarily, commodity cost inputs and FX in the Medical Segment.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "08ab7f66a5deeedf4bccd61a6f76cd5b859e6208eb017ec15c830868ce375279", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ba79424-2511-460e-8c7f-0033dcc8695f", "node_type": "1", "metadata": {"window": "What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n ", "original_text": "Thanks so much.  \n \n"}, "hash": "aaacf67618e6bfbf9166f87d073d9e72e7ea0a8690e8f536ef41fac5c235c8e5", "class_name": "RelatedNodeInfo"}}, "text": "I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.  ", "start_char_idx": 815, "end_char_idx": 905, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7ba79424-2511-460e-8c7f-0033dcc8695f": {"__data__": {"id_": "7ba79424-2511-460e-8c7f-0033dcc8695f", "embedding": null, "metadata": {"window": "What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n ", "original_text": "Thanks so much.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a45b802b-e69f-42f5-ac0b-28e3ac63d084", "node_type": "1", "metadata": {"window": "You admitted it\u2019s not in guidance, it \ncould come back.  \n \n  What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n", "original_text": "I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6195b9f5d1462d75ff95e4abe161d23e8d116a73a1647934e0a111ff77142885", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e2aa03cd-2764-4844-9118-aedfbf1066b7", "node_type": "1", "metadata": {"window": "Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.  ", "original_text": "Dave Evans :  Yes.  "}, "hash": "1af814f636eb1df0753df893f8733bda84b7190b7d2fe10dbe6266f8db0819e8", "class_name": "RelatedNodeInfo"}}, "text": "Thanks so much.  \n \n", "start_char_idx": 905, "end_char_idx": 925, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e2aa03cd-2764-4844-9118-aedfbf1066b7": {"__data__": {"id_": "e2aa03cd-2764-4844-9118-aedfbf1066b7", "embedding": null, "metadata": {"window": "Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.  ", "original_text": "Dave Evans :  Yes.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7ba79424-2511-460e-8c7f-0033dcc8695f", "node_type": "1", "metadata": {"window": "What would be the actual impact or best estimate of the  impact if it does come back in dollar terms?  \n \n  Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n ", "original_text": "Thanks so much.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7a59ea291ea2020a68416acaed77e8d5c2234f20e43cacff93766e563d5d9709", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "66dc3618-b2a8-4390-910d-a00ba0798ca5", "node_type": "1", "metadata": {"window": "I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n ", "original_text": "So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n"}, "hash": "39e38cccc58b48fef7e23fde0f655d52a3a054b1e6d0a0116314c3edb3669349", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes.  ", "start_char_idx": 925, "end_char_idx": 945, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "66dc3618-b2a8-4390-910d-a00ba0798ca5": {"__data__": {"id_": "66dc3618-b2a8-4390-910d-a00ba0798ca5", "embedding": null, "metadata": {"window": "I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n ", "original_text": "So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e2aa03cd-2764-4844-9118-aedfbf1066b7", "node_type": "1", "metadata": {"window": "Secondarily, commodity cost inputs and FX in the Medical Segment.   I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.  ", "original_text": "Dave Evans :  Yes.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "40f00171670eb766ee162677918e5279faa570e30dbaf938b0551858044914e2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4c367544-ec85-4844-adbd-2885360c40c9", "node_type": "1", "metadata": {"window": "Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.  ", "original_text": "So I don\u2019t have a precise answer for you.  \n \n "}, "hash": "19e3500469d17af406905c265985e04741c528ed2b827e7721a30315bc0de9e7", "class_name": "RelatedNodeInfo"}}, "text": "So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n", "start_char_idx": 945, "end_char_idx": 1051, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4c367544-ec85-4844-adbd-2885360c40c9": {"__data__": {"id_": "4c367544-ec85-4844-adbd-2885360c40c9", "embedding": null, "metadata": {"window": "Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.  ", "original_text": "So I don\u2019t have a precise answer for you.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "66dc3618-b2a8-4390-910d-a00ba0798ca5", "node_type": "1", "metadata": {"window": "I\u2019m curious if you can give us some sense of \nthe impact those had on profit in medical.   Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n ", "original_text": "So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "08f4b531b17e6236da769b52de46e1d10e9b43df2c10f26ad000436897646c64", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e6bd754f-131f-47f3-a34b-1635f2a62514", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n ", "original_text": "But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.  "}, "hash": "ccffe39c576c55128972850fa182829597716a7eaf38e144977b5929c5fa56f5", "class_name": "RelatedNodeInfo"}}, "text": "So I don\u2019t have a precise answer for you.  \n \n ", "start_char_idx": 1051, "end_char_idx": 1098, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "e6bd754f-131f-47f3-a34b-1635f2a62514": {"__data__": {"id_": "e6bd754f-131f-47f3-a34b-1635f2a62514", "embedding": null, "metadata": {"window": "Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n ", "original_text": "But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4c367544-ec85-4844-adbd-2885360c40c9", "node_type": "1", "metadata": {"window": "Thanks so much.  \n \n Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.  ", "original_text": "So I don\u2019t have a precise answer for you.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "3f8cb45296b32eefd6272878adfff69b98fbcab2427e31fb6a7d9c2ec0206de6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d3a8788a-c751-4c93-918a-ee3c20a42b94", "node_type": "1", "metadata": {"window": "So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n ", "original_text": "Okay.  \n \n "}, "hash": "21640070b5ccd66b0797aaba868b8d4ab8615cdb6b611b2274efa114864ab2ac", "class_name": "RelatedNodeInfo"}}, "text": "But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.  ", "start_char_idx": 1098, "end_char_idx": 1229, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d3a8788a-c751-4c93-918a-ee3c20a42b94": {"__data__": {"id_": "d3a8788a-c751-4c93-918a-ee3c20a42b94", "embedding": null, "metadata": {"window": "So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n ", "original_text": "Okay.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e6bd754f-131f-47f3-a34b-1635f2a62514", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n ", "original_text": "But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "46bbb4fb9eebb8d09db744d8d2b2a0a972301f919d70e7cc1120548e1820d2ee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9a6649e6-966c-48a7-a7a3-6131ad24f1bc", "node_type": "1", "metadata": {"window": "So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.  ", "original_text": "So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.  "}, "hash": "6b27f1357ec795b30d4d19561e9e957e350358c6f64a5a52433f39ce23dfb63d", "class_name": "RelatedNodeInfo"}}, "text": "Okay.  \n \n ", "start_char_idx": 1229, "end_char_idx": 1240, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9a6649e6-966c-48a7-a7a3-6131ad24f1bc": {"__data__": {"id_": "9a6649e6-966c-48a7-a7a3-6131ad24f1bc", "embedding": null, "metadata": {"window": "So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.  ", "original_text": "So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d3a8788a-c751-4c93-918a-ee3c20a42b94", "node_type": "1", "metadata": {"window": "So first with re spect to the medical device tax it\u2019s, you know we don\u2019t have complete clarity on this.  \n So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n ", "original_text": "Okay.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2749c91a14b2724024cff3ee17a5b8aed89579e28a47eff31b2d53bbe59527f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a467e49c-1d56-4bb8-906e-9c43e05ac260", "node_type": "1", "metadata": {"window": "But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.  ", "original_text": "Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n "}, "hash": "dbd3b9aa334f89c808b5c5382b3195019dd7a91c35853a04b5263ff51ea55946", "class_name": "RelatedNodeInfo"}}, "text": "So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.  ", "start_char_idx": 1240, "end_char_idx": 1343, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "a467e49c-1d56-4bb8-906e-9c43e05ac260": {"__data__": {"id_": "a467e49c-1d56-4bb8-906e-9c43e05ac260", "embedding": null, "metadata": {"window": "But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.  ", "original_text": "Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9a6649e6-966c-48a7-a7a3-6131ad24f1bc", "node_type": "1", "metadata": {"window": "So I don\u2019t have a precise answer for you.  \n \n  But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.  ", "original_text": "So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59f17ce47ec9fb2706ffa32312d4d630eacfca6f3d2a886c5e9fc66971858ebf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "51aede0d-d132-45b2-a211-e635fef12c3b", "node_type": "1", "metadata": {"window": "Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.  ", "original_text": "And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n "}, "hash": "9cf2788ee968ed5d5fbdaa7d228d2c6def07b89be71a72a7991e8a047cabe3e9", "class_name": "RelatedNodeInfo"}}, "text": "Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n ", "start_char_idx": 1343, "end_char_idx": 1445, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "51aede0d-d132-45b2-a211-e635fef12c3b": {"__data__": {"id_": "51aede0d-d132-45b2-a211-e635fef12c3b", "embedding": null, "metadata": {"window": "Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.  ", "original_text": "And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a467e49c-1d56-4bb8-906e-9c43e05ac260", "node_type": "1", "metadata": {"window": "But I would say that on an annualized basis we believe it could be in the neighborhood of 40 to $50 million on an \nannual bas is.   Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.  ", "original_text": "Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c43547ae33ade9fb18c548e8bcbaa79d4d967049beea8598cae4eddfcb369168", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4ffad0f1-e4f0-49f2-8463-4555eca40840", "node_type": "1", "metadata": {"window": "So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n ", "original_text": "The second question was related to FX.  "}, "hash": "a740d7ffab6cf305fbf3830ddfde6aceb53e0dae0861573a6d9d7e1a17256933", "class_name": "RelatedNodeInfo"}}, "text": "And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n ", "start_char_idx": 1445, "end_char_idx": 1563, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4ffad0f1-e4f0-49f2-8463-4555eca40840": {"__data__": {"id_": "4ffad0f1-e4f0-49f2-8463-4555eca40840", "embedding": null, "metadata": {"window": "So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n ", "original_text": "The second question was related to FX.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "51aede0d-d132-45b2-a211-e635fef12c3b", "node_type": "1", "metadata": {"window": "Okay.  \n \n  So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.  ", "original_text": "And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "16c3e72da53cb7d052dfa3ed5027b34dd2a1187ebfd06adf646a738aba91aa66", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b0eef8ec-067c-4bc0-8d59-21d84f74ae1d", "node_type": "1", "metadata": {"window": "Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.  ", "original_text": "Look, we have FX that shows up in different areas of our P&L.  "}, "hash": "bb7ac475c682837f2fec375b194ae54e6d76650b132ae0c5c537d48906b9bdf1", "class_name": "RelatedNodeInfo"}}, "text": "The second question was related to FX.  ", "start_char_idx": 1563, "end_char_idx": 1603, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b0eef8ec-067c-4bc0-8d59-21d84f74ae1d": {"__data__": {"id_": "b0eef8ec-067c-4bc0-8d59-21d84f74ae1d", "embedding": null, "metadata": {"window": "Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.  ", "original_text": "Look, we have FX that shows up in different areas of our P&L.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4ffad0f1-e4f0-49f2-8463-4555eca40840", "node_type": "1", "metadata": {"window": "So if we look at for \u2013 if it\u2019s effective in January, the second half of the year, you\u2019d prorate that.   Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n ", "original_text": "The second question was related to FX.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a36078225a46e8bb844b0c8d3ac21c6833e818802dcbcccd09cd27d324b46cf5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eddfeae3-1256-48d3-9a78-aaed13d39d81", "node_type": "1", "metadata": {"window": "And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n", "original_text": "We have \nsome that\u2019s showing up in the segments.  "}, "hash": "ba7b33cadd7c90a7ec29d6bec8d3002e1584c480f621f4417e9d70addbce9f0f", "class_name": "RelatedNodeInfo"}}, "text": "Look, we have FX that shows up in different areas of our P&L.  ", "start_char_idx": 1603, "end_char_idx": 1666, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "eddfeae3-1256-48d3-9a78-aaed13d39d81": {"__data__": {"id_": "eddfeae3-1256-48d3-9a78-aaed13d39d81", "embedding": null, "metadata": {"window": "And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n", "original_text": "We have \nsome that\u2019s showing up in the segments.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b0eef8ec-067c-4bc0-8d59-21d84f74ae1d", "node_type": "1", "metadata": {"window": "Again I\u2019ll just kind \nof caution that that\u2019s based on a lack of perfect clarity and information.  \n \n  And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.  ", "original_text": "Look, we have FX that shows up in different areas of our P&L.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c993658f0a166210166b49f0b29c956bf358eaf90781cf2254f38b79388d75d1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9a9b16aa-c3df-41f1-96a0-a13ba187c6d4", "node_type": "1", "metadata": {"window": "The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n", "original_text": "And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n "}, "hash": "83107c751f642f9ce94a5dcff44478bffd1c481e5b538c69fbc2bb783e521e0d", "class_name": "RelatedNodeInfo"}}, "text": "We have \nsome that\u2019s showing up in the segments.  ", "start_char_idx": 1666, "end_char_idx": 1716, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9a9b16aa-c3df-41f1-96a0-a13ba187c6d4": {"__data__": {"id_": "9a9b16aa-c3df-41f1-96a0-a13ba187c6d4", "embedding": null, "metadata": {"window": "The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n", "original_text": "And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eddfeae3-1256-48d3-9a78-aaed13d39d81", "node_type": "1", "metadata": {"window": "And so if that were to actually happen we\u2019 d be prepared to provide a more precise answer to that at that stage.  \n \n  The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n", "original_text": "We have \nsome that\u2019s showing up in the segments.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "cb7fbcec201602d877787ad9e72385af27554199cf0c119df1a2cd06a9175de9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ff526ecb-d9eb-4d20-b492-d00f58277269", "node_type": "1", "metadata": {"window": "Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.  ", "original_text": "I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.  "}, "hash": "5d7cf15aded1524ea68d38965616fe9ca201c434e996ac41e294f201ed36eca9", "class_name": "RelatedNodeInfo"}}, "text": "And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n ", "start_char_idx": 1716, "end_char_idx": 1840, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ff526ecb-d9eb-4d20-b492-d00f58277269": {"__data__": {"id_": "ff526ecb-d9eb-4d20-b492-d00f58277269", "embedding": null, "metadata": {"window": "Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.  ", "original_text": "I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9a9b16aa-c3df-41f1-96a0-a13ba187c6d4", "node_type": "1", "metadata": {"window": "The second question was related to FX.   Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n", "original_text": "And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "79a3687578a7735324947854c427f2c6302d6e50357b719cbd46a144453aae01", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "836a3c25-a45a-42d4-8739-df5a2f124c8a", "node_type": "1", "metadata": {"window": "We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n"}, "hash": "c43521501c1cfdcba2e5f3d1ac6d5b105db21b6a11a7ae255a1295c40274dd95", "class_name": "RelatedNodeInfo"}}, "text": "I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.  ", "start_char_idx": 1840, "end_char_idx": 1970, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "836a3c25-a45a-42d4-8739-df5a2f124c8a": {"__data__": {"id_": "836a3c25-a45a-42d4-8739-df5a2f124c8a", "embedding": null, "metadata": {"window": "We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ff526ecb-d9eb-4d20-b492-d00f58277269", "node_type": "1", "metadata": {"window": "Look, we have FX that shows up in different areas of our P&L.   We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.  ", "original_text": "I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "818b87cfc31808b36b6afabaf1e898f66b51ac19e6ecb60b33a21159b582ba1c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b4fd83dc-3d9f-46f1-a6d2-b14f41f4fac8", "node_type": "1", "metadata": {"window": "And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Eric Coldwell :  And the commodity cost.  \n \n"}, "hash": "52ee8ee82903c9a99e71c359a6de7664e935039b75b51676bb730ad99ae651d9", "class_name": "RelatedNodeInfo"}}, "text": "I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n", "start_char_idx": 1970, "end_char_idx": 2079, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b4fd83dc-3d9f-46f1-a6d2-b14f41f4fac8": {"__data__": {"id_": "b4fd83dc-3d9f-46f1-a6d2-b14f41f4fac8", "embedding": null, "metadata": {"window": "And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Eric Coldwell :  And the commodity cost.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "836a3c25-a45a-42d4-8739-df5a2f124c8a", "node_type": "1", "metadata": {"window": "We have \nsome that\u2019s showing up in the segments.   And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "04cb21db314de18b31b69e870dd3b63283e9c080a7f7dc873edcb1d97992efd2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb0df3c6-3846-4200-b7bb-3369e522295e", "node_type": "1", "metadata": {"window": "I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Dave Evans :  Oh I\u2019m sorry.  "}, "hash": "c67b1a4c1b708bc1c295a54f2fe294cd32e70f52253e99d4aa4b9f51df8d43c7", "class_name": "RelatedNodeInfo"}}, "text": "Eric Coldwell :  And the commodity cost.  \n \n", "start_char_idx": 2079, "end_char_idx": 2124, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "eb0df3c6-3846-4200-b7bb-3369e522295e": {"__data__": {"id_": "eb0df3c6-3846-4200-b7bb-3369e522295e", "embedding": null, "metadata": {"window": "I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Dave Evans :  Oh I\u2019m sorry.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b4fd83dc-3d9f-46f1-a6d2-b14f41f4fac8", "node_type": "1", "metadata": {"window": "And then you may have noticed in  interest and other we have other \nchanged a bit and that\u2019s principally driven by FX.  \n \n  I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Eric Coldwell :  And the commodity cost.  \n \n", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5a4f7d9d024767c6ba36b0744bee304add156100523e5b659ec20be84d9dd9ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "23ab27d8-dbe2-491e-8846-671fe152e83f", "node_type": "1", "metadata": {"window": "I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n "}, "hash": "1f7f289adc4e32cb3a2787ad37882d592c43ec7e80e57a9de98c040590617e47", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Oh I\u2019m sorry.  ", "start_char_idx": 2124, "end_char_idx": 2153, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "23ab27d8-dbe2-491e-8846-671fe152e83f": {"__data__": {"id_": "23ab27d8-dbe2-491e-8846-671fe152e83f", "embedding": null, "metadata": {"window": "I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6", "node_type": "4", "metadata": {"page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21496832518c5a34b0591e9bf733b9862e0d5b5fa4c4fefbb87158924483c9e7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb0df3c6-3846-4200-b7bb-3369e522295e", "node_type": "1", "metadata": {"window": "I would say that on a net basis FX in the first quarter was reasonably neutral, was not a material driver positive or \nnegative.   I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Dave Evans :  Oh I\u2019m sorry.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d24db96603ff6a65780f7adf9df4e87021e0fe98dda3fb6ae498bc89efe2e230", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7b36d8f4-0dff-4232-918b-a1bc2b520ee1", "node_type": "1", "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.  ", "original_text": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n"}, "hash": "e05e78ff8d63f9acf2dfc0a993e40e02fbab919d038eff8f2a0aa0165940c2bb", "class_name": "RelatedNodeInfo"}}, "text": "Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "start_char_idx": 2153, "end_char_idx": 2198, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7b36d8f4-0dff-4232-918b-a1bc2b520ee1": {"__data__": {"id_": "7b36d8f4-0dff-4232-918b-a1bc2b520ee1", "embedding": null, "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.  ", "original_text": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "23ab27d8-dbe2-491e-8846-671fe152e83f", "node_type": "1", "metadata": {"window": "I think the team is doing an excellent j ob in managing this and navigating through this as appropriate.  \n \n Eric Coldwell :  And the commodity cost.  \n \n Dave Evans :  Oh I\u2019m sorry.   Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "original_text": "Commodity costs, yes so\u2026  \n \n (Crosstalk)  \n ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a5cba8d396210409e102cb6abaeeb216ccf1ca7a1fc65f38af22a09c9de731ee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab18bf8f-6843-4a87-9efb-3a546370ca8d", "node_type": "1", "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.  ", "original_text": "Dave Evans :  Yes. \n \n"}, "hash": "781644e32cae2929edf7cad1725711a07475ba8f2ffd340c34dd8d2068a1fb7d", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n", "start_char_idx": 0, "end_char_idx": 86, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ab18bf8f-6843-4a87-9efb-3a546370ca8d": {"__data__": {"id_": "ab18bf8f-6843-4a87-9efb-3a546370ca8d", "embedding": null, "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.  ", "original_text": "Dave Evans :  Yes. \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7b36d8f4-0dff-4232-918b-a1bc2b520ee1", "node_type": "1", "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.  ", "original_text": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "42628bd0d673cc5c5026ca268919cdd52a236690dceda1d8718a07e72bbc7b35", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9a153cc-339b-4485-b705-874faf97b3b6", "node_type": "1", "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.  ", "original_text": "Eric Coldwell :  Yes. \n \n"}, "hash": "971cf73cb955b0d967601939838fd4cd32ecbf871573f2c8622307cb9c9d21ed", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes. \n \n", "start_char_idx": 86, "end_char_idx": 108, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d9a153cc-339b-4485-b705-874faf97b3b6": {"__data__": {"id_": "d9a153cc-339b-4485-b705-874faf97b3b6", "embedding": null, "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.  ", "original_text": "Eric Coldwell :  Yes. \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab18bf8f-6843-4a87-9efb-3a546370ca8d", "node_type": "1", "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.  ", "original_text": "Dave Evans :  Yes. \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c726f2b5c1fa3dc8f08ff82c12cb8f32619b49c3d2fc43c56f749a360f220628", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f298d199-a863-4eab-9207-778261ef9c1d", "node_type": "1", "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n", "original_text": "Dave Evans :  Yes.  "}, "hash": "c1e9dafed4de55111658df7945bd789facbb871db1bd3c2d6f046fc875115baa", "class_name": "RelatedNodeInfo"}}, "text": "Eric Coldwell :  Yes. \n \n", "start_char_idx": 108, "end_char_idx": 133, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f298d199-a863-4eab-9207-778261ef9c1d": {"__data__": {"id_": "f298d199-a863-4eab-9207-778261ef9c1d", "embedding": null, "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n", "original_text": "Dave Evans :  Yes.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d9a153cc-339b-4485-b705-874faf97b3b6", "node_type": "1", "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.  ", "original_text": "Eric Coldwell :  Yes. \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ed08feb0912c1deaafe78a9438f9aaecbf113c60b9916454fc67a3a32acff531", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "05d636af-f453-465c-b558-67fc97ab2b16", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n", "original_text": "No, I apologize.  "}, "hash": "707ea224bc2f1fa4c4df1d90c44358b596f624c143efad140838499a1ec64a32", "class_name": "RelatedNodeInfo"}}, "text": "Dave Evans :  Yes.  ", "start_char_idx": 133, "end_char_idx": 153, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "05d636af-f453-465c-b558-67fc97ab2b16": {"__data__": {"id_": "05d636af-f453-465c-b558-67fc97ab2b16", "embedding": null, "metadata": {"window": "Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n", "original_text": "No, I apologize.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f298d199-a863-4eab-9207-778261ef9c1d", "node_type": "1", "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n", "original_text": "Dave Evans :  Yes.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "827d64acee9fa4d9f4ec3931ce562454cc7571d70ab1f81ebc2c01d79eb98363", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a7ba65f-1469-4890-b12c-93c7af09c3d3", "node_type": "1", "metadata": {"window": "Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n", "original_text": "Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.  "}, "hash": "c101a1ae90d4c15e551fba6b8ff83e65c750e562082532c6c786c864f7b79862", "class_name": "RelatedNodeInfo"}}, "text": "No, I apologize.  ", "start_char_idx": 153, "end_char_idx": 171, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7a7ba65f-1469-4890-b12c-93c7af09c3d3": {"__data__": {"id_": "7a7ba65f-1469-4890-b12c-93c7af09c3d3", "embedding": null, "metadata": {"window": "Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n", "original_text": "Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "05d636af-f453-465c-b558-67fc97ab2b16", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n", "original_text": "No, I apologize.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "46fa7365b6c9ca7d82557f6f8c50b44623f39a6632e7f9b99ae1de8555a05d1f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0916aa33-75bb-4859-ad95-ad4e1b0d1bab", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.  ", "original_text": "They were a headwind but not in a material way.  \n \n"}, "hash": "d152b24faf25bca79ed6c9d926e3aa2e57f91b15132aa44c08e19f80f08f7911", "class_name": "RelatedNodeInfo"}}, "text": "Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.  ", "start_char_idx": 171, "end_char_idx": 266, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0916aa33-75bb-4859-ad95-ad4e1b0d1bab": {"__data__": {"id_": "0916aa33-75bb-4859-ad95-ad4e1b0d1bab", "embedding": null, "metadata": {"window": "Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.  ", "original_text": "They were a headwind but not in a material way.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a7ba65f-1469-4890-b12c-93c7af09c3d3", "node_type": "1", "metadata": {"window": "Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n", "original_text": "Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "21a78bc9b9b0854d5cbe69fc34229b18e974c560bb838eaa4046aafea29cfbf3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "08dca213-c882-46a3-9ae8-f0bc388c94a1", "node_type": "1", "metadata": {"window": "No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n", "original_text": "Eric Coldwell :  Thanks very much.  \n \n"}, "hash": "f146ac9ca0b774e0372cc0a146e5324821c21d9be7797d816b8178d090813362", "class_name": "RelatedNodeInfo"}}, "text": "They were a headwind but not in a material way.  \n \n", "start_char_idx": 266, "end_char_idx": 318, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "08dca213-c882-46a3-9ae8-f0bc388c94a1": {"__data__": {"id_": "08dca213-c882-46a3-9ae8-f0bc388c94a1", "embedding": null, "metadata": {"window": "No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n", "original_text": "Eric Coldwell :  Thanks very much.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0916aa33-75bb-4859-ad95-ad4e1b0d1bab", "node_type": "1", "metadata": {"window": "Dave Evans :  Yes.   No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.  ", "original_text": "They were a headwind but not in a material way.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "03a0b1ee9a473046f84e6b4537e437e3fcac884e7f6e513569083b6eedadc76c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d639f79e-fff9-46f5-b2b4-0906a5f30072", "node_type": "1", "metadata": {"window": "Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.  ", "original_text": "Mike Kaufmann :  Absolutely and next question.  \n \n"}, "hash": "92411dd518e56b6ccf39ed7f0431d5e7eafc6d30476835dc21ec5e7e50e29863", "class_name": "RelatedNodeInfo"}}, "text": "Eric Coldwell :  Thanks very much.  \n \n", "start_char_idx": 318, "end_char_idx": 357, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d639f79e-fff9-46f5-b2b4-0906a5f30072": {"__data__": {"id_": "d639f79e-fff9-46f5-b2b4-0906a5f30072", "embedding": null, "metadata": {"window": "Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.  ", "original_text": "Mike Kaufmann :  Absolutely and next question.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "08dca213-c882-46a3-9ae8-f0bc388c94a1", "node_type": "1", "metadata": {"window": "No, I apologize.   Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n", "original_text": "Eric Coldwell :  Thanks very much.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "49c88d8cf75441366a5252624129d7d26cbb580bd616d5e3f1a2a36ad1189f42", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bbc3549a-063a-4daf-a6e2-f28ec1bba8d8", "node_type": "1", "metadata": {"window": "They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?  ", "original_text": "Operator :  Thank you.  "}, "hash": "2578055e4e6a47cff0d3f4fb8bacb3ab8d59a613fcde5ede58dc6ad227f42366", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Absolutely and next question.  \n \n", "start_char_idx": 357, "end_char_idx": 408, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bbc3549a-063a-4daf-a6e2-f28ec1bba8d8": {"__data__": {"id_": "bbc3549a-063a-4daf-a6e2-f28ec1bba8d8", "embedding": null, "metadata": {"window": "They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?  ", "original_text": "Operator :  Thank you.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d639f79e-fff9-46f5-b2b4-0906a5f30072", "node_type": "1", "metadata": {"window": "Let me \u2013 so commodities for us in the first quarter, I \u2019d describe them as a small \nheadwind.   They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.  ", "original_text": "Mike Kaufmann :  Absolutely and next question.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1060bdd6d40756b5a4577e62a0e97ebcc7bce71d13f7ed5a6a3769efc2757185", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2568b6bc-483a-498d-9097-bec593f33d54", "node_type": "1", "metadata": {"window": "Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n", "original_text": "We will take our final question from Kevin Caliendo from UBS.  \n \n"}, "hash": "d74eb2eb3fa721057da13f44c1b9556c4228e9b1acaa387f4d9b693496ad7551", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Thank you.  ", "start_char_idx": 408, "end_char_idx": 432, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2568b6bc-483a-498d-9097-bec593f33d54": {"__data__": {"id_": "2568b6bc-483a-498d-9097-bec593f33d54", "embedding": null, "metadata": {"window": "Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n", "original_text": "We will take our final question from Kevin Caliendo from UBS.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bbc3549a-063a-4daf-a6e2-f28ec1bba8d8", "node_type": "1", "metadata": {"window": "They were a headwind but not in a material way.  \n \n Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?  ", "original_text": "Operator :  Thank you.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "541c9ed921e69e1ae4fda8dad107710f648370a95cca227cb3fff44cd7563f9a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "77d658cf-1ce0-4945-a4c9-f7bfb8cba34b", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.  ", "original_text": "Kevin Caliendo :  And thanks for getting me in guys.  "}, "hash": "02697197b5d1acbae915f333e73fc2020d31e145cdf24882cedded0f78d59941", "class_name": "RelatedNodeInfo"}}, "text": "We will take our final question from Kevin Caliendo from UBS.  \n \n", "start_char_idx": 432, "end_char_idx": 498, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "77d658cf-1ce0-4945-a4c9-f7bfb8cba34b": {"__data__": {"id_": "77d658cf-1ce0-4945-a4c9-f7bfb8cba34b", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.  ", "original_text": "Kevin Caliendo :  And thanks for getting me in guys.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2568b6bc-483a-498d-9097-bec593f33d54", "node_type": "1", "metadata": {"window": "Eric Coldwell :  Thanks very much.  \n \n Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n", "original_text": "We will take our final question from Kevin Caliendo from UBS.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "02261cf23b9a108bfb7347ff6ddaaa06fe8466cd2ad96f3315ae97c608a3a772", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "818929db-9188-4048-9060-667f53e702c4", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.  ", "original_text": "So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?  "}, "hash": "eb4753df1ae161f67ed66b62f8a31d1aea05da2f2cb42c8d185be6008b85a0f9", "class_name": "RelatedNodeInfo"}}, "text": "Kevin Caliendo :  And thanks for getting me in guys.  ", "start_char_idx": 498, "end_char_idx": 552, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "818929db-9188-4048-9060-667f53e702c4": {"__data__": {"id_": "818929db-9188-4048-9060-667f53e702c4", "embedding": null, "metadata": {"window": "Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.  ", "original_text": "So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "77d658cf-1ce0-4945-a4c9-f7bfb8cba34b", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Absolutely and next question.  \n \n Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.  ", "original_text": "Kevin Caliendo :  And thanks for getting me in guys.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5153649f84df51dbc03ea78e7be1434f102766e1c7b67a96bc610c597692cb86", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "987d8d6b-c77c-4b1d-934e-bfc6d40e2bba", "node_type": "1", "metadata": {"window": "We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.  ", "original_text": "T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n"}, "hash": "57960a4c1ce3842394321d25ac009e16e3512d378d0082313a54c8a73d48cdf7", "class_name": "RelatedNodeInfo"}}, "text": "So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?  ", "start_char_idx": 552, "end_char_idx": 758, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "987d8d6b-c77c-4b1d-934e-bfc6d40e2bba": {"__data__": {"id_": "987d8d6b-c77c-4b1d-934e-bfc6d40e2bba", "embedding": null, "metadata": {"window": "We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.  ", "original_text": "T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "818929db-9188-4048-9060-667f53e702c4", "node_type": "1", "metadata": {"window": "Operator :  Thank you.   We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.  ", "original_text": "So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "5e84455cb52e02fa1b0e02770b9ef3ddb862cb533a85bdc87ebf12e36781bc58", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "da05fc83-0262-4702-b2d4-98a4a97bd0fd", "node_type": "1", "metadata": {"window": "Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n ", "original_text": "Mike Kaufmann :  Yes thanks for the question Kevin.  "}, "hash": "fdbe2692741b51b9bcbfb06ca94910e966c912aafeb12487c3bc84422574e2b5", "class_name": "RelatedNodeInfo"}}, "text": "T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n", "start_char_idx": 758, "end_char_idx": 917, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "da05fc83-0262-4702-b2d4-98a4a97bd0fd": {"__data__": {"id_": "da05fc83-0262-4702-b2d4-98a4a97bd0fd", "embedding": null, "metadata": {"window": "Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n ", "original_text": "Mike Kaufmann :  Yes thanks for the question Kevin.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "987d8d6b-c77c-4b1d-934e-bfc6d40e2bba", "node_type": "1", "metadata": {"window": "We will take our final question from Kevin Caliendo from UBS.  \n \n Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.  ", "original_text": "T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "e0295648b368341ce3837cd3d560a154f1b02b1a8e1b7658cd2c1f9827edd2b6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d4766f10-bae8-4c56-b22e-35aa8642fead", "node_type": "1", "metadata": {"window": "So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.  ", "original_text": "I \u2013 you know look, it\u2019s still too early to tell.  "}, "hash": "91c73e468a818e665d4162595269837e45879a699099c7bb7b8b44fda4eef288", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes thanks for the question Kevin.  ", "start_char_idx": 917, "end_char_idx": 970, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d4766f10-bae8-4c56-b22e-35aa8642fead": {"__data__": {"id_": "d4766f10-bae8-4c56-b22e-35aa8642fead", "embedding": null, "metadata": {"window": "So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.  ", "original_text": "I \u2013 you know look, it\u2019s still too early to tell.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "da05fc83-0262-4702-b2d4-98a4a97bd0fd", "node_type": "1", "metadata": {"window": "Kevin Caliendo :  And thanks for getting me in guys.   So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n ", "original_text": "Mike Kaufmann :  Yes thanks for the question Kevin.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ca62f8b744546e0c653526f28cc3855a67f52432eee0fbb41d8eeedebd14ec75", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d71516e3-2772-4167-a95a-058fc5eeb6c4", "node_type": "1", "metadata": {"window": "T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.  ", "original_text": "A s I said, this global \nframework does only impact the first two buckets.  "}, "hash": "72fe23100818c3e760c297427814237f1974e4173d15b9a4221dc580d5bc8c93", "class_name": "RelatedNodeInfo"}}, "text": "I \u2013 you know look, it\u2019s still too early to tell.  ", "start_char_idx": 970, "end_char_idx": 1020, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d71516e3-2772-4167-a95a-058fc5eeb6c4": {"__data__": {"id_": "d71516e3-2772-4167-a95a-058fc5eeb6c4", "embedding": null, "metadata": {"window": "T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.  ", "original_text": "A s I said, this global \nframework does only impact the first two buckets.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d4766f10-bae8-4c56-b22e-35aa8642fead", "node_type": "1", "metadata": {"window": "So my question on the opioids is just how much confidence do you \nhave that $18 billion over 18 years that this will be the final layout in the level 3 or the Tier 3 groupings that you \nmentioned earlier?   T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.  ", "original_text": "I \u2013 you know look, it\u2019s still too early to tell.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d1cfe141e9c3ff407478779d7e87a0975e8fdbe21d00143ee850cd86618255e1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3f379839-fa72-470c-b622-a7a8959d3d65", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.  ", "original_text": "There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n "}, "hash": "e1ce1eb625719d21df19f51f1bddde2c1cce8a27ac5786fa34f7d3620cfb439b", "class_name": "RelatedNodeInfo"}}, "text": "A s I said, this global \nframework does only impact the first two buckets.  ", "start_char_idx": 1020, "end_char_idx": 1096, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "3f379839-fa72-470c-b622-a7a8959d3d65": {"__data__": {"id_": "3f379839-fa72-470c-b622-a7a8959d3d65", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.  ", "original_text": "There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d71516e3-2772-4167-a95a-058fc5eeb6c4", "node_type": "1", "metadata": {"window": "T hat this is really going to be the final number of the MDL and for everybody else and that you \ncan really put this to bed with this kind of settlement.  \n \n Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.  ", "original_text": "A s I said, this global \nframework does only impact the first two buckets.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "04f2d5a4ed478cc3cb1628e49ff25c627f60c4580a74f4815802c28f51761d48", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "11decd58-dd47-4c29-87ac-209480594513", "node_type": "1", "metadata": {"window": "I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.  ", "original_text": "But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.  "}, "hash": "c7d1a386a8c1384a27c53e04cc3b0f3e715a6a44935979c40d42dbc5ab212cd0", "class_name": "RelatedNodeInfo"}}, "text": "There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n ", "start_char_idx": 1096, "end_char_idx": 1218, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "11decd58-dd47-4c29-87ac-209480594513": {"__data__": {"id_": "11decd58-dd47-4c29-87ac-209480594513", "embedding": null, "metadata": {"window": "I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.  ", "original_text": "But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3f379839-fa72-470c-b622-a7a8959d3d65", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Yes thanks for the question Kevin.   I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.  ", "original_text": "There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "fefd6d1feed064023b4eafb51ec3bfd58f9d0cfe3678b60be4f6f3106f11d449", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "22239507-aeeb-4183-9dcc-10c4a606103c", "node_type": "1", "metadata": {"window": "A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n ", "original_text": "And this framework is something that we support.  "}, "hash": "90cb90f2ae3637a7bf5f8cd65f05292405a10634fd5436596758591d7eb689bf", "class_name": "RelatedNodeInfo"}}, "text": "But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.  ", "start_char_idx": 1218, "end_char_idx": 1346, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "22239507-aeeb-4183-9dcc-10c4a606103c": {"__data__": {"id_": "22239507-aeeb-4183-9dcc-10c4a606103c", "embedding": null, "metadata": {"window": "A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n ", "original_text": "And this framework is something that we support.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "11decd58-dd47-4c29-87ac-209480594513", "node_type": "1", "metadata": {"window": "I \u2013 you know look, it\u2019s still too early to tell.   A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.  ", "original_text": "But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a89ac3f40a18d70f949be132d741b15c3bb2fd9dd953004488701e0b805ce582", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "107516bf-dfb3-49c0-a2be-07e38109110d", "node_type": "1", "metadata": {"window": "There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n", "original_text": "We like that it\u2019s being supported by a bipartisan \ngroup of AGs.  "}, "hash": "83dc810d3cb47a5bc62ca816cc70a37bfb514542d16a9f10a04a9b33bb316f1a", "class_name": "RelatedNodeInfo"}}, "text": "And this framework is something that we support.  ", "start_char_idx": 1346, "end_char_idx": 1396, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "107516bf-dfb3-49c0-a2be-07e38109110d": {"__data__": {"id_": "107516bf-dfb3-49c0-a2be-07e38109110d", "embedding": null, "metadata": {"window": "There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n", "original_text": "We like that it\u2019s being supported by a bipartisan \ngroup of AGs.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "22239507-aeeb-4183-9dcc-10c4a606103c", "node_type": "1", "metadata": {"window": "A s I said, this global \nframework does only impact the first two buckets.   There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n ", "original_text": "And this framework is something that we support.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "2529c6b3aca4f099b9b34580e14a7d0ba808e381297115c9e360f58fbc7783b3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c27c0ef2-ad91-44d6-a426-c73bd872e140", "node_type": "1", "metadata": {"window": "But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.  ", "original_text": "And it\u2019s something that we\u2019re behind.  "}, "hash": "cda307f054d783d41a5d8c7b4ab2b1dc3cf3e60deaeabe0b9f0b8ea28c36e646", "class_name": "RelatedNodeInfo"}}, "text": "We like that it\u2019s being supported by a bipartisan \ngroup of AGs.  ", "start_char_idx": 1396, "end_char_idx": 1462, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c27c0ef2-ad91-44d6-a426-c73bd872e140": {"__data__": {"id_": "c27c0ef2-ad91-44d6-a426-c73bd872e140", "embedding": null, "metadata": {"window": "But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.  ", "original_text": "And it\u2019s something that we\u2019re behind.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "107516bf-dfb3-49c0-a2be-07e38109110d", "node_type": "1", "metadata": {"window": "There is no accrual or ability to even estimate and understand \nthe size of the last bucket that we\u2019ve talked about.  \n \n  But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n", "original_text": "We like that it\u2019s being supported by a bipartisan \ngroup of AGs.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1cb4001f2c541e259164af891bfd0c45032719d8cf93ae60e8c95cb017bf529e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0f008cfe-5d81-4336-bf09-553bd1b9e32d", "node_type": "1", "metadata": {"window": "And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.  ", "original_text": "But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n "}, "hash": "91b1ec64ed32b2f541b470a6a249e238db7823f1a5c024873aa0dc58751d5030", "class_name": "RelatedNodeInfo"}}, "text": "And it\u2019s something that we\u2019re behind.  ", "start_char_idx": 1462, "end_char_idx": 1501, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0f008cfe-5d81-4336-bf09-553bd1b9e32d": {"__data__": {"id_": "0f008cfe-5d81-4336-bf09-553bd1b9e32d", "embedding": null, "metadata": {"window": "And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.  ", "original_text": "But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c27c0ef2-ad91-44d6-a426-c73bd872e140", "node_type": "1", "metadata": {"window": "But as far as the global framework we have separate both the acco unting and the likelihood of this getting done in \nour mind.   And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.  ", "original_text": "And it\u2019s something that we\u2019re behind.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "41d882b442439e2f849881fe3d5ac2b7444d0646a05ad894a5529aeee774b1dc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0549446e-5f1d-4dd8-b86b-f63fc79c6194", "node_type": "1", "metadata": {"window": "We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n", "original_text": "But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n"}, "hash": "ac279f7cf126a1fdb4676af0463cab07f28aab46e2ed3416b06ae0536b2b10d5", "class_name": "RelatedNodeInfo"}}, "text": "But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n ", "start_char_idx": 1501, "end_char_idx": 1583, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0549446e-5f1d-4dd8-b86b-f63fc79c6194": {"__data__": {"id_": "0549446e-5f1d-4dd8-b86b-f63fc79c6194", "embedding": null, "metadata": {"window": "We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n", "original_text": "But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0f008cfe-5d81-4336-bf09-553bd1b9e32d", "node_type": "1", "metadata": {"window": "And this framework is something that we support.   We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.  ", "original_text": "But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ab7b3108679b100ffb10c061c4a6f0163f0d87d1fcf8a59014fd522cb8c2946d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f0cbd69e-218c-4fdc-949a-09705318e38a", "node_type": "1", "metadata": {"window": "And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.  ", "original_text": "Kevin Caliendo :  Sure.  "}, "hash": "119e14b72e9e45ca4bf48f234671e930bd9e5073e2ef24c32e28de3ce15f18dc", "class_name": "RelatedNodeInfo"}}, "text": "But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n", "start_char_idx": 1583, "end_char_idx": 1875, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "f0cbd69e-218c-4fdc-949a-09705318e38a": {"__data__": {"id_": "f0cbd69e-218c-4fdc-949a-09705318e38a", "embedding": null, "metadata": {"window": "And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.  ", "original_text": "Kevin Caliendo :  Sure.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0549446e-5f1d-4dd8-b86b-f63fc79c6194", "node_type": "1", "metadata": {"window": "We like that it\u2019s being supported by a bipartisan \ngroup of AGs.   And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n", "original_text": "But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "33131b1069959c9824df7deba240e87decd661035439d8e1452568c33223ca65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3ffba10-5d79-4e7b-a8ce-3288ea658980", "node_type": "1", "metadata": {"window": "But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.  ", "original_text": "And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.  "}, "hash": "81f084fdd336bcbd63518d518b89c493f8669d15ffd84c7dd2f5a0cbbf7062f2", "class_name": "RelatedNodeInfo"}}, "text": "Kevin Caliendo :  Sure.  ", "start_char_idx": 1875, "end_char_idx": 1900, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b3ffba10-5d79-4e7b-a8ce-3288ea658980": {"__data__": {"id_": "b3ffba10-5d79-4e7b-a8ce-3288ea658980", "embedding": null, "metadata": {"window": "But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.  ", "original_text": "And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f0cbd69e-218c-4fdc-949a-09705318e38a", "node_type": "1", "metadata": {"window": "And it\u2019s something that we\u2019re behind.   But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.  ", "original_text": "Kevin Caliendo :  Sure.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "92cf63ab6e206bab707150c86f16a6b08b3464f8f33838227afd13dfcbad0b12", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8d897223-61c4-4252-8dd4-afa42b5b0d9b", "node_type": "1", "metadata": {"window": "But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n"}, "hash": "7ef027eaf71e25c7dfaaf42e7ca2346814fbe715005c77740ead4c57599f8ad1", "class_name": "RelatedNodeInfo"}}, "text": "And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.  ", "start_char_idx": 1900, "end_char_idx": 2041, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "8d897223-61c4-4252-8dd4-afa42b5b0d9b": {"__data__": {"id_": "8d897223-61c4-4252-8dd4-afa42b5b0d9b", "embedding": null, "metadata": {"window": "But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b3ffba10-5d79-4e7b-a8ce-3288ea658980", "node_type": "1", "metadata": {"window": "But it\u2019s still too early to tell you whet her or not it will be \nsuccessful.  \n \n  But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.  ", "original_text": "And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "50a8c982d05c6b0ed4b235c501088082162c4f7f3b0b83fd2b01ab531638a81d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1589309f-da8a-49db-b605-841d70de1422", "node_type": "1", "metadata": {"window": "Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "Mike Kaufmann :  Yes, that\u2019s something.  "}, "hash": "c0b0836be1f1b07c8bf61110afeb211cc343ebd4284f426bde78011bfc992623", "class_name": "RelatedNodeInfo"}}, "text": "Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n", "start_char_idx": 2041, "end_char_idx": 2223, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1589309f-da8a-49db-b605-841d70de1422": {"__data__": {"id_": "1589309f-da8a-49db-b605-841d70de1422", "embedding": null, "metadata": {"window": "Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "Mike Kaufmann :  Yes, that\u2019s something.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8d897223-61c4-4252-8dd4-afa42b5b0d9b", "node_type": "1", "metadata": {"window": "But we do think not only is it something that we can support and has the support of them but it\u2019s something that\u2019s \nimportant to the people that need it much most because it will get dollars, free drugs and some potential ly new \nprocesses out there that I think all benefit the country.  \n \n Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "aa23cbe1877984f6593aea14cd854db3025d9021418f4c82542eeec983028dc8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5018f4dc-a3cf-4148-a349-ce57f18513d8", "node_type": "1", "metadata": {"window": "And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.  "}, "hash": "bf54d560c55188206a1d010a33b59b4ca500aa5f7604b22e242b8e868638a48b", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Yes, that\u2019s something.  ", "start_char_idx": 2223, "end_char_idx": 2264, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5018f4dc-a3cf-4148-a349-ce57f18513d8": {"__data__": {"id_": "5018f4dc-a3cf-4148-a349-ce57f18513d8", "embedding": null, "metadata": {"window": "And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1589309f-da8a-49db-b605-841d70de1422", "node_type": "1", "metadata": {"window": "Kevin Caliendo :  Sure.   And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "Mike Kaufmann :  Yes, that\u2019s something.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "432ab3bdbf118b479a887ef073915310ead82b23c3765ef45873a4ebb7775638", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "10422c86-3a4e-43dd-95fe-dee2804c8ed9", "node_type": "1", "metadata": {"window": "Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n "}, "hash": "20e1ca150a7d9a18fe1f9ac2ede9b2e9f37cedf1c04ed6b43adbd1acc53f2110", "class_name": "RelatedNodeInfo"}}, "text": "You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.  ", "start_char_idx": 2264, "end_char_idx": 2367, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "10422c86-3a4e-43dd-95fe-dee2804c8ed9": {"__data__": {"id_": "10422c86-3a4e-43dd-95fe-dee2804c8ed9", "embedding": null, "metadata": {"window": "Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "6011d214-9584-4479-94e7-01904bd5e931", "node_type": "4", "metadata": {"page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "6136a700607a94787326d0a81b874b570f2a99606416497ef8f3a61d24bc76a0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5018f4dc-a3cf-4148-a349-ce57f18513d8", "node_type": "1", "metadata": {"window": "And just one quick follow -up, when we were out visiting you guys you talked about a restructuring \nof the medical salesforce compensation.   Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.  ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "7ddae822e1d76e6d1809ffce7e705b4e41c7ce7af1c66298895765071854e89e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "00ca753f-4462-4ec4-a182-9f7b50853ffe", "node_type": "1", "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n ", "original_text": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n "}, "hash": "d9f7b46329e9db3ff4915898ef9d68d1d5b1ecb0f3635e341aa7288d9705057a", "class_name": "RelatedNodeInfo"}}, "text": "As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "start_char_idx": 2367, "end_char_idx": 2642, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "00ca753f-4462-4ec4-a182-9f7b50853ffe": {"__data__": {"id_": "00ca753f-4462-4ec4-a182-9f7b50853ffe", "embedding": null, "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n ", "original_text": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "10422c86-3a4e-43dd-95fe-dee2804c8ed9", "node_type": "1", "metadata": {"window": "Did that impact 3Q in any w ay or and how are you thinking about the \nimpact of what that \u2013 the incentive program for salesforce might have or have had on medical going forward?  \n \n Mike Kaufmann :  Yes, that\u2019s something.   You know it\u2019s one of the really key things going on in medical tha t Steve and the \nteam are leading.   As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "original_text": "As I mentioned in the prepared remarks this structure, restructure is a component of not only \ncompensation and sales incentives but also around how we go to market to best address selling to the customers \nthey want to \u2013 to the customers the way they want to be sold to.  \n ", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "46a557638158aec22d2ba5f3476a91a2e591d7fe13f41c41a9d7ee6a85ea9299", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "985adcd8-be24-4cb6-9568-cb1fb260d748", "node_type": "1", "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n ", "original_text": "And so this restructuring was highly defined by a lot of detailed work.  "}, "hash": "7e67a2270496d93c49f42dbe15014ae61236a2e4073d9fe0bc701a2369f50888", "class_name": "RelatedNodeInfo"}}, "text": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n ", "start_char_idx": 0, "end_char_idx": 179, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "985adcd8-be24-4cb6-9568-cb1fb260d748": {"__data__": {"id_": "985adcd8-be24-4cb6-9568-cb1fb260d748", "embedding": null, "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n ", "original_text": "And so this restructuring was highly defined by a lot of detailed work.  ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "00ca753f-4462-4ec4-a182-9f7b50853ffe", "node_type": "1", "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n ", "original_text": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "d7b2f0e829417b173c4f18e8142b3aa8eb4b98f813a944007d6d14bba2465fee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "afe64738-2f7e-4bd2-b7b5-e93b8b199ea1", "node_type": "1", "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n", "original_text": "We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n "}, "hash": "e7ace0aa80c0a33db1100abdbfa204fa4bc4b486d5575cfd02c68336ac4bed77", "class_name": "RelatedNodeInfo"}}, "text": "And so this restructuring was highly defined by a lot of detailed work.  ", "start_char_idx": 179, "end_char_idx": 252, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "afe64738-2f7e-4bd2-b7b5-e93b8b199ea1": {"__data__": {"id_": "afe64738-2f7e-4bd2-b7b5-e93b8b199ea1", "embedding": null, "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n", "original_text": "We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "985adcd8-be24-4cb6-9568-cb1fb260d748", "node_type": "1", "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n ", "original_text": "And so this restructuring was highly defined by a lot of detailed work.  ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "992fa32406d2a06863e006d8f8018b06ab67821516cb28492cbc41db1d161387", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4a716bb6-6297-4419-b0d3-63a5db610401", "node_type": "1", "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n", "original_text": "And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n "}, "hash": "ebea2bfd7b88e542e58a079f95c25fd0b383c71d14e6caa5c97fb47fd856112c", "class_name": "RelatedNodeInfo"}}, "text": "We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n ", "start_char_idx": 252, "end_char_idx": 508, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "4a716bb6-6297-4419-b0d3-63a5db610401": {"__data__": {"id_": "4a716bb6-6297-4419-b0d3-63a5db610401", "embedding": null, "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n", "original_text": "And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "afe64738-2f7e-4bd2-b7b5-e93b8b199ea1", "node_type": "1", "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n", "original_text": "We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "340906ab2e43192e03bbe040ddd608230c73008f38ec43fbcafa983f37bf490f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "12c03ddd-d23e-4551-a66e-6ebc03776f73", "node_type": "1", "metadata": {"window": "And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.  ", "original_text": "So really excited about it and like the progress we\u2019re making.  \n \n "}, "hash": "b3c5a7d62c71a24e5985a0bec146b7bb349c20c27dabf036950f6a797e306191", "class_name": "RelatedNodeInfo"}}, "text": "And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n ", "start_char_idx": 508, "end_char_idx": 686, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "12c03ddd-d23e-4551-a66e-6ebc03776f73": {"__data__": {"id_": "12c03ddd-d23e-4551-a66e-6ebc03776f73", "embedding": null, "metadata": {"window": "And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.  ", "original_text": "So really excited about it and like the progress we\u2019re making.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4a716bb6-6297-4419-b0d3-63a5db610401", "node_type": "1", "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n", "original_text": "And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "ecfcefcb50c3b8be56988fc2d8f09395d47e44f6ecbd8df902e56f3b481fe1e5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7f2aa4bb-3932-454f-a60b-0f0cb022109e", "node_type": "1", "metadata": {"window": "We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n", "original_text": "So next question.  \n \n"}, "hash": "170fea2e5f8f934fae9fe458f0950e25481d39330ab2a47249388585ed9c9231", "class_name": "RelatedNodeInfo"}}, "text": "So really excited about it and like the progress we\u2019re making.  \n \n ", "start_char_idx": 686, "end_char_idx": 754, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7f2aa4bb-3932-454f-a60b-0f0cb022109e": {"__data__": {"id_": "7f2aa4bb-3932-454f-a60b-0f0cb022109e", "embedding": null, "metadata": {"window": "We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n", "original_text": "So next question.  \n \n", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "12c03ddd-d23e-4551-a66e-6ebc03776f73", "node_type": "1", "metadata": {"window": "And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.  ", "original_text": "So really excited about it and like the progress we\u2019re making.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "a4352a87be332723dbf0b860922d755391241a96c22ddbfeb98cc5b3a5ffce00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "85926430-8dc8-4341-9233-7fd38c8f59d0", "node_type": "1", "metadata": {"window": "And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n", "original_text": "Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n"}, "hash": "27c9b1e0934ea7bbf01df018f1fe4f3e38f52790c2b5232aadaecff0525ad07f", "class_name": "RelatedNodeInfo"}}, "text": "So next question.  \n \n", "start_char_idx": 754, "end_char_idx": 776, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "85926430-8dc8-4341-9233-7fd38c8f59d0": {"__data__": {"id_": "85926430-8dc8-4341-9233-7fd38c8f59d0", "embedding": null, "metadata": {"window": "And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n", "original_text": "Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7f2aa4bb-3932-454f-a60b-0f0cb022109e", "node_type": "1", "metadata": {"window": "We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n", "original_text": "So next question.  \n \n", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "f5e42a9e7dd4546811b207c0fa43e0abbf16c003220e31e88ad9ee877d3787c3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d6480018-caa8-454d-be55-75dee2297ec8", "node_type": "1", "metadata": {"window": "So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.  ", "original_text": "Mike Kaufmann :  Well thank you all for joining us this morning.  "}, "hash": "a4b1970bee35974fc9ae334332fbffddb3486efc68a686baac38fc4462b9deea", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n", "start_char_idx": 776, "end_char_idx": 900, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "d6480018-caa8-454d-be55-75dee2297ec8": {"__data__": {"id_": "d6480018-caa8-454d-be55-75dee2297ec8", "embedding": null, "metadata": {"window": "So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.  ", "original_text": "Mike Kaufmann :  Well thank you all for joining us this morning.  ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "85926430-8dc8-4341-9233-7fd38c8f59d0", "node_type": "1", "metadata": {"window": "And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n  So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n", "original_text": "Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "8962546a6f255a1dbe64723039cee9f0df78b51aed3a3009797692f69c1db77d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28495663-ca6b-4084-a9f2-e25920e21c3a", "node_type": "1", "metadata": {"window": "So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.  ", "original_text": "We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n"}, "hash": "58af5ada8315ac301dd488c806467bfa3aef33389c3dbc7812352da148e5508f", "class_name": "RelatedNodeInfo"}}, "text": "Mike Kaufmann :  Well thank you all for joining us this morning.  ", "start_char_idx": 900, "end_char_idx": 966, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "28495663-ca6b-4084-a9f2-e25920e21c3a": {"__data__": {"id_": "28495663-ca6b-4084-a9f2-e25920e21c3a", "embedding": null, "metadata": {"window": "So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.  ", "original_text": "We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d6480018-caa8-454d-be55-75dee2297ec8", "node_type": "1", "metadata": {"window": "So really excited about it and like the progress we\u2019re making.  \n \n  So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.  ", "original_text": "Mike Kaufmann :  Well thank you all for joining us this morning.  ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "324dc662426b6cf4131d9be88d67280d05a210606750443412ce28ce9ef3cc78", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "317662e7-a6aa-4d06-9255-c35362ed3bc1", "node_type": "1", "metadata": {"window": "Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "And we look forward to seeing many of you in the coming months, take care everyone.  \n \n"}, "hash": "4c5fb869af3d481596a065ec077bccb82b91491175e7dbf9616dc3e50cb2ab25", "class_name": "RelatedNodeInfo"}}, "text": "We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n", "start_char_idx": 966, "end_char_idx": 1031, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "317662e7-a6aa-4d06-9255-c35362ed3bc1": {"__data__": {"id_": "317662e7-a6aa-4d06-9255-c35362ed3bc1", "embedding": null, "metadata": {"window": "Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "And we look forward to seeing many of you in the coming months, take care everyone.  \n \n", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "28495663-ca6b-4084-a9f2-e25920e21c3a", "node_type": "1", "metadata": {"window": "So next question.  \n \n Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.  ", "original_text": "We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "c9cb38a3843ba55cc3039a16c550b7b6b533f323fd12954d2977b9181a0c7c2c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ea45079f-5525-4580-836a-3dacaa005dd6", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "Operator :  Ladies and gentlemen this concludes today\u2019s call.  "}, "hash": "0f001c7c44bd70f74047dc839b6368c42b7859d97bee5635ae968075376a6cd1", "class_name": "RelatedNodeInfo"}}, "text": "And we look forward to seeing many of you in the coming months, take care everyone.  \n \n", "start_char_idx": 1031, "end_char_idx": 1119, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ea45079f-5525-4580-836a-3dacaa005dd6": {"__data__": {"id_": "ea45079f-5525-4580-836a-3dacaa005dd6", "embedding": null, "metadata": {"window": "Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "Operator :  Ladies and gentlemen this concludes today\u2019s call.  ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "317662e7-a6aa-4d06-9255-c35362ed3bc1", "node_type": "1", "metadata": {"window": "Operator :  There are no further questions so I\u2019d like to hand back to your host for any additional or closing remarks.  \n \n Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "And we look forward to seeing many of you in the coming months, take care everyone.  \n \n", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "1bae504ae810a2e4878dca2cb354e7069e76838a50e1ab648f22049e224e037b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1563aab8-c8e3-4b19-a5ed-feb3a409ff5f", "node_type": "1", "metadata": {"window": "We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "Thank you all for your participation.  "}, "hash": "cd76f9a69cfe80f146d5fbae47d68406ea5f6ef1f8b37581be3b81135594acad", "class_name": "RelatedNodeInfo"}}, "text": "Operator :  Ladies and gentlemen this concludes today\u2019s call.  ", "start_char_idx": 1119, "end_char_idx": 1182, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1563aab8-c8e3-4b19-a5ed-feb3a409ff5f": {"__data__": {"id_": "1563aab8-c8e3-4b19-a5ed-feb3a409ff5f", "embedding": null, "metadata": {"window": "We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "Thank you all for your participation.  ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ea45079f-5525-4580-836a-3dacaa005dd6", "node_type": "1", "metadata": {"window": "Mike Kaufmann :  Well thank you all for joining us this morning.   We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "Operator :  Ladies and gentlemen this concludes today\u2019s call.  ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "9a85c22603755caf8a1586f316dec07880ea2db6442be0bb76d2200b32fd6ea2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "32151a96-bb44-4b49-9185-1e34efab6a0d", "node_type": "1", "metadata": {"window": "And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "You may now \ndisconnect.  \n "}, "hash": "a23e44e3d7b872a3227073f9694fbb594786c8258903bae2a0f32c1e295bbdf3", "class_name": "RelatedNodeInfo"}}, "text": "Thank you all for your participation.  ", "start_char_idx": 1182, "end_char_idx": 1221, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "32151a96-bb44-4b49-9185-1e34efab6a0d": {"__data__": {"id_": "32151a96-bb44-4b49-9185-1e34efab6a0d", "embedding": null, "metadata": {"window": "And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "You may now \ndisconnect.  \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date", "window", "original_text"], "relationships": {"1": {"node_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173", "node_type": "4", "metadata": {"page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "59d452546692fd6a37d6424a62bf47acc775de2a95333db3f44b1d36f01f7e89", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1563aab8-c8e3-4b19-a5ed-feb3a409ff5f", "node_type": "1", "metadata": {"window": "We\u2019re really pleased to be off to a solid start to our FY \u201920.  \n And we look forward to seeing many of you in the coming months, take care everyone.  \n \n Operator :  Ladies and gentlemen this concludes today\u2019s call.   Thank you all for your participation.   You may now \ndisconnect.  \n ", "original_text": "Thank you all for your participation.  ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}, "hash": "39b38667f8d4f28cb29e84e622e279f2d7a0d5e22e641ed808ca31a3078116fb", "class_name": "RelatedNodeInfo"}}, "text": "You may now \ndisconnect.  \n ", "start_char_idx": 1221, "end_char_idx": 1249, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/metadata": {"098ccb5c-214c-46bf-b7dd-9dae7fed19d5": {"doc_hash": "b467db74ec06bce240b09a77673a9ad747753621c8392b04b3cc22d131b2a826", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "45a8395b-0609-45de-ad6f-e8e3cce6c859": {"doc_hash": "6c9da37446233d2e8475f2ed7fe1b698b54721f3be41ca88f09e8465c950d9ae", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "87ad53bb-b659-42f8-8706-40cf40a96774": {"doc_hash": "534a59b78a97a28ffd34a88e591dd2818256aede3b60568aaaa3812da874bfe6", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "774fd6e0-1db6-4751-9d4b-fbc061993e21": {"doc_hash": "5a46ca9ef74e6cd881627b2cb60a393092a0291201d46b5e16916a30c1cd764c", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "ad0ac148-29ae-40e9-a9ca-7ca7675d2ebb": {"doc_hash": "16723a3a8390e300c0bf6cc628aa35a354e8ba8a96e2ab88650a471a679fd792", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "163e46d2-211c-45d1-9f8c-781e34b80a83": {"doc_hash": "ebf626c5c72bd8604d1db693cc27f9107a5c91aef22ce5c635ee44dbf9f9a31a", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "08019cc7-7082-4aa3-9531-bd7053620f1e": {"doc_hash": "c89d96c1288c6a6df1aa4157348390816ff1fac5977789e9730db93f2599db12", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "7c2e14cd-aab5-4dcf-86f0-786e1400edcb": {"doc_hash": "a950b92777ce388654d266b78ba187f5b8cf52fa4ed0432119da85df0eea4730", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "d54bf293-03eb-4329-b9f8-d6e311ba7da4": {"doc_hash": "f6e4c6edcd5c81ce1a876e398f71fa598d68c5a43df9d38748f808c498721891", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "973bc324-8b97-484b-aa3d-7b6a9dda50cf": {"doc_hash": "2ecd276e3636db952d4ed0dc99f5fe0f4010405746c40bc3d0706a53098861e1", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "d1407d43-4f5f-41d5-a440-8a809addffdc": {"doc_hash": "17ce32a88bc75ea44f58a05717e6f360766ca5502a361db16fb2a57ed139da28", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "599204a7-28da-4d4a-8cf4-882aa2e8225f": {"doc_hash": "c6799c154f821c250189bdbdda9720b7da32475050ace60b6746c81bf2ff4cda", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "b60da593-af2a-4841-9b5a-b11b706fac75": {"doc_hash": "aa7ee8dd2d99495b4e20efa3fb2fdddc9008b252bbdfaf75fc13e730216b5de9", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "9871689e-61d4-4b16-b46b-fcc718c869ec": {"doc_hash": "a1c572ed79d9f51613ec9c9972c29b2d9a424c39d7def9c263695702a9ffd264", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "1d6d608f-3db6-40a1-a4a5-31b25151e9e9": {"doc_hash": "015e4982eee469ee9d33f06af0564538187496c451306fcdbc8d87726e42206e", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "ded9b265-37ec-42cc-a66e-05cd907e5946": {"doc_hash": "705b79b4ddd8ef565470ad9ae590b52415d9935bfda179f1eb3c996a537997a3", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "e12ff96a-1753-463e-bf88-e39735af99ee": {"doc_hash": "cdc4cb71bd62bf301f46be0ec95496dd95042ffdafdc7abf5a2aea389812fcd6", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "e34b4ef3-8e0c-4de4-8474-ca6a8b4548c7": {"doc_hash": "bb0f06150e0470469f8a3f9a5ca40d51395b393762c30e35a28e56920b0e31b0", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "d1fe2718-1456-4fe2-9216-3165571aa96a": {"doc_hash": "1f2e1f06a1952b815d736b2782d2e6c5259441bd6f88fbf59bb45e4afe3d9e0e", "ref_doc_id": "e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6"}, "72e31228-e1a0-41db-99a1-ef11cca01e75": {"doc_hash": "a13d3620d50fef27b701ab1420716c747ef473595efd27491f0c421a50cfcd45", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "1af367e4-522c-4f06-bb55-820ce8ada41f": {"doc_hash": "7b8b629e0af4a6008f39c3e4127e58d68868ab1481b2f62877dcadf195384a88", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "d23a4216-90a0-41b5-9ede-82229d4a762b": {"doc_hash": "21f0326e3477f0750975db883ce2fc2131e5ab7301eb325dcbbb763e6c589513", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "9e64e4e9-1721-434e-a2af-2cbb9b06a3d4": {"doc_hash": "f726d7d7c54259fb95bfa05aa2412969835e62d97c3177147c770db70d80e6c0", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "6723f5db-e9ea-43fe-ac32-bac9f2abf2e9": {"doc_hash": "dc54aebd55758927c9ed10882ef63c960398393727f7b63f02a92ab84654102b", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "9a31ab3f-a91b-40e0-a7dd-7fef77c7d7d9": {"doc_hash": "e1e0ee1c49aade2a7948331e5492bea8773b6455746da50e7496819d3405adb2", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "02fbbe68-6bf4-484b-abf9-ad607a64344e": {"doc_hash": "4ec27a7eccd2c84f1bed909a4d487ad6254a6a67cb0b90bce90c2d12f50a5772", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "b59fcdcc-997f-42ca-aff5-887915b2c1a6": {"doc_hash": "1df49fdc8858dd8475c92e8bc1e152a6bc905f75d6f80ee9f801e0160d419283", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "eb2bf6ef-47fe-490e-b2bd-9ed2b9fd9f19": {"doc_hash": "ab24ac95622f27e2bc85621b8f754643be9258605550b7f248bfab5c83d6315f", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "c10d1631-6dcd-4a65-b04e-3c234e31219d": {"doc_hash": "7f4c8181b94789344798cc315aadcb5736cc4d58a6405d2cb808a8e252753f7e", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "0e3ba029-bdc3-4968-82e4-b2b0d18753d8": {"doc_hash": "332cd4168f28320e1819e96a718b2408ce31980bc5cb38244656a5e499a14283", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "ac561d82-c488-4c3d-bea5-5be77cff3e27": {"doc_hash": "9fc41c8367c9b6b9952cb35cf738344092c8b2a268846629832f50d94003cae6", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "4c9b7ad1-4c46-472d-a812-ccdc318771c5": {"doc_hash": "e9bc6c23e56779d6c2977b2ae9cb5dee9d427deca1e802fced18889ffd0d2c95", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "56127fc9-016e-4a57-bb04-67aac79e3b55": {"doc_hash": "776235ddc8b81924ae487d02eda47517ccf76edf87f944f5d057fe2e571b3927", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "574ecb2d-b1eb-47f3-b593-59cc98906c6b": {"doc_hash": "e6ae227f960b8bf020e7706a94ad73a7880da92874f2e87841ff5483441c5c42", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "1a18fea6-517b-4ebf-af73-43936542f928": {"doc_hash": "eb0c0965618d6be4c6ab930bbabcca06cf81cdb0802cb64882afefeaf3971ac5", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "54cd4fb9-a2c1-4820-9c3b-12136dc23702": {"doc_hash": "3f85f49e616c107b7e46ad490558bcd1a92c17297e9b8c3ae2d414c03e645c43", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "b9cdf2ef-0275-4cb7-a4ac-fe0fa025f270": {"doc_hash": "801346735ad2e9b2bb1d7fdfaf9bc4a2aabae2d02a7476827a09b26a3d23c70b", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "4ce5a288-a297-4d6c-bcd6-d65642c32049": {"doc_hash": "4fa541a17c20d0e6d74ddeac44a9cdf71a956d60d9c474aca023573ccac30fab", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "40913cec-ad92-4ff9-b591-672f60e63825": {"doc_hash": "d7aa23733cad2147becd23e7a4c352e4c40584db468eacfeb1e5aeed27688f1f", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "d04fe166-c60d-4e36-a75b-66b313bdd260": {"doc_hash": "b4ba51906a3e274adb06f58936d87e4ae292808ea0009759da934fdae5ee332b", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "1c425d66-f153-4762-9bb7-ff70aca0bf27": {"doc_hash": "f417d29ca35b57e291934fab3bc1e6d8ed2f8a118f752370f684023ff10338d6", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "045c6fb4-b661-4284-a794-dc28a9c7c807": {"doc_hash": "33cbda7425b71acce1fa9a59691f45c91d58dc83f3e7aa17570bf731e775249b", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "fd4c9c1c-10d5-4cba-a8df-78b98b53cb76": {"doc_hash": "db4145cfc77c4d6a73dbb508b7847dd466d84eaea450216e9448095f316e9954", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "f1f40616-0dfb-4366-9b29-aa9a66bee849": {"doc_hash": "d888fdf4d18a1313f78c92e54925ba1bcbe4318943425360771542a66191308d", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "60b471ee-2ee2-40a7-acd0-803c619e819f": {"doc_hash": "49ec98a73dc5560bc3118e8346092fb778ddc16842a6e29fc4f044154f3dc4fd", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "14ba4a33-1002-4c41-be1f-1daef294e166": {"doc_hash": "6166a24db05b4243e12f2b967b9da7ee1835f9faa2f9961de08f102d502f101d", "ref_doc_id": "9eb0ea55-d633-40ad-84bd-b53cd162e1bc"}, "c1439f13-b668-40e3-b91f-1e389f727b98": {"doc_hash": "71029a6dd258fbabdbdbf6fe3d342e2b530b7cd63808c0775b4e97e0c7d875a2", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "5c815d06-1bd7-407c-ba17-f235c90a0397": {"doc_hash": "2ddd015ce0cf79d31b422aac9bf1f19fe122ae368d5a377e0340d96d3f6c70eb", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "157cc4e5-9d74-406e-a0b0-2e690b522c7d": {"doc_hash": "f8745efed9350559d771539cd9eb74343d655149d79d591fa8fc36e51002cdee", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "1fabb335-b057-4672-b8c7-c9d1a999b210": {"doc_hash": "5290391b5c5157c6b7aa6d28654599108ddfbe312ba93604eaf3f34e9e385aab", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "7cc5cf5f-ef20-41af-99c4-1f88498a036f": {"doc_hash": "8c542b0044c4bc27b30a3c8781d1a95e5a276b60d44dc4f27af6ed0750204acc", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "6c67a8b7-9437-4a0c-a7ba-e7d019b6b95d": {"doc_hash": "a4325b679d68fd48fdfdf54265db9a4079d2068cccaccd070492ac611481e87c", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "9eaf2964-0686-4a90-a0d1-f46ddee4146a": {"doc_hash": "b24a420d6af976f71bc4b3d663b8c340a51bf7e4701bacadc363b9a6a79fb499", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "fc949598-c86f-42be-bc38-8687d6f9eadf": {"doc_hash": "f87341e20e8dd49fc62d95f8771fced79f7666c321cbc6f473303f049bec680f", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "1e39807c-f330-43f4-8143-6e615b59dde8": {"doc_hash": "34be90c8d4e8a296ef350c70f7688ae67a6954e4da1a47490e880660e585bf6c", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "e74ecf86-4f9e-4d37-bc25-dc7b0825d40e": {"doc_hash": "73d2d4ec925f9f801c00b999ed43f841f777aac75e9f9bb4acd7238b54f69ff0", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "fdedb4c4-b374-48ce-8580-43e72d300b53": {"doc_hash": "d568d8f91dbf47f5f7d04bce4e2028b0785d33a513aa014667bc439ad4faea4d", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "02917818-a776-4d2e-9628-2125ef6df6f8": {"doc_hash": "ff215f99596bec8ed77d4c98534e4d6a9816e1e8d50c4d384515102e9c10fbad", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "71750c8b-fd72-4f80-b8fc-aa1df9590979": {"doc_hash": "61b8cc1f106a69ada1d66b8f0bfad5fce50ac7bbbc47775d97cd520c4e48c675", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "7ce658d9-0955-4af0-aeb5-0b99ffcf268e": {"doc_hash": "e2d3b669daa06bf66524c0fbbc84d74b306256019f8b9c296b067970fa4ba8ad", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "20581369-bae2-472c-855f-898348593641": {"doc_hash": "4d84caa5a224da4ae1368ac27356093070bd65b8a09773b937166f911decaf61", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "0df25b83-4c04-406b-8aac-3e45506a0c95": {"doc_hash": "01c55c085364335339c56c2285b0d8e43b0ef1d9447cbbdb5b7a3fb69a16a447", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "1a96f5fb-3c42-4340-a20e-c5593d07a3a3": {"doc_hash": "14f775b2959d499baf3d5176578688421ba530b66b6ca9145a1c6d10f27629d5", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "63aec45e-1839-485c-bd00-1ac906b58995": {"doc_hash": "eee00e2c2e25ba8101be847c8c25fca171d0328a74a0e3c208e766266b5434ed", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "7a85db0f-bae1-4e0a-94c5-57f59cad43c9": {"doc_hash": "3cedb92f662fef5dadaeb271762d12fcac5ee7bb4e97630bcec43ef0f144f348", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "581f93c5-4791-43f3-9361-ca2a4b0cd4f9": {"doc_hash": "4c821abb280adae706c009a79ba5976d743d11e1bafbe9c1e62731f4d65bb2f0", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "f8b9e4b9-6ae8-4818-b6ab-e083931c4e0d": {"doc_hash": "d94c55687bbee7633017efbfa450517e85327292ada11bcc338ef90b1405627a", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "2bbad25f-9404-4488-821c-e4f15b68959f": {"doc_hash": "897c59802f02930b8a68d71768de8f4a557459441c819f71e568a0b36adfddc0", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "5bd8b147-1ad4-41c3-9a4b-96b47b41b7a0": {"doc_hash": "c0c6e88ccc2f67fab518ff7391b24ee0338727bfe3205e96491c3fb06a1ec371", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "026322db-61cc-4c97-8258-d2f1ae7e4a62": {"doc_hash": "a15d272b23b2283bf5894dfb652fa385aaa4cdd8fa135be33ca60a9f4a1465fd", "ref_doc_id": "4b9743c4-7152-4265-bc2c-e1c7288a176b"}, "d482a44d-73d8-4f90-b93e-9b727adc2103": {"doc_hash": "45435860473321415a2a88a6f0387c42fbc2c7ade74bd43c49af206921aeece9", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "08041078-0d74-445a-93f7-7bdb6051c282": {"doc_hash": "f9d54f28f73b57a3d519d7a468db14740d379b31b69aec4c4b95021ebc696779", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "0596d63e-b820-4436-a572-869f0c8b80f8": {"doc_hash": "79b173b3757ad71e155bd3a413fe2d17d0929e270efa098eff4ead36a297479a", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "054736a5-9870-406c-a47b-cbe0bd883514": {"doc_hash": "b8c2213836fcd6b2f7a2a47312c83d302b807e36d3ef6785adc3e486cb78bcac", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "1ead1b5e-e3e2-4751-aeb7-6c7e9c4dfe7e": {"doc_hash": "90b5f2016f842c1c363d94cbfaa53c0c92f195577d310f4b23f720a966fa4a71", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "8763be95-2186-4752-bc63-3ee98b1f7bd9": {"doc_hash": "0cf3c6c60f0918f79ecc6d84b3dbc63ef1dc84fa5b8588c89b3d069b5481a2db", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "f3453cb2-4262-4775-8d77-ff14b47dfa31": {"doc_hash": "fc52f85e7207bff26ad5d65f917bdffc77ca9db2b80b52b5106e187590b490f2", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "5355d0f2-ba65-40e9-bbd9-4b732b9be5b2": {"doc_hash": "8744ec3f9e7a5bfe6b9c58e8312c18b466e2a94db1fd3240586133a68d36414d", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "ee8a2ea1-4a13-4299-a4cf-a485d080ab11": {"doc_hash": "ac236d94b9bcc8d841f67573d17fc645591d308ae025a69290bb897b2391b016", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "fb8676d4-1d63-422a-8b9a-60df54a73436": {"doc_hash": "c9c1f1ac851d9e243a91ed03f82971617988c1cccf8e6d466311b7c25327e59f", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "9f3c357d-c62c-43c1-a7a3-5379c93a0127": {"doc_hash": "f3434753c14e34d406a07de2163f8f701351ec5899882f8caff40f5b6f547497", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "25bf0932-e6bb-4555-a0bb-99133cabead6": {"doc_hash": "f5503212a1d21f740557c1e071acf09708ebc1d29a95e1acb638059707792278", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "10be7e52-e453-4c0f-971a-ebaeecef9b48": {"doc_hash": "1388600b418666ee5a592efa0d9ff9e1fb9927c83a950d8bb953c3a6f4b82452", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "8bc8590d-4ffa-4377-a340-51bf4d21b121": {"doc_hash": "70cebeb8746e7e234b1912172c0d01ee1d7d5353dcf02955e6f74ff0f71a3978", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "5a4e65d6-21ff-46c7-bc99-7d5abf4dfce7": {"doc_hash": "9c1135d45e9a3260f9e97d02e28ed076fc25e7673850f3716fd3ee1fc2bd7def", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "a1715a76-f8cf-41d2-bbf0-b44667e2b609": {"doc_hash": "d615bc08bc6714343341c43c29f61f427d4008829618ff7e912d61e4b8814153", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "d88703d7-9552-4736-9986-f3b34c2afb4b": {"doc_hash": "84f000c14f310e3d5b364af88e8ae38b274bce0d2b5165a376a2b19f15efd9bb", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "4bb83256-706a-4d1f-864b-c25df6679898": {"doc_hash": "76b48ca293017e5ef48e5383c3b2b6774072ef8beb00c73ce3d616fad118ca9a", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "7b10dfe9-0175-4636-b872-8615dfa595fe": {"doc_hash": "4282fd69fa89ee861768d578331ffa6c98afd905ac53837d68a9231d296bf605", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "8fba5ad8-5d01-44f4-b5e9-922f183f8e46": {"doc_hash": "c196ba09c5126aabf1d53c6de971441a94487783214cde6be2aa3f3e0a8ac216", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "7081d97a-73a9-4bb4-ad13-2c1cba02158e": {"doc_hash": "f143e5aac13a076a2d0f5e6c60fbd0a470016ddfccd44ad169ac614fdda02448", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "99e62e57-f369-459e-a9d6-4083067758bc": {"doc_hash": "2dcc8b590107801ae808161149046c6c6ded2127574cd5fb70d2541fcdf6eff8", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "3cf5c00a-2e57-48fc-bf07-a5fe479bd8f1": {"doc_hash": "918148a4aafa147d1b62bde05835b281c3a2c27c67148e17ab408653db334a64", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "73337b61-0bf1-4a5b-8b0e-2b07b4afa2c8": {"doc_hash": "daac31ecb2ffc48d59b7031a4549fa5feeca847ed11260c066687c3067f550b9", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "e58b8aff-6e68-45bf-8210-fc5b084f0980": {"doc_hash": "1915f7e46ffd8b073d84452c90b2b25b1d6fcd0301cc358c93cda49005321847", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "2744cbf2-c69b-4574-a35d-a7cc4e3a4c25": {"doc_hash": "8a1f68dc0b02e8748a1cb37e7bb5be941348acbfe390e65c93828b959409ef53", "ref_doc_id": "9762b381-a11a-4358-99cd-84f89384b121"}, "c26cdc12-c693-47ba-a229-84590021a68f": {"doc_hash": "fc767e2f2f95a19fdf2190695f251a6c0142c8145d8686d05306fd5cb383d2c6", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "d2bb1da2-a477-4711-9b1b-c7c54e06e960": {"doc_hash": "ab69f24e23614cd3a27de840c77f818829d06cb9e9703e36e5f629092fbd205d", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "cbe0d365-5afb-49fd-a6e5-be9ca6ee0f5c": {"doc_hash": "2d21d68c7c264aaa24c0e4eafc1c9f37c1d781f65b72f10f35cdc82be29ef920", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "58ddb258-630b-49dd-84c3-670b7ced8176": {"doc_hash": "38719af687260388c0e7976bf16832118b1ce714a16c27cccdb00754afa0df56", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "b8766ae7-2803-46b6-b678-7812d986689e": {"doc_hash": "46fc3ecfa230017dff300c37dff0885be80cf0498754ca35a5089a14808226ba", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "5b0de04c-a378-441b-afaa-44c6d13c2abb": {"doc_hash": "ebe7d1acba4fd1ec1fe0cb6332d117f6f2230c2a014fcf2b0b29077cc979cf6b", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "292e1438-4464-428b-aa55-c6df8ba31841": {"doc_hash": "efad7dce0779523860470fa0d0a58cf8bd1ecfcf08977bb74b2b60f62a29614d", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "bfd5c152-3018-4cda-bbef-31258545089a": {"doc_hash": "8f628385f6cfcc17f1e67b6bcf3718a49f2df2b82035dd9c492694d97bf59abd", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "0a0dac8a-074e-4f0b-a011-0374e5218f61": {"doc_hash": "441e1991bd340e0dd8fcd76b630ed4fedd672ad5e967a2ad4aecc9034db09421", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "27affbb6-098c-4605-a8b3-e9ea7f0cf721": {"doc_hash": "04f17547530e90ed4d0cd92c0dfca06800aa33afce6050ba1c9829cb3f18fabb", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "10df67a1-91fd-4f50-b32d-7de93aa219b1": {"doc_hash": "a99e8d46a39e65543d7687e05c79134472a1a7f2532796952f568c9fabaf804f", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "ebe2d54c-cd9f-4432-8e3b-6ed5a5e78a57": {"doc_hash": "2669ab93f7e7606b83692eb4c8c0a28a4d04af603f13b662f346df32ef1c95f2", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "8facf4f4-9cc1-4fa0-9f5f-2ced3791deb9": {"doc_hash": "07cfbd06861c000e1c3149b92e481bdcc8ebaf668f4dffedf3d3eb6ae163ee6b", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "53b1ddba-78bd-44ac-a06d-490de3ca4686": {"doc_hash": "3a8def26facf8d89b706c33086ec42b625f06284009f6b6fb614c47adb4105ad", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "af2ff3c8-2869-42db-bcd8-79ea4f4921eb": {"doc_hash": "947f489d14edb7114aa2b23091d29ecdfef41e3380bddcb56ca5f5286df2da47", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "0d6cefb5-6e09-4ca6-b9ec-41a757e2d05c": {"doc_hash": "990ef4529bc745848fc1d9ac10d08ef27b9be941191cbec074c014788085e393", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "19ff95bc-319f-404e-9658-08b26cbb61b2": {"doc_hash": "48656479d8738c83e3f0644c562a6606140c1eaf647e20151fe8021f237ee0e8", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "89570014-d9ac-476c-8c1f-cd85b67c49d0": {"doc_hash": "1f1137ae0989985b185c7f110887a3715ead2e776e682772b72f35fbe4b59484", "ref_doc_id": "94070a92-6692-4b76-a49b-08f36bd565df"}, "ae8e43b9-e3b7-4b58-b110-f693f15170e4": {"doc_hash": "db54ecbe4aeb152e8f0db579c1de264d1397495006e94640bebc8d9aa8403b21", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "ad9664bc-4628-41d0-905e-64398ac61d70": {"doc_hash": "88d7e9bc7c086b510104a84283c2e15e6b12ddcd9fe212b19489fefa2e1d45f0", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "269782c5-80d4-4de6-acb1-58d932791550": {"doc_hash": "722241ffe8655c13fbbe1d0c1a666c2d1d705c643822601076b0a0dbf1a806e7", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "4e1715db-9491-421d-b7f7-4d48ee021cd3": {"doc_hash": "e4e288615ebd427290d93e6d0e6307a246129a20a7bba9688c9ac3e5029601ac", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "ab110ce6-202b-45b6-9571-ad1aa52f3221": {"doc_hash": "1106aba32b550aeedc23136b93af1381e03973f4c79b8c1a80d380280d259c7f", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "ecc469d8-35f7-4a5b-8f3b-8e1b805fab8b": {"doc_hash": "92cab7fcda0f930dfad0a26ba7ad4fb823ee1ac78e729238dd080304b3a9f9ac", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "1a65373f-f6ed-4d7e-ab7e-8fc11f7b8fc8": {"doc_hash": "ca57bc282116e4f43e7e8818bd09e6bbf8e7779b37b4e1383ccd7cd70961edc6", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "e783ba55-ad3f-45e7-a4c9-aa96a7ade91b": {"doc_hash": "acbb0eda4a691964fe1761d62371c442d61821bbda65ac85dfd14b6f63826f4f", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "fa04aaf8-e60d-40a6-a335-6315e0bb7383": {"doc_hash": "ed98a65db81ce3ced1b3b51eddd2baaf8a5211a4d3872938b6f61176edce75d7", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "90b02d47-f364-4e8b-844c-08c3950eaf09": {"doc_hash": "eed1bb7eeb343e48342a62bb445cd29e0837df068f94c88d88ffb5eb71bde316", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "3a51a433-375b-44e3-b5ce-7ec2e44b2599": {"doc_hash": "e6a69d879f9f970c1b6239378ee12174b3360df913123c97f75d9fab2aae6f7f", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "416243c0-dc6c-4f72-9241-6453cd306976": {"doc_hash": "5f036a55353a68bbd964297379f92a004ebdaacfcd1255e8e4f78401fdf3246f", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "0a438360-b1e1-4a31-8f46-c3d27b3da3f3": {"doc_hash": "1aed42a14df99a20708c7529b2d77e2438afa0bfc034ea750cb78c138547d8a6", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "9e81f693-9306-4962-88b4-8511b3a0d4d3": {"doc_hash": "2623d6b93562e98e46c881a98a34e56cdbc20a10c1148c7c58891f5f69441e0b", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "d0237d73-d58b-4066-9635-23e8a04ff174": {"doc_hash": "8827aaaac11bfe1ebbd633d7072edf350a50fc01c285475ff528b88cb7e0dc16", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "096ff9ec-d8d2-4952-b1a0-14c9bbec8da0": {"doc_hash": "0cd0a3e2837540d1a8c997562e3a98af2bbc9c4ba935de06293c3b4d047a09ea", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "6f6b41c1-3ee1-4de9-a415-e3fc2f7594bb": {"doc_hash": "bb84e287f21df65ca251d08aee602c8bee2b993db002bee129da12d819072608", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "d9b7a1a9-04b8-4f9f-9fe8-9bc7d514aede": {"doc_hash": "971b80985d29e683cdf6c0d7242b9765cbf3a5ad1ed866ad3c360d53ac5bd90f", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "31d0cbee-864d-42c1-a54a-6004b5054a20": {"doc_hash": "403e907929c447834e26a8372334d7d5663d05151a715d248cc82063e32630f1", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "b3f2d2c2-19d8-4ffa-9bd1-0bbce9ef12cc": {"doc_hash": "8616e96150f204b3aa4e640f6720b0deca6fec47de56986bcd942997f6f3e4c9", "ref_doc_id": "568426b6-d7a2-4ee4-9fdf-450f1c480d14"}, "bfe9cf12-aa72-467e-b162-c2be7530a4d2": {"doc_hash": "d2d9348c4e317a4a16387048587006312c1758b57fd8a29b892e1f9331a81297", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "1b2563f4-931b-4a27-9eaf-34ab5cb21e73": {"doc_hash": "f8bb05f673386e6e76cbbaac75e895af6cd90a260cfdf08710df2107d7c11fb9", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "7630b64d-0fc0-43bf-b18c-19f494b8c3ec": {"doc_hash": "46b308ce47ad2d5a9d2adde73ea6cf0e9698c5b93613111164f6e8cf1d61b2a5", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "1176cf93-80c7-4243-a3d3-f53fc0a2c2ad": {"doc_hash": "3b800c003947bcd24e07b53bdb3a675c46a4577ce94dc7f9e24e62c7a8dac8b6", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "9d24e060-94aa-4179-bff4-a4cfd0bc43d6": {"doc_hash": "872e0e10b7bc7a18ad5c4f7f99f4ecafb5fd09decb3085e599850661715fb899", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "8ee28bda-0873-4029-96a3-5dd221112f17": {"doc_hash": "57d8f85a77c0c2dd4d0ef18048bbad48c11f9a6700a6204fd5665d29e2540add", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "d054c45a-eca0-4ead-b717-a605d5dfc923": {"doc_hash": "26df3883abd97fff0e685a7f8846bcbaf99e1dd02b69b5ae706975a14bd5627b", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "6ba95085-4058-4329-82d0-595fe7a966a2": {"doc_hash": "c06b329bff91e57401c175396c8fb819cf98c098481627f3c89478fd55777458", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "d419e426-ff94-49e7-813e-a1d18ddbe90f": {"doc_hash": "ab6ef1e247e08ef388ac76d1b741eca7c884e83c2ee513852fb69f2340a2166a", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "75659330-0daf-4bc7-95c9-90d945cbf8f1": {"doc_hash": "94a976fd4be8ee1e48d7d5ba43ad2a4f93fa142092d067323d68faa95820489c", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "35920030-fbf2-4885-b92b-641c544333d6": {"doc_hash": "5fcd5985b33edf43446450967d94e8bdbf3187972a68b8075f4b4182d69dcb26", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "5d9f98b8-d62a-49fc-a53b-8dec7911536b": {"doc_hash": "a1168b4c036f4d36ffe506a9f2d64aeaf52077c8be7b00c301e01c882eb40c56", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "1c7f5266-e575-4eed-b5e1-0920ed67f4a5": {"doc_hash": "b4ddaa54a0e4b370a389c9e5fce516fce7efaf95604a3058085f150c90ad69cd", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "a29ec611-9097-4915-9cff-e8c0b18368dd": {"doc_hash": "4bfebc2831967476d3e98553058a51b0fd9caebf2dd79560cace69bcee918cef", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "5b540a01-8a86-4cfe-88ea-ef84b786faa4": {"doc_hash": "a7d09c8c54f2f96d62b36298f5168372f6253ab3546550677be26eba5ac7882d", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "3b5d423d-b90e-4b26-b20b-aa39f086149e": {"doc_hash": "e8761e38356463c4cdf9178276882c8772080bef580992c02bb8d775a50225c7", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "7645b9dd-7fb1-4879-b47a-1a16af71abc7": {"doc_hash": "016f9d71837cd26c73dce26d4a98718e7db32e6491d5b857ba33059847099b6f", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "a2f016bd-c533-4ce5-8603-d7565d6aede7": {"doc_hash": "68f507dea3a24469f432c954ac08cb04fb225be6640dd06dcf79a6d02a1f0815", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "1ca391aa-9db5-480e-8abf-fdcb06eab3d6": {"doc_hash": "7280fd0df62d3bdee8c8737b2fa36eb500483837812ced23aa1e345b48af4ef2", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "c2931742-9ecb-49de-b665-23f05522bdf4": {"doc_hash": "be67c03f1124f322587956ebf4ecd88ca9a450e3628203b5819ec8547e6866dd", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "f2aacda2-03d1-4b45-ab7d-5edcc778ba91": {"doc_hash": "d153ebd34556c018c5b92425f828e44040c8541ce0b81d6ca7a51c2e0aa97002", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "5dfc6309-d764-4b6d-9cbf-97ea6ce98671": {"doc_hash": "b848ea6534d363de1bf4a00e0dc2e071826034ec8391b2145ad7ffd715d64521", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "0dbac70c-8865-4e42-a2a2-84dbb1912b87": {"doc_hash": "bbb7ffdbc491bcd63aa01bf637740c36581f389c8cb173159a61bb0126cef91a", "ref_doc_id": "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b"}, "67888d04-cb8d-4eba-8f2e-cafafa920c09": {"doc_hash": "30558c6fdb33018ea24a7baf2f138ad97874a813413dcd1618b4bfb2b9f39137", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "ea37b2de-afe1-46c1-96b9-633b0f2e3ae7": {"doc_hash": "3427514f52dcebb63b636b918a89cc4ca7d17e6a8b35b339ec9ad4e00f5f0df2", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "af12a818-6874-41e8-8f62-66c2feab56fa": {"doc_hash": "0370002cca4901523f0ec5b896849ab5653ee03d2121520a317da3fce86bc603", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "1672364d-5323-46d6-9dd3-7d99bad01829": {"doc_hash": "b1c1a10eef3f61b968c9bc8754446603c1b72d1d02aaab28303ba50ff866e938", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "26046145-f26e-4027-a0c5-119e56716eb0": {"doc_hash": "b4c2e6a8a368cb004bea211fc2b2118fdf141d16ef3634fc30d1b6c959840d71", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "90c2bd87-4473-4479-b7a2-e381a64b472d": {"doc_hash": "4a10a867b5e03c0b2cdbc8b63896984afd513b8bba0be46aff082e9ca1d73128", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "238d4a95-4db3-4f8f-bd15-74f494cc4d0f": {"doc_hash": "d357f28eaddc5b9f953395c55fe43dcb4e9d6e3e39edda9caeb09c3954081fab", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "45684b05-af2c-4f76-b25f-da6be3cfc355": {"doc_hash": "7f9cc179bf7c2d1f0a2b56519b1ac2d28a7af1c1d4ff6fd6511000ae5f54c026", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "ae3a7ae8-02ba-409c-b2f9-ac4b9bf1775a": {"doc_hash": "66555baa5fafddd3195739a736599532a5dbcdb7fd8d9582907b96b14e694d64", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "42bfde68-162a-43ea-a86a-9777116fb508": {"doc_hash": "44ab9a649211fae63b2ee8baddb2a06d8fea044e97a6727324611f36216bbe4c", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "8af24bf4-3842-44f7-9254-819e85068a04": {"doc_hash": "5e9fddeab98706fcdce1ee2201c4c2a989a068cb26faff6ed1de516a496a31d0", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "b59a702a-3f71-4642-b7b1-39ea3fe26cbf": {"doc_hash": "fd19956b247c2bc10808cd85ae3d9f67a9266fd32db1543d76337853c40cb847", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "c086de9e-e60f-4b05-9595-fa38d0d15fb4": {"doc_hash": "d68b26d577af22c29d1d8e7382be5a465527de354b6f8dab831cc9d492331769", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "4eb2f0bd-ff23-43c2-9476-efc29ccb4294": {"doc_hash": "caea6f08d8b3d7c84693b1ef50660d5762e8cfc76a56de93c4e5353d2b9ec8a7", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "5dfef621-bf39-47af-ad8d-dd57dc0f3ca7": {"doc_hash": "4d6c028641a0a8cb1b5d87c9a499334a6f86f4071f2c7875e1095944ce0eee78", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "0d410a0e-c79d-4c20-a331-84f18b9d0e38": {"doc_hash": "eceac8d2ec9985e00b0a735114a00d3147b11beb65817f6d89111aecb79c9e39", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "5e622aeb-cf35-4eed-9d0e-fbf7fc9502fa": {"doc_hash": "c27e116814d8a7bc414623961eea696841fc35c1036aff1e01c33db6e0e17784", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "d1eb192c-f13e-4185-83a9-c1d654bc7e9f": {"doc_hash": "83b75b93f931e9fa984a08207bb81e701b9d0344b0a3f1d18317028251563769", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "4bbf0b3c-6ea3-4233-84ca-ed94433e0ade": {"doc_hash": "33e6453aff6d5f4c7995ec747c8ad296b7de52e8412487609634cbebc2ae688e", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "00a73d54-ae97-4fc6-8930-e92518b57270": {"doc_hash": "b06da294627d254132945d7c51a16e58cb24bf246f54e0197d2ac9cd8e0d7e9d", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "81cecd95-5f8b-4116-9c7f-07ee4f1bced0": {"doc_hash": "6caa141c566a1bf1179cb08b253c20e15afe4931433df98bb0f6c2311de85600", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "6f3f1d59-14e1-4221-904e-32d6f1189884": {"doc_hash": "11fa6d3ec94a2f8f26ecac6d30e006e1541a2f1b119375e3c4421f2a147ffa5c", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "d7081f32-363e-42bb-a39a-c56f76149d93": {"doc_hash": "599576929bc209534240bca3cb1130106ae9bd6ace59463bee80e16ae352be37", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "88bbb52b-2a99-4d5e-ac89-e42448b4cfda": {"doc_hash": "d054ca5657893ca84bda82235b8b2a8cc84d1c452633f9f967579b76c93d284a", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "ada1d1bf-fad8-4f1a-a4b3-c16e46e5c7ce": {"doc_hash": "aa075e8eb6ffa0981346feff4a1fa8661ddf8b1b1138aecb32cfaea0e25879be", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "6763d7f5-0083-4195-bec3-840a8d3f075f": {"doc_hash": "385d3a0b211093a4b18902348c9be9c49dd9c59a055d1f5efc365250f252307f", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "ccf11c6f-aaa3-468e-b47c-34fcd6f50c14": {"doc_hash": "c1bc36a8117e5187d759cb4d8d4ba994722b3573cb7c7d0dc95ce3a3c87ce688", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "6889a72b-29fe-4a15-ac78-7424fe34e6ed": {"doc_hash": "75ba4161bef9a04616e4f78dc16bd231b29baafdae3ee48deee64bfaac8b17a5", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "55dfa09d-ff21-4101-b682-303e3a4109b1": {"doc_hash": "bb1c9d2633edd8224432b1279322b48a6ab20b78909cf5e4afb9dcd225fd96b0", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "aa225c5e-c9fb-4176-9717-301e0bba55d5": {"doc_hash": "c18f9f8f626426a4a419a0bf0d5adc55abc20216cbade36d583be66a26320998", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "b35ce096-1642-4450-b42f-d907f59daea1": {"doc_hash": "de4be2fb957e631c4b1ba84d80f66b8c0504943ce2a58fc8c2be5e4a737f27eb", "ref_doc_id": "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8"}, "8a1fb589-4f83-4b19-a7ee-60a727084426": {"doc_hash": "1d9294c0af69f1762d9b89d837d1c9bdb048177a9e38360f8a28b1a734ae9f02", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "f880d04c-a401-4c16-b46b-8e21e6ce4f15": {"doc_hash": "350ed8a225de614d8463e12d9beab0bac985c63bacad177d1981e5f71e8cbe55", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "147a09bd-10dd-48ab-8578-b4328255655e": {"doc_hash": "cf45cdba8366097cf4c005ac564bb0cf42ca852f863ed0406696429632e44a2e", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "9b5185fe-2f6e-4026-afd3-16dd3620cb33": {"doc_hash": "751cc79442fea56027f18789747cdb89224b46f8d451ece6179b7bab5f3c0afb", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "a65c5cc1-8a32-4c8e-bd88-24c42b85f81d": {"doc_hash": "a5f93f48d1b74a32dd38ba094326a4a55377b98a3b4a66c673bff261db95b811", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "c224a1a4-0fa0-47d6-a368-464eb80432f9": {"doc_hash": "6536313709c508c35ca22b3af9edc49ee80e9aa38c9836fba25271ccce291e2b", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "28131108-8de0-4dd7-816f-38e9ee065d25": {"doc_hash": "31a0a95dc86e2180d2bf56bc9e902c514e5ec0097335dc8e6028e2991b37aa99", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "53d46441-e00e-427c-b3a2-6dcd49043af8": {"doc_hash": "aa74e32431993e9ed48415d921174cc984f4931fb394e7451d22f39d6589270a", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "777ac3e1-e730-4dbf-9b2d-b18b7b31900f": {"doc_hash": "153c565de0ac0ea911a88cd65b8ce2318c698327fc80c357b00e19c1b389a55b", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "c9d09df8-59f1-4946-90c7-0c6bb8221aff": {"doc_hash": "6f9fc99561824ed2226903a6382bbd62cec03813f9077dab274703981346a018", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "0cc14c43-fbab-4dfa-a88f-6515de4d9dab": {"doc_hash": "434579e5939dd95161ba28011b876966c56e158e009fdd0d27948de6d52fb0e1", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "cb4adb2a-f159-4c8a-b847-07abaf98a1b9": {"doc_hash": "28eb8535796aaa3f05c346da201cfeb0d523474761309f1fe62bbe30fa5e8a3f", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "c72701e4-d857-4daa-98a3-b0e7ada0d583": {"doc_hash": "31f74bf7f33520c9e3cc5996a35de6c0358afaae520ede22e539c893443facf2", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "8d4386c0-20ad-4a0b-9006-e917ff5106f5": {"doc_hash": "9180706304bbcab6b81af5a2b7d2e340db79207b9d460cc54defbe03a800db98", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "d60d4bd8-b9c6-4127-af4b-9419f5c0c213": {"doc_hash": "e9e23b09f4a3bec7c65e0faac00cbe1f1e63eb89fcfb91f29297095d64869f05", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "38805d88-b4e6-466c-aab2-fc068cdf97d2": {"doc_hash": "b4795f190a7bb38a48121539aee3b56ce29b1efbd32f7e31b3d9bc77af88d555", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "897e194d-48da-49aa-97bb-e85562f5cac6": {"doc_hash": "0602e493ef3441e662b21e27bf356b6b16d692e0f420f68d8e5b59dc9764eab6", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "ec3954ae-02f9-408a-9a10-ff522934b8ea": {"doc_hash": "527442cbc69697c65d1963eeed2a1cf6b91c91e40989b704bf3f5eedb26a7b72", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "f7ad63c3-9081-4081-940d-a64323315c8d": {"doc_hash": "40730d402adee5f675c26d0736f885628c781e188ad1667f34c1f20dd72044bc", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "c6b6c17f-6e6c-41c4-8895-bac614d91b46": {"doc_hash": "5f2d352969ae2c5d414dfaebf3d4ed92db0e82712ef42fdc42a954209ffe47aa", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "abca503a-af37-4ffa-a632-d6995103af18": {"doc_hash": "9dc0f2c425d62d08b621b0dd4f9274259e30eeda7e5976dc0576c12cc3810839", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "4a770cfa-35ec-4782-b05c-f3c776a325fc": {"doc_hash": "6b29e0f54cdfdc3c235ddaec78fbfc7732d66ad67908884d1fb7066d74a4fb28", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "a91be33f-f51d-4297-a92f-1913afa59e49": {"doc_hash": "cd0753fda6fdddf8eca2cf8ca3ba4b33f73981ebc34e4ef132b5e1bd641139d0", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "b92c75eb-693d-46dc-8e27-d5d5f7d453ac": {"doc_hash": "97e0d91260a4eb6c4bcf7d25fcdd9796c39cfc5b19d06e80772c284e5d93a9b0", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "95eeb62a-3053-4462-8364-d2e1085c84f6": {"doc_hash": "986e232549a2474b9474836c051fb2eb96eb4fef19bfeb122ba4d29545fb2655", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "12bb2d84-77f5-4b26-be73-0d222d40db2c": {"doc_hash": "eb126629ad801d403004991ba79097762208e11a3d42cebaff5ab87d4b7b3a09", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "de5d6e25-f8b5-44b1-b5d9-198c9f076605": {"doc_hash": "f362240cb17f8b071760393be2916620a4906d6a4780eea42d3b4073fe1cad48", "ref_doc_id": "1991a006-e6c6-437c-bd28-649de7e63ba3"}, "9b2dd3d3-525d-40b3-9bc0-bc84a6db6343": {"doc_hash": "ff160ed0c03d44425c83be808416a874e873a7f6ae7f0c6211b44f996f242d82", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "8868151e-49cd-4b3e-9d0e-bcaa34dd62b2": {"doc_hash": "ef2271f08502af861d7e1ce37c1448954c069018759b27ff707ca41ab0f4ea84", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "c6f4c976-ed40-4d52-8f65-5f3c64b7fbf4": {"doc_hash": "a90c54e8bb0ee4986f76c3b7a35cfd5a53064e7cd63c282d1a83f215bf9df002", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "0dc4c5d1-32cd-41ac-862e-a481ba0a74f9": {"doc_hash": "945b9d62576b2a5b6a74c0173cd832c41fd1fe4c920d4576884eb81d90de52dd", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "360928ff-42b4-441c-90ec-fb6d46834c9a": {"doc_hash": "3588f6689d911ce3ac2e0eda688ed24703969912721f0e56bc539cf6cacde873", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "87ffdf17-3e3f-4635-8bc7-e57d1d597cf2": {"doc_hash": "6a5b482667032042be099766234fd4bbf97db5d383a90aa649a4a1c43f943c22", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "4fc24d6a-3f60-4c04-9af8-8c921c8f1910": {"doc_hash": "ec1a4c90d5fd3dea183f5a5ffc2e8ec3763993c7a21a916683c6101b8626d610", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "362797e8-c96f-4c4a-bbfd-db92263d96d9": {"doc_hash": "3432b74c78403519ac96820c7ec5c870dfab4447131dd3e5940f30ac84482a73", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "3327ebba-0b00-4547-9cdb-2107734f2ada": {"doc_hash": "1c923da971b0c496d6e1c4f2bdcee2df7707a29e9423e319a4db8021a328f787", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "e298aafd-a317-4eb0-82bd-80e8bc6dce80": {"doc_hash": "83a7a79b98397aae3529e35346c56e5e6b771e2db4ab6389fd816a5cf1bfca5b", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "78f60df7-4014-4594-9c8d-b94b61c3c548": {"doc_hash": "f90f4ab713eab6e159dbd609cf601ba6337402797d5c77a5470973294e26dd77", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "058cbb97-b577-4ba9-a6c9-47271ecb0c29": {"doc_hash": "a85f7420550edde82ab9b4b435202352bab324e487519c0863d5720b47794d24", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "99e69b82-dd21-4e56-8da5-4619e98d5a2c": {"doc_hash": "37fd7c03affa29b243868854b91489655fa3f935cc34c5dfa33174cba1aeedde", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "8ad03270-b485-4117-b86c-3b5b3f0e5209": {"doc_hash": "85af7c289fb2d9bd7525dad66cfde41f3213301e581858f5b84fe2c5f0749742", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "2a97f385-1248-4107-bc90-97042fd39a0a": {"doc_hash": "c64aa2599ed79a2d0373abbe293ee1822f41b2c84da076926ba38f154e987fa5", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "895e65ae-182c-464c-a7fe-ecb136d77734": {"doc_hash": "b7cf3ff13c53ed45667d8dbdba56b6f2b54be5399896fdc4f8ccb48c35712f48", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "bd2ce9ef-ef59-4c9d-9a52-ddb3e220430e": {"doc_hash": "ef36ddf4c98c0f1131db548e9c4fe4eb4f8cd79b77a865725a878f0e2668f140", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "2d0bbdce-27ab-4b0d-8c6c-05d2e328e6f7": {"doc_hash": "f241ed581b51c8f28673f61e219a38a7cdf37ec87de7ce229423378d7d17d390", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "491fb161-5fd6-488e-a5e6-f338b7385f13": {"doc_hash": "1d45e147792290bd349dd4175d3c74080a03134a03227035765158bff45dad63", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "8cd03806-12fe-42e8-a0cc-41fd5c773aef": {"doc_hash": "57e24b4b87a4a164996a2afb5adad1750fe64a0d47c1cd468c93dcff927d3551", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "9a0b3448-d74e-4fd8-8db9-4aa683515147": {"doc_hash": "6e940e18b91a5b239e18f1ed59a60ced9ec992f1a0eedd67f2152a361437e57d", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "38db24d8-e014-4573-82ae-9ddab47c7038": {"doc_hash": "f8cd19d70be6e9a1a3aa5a6b038e25b2e7035ac30f9944f3db9de47a0a0e496e", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "5d8cde7d-1174-44ea-b069-cc77571677ec": {"doc_hash": "0e84687cc61544d699bc0033edcc594d7e0b3b41aed8d3e54e6caae581100147", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "976f0db3-cf55-46c5-8f31-e9e7654764e8": {"doc_hash": "d1199f40a88b3fffeac01eed3667faaa403544d8a82945566d5dbc1b83200da3", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "03ca86e7-eb57-403a-9f5e-12c24d83cac6": {"doc_hash": "93c93b671b08f42915c93bcf92826da56a2061402697c7326f30b3a71055ff1c", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "0cee6ea7-af82-4c27-98dd-83a1eb6fbf4a": {"doc_hash": "968698a373062aaba50dd576d54f65b590f914801498774f49aa7e9e56973534", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "13cde9c9-c561-4801-9876-6562e55ac219": {"doc_hash": "b71f485bd7080f18ff2d3f64a13cf0e16e949180d3b38da8d8bcd9936876dcc7", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "4324e8fc-3add-405a-871e-4d005963b071": {"doc_hash": "22adda6eadc01bf0acd490d7ba91a47b698f9e4a1ede2728e912f6fa0e1275d6", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "5b947b54-9147-41ad-a471-d8b1f21defd0": {"doc_hash": "e25f6ed23ef029df70d1441114514491fe77af9e23c62ee26d1318fe52375959", "ref_doc_id": "68b47fc5-3328-49ec-9e35-e84845d5882b"}, "702c0d9b-9144-47fe-b5c8-3c3255fba23f": {"doc_hash": "2a74d14e4b5789c7f9b8d0b2ca2deddef9a48db31713ad21d641193845187f46", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "e8c32223-de46-417e-9cbc-b21ea4e94658": {"doc_hash": "ddedbd50a33a7ff7ab50245a5c6af4621a586cb0ca45f53d67e84122c51994e4", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "292b4b4f-2e89-4d93-80c8-5735d13b03db": {"doc_hash": "4d645ad2f8b1b1c51e3d76b3bbeaf1df876dd034871b259d035b40bb4bcd4e19", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "c9d0ff23-d164-4c8e-a03a-ca4e15f654b0": {"doc_hash": "bf4b6f85491626e58d25c3b6eac4e33e12feb348fcb73fa9554f00586b1604d6", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "25393370-ca28-46d4-96f3-efcc6cedd41a": {"doc_hash": "b6eb90658a0eae648e66291bbd44dd234562f6dc74f70bf6266c44ad6d84761e", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "74bbe277-56b7-4c7c-b52d-39c09ae8d6b1": {"doc_hash": "02e4418644728659adc98b7cafdf3b54aaa374c3f54610f8b271fe4995c72aa0", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "b078d91c-1f51-493d-ac05-5a9b3998e054": {"doc_hash": "b0c22966771185e62221a7bcd8164c33bd230cadb167b001562f4dd18e92dd3f", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "35e4913a-b03f-4732-814d-10e64a30ab52": {"doc_hash": "62f2653ba22c13129c3257a071675dcbb1b08eb0b34db58772b015280869fa4d", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "16e7baa4-cc76-47e7-a69e-d17db7c3946f": {"doc_hash": "2960974b17c3d835e849f24634e9c09661b9e9a613bfacf328a6adb0601e437d", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "574df1e0-4dab-4298-ae0c-6620afe9e628": {"doc_hash": "d8b4515b2a0bf207df5ef890f8759ccecb56343f281594625b4107729ceee96e", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "42348b3f-9dc4-41aa-9fca-487fe1e6a176": {"doc_hash": "dbe759e98777d1566905868dc0dbf85c190941781a91cff2ce57930f8af99c08", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "edf3584f-df5d-4cba-a2be-b4fbeb555c9b": {"doc_hash": "14ac28b2eb8def4d04ec028cfce82ec22ea09319e6f2039b202c52c0a0ed7724", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "86e62ba4-45a4-463e-8d63-e7901a5aaa9a": {"doc_hash": "23a01281c6aa75269d7ba8577a260c181206d96698fd1f2623858c7e56ff6732", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "10093179-9d6b-4099-9f1f-f5a0c4240eb4": {"doc_hash": "318f79756fa066c01da0c72ad6d00c6217810bcede3f136f97a241fe5a7d8fdc", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "bb431036-2dd5-4d00-aa24-51e613670e1a": {"doc_hash": "3a4eea15a4b857a8f54d1728ac74dc16e877bcf2555818308771392072e866b7", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "f578b07f-070a-4db5-b839-7b8a3844fb18": {"doc_hash": "583d0012b953f4857b5110762319c95c2a65723ab1ce2c4361e6934a9e4eadd6", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "f015e915-c269-4880-9487-2c6de252b0a8": {"doc_hash": "2c6551cda0daeb3b4b9cb5e85e2e261d5d14d79e37df20900c7fd4796945f00b", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "f8f3f987-b23d-473e-9337-ef8b44efe6ce": {"doc_hash": "d05c1b4d9282bce80ffcda2994bbfa1419e3a5ac3da877c1cba05c378085b9bf", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "f39cfa14-a63c-4b77-acc4-f054121af9a9": {"doc_hash": "c1ea88a6fd4edeb3f1d92acadd4bbbddfd088991a5f3ab832e660b63822e55ef", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "d5fd13bb-f375-49ce-a38a-67716e194193": {"doc_hash": "b3d299351cf292427e655177745dfea2336f7903b8007ff5667112f362e944c0", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "6de58eaf-a095-4979-951b-93901687e5fb": {"doc_hash": "7e51b0fa87df1ee4ee7f5a34db4b5ff13fe0ed5d95ffd507e11e309a2927e6f5", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "83654659-13b1-46b3-883f-0f96b96b3d78": {"doc_hash": "d89f6d88238fb25f18a88e2d6af98c3469be0530ba8334f6182de27dcfca4cac", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "5cb73bd5-5efe-46db-95a5-bea125aa4b42": {"doc_hash": "25f21964070728d54193d93b8a2a6aed536117d008ddb201c78e429cffa393c8", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "5f09fd7a-8996-4453-b29a-03b3b174735b": {"doc_hash": "a841284988397b10a2bf246e535d6eb6e62615c569948fa7e5028942928adcdb", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "56b99b5f-27f3-41d2-802f-474e1277da10": {"doc_hash": "6e81dc9fae56d6e97220c4ed4167468e11b4d865e2266b492fcb137df417d959", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "7c7db9c0-2367-481b-a891-3ff370f13beb": {"doc_hash": "42d0d6bb9a256232b748cc5eb92c8f96b1e2b08772522ced100f5da5a39c5cdf", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "cd05510c-92cb-48e0-9991-449192233aa5": {"doc_hash": "f57e7ca3915de9c30c1bb9b5a47271aa2101d89d1e80c6810f74ba55ffcc8a4e", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "1b805b31-db05-40b9-a820-fa645b274696": {"doc_hash": "a1d5dd144a15fd6b126d2874602dd0f96ad90ded74ffb3ac9b7dbc854218b9d7", "ref_doc_id": "1a299195-b7e4-425d-b5e5-32c663e3f7bd"}, "a612e260-f1e2-4bf7-8753-fd64183dc256": {"doc_hash": "bc58c2481ebb3537b2936ca79cc83c6ab34bbc54ca7bdbd11bd40b9265bd6474", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "1ddcedd0-7330-41ac-99b0-bf5ae37f6912": {"doc_hash": "74a584b74e298c4fd133aefe6ca62641153dc0117ef57563d6c81ecf300bdf8b", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "0c9d43cf-2ed0-4297-9983-7adba5e4e459": {"doc_hash": "f61fbac7664af9f315434a6d0e73ac7ed36b845c493ea0896cfacbfc0c7943fe", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "499a37ed-ffcd-4ab8-997a-31e56e3a1c0e": {"doc_hash": "2ae148f56e9c792900f7ca3be9ff661f8e18481cc63677e08941fa881d6388d4", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "54d082da-93c8-49aa-98cc-67f035174c0b": {"doc_hash": "3538fc0ea8feac4d0a6c88a0f5a6097474ba42bb3e389bd028d54a07e1c766dd", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "9185e736-a9e5-4153-8067-6c65855048b1": {"doc_hash": "64c16aaee2d3d8cb678388a406b2b85ec0f1ed9b59b5afe6dacec1a335402b5c", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "e81a0b09-effd-4b71-a563-81d271569916": {"doc_hash": "077e8dc27fd330651944193d3d9eaced69654b0bcca3410604448b4accf1d1ae", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "c035b526-5d77-40fc-be29-ff852f77418e": {"doc_hash": "6b5ac2f7034dd5628a7c960f625543350b982779fd5afc6f2eee812ffd64ed01", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "7b28894a-9a6a-4d2f-a87c-8c03a3f694e1": {"doc_hash": "8f74dbd3b289e24c24bb3fc7bfc96ab8a61f843f924dba1ff150498eab6c6eb3", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "7de08c09-c456-4d2c-9028-0cb6a0bc1415": {"doc_hash": "99054f99ce5fd35beab903d8ee891cad14db4127752f62f3b072e6cdb04da380", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "dc061452-80a8-4327-aa72-cea0c88971ea": {"doc_hash": "939d39820abd5e39f19e69a2d2cfe2112336a4eb7ef258c370122f050821f25c", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "93dad029-21b4-44b7-b0a5-7cc5038c77ec": {"doc_hash": "d17cfece1f5d3226fa2794bca0bfbc098fc0df65a195abee8046cfb827c6e6ac", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "b93e118b-1368-43ad-8b34-ae72cd780194": {"doc_hash": "bea2e7c5570a9b8eee2bd241cb8d518bbc907cbfe78279a5d74c2d25dc3eefd7", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "9713c4b5-1b22-4c64-8c68-6538df6416fa": {"doc_hash": "6ce2c207a941967ee337f7b2ac6e7ed5800afaee4e5889e81146c9a22d9b174e", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "e8205edd-220d-4c3c-a084-a5496ae5adc1": {"doc_hash": "5f1622269f2bdad36338fa52c08da1415a5a047e3ea9c329c3ad08df730aad82", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "d4f9b472-0d98-4dbc-adec-76a5fc9a03a4": {"doc_hash": "fc9b6037619ad6bf0bd6955fdaf13f67231502e9653f9d3c1615e873e4abaddf", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "1669748f-873f-4877-88eb-c18338129c03": {"doc_hash": "4fbfb81343f8e20ec98bb74f8d2d66ee085cb434bfd86afc02888b15f03e2c74", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "77278770-7ec0-45ca-bd31-ad5006865216": {"doc_hash": "b7d4caefce8f0196adf1ae69162d673a5b2aceb643038bd44cb951cffec8e677", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "6d3540ba-8b8f-49cb-9f83-66fbdef07c94": {"doc_hash": "ef7b7686d3deb0d944c4ad52f54d3fc6569babf68e6598a4c3d69b382fac7b59", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "a842546f-5116-4226-b322-cb956e76c9de": {"doc_hash": "f4ffc7daee04ef59807a42dc272c99bf3a5cd49a0f57c9286e1c41e1f658c525", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "8071422a-2753-4599-9f05-a499dc346b37": {"doc_hash": "dab0c2264595a4fb2cee48dd1dc1b1bc3b19f1dfcff5772224db52f51e3fba8a", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "a19bc29a-3e5f-46e3-915d-20cd3167daf3": {"doc_hash": "5dbf75996b9947ccb93657118130705217cb30c1364139bb07ed0ac8298ecca1", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "815450e4-e30c-40b9-a2b1-00e86a2d1731": {"doc_hash": "6347a36c5bf2789183fce0d1d63d17a793dddced56973561943174dad0f82dcf", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "88db782f-6cbb-4ab4-bc82-d9b2a33db909": {"doc_hash": "f8de1d9d11fe46f871e9eb83ea2aa14613c992317d5015d10ee57513aa0e609a", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "7ba599a9-503b-48ea-a08c-a7679c154ab5": {"doc_hash": "9d5205a01b302cab943d02f87566e761714750593a8c0aa75fbdf6ef61e62795", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "e5725bc8-5447-4bfc-b316-afbe63d87564": {"doc_hash": "ba7b8d7750a3952b850c42d7b08eeffaa39f3491f49774c13351d9c492f79d2d", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "850b66c5-c251-4335-942e-9a4863485609": {"doc_hash": "dc0bec7d3ea1cbd3616e4b76a592d50159d3102ac9adc74b29da82cd471633fc", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "e470d086-869e-41df-95f2-f62bcae0764f": {"doc_hash": "257aa2efc55a5a3eb3041d2756df20e7b8ef913c72a74db646ef9bda516ea9d8", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "311db5b6-4611-4644-870d-8d862973603a": {"doc_hash": "b5579b536f9f913adda9750bd56bf1802c1ec3e0d562dc99963eefae9c553d64", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "a1263259-caa8-4520-b520-441ea7f5a153": {"doc_hash": "1bf267e771faa5077d9c63dee945320521f389a21d3ab9ad7568f165338fffc1", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "1bb7a877-41f8-4045-b263-8ecd4ccce4a5": {"doc_hash": "ff454f4fc70fb1949d1dd6c312577b776f98f3ffd709fc9069fd90e19ba65500", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "b52809ae-ecd1-4add-bb22-e6f4c4330a67": {"doc_hash": "9f0c416a7825b94a7ba1363d0878bd206806bb2f5f78190738099e0afec1c2d4", "ref_doc_id": "27c9be5c-48c1-4788-a349-5276dbc93e27"}, "6f4615ee-4303-4194-b68d-de0eae3cc143": {"doc_hash": "41f3a539b351eec91f877fba58fc323dc80b24aa5823b2f3ba078c4992dc24f9", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "1db30304-0634-4aa5-bc43-341ebf61689a": {"doc_hash": "0d41c2a614feddf1809dd67bbfdbd98e67501e9ae0e644d3b636a19c01292d53", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "616aeb05-f465-45fc-99ee-53f6e7b387ec": {"doc_hash": "8a1626187b25eb2f39f2cd3ea7858f8683511e78ad48fca77f0db2005d8edd1b", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "a745bd9b-2141-43b6-992e-f8c4382667a7": {"doc_hash": "c1058d5966c2aa0c5987e68e2542c8d06426c4e508ac051012b6967f268edf5d", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "024d01d4-b053-4374-8d15-a7c84ee006cc": {"doc_hash": "8b6a5a68ecaa28932d5dc0b20bd0fdb4b7d509fe991390c1f1703eb6985c2f04", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "33999732-411f-4df5-af69-9d57a55b7164": {"doc_hash": "44746231ae4ed7a6773e71946f76b4877746ab03ee4a2da732c7c8e3598fe46e", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "643242a6-f397-4100-8161-eba606ccf083": {"doc_hash": "ecb425b4cbca9598911288c3c2571585012966780a8342d703870b120de9f580", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "2856df6f-b598-49b9-9b69-ba750083c843": {"doc_hash": "90b59bee1be8bebefeff1808739ffa5f8c004ced1bfe47cc336ffc2ff2e002da", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "999a48a5-348f-4512-9b46-46ba44982493": {"doc_hash": "2092493489e709a9b077fa01e7a8a3a1bd311e158a208da776f042ddc64eaa90", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "308980b3-9149-48a8-b3c6-35a119771c6d": {"doc_hash": "e9958a87f29f3d16747f4777ab05a5821c181b0c5d59ebddc9d8c05e917163c1", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "840747cb-9318-4749-b45d-1dec02b43f7b": {"doc_hash": "a10b83a8af1dc01858713975c10cde88638d9ed31b0b5d5b851d5d69dd6fde07", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "646b5965-51ae-41b6-b48d-f120bcdb3239": {"doc_hash": "3a6b302d13b44ff53f5af7d4127f461a55c3e1bf10a3bda23fd83fe5c9379bcd", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "478b4e90-a81c-42c6-9f5b-55879b37485f": {"doc_hash": "653d4f4656a52cf8e6f43f7b3bda86fe20423af45570592f63955d15816f9896", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "a8ba5d39-7bec-41d4-ac81-ccddc75ff029": {"doc_hash": "c6d5dd9f9d221bf3cd4f656b8346492d60ed567f89628b60ac53e4e2b40d4f61", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "3ac127cd-1033-43ac-a3f9-16b4ea42a7a8": {"doc_hash": "b9d6bfdbeabaec8d2681830b65cad132b444a278109ad393a2164c377a32a167", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "7c0a3ee7-1aa2-4756-8e06-386cb7e649b2": {"doc_hash": "82135ea661625673a861b93e6449f4485e5b8cd57d0805a1b66a3400467f9528", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "526dc107-27b1-4b99-ae8c-0bb4d574a43d": {"doc_hash": "212efa2f76aa8d2c08559331f9f717ca94c70f219f7fe4889ba6aed3f4855a6c", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "9683f90a-b39e-454b-8ddd-c35f4db60c54": {"doc_hash": "1b0d35268c1fc14d1cef3cc2eecde93f447ea3ac5ead498da4393f4094682501", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "bbb6ee6d-36db-4811-b2e7-a6aafaf74a30": {"doc_hash": "88e44960da69751efda8d469fbce2c21c55c18149131aac8db2a400f3c4c6299", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "1a6f268c-a465-46c0-844e-fe2ecc116c9a": {"doc_hash": "f4e3d2f37cc267242b01d864dade204e4f063bf6e61cd2420ee5f5777738194a", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "afe02bdf-8f2d-4824-9555-26bccbbb1a4f": {"doc_hash": "e8b901e332eb48d066ce96d5538b7a7c91a73a8fbff2ca70cf3c55d1464c6990", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "236b44bd-d75f-41b1-8b50-386e597d3342": {"doc_hash": "e519961bc44a5ee04393a17971082504ac00e9915e725db26d75c104d545a390", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "f9b012a0-5602-4fe5-9891-f68a9068a5cc": {"doc_hash": "7c156bb187fef96204f00413f275f2e7078a3ea1e2c29e9bb5adc7340ee04b6e", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "f098a2af-ff9d-448f-bd88-71706f9eca28": {"doc_hash": "2f6ee083ccf1ffd997d87e63d3a9c67909eb6feac48469cd738f52f98c21aae1", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "28812504-5519-4aea-8f49-2f7caa3d8500": {"doc_hash": "0372dad712ed3c02d27721bb74dc99614d1cd83a0027b2e35a1fae2f740b253f", "ref_doc_id": "b47e77b5-32a4-490a-895d-4d71a61511e8"}, "5ea73402-9713-4c41-941a-79e384b424f2": {"doc_hash": "05488be272ac1134c38210a56c6e90fd7584cc5c48c0a8bdb81cd2374d89fced", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "c1e2bcbc-20f5-4695-b220-d8324bb8fe9a": {"doc_hash": "f6409ff63f6ed716068d5e93c4f08d1041cfcfacc5183712fa9397414abe51d6", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "a587e070-23c3-4e39-be76-e01bc5cbe643": {"doc_hash": "31b6a8de51118d197a00469e9dc36eda7a66249367fecb80e9532ca75037d5ab", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "939e1e98-f059-44c6-9582-8c335a181593": {"doc_hash": "f86ad046145bc386c9790c8f2a4e7eaa74e945bec92539130ae8d4008266e472", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "11fbf32f-e37f-4678-9220-5666b0bca92f": {"doc_hash": "ac994362e39a9cb81a7df66139992266dea4054daf4ea4d2c6d6879862d1fb7b", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "3f386601-d873-4ac2-aebf-6e6b0f223774": {"doc_hash": "f24707d92e9947f4f5dbe47974a5ef83c27a460cc3111888e9dc869c1ee356ad", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "eb886d4b-87a2-489b-96f9-061e6dd0e75b": {"doc_hash": "92829ae65ec89749e3f9a99e75ca2835b9dc93f04a9f32a1a0a3f3ae1e5977d8", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "72cf6f03-7ad3-4c3c-88f9-c2f60e3bed72": {"doc_hash": "f6c2495396edeed871e29f2f76221062c13ad4dcfd6e3dff7374a54c0f942d30", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "0e36ef52-4593-4935-94ef-d24d49fe25ca": {"doc_hash": "232e0a891e84e26cc2e9d9a6140332b85575e60ee028f241436d963d21e20d9b", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "ea92f815-a353-4a43-9fc3-34e7df3b0e7f": {"doc_hash": "b510d2245d48e804270ec04e21d591e998519d6a88968c44a5f3960427b90575", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "046ade57-bdf2-453e-9d74-4bf48c9c1828": {"doc_hash": "4e8c1b229875b774df4c14a8bc960a23c057db98aa39c4b2ae8d0e7f4f5e0deb", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "51fd04ff-bb8d-4459-937a-ca742340d943": {"doc_hash": "2b5f59ede3eb4eaddd0375d4e7192b755369f4bdfb4fb42e8c4896b3ba3cc0a2", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "fccb6151-0cd0-4b8b-9800-9efa9a2e3da3": {"doc_hash": "25970420a454a3566b216142ea5315adb861afd7d8dc84b98964035c52674182", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "ab991b2f-2cd7-4656-84c7-ff6f0c19eb9c": {"doc_hash": "4d7b56e513cf5961b8c25034414b51b08e69f9f23a75abd56a9fa84ff37a002e", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "70518751-c6fa-4514-beb5-b8a3fa28c498": {"doc_hash": "b95986d4f1fde58fa923a15810701deffd1d0f11f9b54338ccadb312de76c7bf", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "962f6fcf-7d6f-44c4-ae76-9cad7493a257": {"doc_hash": "132cad879b2a3761397170824d9005faa7e9689c49fc66b3c74f65b3d28bb0e2", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "20256c4d-a688-4b56-be86-47674f79e462": {"doc_hash": "cd5ad4d5f5c3081e02ec89faf7ed617be42aaab71b0e50a3be3052367cd4775b", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "20726868-bc28-4d2e-a7f7-d58e79481ea9": {"doc_hash": "cd05145fd9b58a9fc27fe48c51d791c02d1db6506a36c1c74bab7642a5a37d0d", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "1c718ccc-3eb9-4b6a-a4ab-d22b79f64df6": {"doc_hash": "6d24df95fe49927adaae1a212c1c05fca9d12e8294d39ec65c0e94f3c207d9ca", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "ae51b47f-2680-4edf-af06-0e0bbb8af605": {"doc_hash": "8521ee945bf7265bf6a5f725c7782b7db67b1b56402b87affd295b8f9f2aa2d9", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "e8831708-fb48-4478-81ba-0018b39582cf": {"doc_hash": "912edc10db3eff70b0b93daf8b09d8f3065ba0ba42baae9570f58f01c5c1b0fd", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "98fda166-d1ec-4d81-b453-aea6804c2bde": {"doc_hash": "c0dd787cbb064e6d4122948434b9e362f17ea877e700010b446b59fd16a42c7a", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "75230058-30a1-4908-afc6-c5e078227e1b": {"doc_hash": "a870575a3819237a8535394d7ac26fd9e9c1c71f5ab1f53c58a21125c65e10b5", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "409b38e6-68a1-40d2-acaf-6f918a991479": {"doc_hash": "00e5b6bf220e5997362a0f644bad62e9dd43b2ee5e22e4f6fe7cf38f84893d2f", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "a3a4d410-8b8d-4ed5-884a-49312e967bfb": {"doc_hash": "f8adf2d1ebc380d23618acd36ed437ff8f0692cea82fec70caeea18e6801f480", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "8a6cc63a-89f3-4789-9f46-82be58dc2fb0": {"doc_hash": "9df4a2573b0f9def9945a01976ea886dcb52d3c3f8720f413b5151d99f2e46fd", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "fd1efa7c-2739-482e-8f08-424099a49e42": {"doc_hash": "c3fd2050bde9bd12d97dea9818abc8706be610a5428475a221bad3b0b02dcd63", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "370843e0-cddd-4486-b64a-2801a0b80832": {"doc_hash": "597885df8a53f0b22634c4dca5800df95c384d6fced06a729183e47dee63ad10", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "225287ce-5b47-4adc-834b-86d9ea22210b": {"doc_hash": "cff248318b24168da8074f5f6b3ac9ce78d4e2cf5603c9a500a43ce97349caab", "ref_doc_id": "a6b8cb84-766e-4361-8388-11fdf71b8e11"}, "c872664b-a508-4911-b0d0-584cd5eec9f5": {"doc_hash": "6c41c521ae815bcaac04e3c2f759191d470837ce560e036f78e4b1dae6bc600b", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "712fa1db-3680-426c-9e5e-5acb827b28de": {"doc_hash": "940a4c261756b6ebc5fd36149a75a12774589eebe6874d7c05137cbc90d1ba0b", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "4e747e56-91fa-4c40-b509-6a1846d7154d": {"doc_hash": "e1ebd30c845d3db66f34e6f3a4d03c3cb8057fd6018439e7b287d815cf060973", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "bb60e733-3d30-4700-b466-809ad3ecb5e9": {"doc_hash": "2052f37aa650359b1758e7f3949f0967d21e7d0337cb2d6ab6b52c5ca147111e", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "3a6b9eb3-78b4-4928-9959-9c04e84b9af9": {"doc_hash": "663e1e4f1021f8ae747beaf0accd9060b881c2d59ec286b843754bf2ef83df0d", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "a34c1ad6-8c15-4b1d-8e8d-85f74e127917": {"doc_hash": "1558f72da97c65acb0952e5821d94c98b844c780f09c6af946137ac64397c285", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "ae139f29-0ddc-4e54-bddd-fa84f1803e3d": {"doc_hash": "34e315cdff47d60d068e26c7eed1fe757d06294c86bb543babe46606ce55b12a", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "0190391f-0fe0-4e58-8475-395b25b06352": {"doc_hash": "5a3f4a124eac84815a458af6edd39b3957d6064212420278ad41ebc0e9a64d8d", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "b6ba3e24-8301-436c-97d3-299becae3a16": {"doc_hash": "ab4b153f6f2918758d051a6d5e64292e9dc6f41f94e4c875f66b26de0ab3a1ce", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "8b3f722a-adce-4b40-a1a1-b070a33a0ad7": {"doc_hash": "407ee6173255fdf1cd67c4d5d8359718f69c1378d60fca7d25e1443c18141c1e", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "98bfca33-4524-4d1a-9c19-982d3cd9d8a9": {"doc_hash": "7d1f993353bd9115cb8fd92997ee79e8a22e2e82055f6ed2e35ff55cecc8d944", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "0849ac87-bc71-4a9a-91d2-27cb7cb055ed": {"doc_hash": "7cbecb2c862a332d7dcb4e8b106e43bc2a022943be26dfc2ec1d27450814f92d", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "0daf13da-257d-49b2-bc71-d3022ab6b96c": {"doc_hash": "ad5cc254516e51462a86de31a76dfc0bdcf2e7f26479b8dc109379991a0c8c94", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "971356d8-67e6-46d1-81e9-51c936424a9a": {"doc_hash": "d032216de04f4f6caf7acaded1dde3ac2215acd72eada2257aac25659004856e", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "aa05ded3-e7cf-44bb-9178-abbe6d007116": {"doc_hash": "cd650314b52b807ca8a4686c274653c07ec374bede3d28fd2e65b154eb448e0f", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "885c3bb3-44ac-49f0-ad57-aef9af2d72b8": {"doc_hash": "f19869ea4c727d7781977e3cc6c105196a4f0d0b084805fd21a5d852a573d453", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "672db77e-ee80-456d-8168-a925006d7593": {"doc_hash": "9179b9cb1605e3ac74bfa89f9865d4b289707a5a09901a8aa538c5a0558a5a07", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "a70b1a7f-4e08-461f-b154-e2ea1c1e7934": {"doc_hash": "30b8c85f890959541c939a49009058c820457ab2b4f84dcb56e2888e92e47523", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "a1c53aea-561c-4863-940c-20bf49c53be1": {"doc_hash": "b8722b57cc6876fa6c9fff88568de545d63e056ed161ee9f97146b779d69ebe3", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "bf638cbf-35a9-43c1-8f16-9285c833de46": {"doc_hash": "d77fd6d98d0ffb9653e0be7dea81765d27e00c234dd6953c0b4b9ece356e2df7", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "30d187d7-3495-4f45-8349-25df2bc7172f": {"doc_hash": "6987b8eade6d66e47877003c065edb9491e3ace9d3b814305c97dfb3035b0bb7", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "e192b5e4-8199-4c14-854f-d331c0021d84": {"doc_hash": "4fda891715ab3a3200a8347cbb4231b570a4d4a9e52e30611b23f75652df5597", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "37228113-eb2a-4730-b65e-7631f569e7a2": {"doc_hash": "716dd47c7bab91bf60e914ac626568b0ad6ff76a3a8035d0f556f1442edeb837", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "edb0ca46-d8a4-4a35-b0c9-988d2a1054ac": {"doc_hash": "0622832c368a421e1cd808abecaf9c1170b11f4cfcc392679705e73bfc4f0370", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "cff9d501-7854-4cf7-b7cb-4e257579d73e": {"doc_hash": "4ac17c82ab749075f652117b422a87c80f667f66fcd2d9f4475171bae42664df", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "8a9496e4-29de-4642-86d9-bbd688e36b30": {"doc_hash": "dca091bf0829c5461352f52ce95f19f7aa4567a9cea7946a2d978cae618716ae", "ref_doc_id": "88c91c57-d901-4d1d-a762-8e2940612333"}, "b96bfe4f-35d5-44c1-a268-f8baaacd1bd2": {"doc_hash": "d7542530a18976d504bce9784ce00ccdce9003457376e5d16062baf7c362cb72", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "41911e82-df2d-4be9-944e-c006b88f32dd": {"doc_hash": "cdb8f1579f4b9fe8d592aa708d4a96be9a33dfe222869d8b267833c4264109a3", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "5f9f014d-4d9e-4394-8247-be5e01b0819b": {"doc_hash": "ff81f8084a6335928664e23f15508ec4b181d9c67696a732950721cf6e7b63a6", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "be9c4aff-3957-4cfd-859c-619e2db5c82d": {"doc_hash": "ef742e7f8f1f90b2921a271094af6fb9bc6869d3f90b60aa049b8cdc810de602", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "5f12fc62-1029-42a7-93be-15f7ccf71247": {"doc_hash": "03f83370a80512cc7c558a6d726018ec1aa3610dd0a165c9bb2056c3b0081cfe", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "c824db30-5958-4f3c-81eb-978b5a2e5c32": {"doc_hash": "19acf300d27f5d8288056d860689f47c0fdc7daba98d30ce9b86001cbe55341c", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "e0ee4c4f-07ec-4c12-8a3f-dd88ca4cbe11": {"doc_hash": "abda3b3c89f5273e97a0cc7ea3be15fd7c23fb12a161f3f1f39d12346cd1fc00", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "25a2c693-7ab1-4d2c-9d9e-9d1722fe0569": {"doc_hash": "6ff2e0ba6634d1c5c499680400770c6a5da6ec3856907b6026ff9a9f233f9cb7", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "6dd40e66-899d-4b91-9be3-53d9bf4664cf": {"doc_hash": "179a8689d6bb2828f61c0beb813cf72fb6be7b1348e9ff6b6aa127515550d9db", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "7a2a3991-6bb0-4921-94b3-8505df2db096": {"doc_hash": "00147642a257df59ca034d938759723bed94834c62aa77758a77ae7e74b5e107", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "08b9ca72-46a6-4521-b57a-b1ad47e09fd5": {"doc_hash": "dca6d20b49115a28447bb6f3fac7dff1685ba7891e759664f09e55fa4d9337b2", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "a7f96fb8-b578-4039-aed6-262f4a199e86": {"doc_hash": "9462db64986806a0b7c7d3010814158d24e869ad590bbd584047a16ed993a7f9", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "6311f47f-951e-4fcc-b3bc-12c19ff976b8": {"doc_hash": "02bf3a32a8c3640f3e0f18b6775997de2c09569b90ba5f7155a1b19b50fc0ae4", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "22e0680d-c820-4156-bc7d-ae035b4bb95c": {"doc_hash": "7d842ca329be7a64cd49069fef4bc239208c221d3f86d0aab8daf80d3d5bb528", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "913ae25b-52a3-4a26-adf9-ad54492c719b": {"doc_hash": "871e3948e3b172b78ed4ef7934d173b91698dd4d7d5cae8d1a18ed609c2a46a4", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "1c54f018-909e-455f-be27-874fd1f12292": {"doc_hash": "a60440776ea7213ffd389a8be47a5bae4a5dd35d0a2d641c74194d035484f977", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "f5e16df8-b5e9-4b4e-b01c-9f90ae59090e": {"doc_hash": "a3b933761ef735a96bacf8d88075130890b38d4dde4ee0614bbc6c1c1c5a1039", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "2b95e35e-9cbb-460d-86df-b28f6835dfe9": {"doc_hash": "ca16af6ca7f6ae9b0f6606f28425ccca1e89602725d814611e2b56a75a39b598", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "8089135d-1d44-4b82-9d30-96f51cf3e0a3": {"doc_hash": "29734827c8bc151f18d657b1b7e8a73658cea2e0052d7da5bac6e54ff775fe1a", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "c96955ca-5c0d-423b-952b-944e7d53c7c7": {"doc_hash": "5e782c21f8b00c50307432f5b9f46ea35db42a549038ad4a8ce252b55c6a4be9", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "6bda9280-95cb-4c6e-a8b5-ffdfbb1aa65e": {"doc_hash": "728e08593ec396ce1b6bf4b0e266f9e2d2eb68ec20cc0ffa1ceb845c88d9608e", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "cc2a4062-f1ee-43ef-98aa-013f43808b01": {"doc_hash": "118553d4dc0bdbad432795ee71c8a0c2b47a42baa21e2802da84887f0269c552", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "37b1646a-c13e-4d47-85f1-d3501d0b20b1": {"doc_hash": "54be651924ad36b2d3c0c0f4ec8da9c7fbc8645a630036b82b019e3d31712ff6", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "3870efa9-6d78-4d63-a3e5-9c55a1a11749": {"doc_hash": "84a1356c5a9092cd0504fe91136500fd5425cfc817931741a09464af0ef780a3", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "edbd3b93-3fe4-49d4-890b-abb75bbe1044": {"doc_hash": "0ca5c11550e427882eedb296379b020886a386f6fcc738803ca8e849d2cb6233", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "10cfea86-aa07-40ea-abb5-638e6af14800": {"doc_hash": "1666dc83ce5b0b897cdf834d233d5f971c672af4d3bdeaff99f3eb64790140a7", "ref_doc_id": "7d9e6cfb-638c-46cd-a822-9697bbe91354"}, "295830c3-153a-4ff7-a6be-5f2eb8e38857": {"doc_hash": "2095b8df48d7a68492f8dfd9244f7bebe267e8228b9732a7ec7abd922e5864f0", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "19cb1164-e9fc-4432-8a35-89afb7d1dd49": {"doc_hash": "077fcbfb1a1ddc0ff94030c206aa2e00d1a251e277f1e9a83792196c974daf77", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "fd753d8c-7ede-4882-9796-bae2c6f2fea7": {"doc_hash": "00cfb9fb73a96c0d2cf387f382eb1eb1c9f91da69f310b73cde7ee2c5ba1ee81", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "22508794-275a-4332-a5a0-100f994d38d1": {"doc_hash": "4ac48eb30a11619f645b14e193e038de96780f0c8f8902632bd36c158b12048f", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "20c6504f-3fc5-43aa-ba8a-1e5502831bcb": {"doc_hash": "09190fa65a17396293950288289ee8c0269a08866d3fcc853c91021c9988f1ec", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "43cbd5a3-3b85-4dc9-a76e-e8de507d6655": {"doc_hash": "40c948d1dc4a7f2b3cd35fd429f93023bca7d26fc1521b150da84fda1c3bd1e8", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "7d7a5332-e1dc-419d-8df6-9bd829a7581d": {"doc_hash": "c96d99a631a37b26f2f78a47dbadcbd787fff773fc7cc174fed0bddae634b7a9", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "b95dd5c7-3de6-4629-b734-4e5da2c1688f": {"doc_hash": "3d1256565fd40239c0068cdbc9536255848c9d3234408e7353bcc3d68865f304", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "d148ed3f-ff48-466f-8267-5131d6741bc3": {"doc_hash": "888237c4ae05b18e198011bba08859104d6c0b556505af6ad317142a3dd1019a", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "d289994f-836f-420d-af08-feb6eec8ff70": {"doc_hash": "9b5e5aa56b7c8e88b525ef052dbf23d52a0be780f7e3f2da8b4e872a0b0f18a5", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "bcbc4a65-4364-4dac-8597-84a4a2bdff13": {"doc_hash": "3f74917574f626f6be379688ce0bb34b1284cf41dc5aa4a1f1ecd51e93da89c0", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "03744e1d-e7e1-45ab-b073-0385182ec76c": {"doc_hash": "e86bb21f4c7dc91c39a6c7cfbe211c7d1a1c5d561b06589ddf9ab03e544d840b", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "08d16d59-6a2a-4089-906c-1cb8ab277005": {"doc_hash": "05ec3b088dff8f1a2339312d1e76d74eff7b73f3aeee5e349ef6aef65d4105c7", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "0744b941-95fb-43ae-8a48-0660521bbdf3": {"doc_hash": "afde9ddaa3f419689a900a14e9dce00f858759c198076c10d1037b95cf423c00", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "06fc5140-4cab-4070-968d-f47afe1fd517": {"doc_hash": "48ce2b139c119a808771a8bc40eedc137fab4d2a0e82672f52d1b395bccb6f04", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "95c8f207-9cee-41c4-8e32-eae6624e6376": {"doc_hash": "83ed675eaa18537d5f1230a07677f979e0135f9330563b087e658905203af6f9", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "32ed7e7d-2982-4e62-9a97-86b284c30c7c": {"doc_hash": "aa30aedd79b8df4b21ba2347df178fdcd7603211a13201488a8cb0c97d04fc7b", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "d023bd02-947d-4982-832c-363ea87705c3": {"doc_hash": "4e6109f7ed5b06e7ac2da1642d985af722904ef1656adaad32005b9d9140a333", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "646a7789-e121-49cc-be94-77bb2c6e60c6": {"doc_hash": "defba77dc6315a5f352196a002e085e3544b7c374322355d3e8c37e6f3bdb294", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "097057cd-ff5c-42f7-9c53-a42be87e92a3": {"doc_hash": "0c8d8a280240f76f18f66f4b509a311d47a0a3739afc67aae8d6ab6d2c365dd8", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "40e1c169-7d51-46d9-9f5f-ccc5913d0797": {"doc_hash": "3f3c342c7064fed7f69891ae49bb9a963662aefbdb55671097d03bbbcb8d21f9", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "be5e8613-0d16-4b02-b719-d8622548e631": {"doc_hash": "9719e9749d11f2c0794d1cca0e516a2afa53c5acb950ac2917dc8dc380c60e5e", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "d55b7ea5-cdb3-4329-90b7-56c499ad9c4d": {"doc_hash": "da128adf107a9b1b62273105b2eb592c7fdd1c462300b864b4f038919d3294bf", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "f2b6cd62-41db-400e-b55b-40dafd6627e5": {"doc_hash": "3839c4d8e6c092ba867e7460bf133128feea1de7a4dcc09344bd34ebc2750c56", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "8f23b26a-821d-4c8b-9b36-444c99eda683": {"doc_hash": "85b178e3246d3b8becbd6356b042e471a986c3ccb86d4f7aaed3ae0e8ae3d87c", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "6abe3f27-2007-4214-a94f-09392a00419e": {"doc_hash": "2d72d57bae2cd15e4e7ec957fe0339266121e75eb636a15ec8766bc3a7c5a0e3", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "aa6cae09-622a-4c68-882f-4a2986e6e76b": {"doc_hash": "6a98c282723185530dec882fdcbdcdbc0a479fe02b7c9b15ddbf8678eb16542b", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "11eafe58-27fd-4faf-b909-ade3bc0a8755": {"doc_hash": "55c8817e57d839fdcafe4899fad2a52b03479bd54065f6e69c54b5b679d461be", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "cfb090fe-1bd1-4adb-ab6d-acc3b10be4d1": {"doc_hash": "dfd309bb0e4f73b68f7a253b186d740da64c53d19faf111cf9363571c09ba1d9", "ref_doc_id": "80ed3866-65df-4bc9-896b-dfea17911a75"}, "7774d7f9-d4ae-4f8d-a777-477f4d0d9132": {"doc_hash": "86e5dd7e0d3f394270fae7af4b3a1834b4b8fb50fb0794a69930fc9d72ce1e73", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "f3bc6a48-101d-4db9-8e59-5ffa9ac7aaea": {"doc_hash": "34f1c7800898a906dbd71b566de73d0e38bfe3a397f4c0a5f25315c93dc3e196", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "fdf871bd-3afe-4b6f-a066-8344a846bb5a": {"doc_hash": "b4fb66c5edda595ad57c846f10adb3d528d51494640a42ca894b4bae9066f510", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "782dd7ab-8a16-44c1-94a2-e3a3c6795ed8": {"doc_hash": "55cb587e6c96801c7cc4fd78ac938464f32f868fc230832cc0056b4cfffe1b38", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "d624812e-18a5-4a02-9e02-e2fbbc60d9b4": {"doc_hash": "5c0503f903e88e375c627145ec6c20def824768e579314c22d34290563238ca6", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "40b6cc09-934a-462e-a424-eed0bc7e7f15": {"doc_hash": "da3b955cd013b3c2c0bb14e43646a801b9e886a1ccbb8ff5e17c061e2617c0bd", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "06f7e4c5-237a-48d6-bfc8-d4eac5e39b4a": {"doc_hash": "6e9b96727fd44e43d6c85561c783ef78158576ea8cc3fba11419b694d9bc0494", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "f6f1f507-f1cd-4a71-92dc-605f10604d61": {"doc_hash": "9f0955c9d55b10273959f415802b16fd98c9869e9c9d2559353d91982eb87b00", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "cd95685a-880e-418d-ae23-752e9d3edec9": {"doc_hash": "cc540ab3240f6816337d2d63d09109fc3c87c906cf7cde235d03f6f4528a1a5e", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "67ffef54-0e07-4b38-8a44-5a7fccfb6c89": {"doc_hash": "c85eaf540a17336eb74ed2036a8a86e49e7ae13dd881be1bae6fd835424e8556", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "512f83fe-0191-44d4-b367-c9fb4729d0e0": {"doc_hash": "1a315b85ed60bbc436eff06e2500a910ea17cf2ff9dcee26295343861a627a7c", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "3a7785c4-135c-46df-9a75-c0e83006b65c": {"doc_hash": "d0488367da8d5f1053a488bd926dc746e65bbd89b32d35999e37ec9fb93046ea", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "28078d6b-a2f2-47b5-acbf-65683859a17d": {"doc_hash": "50fb2587c63711583b47b7d387a8f1b6b8c43688efa5fdef9746b915ccb9a6ad", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "1a637dc0-4abd-4ef5-abcb-cd0223385a9e": {"doc_hash": "f80fec96f56cb4dbd0a5acf81bb961b07d37e6d915948ce2a2e18d8f78f4c404", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "c3d4c6ac-f16d-4236-a83a-9c73df0012de": {"doc_hash": "1baceb0c31769e3b9866c8d596ba51d3f61ecd2953ae7f67e4cfdcb89ab40289", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "2fdf1548-0296-4272-9937-f68783487426": {"doc_hash": "6dc0f0835f56ee2ed70b172e2ac55418343010305fa43d917001e263c5010c3a", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "375b54c5-08ed-42a2-9318-264a655db803": {"doc_hash": "04343a7ff650b8da39287e4c23382d43ceb922fec52791b584884ce9a9ed1fd4", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "765d0509-5c00-4d7f-90a3-7d6c05c1e5f9": {"doc_hash": "a699011f69d1cd037f65b4030002cb047b924171697fdbcb29d0652a6a944435", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "8450ef67-c432-46f7-84a1-1f7bd8ed4f70": {"doc_hash": "bff334ce9ac34434ac99c448fc285eeac1d1ae1c975c58189fdb17d112f4c254", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "f5401a1a-d916-499e-88b4-638a3546eeae": {"doc_hash": "c85de5c217cb0db0bdb5da3a94d3fbffa6b53f10c68663bfe5cada922cb3c079", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "97e655b2-3e90-44b5-929b-98971769c548": {"doc_hash": "97ae0d935ff51a6b366e1ac520b619cafc9f4f033d7d1af4aa728047b7499139", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "2791ad2f-1049-433e-afaa-0bdd442c78ab": {"doc_hash": "a7b35d710d154642b1cc8918c4223b10054177e65df51819c2db9cef7c3e2bb4", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "a82b6d8c-9898-4af0-bccf-00e418120f64": {"doc_hash": "2d2b61b8a98b65811e6f16c38a05234a09a8e20ed1997467866c25b2525d75d1", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "30eb2648-3f6e-4a75-b904-678857038704": {"doc_hash": "e25cb3a9c0adf52d15c3fbb9f5cbf4c4e2d74918c23b539d0579fa41a373cbeb", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "1d927ba6-a372-4cef-b648-2aaedd659e08": {"doc_hash": "c986da705b4d36cbf8a3a67ec05583a822c5f17306dfc5bb6826b0199270a923", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "bc37b18c-d69d-419c-8c6d-fe024d81907c": {"doc_hash": "3de8316f20dd4bf40e2bca526cbb9a45be279f07f9c12574b710c50d4cb6b940", "ref_doc_id": "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4"}, "871d5f0c-4bd6-441c-99c6-94527a6c5457": {"doc_hash": "e40ad169ef4eb0aaa27e07cd0e097ed5e35e89753702fec8b51a7eab88b43816", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "68b21a74-869b-4ae5-8cf4-1a59fb5fd985": {"doc_hash": "5ddb5101084ae967fb481058b34ac32dc5facd6cd29c1904e378152fbe82a850", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "ac2d93da-82db-44f8-ae8d-91c714f2192f": {"doc_hash": "e0eb5052b3e6b384c7798d2a0a70f7109bd49c630b59fad2fb28ce0a8f66d140", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "e16c2fec-2b49-439c-8c89-62c70081b5b5": {"doc_hash": "6673873f89b3a9a89becfbfce5757d5789f7a77eeb3dadde0aa17764406e880e", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "7887eed6-4b10-4f58-95c0-0ca32ff89332": {"doc_hash": "c10b2f05152d63696b90ac6966a1874ef058dee6e36cebd5a1650edcba6656d3", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "dd0c7442-6fe9-47b1-bf85-e330e9a599d5": {"doc_hash": "6b18eee0446f08241fa0d94440787c292e6364f45143fb70ce4647906bef5ebb", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "073e984e-7a16-45b1-b77f-e367cbe0dd3d": {"doc_hash": "1b03147e3eab508421121e802327b64d38232af31af630f16e56aeed1288df33", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "9175580d-c96f-4e16-8401-67eed8e050d8": {"doc_hash": "ce47993d81a7b4f62fd64bc3e90e3122174779691aa3c74fb69d9f50876188bf", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "d3526242-993b-4e5f-867c-5dbe0b4d696b": {"doc_hash": "9989626645ab1e06f5c053403fedf50b72430fc0f96e18828c2b028b66519157", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "09956537-c95e-4e16-8b3e-fa1c975e8de4": {"doc_hash": "cd4b03a71cb29a2c00ba7e9f4243f443d047db472c8fdf8c7d2c2db6a9b370e0", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "dce83d00-6059-496b-9d1f-88e92e927573": {"doc_hash": "d0c500b963d486210c03ca568bef319dee6ebf2877f33cef43d7451c349017a4", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "010eb556-bcd8-49d1-acd0-b663fb2608ff": {"doc_hash": "a2242a845d01d8dd2c35217cd925a624b4c1568b37e83c61150782ef52ee8425", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "b6cec0e1-ec2f-4952-afe1-044a6d06ef13": {"doc_hash": "890ddcc2c62283b2e2440a9581cb00bd9a8ab390f8f8e22e1efcabe786bc41c4", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "b614e4be-0ca3-49eb-8e67-09bc434d0686": {"doc_hash": "36d28330a3bc1796f4b0652188293c219d3f02bf5a9e3d8b15160ad4f330468e", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "438e3852-9f4a-4a9e-81a0-4d28382d2f3f": {"doc_hash": "71c44abbcbfc62ca3f1b0cf7b2476c0369d8876983818514b719596bab4588e5", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "13d671f9-e5fa-4ee3-9230-61d27ee9c698": {"doc_hash": "4f2f868aa65e38c1e206c190c8ae746cfe6c39a2cb21a44f3f5f2a0e7fef4a9d", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "159f271f-016b-427d-a31d-d0827bbf8a3f": {"doc_hash": "8b7f7ebc52ae234278a4357645e3f07f8da27b25ba817f608d661e5d19780036", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "2fa3fc1a-6a7d-4245-98c5-0a1e8d6b5ac3": {"doc_hash": "d24a894dc7596dd636d5eef97321a5649bb553b2a0ac178c043ef0a109e29558", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "0216dbe6-ad6e-436e-bf1c-a9f277163add": {"doc_hash": "89e685825cb25153014faae3bee4cb1e9b98792aded5222eccbfc01a73ea5b33", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "72b74c30-aa55-48dc-a1b0-5842e768cda5": {"doc_hash": "562f2eb6032d70d96e9806623a41ee6bd2f9e167f69ea01ad47a07da7d2af5dd", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "d5aa8cda-0082-4f52-bb10-45f198361adb": {"doc_hash": "0122f838d2eb11a5be016eca996f845d1800d1a1e8056596208202df7879d09b", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "48e666fe-03a0-4064-98e9-32dd5414bb5b": {"doc_hash": "47d072d0f9ee1625ddb238797787d7775fc87d7b6326ba0b7dce9f9358b13072", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "bd97adbe-4ebc-4ba4-8d95-44e0f2e5ad65": {"doc_hash": "183dc036c4efae8c076fb1854876d0a457c5fadc43ab165f1ee053f36b1f38f8", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "7209d633-68c1-4d38-851a-383694da7154": {"doc_hash": "6dae4da0d136849eacbd7d8a7358e52a3cbf7eb8c38a61cc25f056972ecbfcb8", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "302a9883-7627-40b6-9ccd-83ca4bad4a4d": {"doc_hash": "c2c8bde0f5e1e83642e39352db30595ba2814d69e947b3283fc5c9edef3d3efb", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "e21f178d-ba41-4362-bec0-9c627e80266b": {"doc_hash": "ad631059841d882c90d1c16aebbaef5fc56c17a241ff0f8b7a1b2457a284e478", "ref_doc_id": "c8dbda70-76e8-4883-857e-5a79d45705b2"}, "40d73317-d6b2-4086-b079-461e19906f34": {"doc_hash": "0c4f7c679126bc9e795224722584ff54a80c2ed37c6393bdce19b5402f5591db", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "20173cba-abee-4146-a4aa-9668a686eb54": {"doc_hash": "3a9533c31bb5519ad7cf53644c1434fe60fded9172f7ff7de166736f2157bc4d", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "952dce95-3d44-439e-b9f5-eaddfd1373c7": {"doc_hash": "b8c01d286037fc9132d84a53a242529bb723373ce8df029f88e75848239ccd0b", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "5694d8c8-cb69-4c67-be9b-cd31c8f52c35": {"doc_hash": "30c9455de0ae7415374d9c4616fe5523796a6fe36ccfa767ad0ce98f1add696e", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "ff7c0d70-d304-4dc2-8d53-d17c3a53ac30": {"doc_hash": "17b3ec4c69cefc04c001593d5e5f3cf9946f898ce546486f241943b7dda97f3b", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "c092c063-f606-45e1-b1d6-4ce9911d78ca": {"doc_hash": "e2ae13041fd39cc7d9569ab924af9e7ca389bc7c891ce2d566db41f061abca0d", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "d1710972-d74c-4ff1-ba2c-025747f22447": {"doc_hash": "27ddaa5480d13b2749108f33d5d6b0a2a206c809095f1ee9fff51a385050547e", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "a52851b9-3e7d-482a-a301-216df11c6744": {"doc_hash": "1c2a4132f12fb8e6b6f0ec3533c7e79834a890036adeec0a4eaad371472eb2b1", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "a4a6e976-887f-47ae-8752-89d1456ae07f": {"doc_hash": "a4463faf1af0af4b0effbb4935da8270a8c7a4e4c2147e603999775092323e15", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "4b6eafd5-eb1e-44b9-9d17-aa5d4cf71527": {"doc_hash": "10ffefded1e0d2c0bee336a69606bbf710edd5f9bb81e8918c93e5f4e8c60d2f", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "705d6b24-92fa-4f60-bf27-f76dde3da774": {"doc_hash": "4d509d019ef93ab405b5c3c9369fc216467217e72055c7b0c332f02779bc58a4", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "2006df42-ed71-4e46-8b60-9dcdb0b1b54f": {"doc_hash": "64f9c2c40f7d08754d30aee9eb81f6066f242a1e3e27bc884d32bbd9762e7937", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "72765fed-930d-42e2-8d43-5c2789a24b53": {"doc_hash": "b15ba35e8a6995bab7ebd91f1192d168bd02d7b8a531aa9dd48fec38197a3194", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "82567661-b2c9-4918-b9d0-3f84c8a904b2": {"doc_hash": "08ab7f66a5deeedf4bccd61a6f76cd5b859e6208eb017ec15c830868ce375279", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "a45b802b-e69f-42f5-ac0b-28e3ac63d084": {"doc_hash": "6195b9f5d1462d75ff95e4abe161d23e8d116a73a1647934e0a111ff77142885", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "7ba79424-2511-460e-8c7f-0033dcc8695f": {"doc_hash": "7a59ea291ea2020a68416acaed77e8d5c2234f20e43cacff93766e563d5d9709", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "e2aa03cd-2764-4844-9118-aedfbf1066b7": {"doc_hash": "40f00171670eb766ee162677918e5279faa570e30dbaf938b0551858044914e2", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "66dc3618-b2a8-4390-910d-a00ba0798ca5": {"doc_hash": "08f4b531b17e6236da769b52de46e1d10e9b43df2c10f26ad000436897646c64", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "4c367544-ec85-4844-adbd-2885360c40c9": {"doc_hash": "3f8cb45296b32eefd6272878adfff69b98fbcab2427e31fb6a7d9c2ec0206de6", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "e6bd754f-131f-47f3-a34b-1635f2a62514": {"doc_hash": "46bbb4fb9eebb8d09db744d8d2b2a0a972301f919d70e7cc1120548e1820d2ee", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "d3a8788a-c751-4c93-918a-ee3c20a42b94": {"doc_hash": "2749c91a14b2724024cff3ee17a5b8aed89579e28a47eff31b2d53bbe59527f9", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "9a6649e6-966c-48a7-a7a3-6131ad24f1bc": {"doc_hash": "59f17ce47ec9fb2706ffa32312d4d630eacfca6f3d2a886c5e9fc66971858ebf", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "a467e49c-1d56-4bb8-906e-9c43e05ac260": {"doc_hash": "c43547ae33ade9fb18c548e8bcbaa79d4d967049beea8598cae4eddfcb369168", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "51aede0d-d132-45b2-a211-e635fef12c3b": {"doc_hash": "16c3e72da53cb7d052dfa3ed5027b34dd2a1187ebfd06adf646a738aba91aa66", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "4ffad0f1-e4f0-49f2-8463-4555eca40840": {"doc_hash": "a36078225a46e8bb844b0c8d3ac21c6833e818802dcbcccd09cd27d324b46cf5", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "b0eef8ec-067c-4bc0-8d59-21d84f74ae1d": {"doc_hash": "c993658f0a166210166b49f0b29c956bf358eaf90781cf2254f38b79388d75d1", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "eddfeae3-1256-48d3-9a78-aaed13d39d81": {"doc_hash": "cb7fbcec201602d877787ad9e72385af27554199cf0c119df1a2cd06a9175de9", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "9a9b16aa-c3df-41f1-96a0-a13ba187c6d4": {"doc_hash": "79a3687578a7735324947854c427f2c6302d6e50357b719cbd46a144453aae01", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "ff526ecb-d9eb-4d20-b492-d00f58277269": {"doc_hash": "818b87cfc31808b36b6afabaf1e898f66b51ac19e6ecb60b33a21159b582ba1c", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "836a3c25-a45a-42d4-8739-df5a2f124c8a": {"doc_hash": "04cb21db314de18b31b69e870dd3b63283e9c080a7f7dc873edcb1d97992efd2", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "b4fd83dc-3d9f-46f1-a6d2-b14f41f4fac8": {"doc_hash": "5a4f7d9d024767c6ba36b0744bee304add156100523e5b659ec20be84d9dd9ac", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "eb0df3c6-3846-4200-b7bb-3369e522295e": {"doc_hash": "d24db96603ff6a65780f7adf9df4e87021e0fe98dda3fb6ae498bc89efe2e230", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "23ab27d8-dbe2-491e-8846-671fe152e83f": {"doc_hash": "a5cba8d396210409e102cb6abaeeb216ccf1ca7a1fc65f38af22a09c9de731ee", "ref_doc_id": "75b7060c-dc7d-4eae-80b4-75c7c41845b6"}, "7b36d8f4-0dff-4232-918b-a1bc2b520ee1": {"doc_hash": "42628bd0d673cc5c5026ca268919cdd52a236690dceda1d8718a07e72bbc7b35", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "ab18bf8f-6843-4a87-9efb-3a546370ca8d": {"doc_hash": "c726f2b5c1fa3dc8f08ff82c12cb8f32619b49c3d2fc43c56f749a360f220628", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "d9a153cc-339b-4485-b705-874faf97b3b6": {"doc_hash": "ed08feb0912c1deaafe78a9438f9aaecbf113c60b9916454fc67a3a32acff531", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "f298d199-a863-4eab-9207-778261ef9c1d": {"doc_hash": "827d64acee9fa4d9f4ec3931ce562454cc7571d70ab1f81ebc2c01d79eb98363", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "05d636af-f453-465c-b558-67fc97ab2b16": {"doc_hash": "46fa7365b6c9ca7d82557f6f8c50b44623f39a6632e7f9b99ae1de8555a05d1f", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "7a7ba65f-1469-4890-b12c-93c7af09c3d3": {"doc_hash": "21a78bc9b9b0854d5cbe69fc34229b18e974c560bb838eaa4046aafea29cfbf3", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "0916aa33-75bb-4859-ad95-ad4e1b0d1bab": {"doc_hash": "03a0b1ee9a473046f84e6b4537e437e3fcac884e7f6e513569083b6eedadc76c", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "08dca213-c882-46a3-9ae8-f0bc388c94a1": {"doc_hash": "49c88d8cf75441366a5252624129d7d26cbb580bd616d5e3f1a2a36ad1189f42", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "d639f79e-fff9-46f5-b2b4-0906a5f30072": {"doc_hash": "1060bdd6d40756b5a4577e62a0e97ebcc7bce71d13f7ed5a6a3769efc2757185", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "bbc3549a-063a-4daf-a6e2-f28ec1bba8d8": {"doc_hash": "541c9ed921e69e1ae4fda8dad107710f648370a95cca227cb3fff44cd7563f9a", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "2568b6bc-483a-498d-9097-bec593f33d54": {"doc_hash": "02261cf23b9a108bfb7347ff6ddaaa06fe8466cd2ad96f3315ae97c608a3a772", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "77d658cf-1ce0-4945-a4c9-f7bfb8cba34b": {"doc_hash": "5153649f84df51dbc03ea78e7be1434f102766e1c7b67a96bc610c597692cb86", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "818929db-9188-4048-9060-667f53e702c4": {"doc_hash": "5e84455cb52e02fa1b0e02770b9ef3ddb862cb533a85bdc87ebf12e36781bc58", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "987d8d6b-c77c-4b1d-934e-bfc6d40e2bba": {"doc_hash": "e0295648b368341ce3837cd3d560a154f1b02b1a8e1b7658cd2c1f9827edd2b6", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "da05fc83-0262-4702-b2d4-98a4a97bd0fd": {"doc_hash": "ca62f8b744546e0c653526f28cc3855a67f52432eee0fbb41d8eeedebd14ec75", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "d4766f10-bae8-4c56-b22e-35aa8642fead": {"doc_hash": "d1cfe141e9c3ff407478779d7e87a0975e8fdbe21d00143ee850cd86618255e1", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "d71516e3-2772-4167-a95a-058fc5eeb6c4": {"doc_hash": "04f2d5a4ed478cc3cb1628e49ff25c627f60c4580a74f4815802c28f51761d48", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "3f379839-fa72-470c-b622-a7a8959d3d65": {"doc_hash": "fefd6d1feed064023b4eafb51ec3bfd58f9d0cfe3678b60be4f6f3106f11d449", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "11decd58-dd47-4c29-87ac-209480594513": {"doc_hash": "a89ac3f40a18d70f949be132d741b15c3bb2fd9dd953004488701e0b805ce582", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "22239507-aeeb-4183-9dcc-10c4a606103c": {"doc_hash": "2529c6b3aca4f099b9b34580e14a7d0ba808e381297115c9e360f58fbc7783b3", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "107516bf-dfb3-49c0-a2be-07e38109110d": {"doc_hash": "1cb4001f2c541e259164af891bfd0c45032719d8cf93ae60e8c95cb017bf529e", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "c27c0ef2-ad91-44d6-a426-c73bd872e140": {"doc_hash": "41d882b442439e2f849881fe3d5ac2b7444d0646a05ad894a5529aeee774b1dc", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "0f008cfe-5d81-4336-bf09-553bd1b9e32d": {"doc_hash": "ab7b3108679b100ffb10c061c4a6f0163f0d87d1fcf8a59014fd522cb8c2946d", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "0549446e-5f1d-4dd8-b86b-f63fc79c6194": {"doc_hash": "33131b1069959c9824df7deba240e87decd661035439d8e1452568c33223ca65", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "f0cbd69e-218c-4fdc-949a-09705318e38a": {"doc_hash": "92cf63ab6e206bab707150c86f16a6b08b3464f8f33838227afd13dfcbad0b12", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "b3ffba10-5d79-4e7b-a8ce-3288ea658980": {"doc_hash": "50a8c982d05c6b0ed4b235c501088082162c4f7f3b0b83fd2b01ab531638a81d", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "8d897223-61c4-4252-8dd4-afa42b5b0d9b": {"doc_hash": "aa23cbe1877984f6593aea14cd854db3025d9021418f4c82542eeec983028dc8", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "1589309f-da8a-49db-b605-841d70de1422": {"doc_hash": "432ab3bdbf118b479a887ef073915310ead82b23c3765ef45873a4ebb7775638", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "5018f4dc-a3cf-4148-a349-ce57f18513d8": {"doc_hash": "7ddae822e1d76e6d1809ffce7e705b4e41c7ce7af1c66298895765071854e89e", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "10422c86-3a4e-43dd-95fe-dee2804c8ed9": {"doc_hash": "46a557638158aec22d2ba5f3476a91a2e591d7fe13f41c41a9d7ee6a85ea9299", "ref_doc_id": "6011d214-9584-4479-94e7-01904bd5e931"}, "00ca753f-4462-4ec4-a182-9f7b50853ffe": {"doc_hash": "d7b2f0e829417b173c4f18e8142b3aa8eb4b98f813a944007d6d14bba2465fee", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "985adcd8-be24-4cb6-9568-cb1fb260d748": {"doc_hash": "992fa32406d2a06863e006d8f8018b06ab67821516cb28492cbc41db1d161387", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "afe64738-2f7e-4bd2-b7b5-e93b8b199ea1": {"doc_hash": "340906ab2e43192e03bbe040ddd608230c73008f38ec43fbcafa983f37bf490f", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "4a716bb6-6297-4419-b0d3-63a5db610401": {"doc_hash": "ecfcefcb50c3b8be56988fc2d8f09395d47e44f6ecbd8df902e56f3b481fe1e5", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "12c03ddd-d23e-4551-a66e-6ebc03776f73": {"doc_hash": "a4352a87be332723dbf0b860922d755391241a96c22ddbfeb98cc5b3a5ffce00", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "7f2aa4bb-3932-454f-a60b-0f0cb022109e": {"doc_hash": "f5e42a9e7dd4546811b207c0fa43e0abbf16c003220e31e88ad9ee877d3787c3", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "85926430-8dc8-4341-9233-7fd38c8f59d0": {"doc_hash": "8962546a6f255a1dbe64723039cee9f0df78b51aed3a3009797692f69c1db77d", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "d6480018-caa8-454d-be55-75dee2297ec8": {"doc_hash": "324dc662426b6cf4131d9be88d67280d05a210606750443412ce28ce9ef3cc78", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "28495663-ca6b-4084-a9f2-e25920e21c3a": {"doc_hash": "c9cb38a3843ba55cc3039a16c550b7b6b533f323fd12954d2977b9181a0c7c2c", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "317662e7-a6aa-4d06-9255-c35362ed3bc1": {"doc_hash": "1bae504ae810a2e4878dca2cb354e7069e76838a50e1ab648f22049e224e037b", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "ea45079f-5525-4580-836a-3dacaa005dd6": {"doc_hash": "9a85c22603755caf8a1586f316dec07880ea2db6442be0bb76d2200b32fd6ea2", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "1563aab8-c8e3-4b19-a5ed-feb3a409ff5f": {"doc_hash": "39b38667f8d4f28cb29e84e622e279f2d7a0d5e22e641ed808ca31a3078116fb", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}, "32151a96-bb44-4b49-9185-1e34efab6a0d": {"doc_hash": "e32f436dc0b6f7552f2d96833cd02f48a242af502e0dd706b3c52eb6ea2f50da", "ref_doc_id": "29bc8ec3-1dba-44a6-bf7d-ea1974f16173"}}, "docstore/ref_doc_info": {"e31d8d9a-d236-4bf9-a65c-fa4faadc5cf6": {"node_ids": ["098ccb5c-214c-46bf-b7dd-9dae7fed19d5", "45a8395b-0609-45de-ad6f-e8e3cce6c859", "87ad53bb-b659-42f8-8706-40cf40a96774", "774fd6e0-1db6-4751-9d4b-fbc061993e21", "ad0ac148-29ae-40e9-a9ca-7ca7675d2ebb", "163e46d2-211c-45d1-9f8c-781e34b80a83", "08019cc7-7082-4aa3-9531-bd7053620f1e", "7c2e14cd-aab5-4dcf-86f0-786e1400edcb", "d54bf293-03eb-4329-b9f8-d6e311ba7da4", "973bc324-8b97-484b-aa3d-7b6a9dda50cf", "d1407d43-4f5f-41d5-a440-8a809addffdc", "599204a7-28da-4d4a-8cf4-882aa2e8225f", "b60da593-af2a-4841-9b5a-b11b706fac75", "9871689e-61d4-4b16-b46b-fcc718c869ec", "1d6d608f-3db6-40a1-a4a5-31b25151e9e9", "ded9b265-37ec-42cc-a66e-05cd907e5946", "e12ff96a-1753-463e-bf88-e39735af99ee", "e34b4ef3-8e0c-4de4-8474-ca6a8b4548c7", "d1fe2718-1456-4fe2-9216-3165571aa96a"], "metadata": {"window": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc.  Earnings \nConference Call  \nNovember 7th , 201 9 8:00AM Eastern  \n \nOperator :  Good day and welcome to the Cardinal Health, Inc.  First Quarter Fiscal Year 2020 Earnings conference call.  \n \n  Today\u2019s conference is being recorded.  \n \n ", "original_text": " \nPage 1 of 22 \n \nQ1 FY20 Cardinal Health, Inc. ", "page_label": "1", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "9eb0ea55-d633-40ad-84bd-b53cd162e1bc": {"node_ids": ["72e31228-e1a0-41db-99a1-ef11cca01e75", "1af367e4-522c-4f06-bb55-820ce8ada41f", "d23a4216-90a0-41b5-9ede-82229d4a762b", "9e64e4e9-1721-434e-a2af-2cbb9b06a3d4", "6723f5db-e9ea-43fe-ac32-bac9f2abf2e9", "9a31ab3f-a91b-40e0-a7dd-7fef77c7d7d9", "02fbbe68-6bf4-484b-abf9-ad607a64344e", "b59fcdcc-997f-42ca-aff5-887915b2c1a6", "eb2bf6ef-47fe-490e-b2bd-9ed2b9fd9f19", "c10d1631-6dcd-4a65-b04e-3c234e31219d", "0e3ba029-bdc3-4968-82e4-b2b0d18753d8", "ac561d82-c488-4c3d-bea5-5be77cff3e27", "4c9b7ad1-4c46-472d-a812-ccdc318771c5", "56127fc9-016e-4a57-bb04-67aac79e3b55", "574ecb2d-b1eb-47f3-b593-59cc98906c6b", "1a18fea6-517b-4ebf-af73-43936542f928", "54cd4fb9-a2c1-4820-9c3b-12136dc23702", "b9cdf2ef-0275-4cb7-a4ac-fe0fa025f270", "4ce5a288-a297-4d6c-bcd6-d65642c32049", "40913cec-ad92-4ff9-b591-672f60e63825", "d04fe166-c60d-4e36-a75b-66b313bdd260", "1c425d66-f153-4762-9bb7-ff70aca0bf27", "045c6fb4-b661-4284-a794-dc28a9c7c807", "fd4c9c1c-10d5-4cba-a8df-78b98b53cb76", "f1f40616-0dfb-4366-9b29-aa9a66bee849", "60b471ee-2ee2-40a7-acd0-803c619e819f", "14ba4a33-1002-4c41-be1f-1daef294e166"], "metadata": {"window": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.   Good morning everyone.   Thanks for joining us \ntoday.  \n \n  I am here with Dave Evans and I\u2019d like to welcome him to his first call as our interim CFO.  ", "original_text": " \nPage 2 of 22 \n \nMike Kaufmann :  Thanks Kevin and congratulations on your new role.  ", "page_label": "2", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "4b9743c4-7152-4265-bc2c-e1c7288a176b": {"node_ids": ["c1439f13-b668-40e3-b91f-1e389f727b98", "5c815d06-1bd7-407c-ba17-f235c90a0397", "157cc4e5-9d74-406e-a0b0-2e690b522c7d", "1fabb335-b057-4672-b8c7-c9d1a999b210", "7cc5cf5f-ef20-41af-99c4-1f88498a036f", "6c67a8b7-9437-4a0c-a7ba-e7d019b6b95d", "9eaf2964-0686-4a90-a0d1-f46ddee4146a", "fc949598-c86f-42be-bc38-8687d6f9eadf", "1e39807c-f330-43f4-8143-6e615b59dde8", "e74ecf86-4f9e-4d37-bc25-dc7b0825d40e", "fdedb4c4-b374-48ce-8580-43e72d300b53", "02917818-a776-4d2e-9628-2125ef6df6f8", "71750c8b-fd72-4f80-b8fc-aa1df9590979", "7ce658d9-0955-4af0-aeb5-0b99ffcf268e", "20581369-bae2-472c-855f-898348593641", "0df25b83-4c04-406b-8aac-3e45506a0c95", "1a96f5fb-3c42-4340-a20e-c5593d07a3a3", "63aec45e-1839-485c-bd00-1ac906b58995", "7a85db0f-bae1-4e0a-94c5-57f59cad43c9", "581f93c5-4791-43f3-9361-ca2a4b0cd4f9", "f8b9e4b9-6ae8-4818-b6ab-e083931c4e0d", "2bbad25f-9404-4488-821c-e4f15b68959f", "5bd8b147-1ad4-41c3-9a4b-96b47b41b7a0", "026322db-61cc-4c97-8258-d2f1ae7e4a62"], "metadata": {"window": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.   But I\u2019d like to say that in just a few \u2013 the few \nmonths that I\u2019ve been here I\u2019ve already seen this effort evolve from a cost reduction initiative to broader cultu ral \nmindset of efficiency and improvement.  \n \n  Total operating earnings were $577 million, a 6% increase from the prior year driven by performance in the \nMedical Segment.   Interest and other expenses were roughly flat versus prior year at $80 million.  ", "original_text": " \nPage 3 of 22 \n \n Mike will elaborate more on some of these efforts in a few minutes.  ", "page_label": "3", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "9762b381-a11a-4358-99cd-84f89384b121": {"node_ids": ["d482a44d-73d8-4f90-b93e-9b727adc2103", "08041078-0d74-445a-93f7-7bdb6051c282", "0596d63e-b820-4436-a572-869f0c8b80f8", "054736a5-9870-406c-a47b-cbe0bd883514", "1ead1b5e-e3e2-4751-aeb7-6c7e9c4dfe7e", "8763be95-2186-4752-bc63-3ee98b1f7bd9", "f3453cb2-4262-4775-8d77-ff14b47dfa31", "5355d0f2-ba65-40e9-bbd9-4b732b9be5b2", "ee8a2ea1-4a13-4299-a4cf-a485d080ab11", "fb8676d4-1d63-422a-8b9a-60df54a73436", "9f3c357d-c62c-43c1-a7a3-5379c93a0127", "25bf0932-e6bb-4555-a0bb-99133cabead6", "10be7e52-e453-4c0f-971a-ebaeecef9b48", "8bc8590d-4ffa-4377-a340-51bf4d21b121", "5a4e65d6-21ff-46c7-bc99-7d5abf4dfce7", "a1715a76-f8cf-41d2-bbf0-b44667e2b609", "d88703d7-9552-4736-9986-f3b34c2afb4b", "4bb83256-706a-4d1f-864b-c25df6679898", "7b10dfe9-0175-4636-b872-8615dfa595fe", "8fba5ad8-5d01-44f4-b5e9-922f183f8e46", "7081d97a-73a9-4bb4-ad13-2c1cba02158e", "99e62e57-f369-459e-a9d6-4083067758bc", "3cf5c00a-2e57-48fc-bf07-a5fe479bd8f1", "73337b61-0bf1-4a5b-8b0e-2b07b4afa2c8", "e58b8aff-6e68-45bf-8210-fc5b084f0980", "2744cbf2-c69b-4574-a35d-a7cc4e3a4c25"], "metadata": {"window": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.   This was due  to organic \ngrowth across the segment led by products and distribution as well as in Cardinal Health at -Home, one of our \nstrategic growth areas.   This growth was partially offset by the divestiture of naviHealth in August 2018.  \n \n  Segment profit increased 2 6% to $170 million.  ", "original_text": " \nPage 4 of 22 \n \n Transitioning to medical, segment revenue for Q1 increased 3% to about $4 billion.  ", "page_label": "4", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "94070a92-6692-4b76-a49b-08f36bd565df": {"node_ids": ["c26cdc12-c693-47ba-a229-84590021a68f", "d2bb1da2-a477-4711-9b1b-c7c54e06e960", "cbe0d365-5afb-49fd-a6e5-be9ca6ee0f5c", "58ddb258-630b-49dd-84c3-670b7ced8176", "b8766ae7-2803-46b6-b678-7812d986689e", "5b0de04c-a378-441b-afaa-44c6d13c2abb", "292e1438-4464-428b-aa55-c6df8ba31841", "bfd5c152-3018-4cda-bbef-31258545089a", "0a0dac8a-074e-4f0b-a011-0374e5218f61", "27affbb6-098c-4605-a8b3-e9ea7f0cf721", "10df67a1-91fd-4f50-b32d-7de93aa219b1", "ebe2d54c-cd9f-4432-8e3b-6ed5a5e78a57", "8facf4f4-9cc1-4fa0-9f5f-2ced3791deb9", "53b1ddba-78bd-44ac-a06d-490de3ca4686", "af2ff3c8-2869-42db-bcd8-79ea4f4921eb", "0d6cefb5-6e09-4ca6-b9ec-41a757e2d05c", "19ff95bc-319f-404e-9658-08b26cbb61b2", "89570014-d9ac-476c-8c1f-cd85b67c49d0"], "metadata": {"window": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n  Importantly with the commitment of both funds and a distribution of treatment medication this framework provides \nan immediate solution to the communities and families that need it mos t. \n \n As you know, we have an important but limited role in the pharmaceutical supply chain.   We take that role and the \nresponsibility that comes with it seriously.   We remain committed to being part of the solution to this epidemic and \nthat is why we are c ommitted to the global framework and continue to be actively involved in its progression.  \n \n ", "original_text": " \nPage 5 of 22 \n \nattorneys general, is designed to resolve all pendi ng and potential opioid lawsuits by states and political \nsubdivisions.  \n \n ", "page_label": "5", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "568426b6-d7a2-4ee4-9fdf-450f1c480d14": {"node_ids": ["ae8e43b9-e3b7-4b58-b110-f693f15170e4", "ad9664bc-4628-41d0-905e-64398ac61d70", "269782c5-80d4-4de6-acb1-58d932791550", "4e1715db-9491-421d-b7f7-4d48ee021cd3", "ab110ce6-202b-45b6-9571-ad1aa52f3221", "ecc469d8-35f7-4a5b-8f3b-8e1b805fab8b", "1a65373f-f6ed-4d7e-ab7e-8fc11f7b8fc8", "e783ba55-ad3f-45e7-a4c9-aa96a7ade91b", "fa04aaf8-e60d-40a6-a335-6315e0bb7383", "90b02d47-f364-4e8b-844c-08c3950eaf09", "3a51a433-375b-44e3-b5ce-7ec2e44b2599", "416243c0-dc6c-4f72-9241-6453cd306976", "0a438360-b1e1-4a31-8f46-c3d27b3da3f3", "9e81f693-9306-4962-88b4-8511b3a0d4d3", "d0237d73-d58b-4066-9635-23e8a04ff174", "096ff9ec-d8d2-4952-b1a0-14c9bbec8da0", "6f6b41c1-3ee1-4de9-a415-e3fc2f7594bb", "d9b7a1a9-04b8-4f9f-9fe8-9bc7d514aede", "31d0cbee-864d-42c1-a54a-6004b5054a20", "b3f2d2c2-19d8-4ffa-9bd1-0bbce9ef12cc"], "metadata": {"window": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.   We expect these enhancements to be complete by Q3 and their \nbenefit will begin to materialize in FY \u201921.  \n \n  As part of our supply chain work we are  reconfiguring our North America network.   For example, in California we \nare consolidating two of our Distribution Centers into a modern flagship center, which will enhance customer \nexperience at a lower cost to serve and position the segment for growth.  \n \n ", "original_text": " \nPage 6 of 22 \n \n Commercially we are more closely aligning  ourselves with the needs of our customers and incentivizing our \nsalesforce to sell Cardinal Brand products.  ", "page_label": "6", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "0ac7e018-dbf9-43cb-b74f-2f8eef86b24b": {"node_ids": ["bfe9cf12-aa72-467e-b162-c2be7530a4d2", "1b2563f4-931b-4a27-9eaf-34ab5cb21e73", "7630b64d-0fc0-43bf-b18c-19f494b8c3ec", "1176cf93-80c7-4243-a3d3-f53fc0a2c2ad", "9d24e060-94aa-4179-bff4-a4cfd0bc43d6", "8ee28bda-0873-4029-96a3-5dd221112f17", "d054c45a-eca0-4ead-b717-a605d5dfc923", "6ba95085-4058-4329-82d0-595fe7a966a2", "d419e426-ff94-49e7-813e-a1d18ddbe90f", "75659330-0daf-4bc7-95c9-90d945cbf8f1", "35920030-fbf2-4885-b92b-641c544333d6", "5d9f98b8-d62a-49fc-a53b-8dec7911536b", "1c7f5266-e575-4eed-b5e1-0920ed67f4a5", "a29ec611-9097-4915-9cff-e8c0b18368dd", "5b540a01-8a86-4cfe-88ea-ef84b786faa4", "3b5d423d-b90e-4b26-b20b-aa39f086149e", "7645b9dd-7fb1-4879-b47a-1a16af71abc7", "a2f016bd-c533-4ce5-8603-d7565d6aede7", "1ca391aa-9db5-480e-8abf-fdcb06eab3d6", "c2931742-9ecb-49de-b665-23f05522bdf4", "f2aacda2-03d1-4b45-ab7d-5edcc778ba91", "5dfc6309-d764-4b6d-9cbf-97ea6ce98671", "0dbac70c-8865-4e42-a2a2-84dbb1912b87"], "metadata": {"window": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n  As part of this partnership, Genpact will create a data analytics and FP&A hub here in Central Ohio to drive \nindustry leading innovation.   About 200 current Cardinal Health FP&A and data analytics employees are \ntransit ioning to the Genpact hub next week alongside a team of Genpact\u2019s process, finance and data analytics \nexperts.  \n \n  This is just one of the many initiatives across the company to streamline our processes, leverage our scale and \nenhance our data capabilities.  ", "original_text": " \nPage 7 of 22 \n \n One example is our recent partnership with Genpact, a global professional services firm focused on digital \nbusiness transformation who will help us tra nsform our finance operating model.  \n \n ", "page_label": "7", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "3ac7dc10-b9f2-4893-bd7b-c3f6e1cf80c8": {"node_ids": ["67888d04-cb8d-4eba-8f2e-cafafa920c09", "ea37b2de-afe1-46c1-96b9-633b0f2e3ae7", "af12a818-6874-41e8-8f62-66c2feab56fa", "1672364d-5323-46d6-9dd3-7d99bad01829", "26046145-f26e-4027-a0c5-119e56716eb0", "90c2bd87-4473-4479-b7a2-e381a64b472d", "238d4a95-4db3-4f8f-bd15-74f494cc4d0f", "45684b05-af2c-4f76-b25f-da6be3cfc355", "ae3a7ae8-02ba-409c-b2f9-ac4b9bf1775a", "42bfde68-162a-43ea-a86a-9777116fb508", "8af24bf4-3842-44f7-9254-819e85068a04", "b59a702a-3f71-4642-b7b1-39ea3fe26cbf", "c086de9e-e60f-4b05-9595-fa38d0d15fb4", "4eb2f0bd-ff23-43c2-9476-efc29ccb4294", "5dfef621-bf39-47af-ad8d-dd57dc0f3ca7", "0d410a0e-c79d-4c20-a331-84f18b9d0e38", "5e622aeb-cf35-4eed-9d0e-fbf7fc9502fa", "d1eb192c-f13e-4185-83a9-c1d654bc7e9f", "4bbf0b3c-6ea3-4233-84ca-ed94433e0ade", "00a73d54-ae97-4fc6-8930-e92518b57270", "81cecd95-5f8b-4116-9c7f-07ee4f1bced0", "6f3f1d59-14e1-4221-904e-32d6f1189884", "d7081f32-363e-42bb-a39a-c56f76149d93", "88bbb52b-2a99-4d5e-ac89-e42448b4cfda", "ada1d1bf-fad8-4f1a-a4b3-c16e46e5c7ce", "6763d7f5-0083-4195-bec3-840a8d3f075f", "ccf11c6f-aaa3-468e-b47c-34fcd6f50c14", "6889a72b-29fe-4a15-ac78-7424fe34e6ed", "55dfa09d-ff21-4101-b682-303e3a4109b1", "aa225c5e-c9fb-4176-9717-301e0bba55d5", "b35ce096-1642-4450-b42f-d907f59daea1"], "metadata": {"window": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.   Thanks for the question.   Look, I t hink the way we\u2019re thinking about this is we\u2019re really pleased \nwith the first quarter results.   I\u2019ll start with that.  ", "original_text": " \nPage 8 of 22 \n \n \nDave Evans :  Yes George.  ", "page_label": "8", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "1991a006-e6c6-437c-bd28-649de7e63ba3": {"node_ids": ["8a1fb589-4f83-4b19-a7ee-60a727084426", "f880d04c-a401-4c16-b46b-8e21e6ce4f15", "147a09bd-10dd-48ab-8578-b4328255655e", "9b5185fe-2f6e-4026-afd3-16dd3620cb33", "a65c5cc1-8a32-4c8e-bd88-24c42b85f81d", "c224a1a4-0fa0-47d6-a368-464eb80432f9", "28131108-8de0-4dd7-816f-38e9ee065d25", "53d46441-e00e-427c-b3a2-6dcd49043af8", "777ac3e1-e730-4dbf-9b2d-b18b7b31900f", "c9d09df8-59f1-4946-90c7-0c6bb8221aff", "0cc14c43-fbab-4dfa-a88f-6515de4d9dab", "cb4adb2a-f159-4c8a-b847-07abaf98a1b9", "c72701e4-d857-4daa-98a3-b0e7ada0d583", "8d4386c0-20ad-4a0b-9006-e917ff5106f5", "d60d4bd8-b9c6-4127-af4b-9419f5c0c213", "38805d88-b4e6-466c-aab2-fc068cdf97d2", "897e194d-48da-49aa-97bb-e85562f5cac6", "ec3954ae-02f9-408a-9a10-ff522934b8ea", "f7ad63c3-9081-4081-940d-a64323315c8d", "c6b6c17f-6e6c-41c4-8895-bac614d91b46", "abca503a-af37-4ffa-a632-d6995103af18", "4a770cfa-35ec-4782-b05c-f3c776a325fc", "a91be33f-f51d-4297-a92f-1913afa59e49", "b92c75eb-693d-46dc-8e27-d5d5f7d453ac", "95eeb62a-3053-4462-8364-d2e1085c84f6", "12bb2d84-77f5-4b26-be73-0d222d40db2c", "de5d6e25-f8b5-44b1-b5d9-198c9f076605"], "metadata": {"window": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n  So we made a lot of progress in service levels.   We\u2019re making solid progress on both SG&A and item s that will \nreally drive COGs.  \n \n  And we\u2019re in different innings on each one of those.  ", "original_text": " \nPage 9 of 22 \n \n For one example, service levels now are not only back to where they were at the acquisition of Patient Recovery \nbut \u2013 products but actually better than at any time while we\u2019ve  held the business.  \n \n ", "page_label": "9", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "68b47fc5-3328-49ec-9e35-e84845d5882b": {"node_ids": ["9b2dd3d3-525d-40b3-9bc0-bc84a6db6343", "8868151e-49cd-4b3e-9d0e-bcaa34dd62b2", "c6f4c976-ed40-4d52-8f65-5f3c64b7fbf4", "0dc4c5d1-32cd-41ac-862e-a481ba0a74f9", "360928ff-42b4-441c-90ec-fb6d46834c9a", "87ffdf17-3e3f-4635-8bc7-e57d1d597cf2", "4fc24d6a-3f60-4c04-9af8-8c921c8f1910", "362797e8-c96f-4c4a-bbfd-db92263d96d9", "3327ebba-0b00-4547-9cdb-2107734f2ada", "e298aafd-a317-4eb0-82bd-80e8bc6dce80", "78f60df7-4014-4594-9c8d-b94b61c3c548", "058cbb97-b577-4ba9-a6c9-47271ecb0c29", "99e69b82-dd21-4e56-8da5-4619e98d5a2c", "8ad03270-b485-4117-b86c-3b5b3f0e5209", "2a97f385-1248-4107-bc90-97042fd39a0a", "895e65ae-182c-464c-a7fe-ecb136d77734", "bd2ce9ef-ef59-4c9d-9a52-ddb3e220430e", "2d0bbdce-27ab-4b0d-8c6c-05d2e328e6f7", "491fb161-5fd6-488e-a5e6-f338b7385f13", "8cd03806-12fe-42e8-a0cc-41fd5c773aef", "9a0b3448-d74e-4fd8-8db9-4aa683515147", "38db24d8-e014-4573-82ae-9ddab47c7038", "5d8cde7d-1174-44ea-b069-cc77571677ec", "976f0db3-cf55-46c5-8f31-e9e7654764e8", "03ca86e7-eb57-403a-9f5e-12c24d83cac6", "0cee6ea7-af82-4c27-98dd-83a1eb6fbf4a", "13cde9c9-c561-4801-9876-6562e55ac219", "4324e8fc-3add-405a-871e-4d005963b071", "5b947b54-9147-41ad-a471-d8b1f21defd0"], "metadata": {"window": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.   Good morning.   My question is related to the opioid comments.   When we think about that \n$5.6 billion (that you are reserving) if that ends up being the final number and within that 18  year timeframe would \nthat have any impact on the business, the core business?  ", "original_text": " \nPage 10 of 22 \n \nRicky Goldwasser :  Yes hi.  ", "page_label": "10", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "1a299195-b7e4-425d-b5e5-32c663e3f7bd": {"node_ids": ["702c0d9b-9144-47fe-b5c8-3c3255fba23f", "e8c32223-de46-417e-9cbc-b21ea4e94658", "292b4b4f-2e89-4d93-80c8-5735d13b03db", "c9d0ff23-d164-4c8e-a03a-ca4e15f654b0", "25393370-ca28-46d4-96f3-efcc6cedd41a", "74bbe277-56b7-4c7c-b52d-39c09ae8d6b1", "b078d91c-1f51-493d-ac05-5a9b3998e054", "35e4913a-b03f-4732-814d-10e64a30ab52", "16e7baa4-cc76-47e7-a69e-d17db7c3946f", "574df1e0-4dab-4298-ae0c-6620afe9e628", "42348b3f-9dc4-41aa-9fca-487fe1e6a176", "edf3584f-df5d-4cba-a2be-b4fbeb555c9b", "86e62ba4-45a4-463e-8d63-e7901a5aaa9a", "10093179-9d6b-4099-9f1f-f5a0c4240eb4", "bb431036-2dd5-4d00-aa24-51e613670e1a", "f578b07f-070a-4db5-b839-7b8a3844fb18", "f015e915-c269-4880-9487-2c6de252b0a8", "f8f3f987-b23d-473e-9337-ef8b44efe6ce", "f39cfa14-a63c-4b77-acc4-f054121af9a9", "d5fd13bb-f375-49ce-a38a-67716e194193", "6de58eaf-a095-4979-951b-93901687e5fb", "83654659-13b1-46b3-883f-0f96b96b3d78", "5cb73bd5-5efe-46db-95a5-bea125aa4b42", "5f09fd7a-8996-4453-b29a-03b3b174735b", "56b99b5f-27f3-41d2-802f-474e1277da10", "7c7db9c0-2367-481b-a891-3ff370f13beb", "cd05510c-92cb-48e0-9991-449192233aa5", "1b805b31-db05-40b9-a820-fa645b274696"], "metadata": {"window": " \nPage 11 of 22 \n \n And really have this built into our overall culture.   And but again it\u2019s just too early for us to  make comments on \u201921 \nand beyond.   But we feel that we are not only getting after our cost structure but investing for growth which is \nreally important.  \n \n  Next question.  \n \n", "original_text": " \nPage 11 of 22 \n \n And really have this built into our overall culture.  ", "page_label": "11", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "27c9be5c-48c1-4788-a349-5276dbc93e27": {"node_ids": ["a612e260-f1e2-4bf7-8753-fd64183dc256", "1ddcedd0-7330-41ac-99b0-bf5ae37f6912", "0c9d43cf-2ed0-4297-9983-7adba5e4e459", "499a37ed-ffcd-4ab8-997a-31e56e3a1c0e", "54d082da-93c8-49aa-98cc-67f035174c0b", "9185e736-a9e5-4153-8067-6c65855048b1", "e81a0b09-effd-4b71-a563-81d271569916", "c035b526-5d77-40fc-be29-ff852f77418e", "7b28894a-9a6a-4d2f-a87c-8c03a3f694e1", "7de08c09-c456-4d2c-9028-0cb6a0bc1415", "dc061452-80a8-4327-aa72-cea0c88971ea", "93dad029-21b4-44b7-b0a5-7cc5038c77ec", "b93e118b-1368-43ad-8b34-ae72cd780194", "9713c4b5-1b22-4c64-8c68-6538df6416fa", "e8205edd-220d-4c3c-a084-a5496ae5adc1", "d4f9b472-0d98-4dbc-adec-76a5fc9a03a4", "1669748f-873f-4877-88eb-c18338129c03", "77278770-7ec0-45ca-bd31-ad5006865216", "6d3540ba-8b8f-49cb-9f83-66fbdef07c94", "a842546f-5116-4226-b322-cb956e76c9de", "8071422a-2753-4599-9f05-a499dc346b37", "a19bc29a-3e5f-46e3-915d-20cd3167daf3", "815450e4-e30c-40b9-a2b1-00e86a2d1731", "88db782f-6cbb-4ab4-bc82-d9b2a33db909", "7ba599a9-503b-48ea-a08c-a7679c154ab5", "e5725bc8-5447-4bfc-b316-afbe63d87564", "850b66c5-c251-4335-942e-9a4863485609", "e470d086-869e-41df-95f2-f62bcae0764f", "311db5b6-4611-4644-870d-8d862973603a", "a1263259-caa8-4520-b520-441ea7f5a153", "1bb7a877-41f8-4045-b263-8ecd4ccce4a5", "b52809ae-ecd1-4add-bb22-e6f4c4330a67"], "metadata": {"window": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n Mike Kaufmann :  Yes good question.   I would say this.   I would say \u2013 I would put the \u2013 you co uld probably put them in \nmany, many buckets.  ", "original_text": " \nPage 12 of 22 \n \nyou know , after, you know a number of players here or is it kind of just structured in a way would you think that, \nyou know, this will achieve ((inaudible)) looking for?  \n \n", "page_label": "12", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "b47e77b5-32a4-490a-895d-4d71a61511e8": {"node_ids": ["6f4615ee-4303-4194-b68d-de0eae3cc143", "1db30304-0634-4aa5-bc43-341ebf61689a", "616aeb05-f465-45fc-99ee-53f6e7b387ec", "a745bd9b-2141-43b6-992e-f8c4382667a7", "024d01d4-b053-4374-8d15-a7c84ee006cc", "33999732-411f-4df5-af69-9d57a55b7164", "643242a6-f397-4100-8161-eba606ccf083", "2856df6f-b598-49b9-9b69-ba750083c843", "999a48a5-348f-4512-9b46-46ba44982493", "308980b3-9149-48a8-b3c6-35a119771c6d", "840747cb-9318-4749-b45d-1dec02b43f7b", "646b5965-51ae-41b6-b48d-f120bcdb3239", "478b4e90-a81c-42c6-9f5b-55879b37485f", "a8ba5d39-7bec-41d4-ac81-ccddc75ff029", "3ac127cd-1033-43ac-a3f9-16b4ea42a7a8", "7c0a3ee7-1aa2-4756-8e06-386cb7e649b2", "526dc107-27b1-4b99-ae8c-0bb4d574a43d", "9683f90a-b39e-454b-8ddd-c35f4db60c54", "bbb6ee6d-36db-4811-b2e7-a6aafaf74a30", "1a6f268c-a465-46c0-844e-fe2ecc116c9a", "afe02bdf-8f2d-4824-9555-26bccbbb1a4f", "236b44bd-d75f-41b1-8b50-386e597d3342", "f9b012a0-5602-4fe5-9891-f68a9068a5cc", "f098a2af-ff9d-448f-bd88-71706f9eca28", "28812504-5519-4aea-8f49-2f7caa3d8500"], "metadata": {"window": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.   And we\u2019re fully suppo rtive and we\u2019ll do what we can to help in that process.  \n \n  And it will take some amount of time but it\u2019s really hard to predict what that will be.  \n \n  Next question.  \n \n", "original_text": " \nPage 13 of 22 \n \n And as I mentioned we believe settling the two counties, getting that behind us and allowing the state AGs to \nbegin the process of working with the political subdivisions, plaintiffs, attorneys, etcetera, that that process has \nbegun.  ", "page_label": "13", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "a6b8cb84-766e-4361-8388-11fdf71b8e11": {"node_ids": ["5ea73402-9713-4c41-941a-79e384b424f2", "c1e2bcbc-20f5-4695-b220-d8324bb8fe9a", "a587e070-23c3-4e39-be76-e01bc5cbe643", "939e1e98-f059-44c6-9582-8c335a181593", "11fbf32f-e37f-4678-9220-5666b0bca92f", "3f386601-d873-4ac2-aebf-6e6b0f223774", "eb886d4b-87a2-489b-96f9-061e6dd0e75b", "72cf6f03-7ad3-4c3c-88f9-c2f60e3bed72", "0e36ef52-4593-4935-94ef-d24d49fe25ca", "ea92f815-a353-4a43-9fc3-34e7df3b0e7f", "046ade57-bdf2-453e-9d74-4bf48c9c1828", "51fd04ff-bb8d-4459-937a-ca742340d943", "fccb6151-0cd0-4b8b-9800-9efa9a2e3da3", "ab991b2f-2cd7-4656-84c7-ff6f0c19eb9c", "70518751-c6fa-4514-beb5-b8a3fa28c498", "962f6fcf-7d6f-44c4-ae76-9cad7493a257", "20256c4d-a688-4b56-be86-47674f79e462", "20726868-bc28-4d2e-a7f7-d58e79481ea9", "1c718ccc-3eb9-4b6a-a4ab-d22b79f64df6", "ae51b47f-2680-4edf-af06-0e0bbb8af605", "e8831708-fb48-4478-81ba-0018b39582cf", "98fda166-d1ec-4d81-b453-aea6804c2bde", "75230058-30a1-4908-afc6-c5e078227e1b", "409b38e6-68a1-40d2-acaf-6f918a991479", "a3a4d410-8b8d-4ed5-884a-49312e967bfb", "8a6cc63a-89f3-4789-9f46-82be58dc2fb0", "fd1efa7c-2739-482e-8f08-424099a49e42", "370843e0-cddd-4486-b64a-2801a0b80832", "225287ce-5b47-4adc-834b-86d9ea22210b"], "metadata": {"window": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.   And I think that Cardinal is as well po sitioned \nas anybody that if this were to get some legs that we would be able to work with folks to help make sure that any \nre-importation was done on a safe basis.  \n \n  It\u2019s hard to imagine that it could be material in any way to affect our businesses.   But i f it did happen I think \nCardinal was well positioned to help any of the folks that would do that.  \n \n ", "original_text": " \nPage 14 of 22 \n \n And I think the focus on re -importation has to be on patient safety.  ", "page_label": "14", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "88c91c57-d901-4d1d-a762-8e2940612333": {"node_ids": ["c872664b-a508-4911-b0d0-584cd5eec9f5", "712fa1db-3680-426c-9e5e-5acb827b28de", "4e747e56-91fa-4c40-b509-6a1846d7154d", "bb60e733-3d30-4700-b466-809ad3ecb5e9", "3a6b9eb3-78b4-4928-9959-9c04e84b9af9", "a34c1ad6-8c15-4b1d-8e8d-85f74e127917", "ae139f29-0ddc-4e54-bddd-fa84f1803e3d", "0190391f-0fe0-4e58-8475-395b25b06352", "b6ba3e24-8301-436c-97d3-299becae3a16", "8b3f722a-adce-4b40-a1a1-b070a33a0ad7", "98bfca33-4524-4d1a-9c19-982d3cd9d8a9", "0849ac87-bc71-4a9a-91d2-27cb7cb055ed", "0daf13da-257d-49b2-bc71-d3022ab6b96c", "971356d8-67e6-46d1-81e9-51c936424a9a", "aa05ded3-e7cf-44bb-9178-abbe6d007116", "885c3bb3-44ac-49f0-ad57-aef9af2d72b8", "672db77e-ee80-456d-8168-a925006d7593", "a70b1a7f-4e08-461f-b154-e2ea1c1e7934", "a1c53aea-561c-4863-940c-20bf49c53be1", "bf638cbf-35a9-43c1-8f16-9285c833de46", "30d187d7-3495-4f45-8349-25df2bc7172f", "e192b5e4-8199-4c14-854f-d331c0021d84", "37228113-eb2a-4730-b65e-7631f569e7a2", "edb0ca46-d8a4-4a35-b0c9-988d2a1054ac", "cff9d501-7854-4cf7-b7cb-4e257579d73e", "8a9496e4-29de-4642-86d9-bbd688e36b30"], "metadata": {"window": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.   We\u2019ve \nbuilt-in nothing with respect to the med device tax.   So if it doesn\u2019t come to fruition t hen that\u2019s consistent with the \nguidance we provided.  \n \n  And clearly if it does then that\u2019s going to be a headwind we\u2019re going to have to manage through.  \n \n ", "original_text": " \nPage 15 of 22 \n \n \n With respect to the balance of the year, we have not built -in, as we said last quarter our full year guidance.  ", "page_label": "15", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "7d9e6cfb-638c-46cd-a822-9697bbe91354": {"node_ids": ["b96bfe4f-35d5-44c1-a268-f8baaacd1bd2", "41911e82-df2d-4be9-944e-c006b88f32dd", "5f9f014d-4d9e-4394-8247-be5e01b0819b", "be9c4aff-3957-4cfd-859c-619e2db5c82d", "5f12fc62-1029-42a7-93be-15f7ccf71247", "c824db30-5958-4f3c-81eb-978b5a2e5c32", "e0ee4c4f-07ec-4c12-8a3f-dd88ca4cbe11", "25a2c693-7ab1-4d2c-9d9e-9d1722fe0569", "6dd40e66-899d-4b91-9be3-53d9bf4664cf", "7a2a3991-6bb0-4921-94b3-8505df2db096", "08b9ca72-46a6-4521-b57a-b1ad47e09fd5", "a7f96fb8-b578-4039-aed6-262f4a199e86", "6311f47f-951e-4fcc-b3bc-12c19ff976b8", "22e0680d-c820-4156-bc7d-ae035b4bb95c", "913ae25b-52a3-4a26-adf9-ad54492c719b", "1c54f018-909e-455f-be27-874fd1f12292", "f5e16df8-b5e9-4b4e-b01c-9f90ae59090e", "2b95e35e-9cbb-460d-86df-b28f6835dfe9", "8089135d-1d44-4b82-9d30-96f51cf3e0a3", "c96955ca-5c0d-423b-952b-944e7d53c7c7", "6bda9280-95cb-4c6e-a8b5-ffdfbb1aa65e", "cc2a4062-f1ee-43ef-98aa-013f43808b01", "37b1646a-c13e-4d47-85f1-d3501d0b20b1", "3870efa9-6d78-4d63-a3e5-9c55a1a11749", "edbd3b93-3fe4-49d4-890b-abb75bbe1044", "10cfea86-aa07-40ea-abb5-638e6af14800"], "metadata": {"window": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n  But the concept is just being able to take those drugs and then using the efficiency of our overall supply chain of \nthe distributors to get to those to the folks that need them most.  \n \n Dolph Warburton :  Great thank you.   And then just a follow -up, the difference between the charge listed in the text of the \nrelease and what\u2019s listed as an addback pretax, looks like about $40 million.  ", "original_text": " \nPage 16 of 22 \n \n That being said we at t his time don\u2019t think that would be material but don\u2019t have enough information to know.  \n \n ", "page_label": "16", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "80ed3866-65df-4bc9-896b-dfea17911a75": {"node_ids": ["295830c3-153a-4ff7-a6be-5f2eb8e38857", "19cb1164-e9fc-4432-8a35-89afb7d1dd49", "fd753d8c-7ede-4882-9796-bae2c6f2fea7", "22508794-275a-4332-a5a0-100f994d38d1", "20c6504f-3fc5-43aa-ba8a-1e5502831bcb", "43cbd5a3-3b85-4dc9-a76e-e8de507d6655", "7d7a5332-e1dc-419d-8df6-9bd829a7581d", "b95dd5c7-3de6-4629-b734-4e5da2c1688f", "d148ed3f-ff48-466f-8267-5131d6741bc3", "d289994f-836f-420d-af08-feb6eec8ff70", "bcbc4a65-4364-4dac-8597-84a4a2bdff13", "03744e1d-e7e1-45ab-b073-0385182ec76c", "08d16d59-6a2a-4089-906c-1cb8ab277005", "0744b941-95fb-43ae-8a48-0660521bbdf3", "06fc5140-4cab-4070-968d-f47afe1fd517", "95c8f207-9cee-41c4-8e32-eae6624e6376", "32ed7e7d-2982-4e62-9a97-86b284c30c7c", "d023bd02-947d-4982-832c-363ea87705c3", "646a7789-e121-49cc-be94-77bb2c6e60c6", "097057cd-ff5c-42f7-9c53-a42be87e92a3", "40e1c169-7d51-46d9-9f5f-ccc5913d0797", "be5e8613-0d16-4b02-b719-d8622548e631", "d55b7ea5-cdb3-4329-90b7-56c499ad9c4d", "f2b6cd62-41db-400e-b55b-40dafd6627e5", "8f23b26a-821d-4c8b-9b36-444c99eda683", "6abe3f27-2007-4214-a94f-09392a00419e", "aa6cae09-622a-4c68-882f-4a2986e6e76b", "11eafe58-27fd-4faf-b909-ade3bc0a8755", "cfb090fe-1bd1-4adb-ab6d-acc3b10be4d1"], "metadata": {"window": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.   First of all, I would say that we \u2013 I wouldn\u2019t say that \u2013 remember there\u2019s a consideration.   We said \nwe don\u2019t see it necessarily as a limitation.  \n \n  But clearly once we understand the flows of the cash over the 18 year period we\u2019re going to have to take that into \nconsideration in all of our capital deployment pieces.  \n \n ", "original_text": " \nPage 17 of 22 \n \nMike Kaufmann :  Yes.  ", "page_label": "17", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "770a5d83-40ea-4568-b8ae-c0a9bc61f9c4": {"node_ids": ["7774d7f9-d4ae-4f8d-a777-477f4d0d9132", "f3bc6a48-101d-4db9-8e59-5ffa9ac7aaea", "fdf871bd-3afe-4b6f-a066-8344a846bb5a", "782dd7ab-8a16-44c1-94a2-e3a3c6795ed8", "d624812e-18a5-4a02-9e02-e2fbbc60d9b4", "40b6cc09-934a-462e-a424-eed0bc7e7f15", "06f7e4c5-237a-48d6-bfc8-d4eac5e39b4a", "f6f1f507-f1cd-4a71-92dc-605f10604d61", "cd95685a-880e-418d-ae23-752e9d3edec9", "67ffef54-0e07-4b38-8a44-5a7fccfb6c89", "512f83fe-0191-44d4-b367-c9fb4729d0e0", "3a7785c4-135c-46df-9a75-c0e83006b65c", "28078d6b-a2f2-47b5-acbf-65683859a17d", "1a637dc0-4abd-4ef5-abcb-cd0223385a9e", "c3d4c6ac-f16d-4236-a83a-9c73df0012de", "2fdf1548-0296-4272-9937-f68783487426", "375b54c5-08ed-42a2-9318-264a655db803", "765d0509-5c00-4d7f-90a3-7d6c05c1e5f9", "8450ef67-c432-46f7-84a1-1f7bd8ed4f70", "f5401a1a-d916-499e-88b4-638a3546eeae", "97e655b2-3e90-44b5-929b-98971769c548", "2791ad2f-1049-433e-afaa-0bdd442c78ab", "a82b6d8c-9898-4af0-bccf-00e418120f64", "30eb2648-3f6e-4a75-b904-678857038704", "1d927ba6-a372-4cef-b648-2aaedd659e08", "bc37b18c-d69d-419c-8c6d-fe024d81907c"], "metadata": {"window": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n Mike Kaufmann :  Next question.  \n \n Operator :  Thank you.   Thank you.  ", "original_text": " \nPage 18 of 22 \n \n But I wouldn\u2019t say we expect anything, you know, materially different year -over-year without providing a finer point \nto it in terms of giving you any specific guidance.  \n \n", "page_label": "18", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "c8dbda70-76e8-4883-857e-5a79d45705b2": {"node_ids": ["871d5f0c-4bd6-441c-99c6-94527a6c5457", "68b21a74-869b-4ae5-8cf4-1a59fb5fd985", "ac2d93da-82db-44f8-ae8d-91c714f2192f", "e16c2fec-2b49-439c-8c89-62c70081b5b5", "7887eed6-4b10-4f58-95c0-0ca32ff89332", "dd0c7442-6fe9-47b1-bf85-e330e9a599d5", "073e984e-7a16-45b1-b77f-e367cbe0dd3d", "9175580d-c96f-4e16-8401-67eed8e050d8", "d3526242-993b-4e5f-867c-5dbe0b4d696b", "09956537-c95e-4e16-8b3e-fa1c975e8de4", "dce83d00-6059-496b-9d1f-88e92e927573", "010eb556-bcd8-49d1-acd0-b663fb2608ff", "b6cec0e1-ec2f-4952-afe1-044a6d06ef13", "b614e4be-0ca3-49eb-8e67-09bc434d0686", "438e3852-9f4a-4a9e-81a0-4d28382d2f3f", "13d671f9-e5fa-4ee3-9230-61d27ee9c698", "159f271f-016b-427d-a31d-d0827bbf8a3f", "2fa3fc1a-6a7d-4245-98c5-0a1e8d6b5ac3", "0216dbe6-ad6e-436e-bf1c-a9f277163add", "72b74c30-aa55-48dc-a1b0-5842e768cda5", "d5aa8cda-0082-4f52-bb10-45f198361adb", "48e666fe-03a0-4064-98e9-32dd5414bb5b", "bd97adbe-4ebc-4ba4-8d95-44e0f2e5ad65", "7209d633-68c1-4d38-851a-383694da7154", "302a9883-7627-40b6-9ccd-83ca4bad4a4d", "e21f178d-ba41-4362-bec0-9c627e80266b"], "metadata": {"window": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.   You know we\u2019re all kind of scratching our heads \nabout how to treat this settlement.  \n \n  But if this is going to, you know, if it\u2019s an 18 year settlement and it\u2019s just an annual cash outlay, why would that be \nadded back to adjusted earnings?   I mea n it\u2019s not something like amortization, it\u2019s noncash or it\u2019s not a one year, \none-time?  ", "original_text": " \nPage 19 of 22 \n \n \nJohn Ransom :  Okay and just switching gears, a philosophical question.  ", "page_label": "19", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "75b7060c-dc7d-4eae-80b4-75c7c41845b6": {"node_ids": ["40d73317-d6b2-4086-b079-461e19906f34", "20173cba-abee-4146-a4aa-9668a686eb54", "952dce95-3d44-439e-b9f5-eaddfd1373c7", "5694d8c8-cb69-4c67-be9b-cd31c8f52c35", "ff7c0d70-d304-4dc2-8d53-d17c3a53ac30", "c092c063-f606-45e1-b1d6-4ce9911d78ca", "d1710972-d74c-4ff1-ba2c-025747f22447", "a52851b9-3e7d-482a-a301-216df11c6744", "a4a6e976-887f-47ae-8752-89d1456ae07f", "4b6eafd5-eb1e-44b9-9d17-aa5d4cf71527", "705d6b24-92fa-4f60-bf27-f76dde3da774", "2006df42-ed71-4e46-8b60-9dcdb0b1b54f", "72765fed-930d-42e2-8d43-5c2789a24b53", "82567661-b2c9-4918-b9d0-3f84c8a904b2", "a45b802b-e69f-42f5-ac0b-28e3ac63d084", "7ba79424-2511-460e-8c7f-0033dcc8695f", "e2aa03cd-2764-4844-9118-aedfbf1066b7", "66dc3618-b2a8-4390-910d-a00ba0798ca5", "4c367544-ec85-4844-adbd-2885360c40c9", "e6bd754f-131f-47f3-a34b-1635f2a62514", "d3a8788a-c751-4c93-918a-ee3c20a42b94", "9a6649e6-966c-48a7-a7a3-6131ad24f1bc", "a467e49c-1d56-4bb8-906e-9c43e05ac260", "51aede0d-d132-45b2-a211-e635fef12c3b", "4ffad0f1-e4f0-49f2-8463-4555eca40840", "b0eef8ec-067c-4bc0-8d59-21d84f74ae1d", "eddfeae3-1256-48d3-9a78-aaed13d39d81", "9a9b16aa-c3df-41f1-96a0-a13ba187c6d4", "ff526ecb-d9eb-4d20-b492-d00f58277269", "836a3c25-a45a-42d4-8739-df5a2f124c8a", "b4fd83dc-3d9f-46f1-a6d2-b14f41f4fac8", "eb0df3c6-3846-4200-b7bb-3369e522295e", "23ab27d8-dbe2-491e-8846-671fe152e83f"], "metadata": {"window": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.   So there won\u2019t be anything to add back.  \n \n Mike Kaufmann:  Next question.  \n \n Operator :  Thank you.  ", "original_text": " \nPage 20 of 22 \n \n But that\u2019s separate from, you know, really it\u2019s just won\u2019t really be in the equation in terms of a GAAP versus non -\nGAAP adjustment because it won\u2019t be a charge in future P&Ls.  ", "page_label": "20", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "6011d214-9584-4479-94e7-01904bd5e931": {"node_ids": ["7b36d8f4-0dff-4232-918b-a1bc2b520ee1", "ab18bf8f-6843-4a87-9efb-3a546370ca8d", "d9a153cc-339b-4485-b705-874faf97b3b6", "f298d199-a863-4eab-9207-778261ef9c1d", "05d636af-f453-465c-b558-67fc97ab2b16", "7a7ba65f-1469-4890-b12c-93c7af09c3d3", "0916aa33-75bb-4859-ad95-ad4e1b0d1bab", "08dca213-c882-46a3-9ae8-f0bc388c94a1", "d639f79e-fff9-46f5-b2b4-0906a5f30072", "bbc3549a-063a-4daf-a6e2-f28ec1bba8d8", "2568b6bc-483a-498d-9097-bec593f33d54", "77d658cf-1ce0-4945-a4c9-f7bfb8cba34b", "818929db-9188-4048-9060-667f53e702c4", "987d8d6b-c77c-4b1d-934e-bfc6d40e2bba", "da05fc83-0262-4702-b2d4-98a4a97bd0fd", "d4766f10-bae8-4c56-b22e-35aa8642fead", "d71516e3-2772-4167-a95a-058fc5eeb6c4", "3f379839-fa72-470c-b622-a7a8959d3d65", "11decd58-dd47-4c29-87ac-209480594513", "22239507-aeeb-4183-9dcc-10c4a606103c", "107516bf-dfb3-49c0-a2be-07e38109110d", "c27c0ef2-ad91-44d6-a426-c73bd872e140", "0f008cfe-5d81-4336-bf09-553bd1b9e32d", "0549446e-5f1d-4dd8-b86b-f63fc79c6194", "f0cbd69e-218c-4fdc-949a-09705318e38a", "b3ffba10-5d79-4e7b-a8ce-3288ea658980", "8d897223-61c4-4252-8dd4-afa42b5b0d9b", "1589309f-da8a-49db-b605-841d70de1422", "5018f4dc-a3cf-4148-a349-ce57f18513d8", "10422c86-3a4e-43dd-95fe-dee2804c8ed9"], "metadata": {"window": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n Dave Evans :  Yes. \n \n Eric Coldwell :  Yes. \n \n Dave Evans :  Yes.  ", "original_text": " \nPage 21 of 22 \n \nEric Coldwell :  Yes ((inaudible)) pointed that out yesterday.  \n \n", "page_label": "21", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}, "29bc8ec3-1dba-44a6-bf7d-ea1974f16173": {"node_ids": ["00ca753f-4462-4ec4-a182-9f7b50853ffe", "985adcd8-be24-4cb6-9568-cb1fb260d748", "afe64738-2f7e-4bd2-b7b5-e93b8b199ea1", "4a716bb6-6297-4419-b0d3-63a5db610401", "12c03ddd-d23e-4551-a66e-6ebc03776f73", "7f2aa4bb-3932-454f-a60b-0f0cb022109e", "85926430-8dc8-4341-9233-7fd38c8f59d0", "d6480018-caa8-454d-be55-75dee2297ec8", "28495663-ca6b-4084-a9f2-e25920e21c3a", "317662e7-a6aa-4d06-9255-c35362ed3bc1", "ea45079f-5525-4580-836a-3dacaa005dd6", "1563aab8-c8e3-4b19-a5ed-feb3a409ff5f", "32151a96-bb44-4b49-9185-1e34efab6a0d"], "metadata": {"window": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n  And so this restructuring was highly defined by a lot of detailed work.   We started to \u2013 we put it in place in our Q1 \nas far as incentives go, changing the jobs, interviewing folks for roles both internally and deciding that in some \nroles we needed to go externally for the right level of talent the way we  want to work.  \n \n  And we would expect that that entire restructuring would be done and behind us by the end of our Q3 and that we \nwould start to see benefits from that next year and FY \u201921.  \n \n ", "original_text": " \nPage 22 of 22 \n \n So we did a lot of work out talking to and understanding the way our customer base would like us to come to them \nand how they would like to be serviced.  \n \n ", "page_label": "22", "file_name": "CAH-Q1-FY20-ECT.pdf", "file_path": "pdfs\\CAH-Q1-FY20-ECT.pdf", "file_type": "application/pdf", "file_size": 227626, "creation_date": "2024-07-16", "last_modified_date": "2024-07-16"}}}}